FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU de Jesus, JG
   Graf, T
   Giovanetti, M
   Mares-Guia, MA
   Xavier, J
   Maia, ML
   Fonseca, V
   Fabri, A
   dos Santos, RF
   Pereira, FM
   Santos, LFO
   da Silva, LRD
   Maia, ZPG
   Cerqueira, JXG
   Theze, J
   Abade, L
   Cordeiro, MDS
   Torquato, SSC
   Santana, EB
   Silva, NSD
   Dourado, RSO
   Alves, AB
   Guedes, AD
   da Silva, PM
   Faria, NR
   de Albuquerque, CFC
   de Abreu, AL
   Romano, APM
   Croda, J
   Said, RFD
   Cunha, GM
   Cerqueira, JMD
   de Mello, ALES
   de Filippis, AMB
   Alcantara, LC
AF de Jesus, Jaqueline Goes
   Graf, Tiago
   Giovanetti, Marta
   Mares-Guia, Maria Angelica
   Xavier, Joilson
   Maia, Maricelia Lima
   Fonseca, Vagner
   Fabri, Allison
   dos Santos, Roberto Fonseca
   Pereira, Felicidade Mota
   Oliveira Santos, Leandro Ferraz
   de Oliveira da Silva, Luciana Reboredo
   Gusmao Maia, Zuinara Pereira
   Gomes Cerqueira, Jananci Xavier
   Theze, Julien
   Abade, Leandro
   Santana Cordeiro, Mirza de Carvalho
   Cerqueira Torquato, Sintia Sacramento
   Santana, Eloisa Bahia
   de Jesus Silva, Neuza Santos
   Oiticica Dourado, Rosemary Sarmento
   Alves, Ademilson Bras
   Guedes, Adeilde do Socorro
   da Silva Filho, Pedro Macedo
   Faria, Nuno Rodrigues
   Campelo de Albuquerque, Carlos F.
   de Abreu, Andre Luiz
   Martins Romano, Alessandro Pecego
   Croda, Julio
   do Carmo Said, Rodrigo Fabiano
   Cunha, Gabriel Muricy
   da Fonseca Cerqueira, Jeane Magnavita
   de Mello, Arabela Leal e Silva
   Bispo de Filippis, Ana Maria
   Alcantara, Luiz Carlos Junior
TI Yellow fever transmission in non-human primates, Bahia, Northeastern
   Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID EPIDEMIOLOGY; MODEL
AB Author summary Between 2016 and 2018, Brazil witnessed the largest YFV outbreak since years, with 2.154 cases and 745 deaths. Here we report the introduction of the virus in the state of Bahia suggesting two independent introductions from Minas Gerais and Espirito Santo. We also highlight the actions taken by epidemiological surveillance division that may have prevent human infections.
   Yellow fever virus (YFV) causes a clinical syndrome of acute hemorrhagic hepatitis. YFV transmission involves non-human primates (NHP), mosquitoes and humans. By late 2016, Brazil experienced the largest YFV outbreak of the last 100 years, with 2050 human confirmed cases, with 681 cases ending in death and 764 confirmed epizootic cases in NHP. Among affected areas, Bahia state in Northeastern was the only region with no autochthonous human cases. By using next generation sequence approach, we investigated the molecular epidemiology of YFV in NHP in Bahia and discuss what factors might have prevented human cases. We investigated 47 YFV positive tissue samples from NHP cases to generate 8 novel YFV genomes. ML phylogenetic tree reconstructions and automated subtyping tools placed the newly generated genomes within the South American genotype I (SA I). Our analysis revealed that the YFV genomes from Bahia formed two distinct well-supported phylogenetic clusters that emerged most likely of an introduction from Minas Gerais and Espirito Santo states. Vegetation coverage analysis performed shows predominantly low to medium vegetation coverage in Bahia state. Together, our findings support the hypothesis of two independent YFV SA-I introductions. We also highlighted the effectiveness of the actions taken by epidemiological surveillance team of the state to prevented human cases.
C1 [de Jesus, Jaqueline Goes; Graf, Tiago] Fundacao Oswaldo Cruz, Lab Patol Expt, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [de Jesus, Jaqueline Goes] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Parasitol Med, Sao Paulo, SP, Brazil.
   [Giovanetti, Marta; Mares-Guia, Maria Angelica; Fabri, Allison; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Xavier, Joilson; Fonseca, Vagner; Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
   [Maia, Maricelia Lima] Univ Estadual Feira de Santana, Feira De Santana, BA, Brazil.
   [Maia, Maricelia Lima; Santana Cordeiro, Mirza de Carvalho; Cerqueira Torquato, Sintia Sacramento; Santana, Eloisa Bahia; de Jesus Silva, Neuza Santos; Oiticica Dourado, Rosemary Sarmento] Minist Saude, Secretaria Saude Feira de Santana, Feira De Santana, BA, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, ZA-4001 Durban, South Africa.
   [dos Santos, Roberto Fonseca; Pereira, Felicidade Mota; Oliveira Santos, Leandro Ferraz; de Oliveira da Silva, Luciana Reboredo; de Mello, Arabela Leal e Silva] Lab Cent Saude Publ Bahia Prof Goncalo Moniz LACE, Salvador, BA, Brazil.
   [Gusmao Maia, Zuinara Pereira] Fac Maria Milza FAMAM, Mangabeira, BA, Brazil.
   [Gomes Cerqueira, Jananci Xavier; Alves, Ademilson Bras; Guedes, Adeilde do Socorro; da Silva Filho, Pedro Macedo; Cunha, Gabriel Muricy; da Fonseca Cerqueira, Jeane Magnavita] Secretaria Saude Estado Bahia, Vigilancia Epidemiol Estado Bahia, Salvador, BA, Brazil.
   [Theze, Julien; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Abade, Leandro] Univ Oxford, Nuffield Dept Med, Global Hlth Network, Oxford, England.
   [Campelo de Albuquerque, Carlos F.] Org Panamer Saude, Org Mundial Saude, Brasilia, DF, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, CGLAB SVS MS Brasilia, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Martins Romano, Alessandro Pecego; do Carmo Said, Rodrigo Fabiano] Coordenacao Geral Vigilancia Arboviroses CGARB, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Campo Grande, MS, Brazil.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
EM luiz.alcantara@ioc.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Graf, Tiago/S-8535-2019; Maia,
   Zuinara/M-7713-2019
OI Faria, Nuno R/0000-0001-8839-2798; Graf, Tiago/0000-0003-4921-7975;
   Fonseca, Vagner/0000-0001-5521-6448; Xavier, Joilson/0000-0003-3916-2018
FU CNPq/MCTI [440685/2016-8]; DECIT/SCTIE/MoH [440685/2016-8]; CAPESCAPES
   [88887.130716/2016-00]
FX This work was supported by CNPq/MCTI and DECIT/SCTIE/MoH
   (440685/2016-8), CAPES (88887.130716/2016-00). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2019, B EP MON FEBR AM BRA
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EP EM EP FEBR AM B, V48
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2019, B EP MON CAS ARB URB, V50
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47, P7
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EP MON PER SAZ FEB
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude. Diretoria de Vigilancia Epidemiologica. Superintendencia de Vigilancia em Saude, 2019, B EP FEBR AM
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Chen C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006738
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Huang YJS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-60
   Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Mares-Guia MAMD, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3966-x
   Mondet B, 1996, B SOC PATHOL EXOT, V89, P155
   Mondet B, 2001, B SOC PATHOL EXOT, V94, P260
   Possas C, 2019, INTELLECTUAL PROPERT
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Sanna A, 2018, EURO SURVEILLANCE B, V23
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Simon LV, 2019, STATPEARLS
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   WHO, 2017, GLOB STRAT EL YELL F
   World Health Organization, 2019, EM PREP RESP YELL FE
NR 35
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2020
VL 14
IS 8
AR e0008405
DI 10.1371/journal.pntd.0008405
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA NC9JH
UT WOS:000561526200001
PM 32780745
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Hill, SC
   de Souza, R
   Theze, J
   Claro, I
   Aguiar, RS
   Abade, L
   Santos, FCP
   Cunha, MS
   Nogueira, JS
   Salles, FCS
   Rocco, IM
   Maeda, AY
   Vasami, FGS
   du Plessis, L
   Silveira, PP
   de Jesus, JG
   Quick, J
   Fernandes, NCCA
   Guerra, JM
   Ressio, RA
   Giovanetti, M
   Alcantara, LCJ
   Cirqueira, CS
   Diaz-Delgado, J
   Macedo, FLL
   Timenetsky, MDST
   de Paula, R
   Spinola, R
   de Deus, JT
   Mucci, LF
   Tubaki, RM
   de Menezes, RMT
   Ramos, PL
   de Abreu, AL
   Cruz, LN
   Loman, N
   Dellicour, S
   Pybus, OG
   Sabino, EC
   Faria, NR
AF Hill, Sarah C.
   de Souza, Renato
   Theze, Julien
   Claro, Ingra
   Aguiar, Renato S.
   Abade, Leandro
   Santos, Fabiana C. P.
   Cunha, Mariana S.
   Nogueira, Juliana S.
   Salles, Flavia C. S.
   Rocco, Iray M.
   Maeda, Adriana Y.
   Vasami, Fernanda G. S.
   du Plessis, Louis
   Silveira, Paola P.
   de Jesus, Jaqueline G.
   Quick, Joshua
   Fernandes, Natalia C. C. A.
   Guerra, Juliana M.
   Ressio, Rodrigo A.
   Giovanetti, Marta
   Alcantara, Luiz C. J.
   Cirqueira, Cinthya S.
   Diaz-Delgado, Josue
   Macedo, Fernando L. L.
   Timenetsky, Maria do Carmo S. T.
   de Paula, Regiane
   Spinola, Roberta
   de Deus, Juliana Telles
   Mucci, Luis F.
   Tubaki, Rosa Maria
   de Menezes, Regiane M. T.
   Ramos, Patricia L.
   de Abreu, Andre L.
   Cruz, Laura N.
   Loman, Nick
   Dellicour, Simon
   Pybus, Oliver G.
   Sabino, Ester C.
   Faria, Nuno R.
TI Genomic Surveillance of Yellow Fever Virus Epizootic in Sao Paulo,
   Brazil, 2016-2018
SO PLOS PATHOGENS
LA English
DT Article
ID REAL-TIME; STATE; PERFORMANCE; ALIGNMENT; DYNAMICS; EBOLA
AB Sao Paulo, a densely inhabited state in southeast Brazil that contains the fourth most populated city in the world, recently experienced its largest yellow fever virus (YFV) outbreak in decades. YFV does not normally circulate extensively in Sao Paulo, so most people were unvaccinated when the outbreak began. Surveillance in non-human primates (NHPs) is important for determining the magnitude and geographic extent of an epizootic, thereby helping to evaluate the risk of YFV spill over to humans. Data from infected NHPs can give more accurate insights into YFV spread than when using data from human cases alone. To contextualise human cases, identify epizootic foci and uncover the rate and direction of YFV spread in Sao Paulo, we generated and analysed virus genomic data and epizootic case data from NHP in Sao Paulo. We report the occurrence of three spatiotemporally distinct phases of the outbreak in Sao Paulo prior to February 2018. We generated 51 new virus genomes from YFV positive cases identified in 23 different municipalities in Sao Paulo, mostly sampled from NHPs between October 2016 and January 2018. Although we observe substantial heterogeneity in lineage dispersal velocities between phylogenetic branches, continuous phylogeographic analyses of generated YFV genomes suggest that YFV lineages spread in Sao Paulo at a mean rate of approximately 1km per day during all phases of the outbreak. Viral lineages from the first epizootic phase in northern Sao Paulo subsequently dispersed towards the south of the state to cause the second and third epizootic phases there. This alters our understanding of how YFV was introduced into the densely populated south of Sao Paulo state. Our results shed light on the sylvatic transmission of YFV in highly fragmented forested regions in Sao Paulo state and highlight the importance of continued surveillance of zoonotic pathogens in sentinel species.
C1 [Hill, Sarah C.; Theze, Julien; Abade, Leandro; du Plessis, Louis; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [Hill, Sarah C.; Pybus, Oliver G.] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hawkshead, England.
   [de Souza, Renato; Santos, Fabiana C. P.; Cunha, Mariana S.; Nogueira, Juliana S.; Rocco, Iray M.; Maeda, Adriana Y.; Vasami, Fernanda G. S.; Fernandes, Natalia C. C. A.; Guerra, Juliana M.; Ressio, Rodrigo A.; Cirqueira, Cinthya S.; Diaz-Delgado, Josue; Macedo, Fernando L. L.; Timenetsky, Maria do Carmo S. T.; Cruz, Laura N.] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Theze, Julien] Univ Clermont Auvergne, INRAE, VetAgro Sup, UMR EPIA, St Genes Champanelle, France.
   [Claro, Ingra; Salles, Flavia C. S.; de Jesus, Jaqueline G.; Sabino, Ester C.] Inst Med Trop, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.
   [Claro, Ingra; Salles, Flavia C. S.; de Jesus, Jaqueline G.; Sabino, Ester C.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Aguiar, Renato S.; Silveira, Paola P.] Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Quick, Joshua; Loman, Nick] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [de Paula, Regiane; Spinola, Roberta] Ctr Vigilancia Epidemiol Prof Alexandre Vranjac, Sao Paulo, Brazil.
   [de Deus, Juliana Telles; Mucci, Luis F.; Tubaki, Rosa Maria; de Menezes, Regiane M. T.] Superintendencia Controle Endemias Estado Sao Paul, Sao Paulo, Brazil.
   [Ramos, Patricia L.] Fundacao Parque Zool Sao Paulo, Sao Paulo, Brazil.
   [de Abreu, Andre L.] Minist Saude SVS MS, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, CP160-12 50, Brussels, Belgium.
   [Dellicour, Simon] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.
RP Hill, SC; Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Hill, SC (corresponding author), Royal Vet Coll, Dept Pathobiol & Populat Sci, Hawkshead, England.; Sabino, EC (corresponding author), Inst Med Trop, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.; Sabino, EC (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.
EM sarah.hill@zoo.ox.ac.uk; sabinoec@gmail.com; nuno.faria@zoo.ox.ac.uk
RI Dellicour, Simon/AAE-9054-2020; Guerra, Juliana Mariotti/H-5310-2012;
   Faria, Nuno R/I-2975-2012; Fernandes, Natalia/H-4537-2012
OI Dellicour, Simon/0000-0001-9558-1052; Guerra, Juliana
   Mariotti/0000-0002-0326-7187; Faria, Nuno R/0000-0001-8839-2798;
   Fernandes, Natalia/0000-0003-4754-4200; da Silva Sales, Flavia
   Cristina/0000-0002-9048-0030
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); Medical Research Council CADDE partnership
   award [MR/S0195/1, FAPESP 18/14389-0]; Wellcome TrustWellcome Trust;
   Royal Society Sir Henry Dale Fellowship [204311/Z/16/Z]; internal HEFCE
   GCRF grant [005073]; John Fell Research Fund [005166]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2]; Oxford Martin School; Fonds National de
   la Recherche Scientifique (FNRS, Belgium)Fonds de la Recherche
   Scientifique - FNRS; Fonds Wetenschappelijk Onderzoek (FWO, Belgium)FWO;
   CNPq/MCTI Decit/SCTIE/MoH [440685/2016-8]; CAPESCAPES
   [88887.130716/2016-00]; Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro - FAPERJCarlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ)
FX NRF, ECS, OGP, SCH, NL and RdS were supported through a Sao Paulo
   Research Foundation (FAPESP) and Medical Research Council CADDE
   partnership award (MR/S0195/1 and FAPESP 18/14389-0)
   (http://caddecentre.org/).NRF and SCH were supported by a Wellcome Trust
   and Royal Society Sir Henry Dale Fellowship awarded to NRF (grant
   204311/Z/16/Z). The research was supported by an internal HEFCE GCRF
   grant 005073 and John Fell Research Fund Grant 005166, awarded to NRF.
   ECS was supported by grants CNPq #400354/2016-0 and FAPESP#2016/01735-2.
   OGP, NRF and LdP were supported by the Oxford Martin School. SD is
   supported by the Fonds National de la Recherche Scientifique (FNRS,
   Belgium) and was previously funded by the Fonds Wetenschappelijk
   Onderzoek (FWO, Belgium). LCJA was supported by CNPq/MCTI
   Decit/SCTIE/MoH (440685/2016-8) and CAPES (88887.130716/2016-00). MG was
   supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro -
   FAPERJ. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2008, BEPA, V5, P12
   Arruda DM, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1456-6
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Centro de Vigilancia Epidemiologica, 2019, B EP FEBR AM 18 11 2
   Centro de Vigilancia Epidemiologica, 2019, B EP FEBR AM 21 01 2
   Centro de Vigilancia Epidemiologica, 2019, B EP FEBR AM 02 01 2
   Culot L, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2525
   Cunha MS, 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189
   DELATORRE C, 2018, FRONT MICROBIOL, V10, P42744, DOI DOI 10.3389/FMICB.2019.00010
   Dellicour S, 2017, MOL BIOL EVOL, V34, P2563, DOI 10.1093/molbev/msx176
   Dellicour S, 2016, BIOINFORMATICS, V32, P3204, DOI 10.1093/bioinformatics/btw384
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Instituto Brasileiro de Geografia e Estatistica, 2019, MUN NETW
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Silva NIO, 2020, VIROL J, V17, DOI 10.1186/s12985-019-1277-7
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   QGIS Development Team, 2018, QGIS GEOGR INF SYST
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Saad LD, 2016, EPIDEMIOL SERV SAUDE, V25, P531, DOI [10.5123/s1679-49742016000300009, 10.5123/S1679-49742016000300009]
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Souza Renato Pereira de, 2011, Rev. Inst. Med. trop. S. Paulo, V53, P133, DOI 10.1590/S0036-46652011000300004
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Vainio J, 1998, YELLOW FEVER
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2003, T ROY SOC TROP MED H, V97, P60, DOI 10.1016/S0035-9203(03)90023-X
   WHO, YELL FEV BRAZ
NR 43
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD AUG
PY 2020
VL 16
IS 8
AR e1008699
DI 10.1371/journal.ppat.1008699
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA NB9AT
UT WOS:000560808000002
PM 32764827
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Deng, XD
   Gu, W
   Federman, S
   Du Plessis, L
   Pybus, OG
   Faria, NR
   Wang, C
   Yu, GX
   Bushnell, B
   Pan, CY
   Guevara, H
   Sotomayor-Gonzalez, A
   Zorn, K
   Gopez, A
   Servellita, V
   Hsu, E
   Miller, S
   Bedford, T
   Greninger, AL
   Roychoudhury, P
   Starita, LM
   Famulare, M
   Chu, HY
   Shendure, J
   Jerome, KR
   Anderson, C
   Gangavarapu, K
   Zeller, M
   Spencer, E
   Andersen, KG
   MacCannell, D
   Paden, CR
   Li, Y
   Zhang, J
   Tong, SX
   Armstrong, G
   Morrow, S
   Willis, M
   Matyas, BT
   Mase, S
   Kasirye, O
   Park, M
   Masinde, G
   Chan, C
   Yu, AT
   Chai, SJ
   Villarino, E
   Bonin, B
   Wadford, DA
   Chiu, CY
AF Deng, Xianding
   Gu, Wei
   Federman, Scot
   Du Plessis, Louis
   Pybus, Oliver G.
   Faria, Nuno R.
   Wang, Candace
   Yu, Guixia
   Bushnell, Brian
   Pan, Chao-Yang
   Guevara, Hugo
   Sotomayor-Gonzalez, Alicia
   Zorn, Kelsey
   Gopez, Allan
   Servellita, Venice
   Hsu, Elaine
   Miller, Steve
   Bedford, Trevor
   Greninger, Alexander L.
   Roychoudhury, Pavitra
   Starita, Lea M.
   Famulare, Michael
   Chu, Helen Y.
   Shendure, Jay
   Jerome, Keith R.
   Anderson, Catie
   Gangavarapu, Karthik
   Zeller, Mark
   Spencer, Emily
   Andersen, Kristian G.
   MacCannell, Duncan
   Paden, Clinton R.
   Li, Yan
   Zhang, Jing
   Tong, Suxiang
   Armstrong, Gregory
   Morrow, Scott
   Willis, Matthew
   Matyas, Bela T.
   Mase, Sundari
   Kasirye, Olivia
   Park, Maggie
   Masinde, Godfred
   Chan, Curtis
   Yu, Alexander T.
   Chai, Shua J.
   Villarino, Elsa
   Bonin, Brandon
   Wadford, Debra A.
   Chiu, Charles Y.
TI Genomic surveillance reveals multiple introductions of SARS-CoV-2 into
   Northern California
SO SCIENCE
LA English
DT Article
ID ZIKA VIRUS; TRANSMISSION
AB The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, with >365,000 cases in California as of 17 July 2020. We investigated the genomic epidemiology of SARS-CoV-2 in Northern California from late January tomid-March 2020, using samples from 36 patients spanning nine counties and the Grand Princess cruise ship. Phylogenetic analyses revealed the cryptic introduction of at least seven different SARS-CoV-2 lineages into California, including epidemic WA1 strains associated with Washington state, with lack of a predominant lineage and limited transmission among communities. Lineages associated with outbreak clusters in two counties were defined by a single base substitution in the viral genome. These findings support contact tracing, social distancing, and travel restrictions to contain the spread of SARS-CoV-2 in California and other states.
C1 [Deng, Xianding; Gu, Wei; Federman, Scot; Wang, Candace; Yu, Guixia; Sotomayor-Gonzalez, Alicia; Gopez, Allan; Servellita, Venice; Hsu, Elaine; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Deng, Xianding; Gu, Wei; Federman, Scot; Wang, Candace; Yu, Guixia; Sotomayor-Gonzalez, Alicia; Chiu, Charles Y.] Univ Calif San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.
   [Du Plessis, Louis; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [Pybus, Oliver G.] Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England.
   [Faria, Nuno R.] Imperial Coll London, J IDEA, MRC Ctr Global Infect Dis Anal, London, England.
   [Bushnell, Brian] Lawrence Berkeley Natl Lab, Berkeley, CA USA.
   [Pan, Chao-Yang; Guevara, Hugo; Yu, Alexander T.; Chai, Shua J.; Wadford, Debra A.] Calif Dept Publ Hlth, Richmond, CA USA.
   [Zorn, Kelsey] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA.
   [Bedford, Trevor; Greninger, Alexander L.; Roychoudhury, Pavitra; Jerome, Keith R.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   [Bedford, Trevor; Starita, Lea M.; Chu, Helen Y.; Shendure, Jay] Brotman Baty Inst Precis Med, Seattle, WA USA.
   [Greninger, Alexander L.; Roychoudhury, Pavitra; Shendure, Jay; Jerome, Keith R.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
   [Starita, Lea M.; Matyas, Bela T.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Famulare, Michael] Inst Dis Modelling, Bellevue, WA USA.
   [Chu, Helen Y.] Univ Washington, Dept Med, Seattle, WA USA.
   [Shendure, Jay] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.
   [Anderson, Catie; Gangavarapu, Karthik; Zeller, Mark; Spencer, Emily; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [MacCannell, Duncan; Paden, Clinton R.; Li, Yan; Zhang, Jing; Tong, Suxiang; Armstrong, Gregory; Chai, Shua J.] US Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Morrow, Scott] San Mateo Cty Dept Publ Hlth, San Mateo, CA USA.
   [Willis, Matthew] Marin Cty Div Publ Hlth, San Rafael, CA USA.
   Solano Cty Dept Publ Hlth, Fairfield, CA USA.
   [Mase, Sundari] Sonoma Cty Dept Publ Hlth, Santa Rosa, CA USA.
   [Kasirye, Olivia] Sacramento Cty Div Publ Hlth, Sacramento, CA USA.
   [Park, Maggie] San Joaquin Cty Dept Publ Hlth, Stockton, CA USA.
   [Masinde, Godfred; Chan, Curtis] San Francisco Cty Dept Publ Hlth, San Francisco, CA USA.
   [Villarino, Elsa; Bonin, Brandon] Cty Santa Clara, Dept Publ Hlth, Santa Clara, CA USA.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.
EM charles.chiu@ucsf.edu
RI Deng, Wayne Xianding/AAV-1109-2020; Pybus, Oliver G/B-2640-2012; Faria,
   Nuno R/I-2975-2012; du Plessis, Louis/K-1667-2013
OI Deng, Wayne Xianding/0000-0001-7648-4652; Pybus, Oliver
   G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798; du Plessis,
   Louis/0000-0003-0352-6289; Federman, Scot/0000-0001-8712-3131;
   Servellita, Venice/0000-0002-1745-4012; Wang,
   Candace/0000-0002-4678-7860
FU NIH from the National Institute of Allergy and Infectious DiseasesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R33-AI129455]; NIH from the National Cancer Institute
   [K08-CA230156]; California Initiative to Advance Precision Medicine;
   Charles and Helen Schwab Foundation; Burroughs-Wellcome CAMS Award;
   Oxford Martin School; European Research Council of the European
   Commission [614725]; Wellcome TrustWellcome Trust [204311/Z/16/Z]; Royal
   SocietyRoyal Society of London [204311/Z/16/Z]; Medical Research
   Council-Sao Paulo Research Foundation [MR/S0195/1, FAPESP 18/14389-0]
FX Supported by NIH grants R33-AI129455 (C.Y.C.) from the National
   Institute of Allergy and Infectious Diseases and K08-CA230156 (W.G.)
   from the National Cancer Institute, the California Initiative to Advance
   Precision Medicine (C.Y.C.), the Charles and Helen Schwab Foundation
   (C.Y.C.), the Burroughs-Wellcome CAMS Award (W.G.), the Oxford Martin
   School and the European Research Council under the Seventh Framework
   Program of the European Commission (Pathogen Phylodynamics grant 614725)
   (O.G.P. and L.d.P.), Wellcome Trust and Royal Society (204311/Z/16/Z),
   and Medical Research Council-Sao Paulo Research Foundation (MR/S0195/1,
   FAPESP 18/14389-0).
CR Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Bedford T., 2020, 20051417 MEDRXIV
   Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109
   Brufsky A., 2020, J MED VIROL
   Brufsky A, 2020, J MED VIROL, V92, P1386, DOI 10.1002/jmv.25902
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Centers for Disease Control and Prevention, 2020, CDC 2019 NOV COR 201
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7
   Deng XD, 2020, NAT MICROBIOL, V5, P443, DOI 10.1038/s41564-019-0637-9
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gonzalez-Reiche AS, 2020, SCIENCE, V369, P297, DOI 10.1126/science.abc1917
   GonzalezReiche A. S., 2020, SCIENCE, V368
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gu W., 2020, CLIN INFECT DIS
   Gu Wei, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa599
   Gu W, 2019, ANNU REV PATHOL-MECH, V14, P319, DOI 10.1146/annurev-pathmechdis-012418-012751
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hill V., 2020, PHYLODYNAMIC ANAL SA
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Klompas M, 2020, ANN INTERN MED, V172, P619, DOI 10.7326/M20-0751
   Li RY, 2020, SCIENCE, V368, P489, DOI 10.1126/science.abb3221
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Maurano M. T., 2020, 2006493 MEDRXIV
   Maurano M. T., 2020, 20064931 MEDRXIV
   Miller S, 2019, GENOME RES, V29, P831, DOI 10.1101/gr.238170.118
   Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3
   Otani A., 2020, WALL STREET J
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013
   YANG ZB, 1994, J MOL EVOL, V39, P105
NR 42
TC 4
Z9 4
U1 2
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 31
PY 2020
VL 369
IS 6503
BP 582
EP +
DI 10.1126/science.abb9263
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MV7YK
UT WOS:000556568100050
PM 32513865
OA Other Gold, Green Published
DA 2020-09-29
ER

PT J
AU de Souza, WM
   Buss, LF
   Candido, DD
   Carrera, JP
   Li, S
   Zarebski, AE
   Pereira, RHM
   Prete, CA
   de Souza-Santos, AA
   Parag, KV
   Belotti, MCTD
   Vincenti-Gonzalez, MF
   Messina, J
   Sales, FCD
   Andrade, PD
   Nascimento, VH
   Ghilardi, F
   Abade, L
   Gutierrez, B
   Kraemer, MUG
   Braga, CKV
   Aguiar, RS
   Alexander, N
   Mayaud, P
   Brady, OJ
   Marcilio, I
   Gouveia, N
   Li, GD
   Tami, A
   de Oliveira, SB
   Porto, VBG
   Ganem, F
   de Almeida, WAF
   Fantinato, FFST
   Macario, EM
   de Oliveira, WK
   Nogueira, ML
   Pybus, OG
   Wu, CH
   Croda, J
   Sabino, EC
   Faria, NR
AF de Souza, William Marciel
   Buss, Lewis Fletcher
   Candido, Darlan da Silva
   Carrera, Jean-Paul
   Li, Sabrina
   Zarebski, Alexander E.
   Pereira, Rafael Henrique Moraes
   Prete, Carlos A., Jr.
   de Souza-Santos, Andreza Aruska
   Parag, Kris V.
   Belotti, Maria Carolina T. D.
   Vincenti-Gonzalez, Maria F.
   Messina, Janey
   da Silva Sales, Flavia Cristina
   Andrade, Pamela dos Santos
   Nascimento, Vitor Heloiz
   Ghilardi, Fabio
   Abade, Leandro
   Gutierrez, Bernardo
   Kraemer, Moritz U. G.
   Braga, Carlos K. V.
   Aguiar, Renato Santana
   Alexander, Neal
   Mayaud, Philippe
   Brady, Oliver J.
   Marcilio, Izabel
   Gouveia, Nelson
   Li, Guangdi
   Tami, Adriana
   de Oliveira, Silvano Barbosa
   Porto, Victor Bertollo Gomes
   Ganem, Fabiana
   de Almeida, Walquiria Aparecida Ferreira
   Fantinato, Francieli Fontana Sutile Tardetti
   Macario, Eduardo Marques
   de Oliveira, Wanderson Kleber
   Nogueira, Mauricio L.
   Pybus, Oliver G.
   Wu, Chieh-Hsi
   Croda, Julio
   Sabino, Ester C.
   Faria, Nuno Rodrigues
TI Epidemiological and clinical characteristics of the COVID-19 epidemic in
   Brazil
SO NATURE HUMAN BEHAVIOUR
LA English
DT Article
AB Brazil has one of the fastest-growing COVID-19 epidemics in the world. De Souza et al. report epidemiological, demographic and clinical findings for COVID-19 cases in the country during the first 3 months of the epidemic.
   The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and contextualize epidemiological, demographic and clinical findings for COVID-19 cases during the first 3 months of the epidemic. By 31 May 2020, 514,200 COVID-19 cases, including 29,314 deaths, had been reported in 75.3% (4,196 of 5,570) of municipalities across all five administrative regions of Brazil. TheR(0)value for Brazil was estimated at 3.1 (95% Bayesian credible interval = 2.4-5.5), with a higher median but overlapping credible intervals compared with some other seriously affected countries. A positive association between higher per-capita income and COVID-19 diagnosis was identified. Furthermore, the severe acute respiratory infection cases with unknown aetiology were associated with lower per-capita income. Co-circulation of six respiratory viruses was detected but at very low levels. These findings provide a comprehensive description of the ongoing COVID-19 epidemic in Brazil and may help to guide subsequent measures to control virus transmission.
C1 [de Souza, William Marciel] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, Brazil.
   [Buss, Lewis Fletcher; Candido, Darlan da Silva; da Silva Sales, Flavia Cristina; Andrade, Pamela dos Santos; Ghilardi, Fabio; Sabino, Ester C.; Faria, Nuno Rodrigues] Univ Sao Paulo, Fac Med, Inst Med Trop, Sao Paulo, Brazil.
   [Candido, Darlan da Silva; Carrera, Jean-Paul; Zarebski, Alexander E.; Abade, Leandro; Gutierrez, Bernardo; Kraemer, Moritz U. G.; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Carrera, Jean-Paul] Gorgas Mem Inst Hlth Studies, Dept Res Virol & Biotechnol, Panama City, Panama.
   [Li, Sabrina; Messina, Janey] Univ Oxford, Sch Geog & Environm, Oxford, England.
   [Pereira, Rafael Henrique Moraes; Braga, Carlos K. V.] Inst Appl Econom Res, IPEA, Brasilia, DF, Brazil.
   [Prete, Carlos A., Jr.; Belotti, Maria Carolina T. D.; Nascimento, Vitor Heloiz] Univ Sao Paulo, Escola Politecn, Sao Paulo, Brazil.
   [de Souza-Santos, Andreza Aruska] Univ Oxford, Latin Amer Ctr, Brazilian Studies Programme, Oxford, England.
   [Parag, Kris V.; Faria, Nuno Rodrigues] Imperial Coll London, MRC Centre Global Infect Dis Anal, IDEA, London, England.
   [Vincenti-Gonzalez, Maria F.; Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands.
   [Messina, Janey] Univ Oxford, Oxford Sch Global & Area Studies, Oxford, England.
   [Gutierrez, Bernardo] Univ San Francisco Quito USFQ, Sch Biol & Environm Sci, Quito, Ecuador.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Aguiar, Renato Santana; Brady, Oliver J.] Univ Fed Minas Gerais, Dept Genet Ecol & Evolucao, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Alexander, Neal] Univ Fed Minas Gerais, Dept Infect Dis Epidemiol, MRC Tropical Epidemiol, Fac Epidemiol & Population Hlth,London Sch Hyg &, London, England.
   [Mayaud, Philippe] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Clin Res, London, England.
   [Brady, Oliver J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Dept Infect Dis Epidemiol, London, England.
   [Marcilio, Izabel] Univ Sao Paulo, Nucleo Vigilancia Epidmiol Hosp Clin, Fac Med, Sao Paulo, Brazil.
   [Gouveia, Nelson] Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, Brazil.
   [Li, Guangdi] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Fac Med, Changsha, Peoples R China.
   [de Oliveira, Silvano Barbosa; Porto, Victor Bertollo Gomes; Ganem, Fabiana; de Almeida, Walquiria Aparecida Ferreira; Fantinato, Francieli Fontana Sutile Tardetti] Brazilian Minist Hlth, Dept Immunizat & Communicable Dis, Secretariat Hlth Surveillance, Brasilia, Brazil.
   [Macario, Eduardo Marques; de Oliveira, Wanderson Kleber; Croda, Julio] Brazilian Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Nogueira, Mauricio L.] Fac Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Wu, Chieh-Hsi] Univ Southampton, Math Sci, Southampton, England.
   [Croda, Julio] Fundacao Univ Fed Grande Dourados, Lab Pesquisa Ciencias Saude, Dourados, Brazil.
   [Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
   [Croda, Julio] Yale Univ, Yale Sch Publ Hlth, Dept Epidmiol Microbial Dis, New Haven, CT USA.
RP Faria, NR (corresponding author), Univ Sao Paulo, Fac Med, Inst Med Trop, Sao Paulo, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Faria, NR (corresponding author), Imperial Coll London, MRC Centre Global Infect Dis Anal, IDEA, London, England.; Croda, J (corresponding author), Brazilian Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.; Croda, J (corresponding author), Fundacao Univ Fed Grande Dourados, Lab Pesquisa Ciencias Saude, Dourados, Brazil.; Croda, J (corresponding author), Fundacao Oswaldo Cruz, Campo Grande, Brazil.; Croda, J (corresponding author), Yale Univ, Yale Sch Publ Hlth, Dept Epidmiol Microbial Dis, New Haven, CT USA.
EM juliocroda@gmail.com; nfaria@ic.ac.uk
RI Nascimento, Vitor H/E-8194-2012; Faria, Nuno R/I-2975-2012; Li,
   Guangdi/AAU-6951-2020; Pybus, Oliver G/B-2640-2012; Souza,
   William/D-3044-2017
OI Nascimento, Vitor H/0000-0002-0543-4735; Faria, Nuno
   R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667; Tami,
   Adriana/0000-0002-1918-9144; Souza, William/0000-0002-0025-8293;
   Zarebski, Alexander/0000-0003-1824-7653; Parag, Kris
   Varun/0000-0002-7806-3605; Prete Junior, Carlos
   Augusto/0000-0002-3907-423X
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2018/12579-7, 2018/14389-0]; Medical Research CouncilMedical Research
   Council UK (MRC); CADDE [MR/S0195/1]; Sao Paulo Research Foundation,
   Brazil [2017/13981-0, 2019/24251-9]; Wellcome TrustWellcome Trust
   [206471/Z/17/Z]; Royal SocietyRoyal Society of London [204311/Z/16/Z];
   Oxford Martin School
FX We thank M. Gome, L. Bastos and L. M. Carvalho (MAVE) for useful
   discussions on SIVEP-Gripe, and we thank L. Matkin (Oxford) for
   technical support. This work was supported by a FAPESP (2018/14389-0)
   and Medical Research Council and CADDE partnership award (MR/S0195/1)
   (http://caddecentre.org/).W.M.S.is supported by the Sao Paulo Research
   Foundation, Brazil (2017/13981-0 and 2019/24251-9). N.R.F. is supported
   by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship
   (204311/Z/16/Z). O.J.B. was funded by a Sir Henry Wellcome Fellowship
   funded by the Wellcome Trust (206471/Z/17/Z). V.H.N. and C.A.P. were
   supported by FAPESP (2018/12579-7). A.E.Z. and B.G. were supported by
   Oxford Martin School. The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR Andrus Jon Kim, 2020, Am J Trop Med Hyg, V103, P593, DOI 10.4269/ajtmh.20-0571
   [Anonymous], 2015, PESQ NAC SAUD 2013 P
   [Anonymous], 2020, INFL UPD
   [Anonymous], 2020, COR COVID 19 DIR DIA
   [Anonymous], 2020, COVID 19 COD ICD 10
   Asner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099392
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Black A, 2020, NAT MED, V26, P832, DOI 10.1038/s41591-020-0935-z
   Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021
   Burki T, 2020, LANCET INFECT DIS, V20, P547, DOI 10.1016/S1473-3099(20)30303-0
   Caicedo-Ochoa Y, 2020, INT J INFECT DIS, V95, P316, DOI 10.1016/j.ijid.2020.04.069
   Candido DD, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa042
   Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161
   Cimerman S, 2020, BRAZ J INFECT DIS, V24, P93, DOI 10.1016/j.bjid.2020.04.005
   Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3
   Croda Julio, 2020, Rev Soc Bras Med Trop, V53, pe20200167, DOI 10.1590/0037-8682-0167-2020
   Cuadrado-Payan E, 2020, LANCET, V395, pE84, DOI 10.1016/S0140-6736(20)31052-7
   de Jesus JG, 2020, REV INST MED TROP SP, V62, DOI [10.1590/s1678-9946202062030, 10.1590/S1678-9946202062030]
   De Oliveira S. B, 2020, MONITORING SOCIAL DI, DOI [10.1101/2020.04.30.20082172, DOI 10.1101/2020.04.30.20082172]
   Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789
   Deng XD, 2020, SCIENCE, V369, P582, DOI 10.1126/science.abb9263
   Ezequiel GarciaElorrio, 2020, Int J Qual Health Care, DOI 10.1093/intqhc/mzaa062
   Ferguson N, 2020, REPORT 9 IMPACT NONP
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Khalatbari-Soltani S, 2020, J EPIDEMIOL COMMUN H, V74, P620, DOI 10.1136/jech-2020-214297
   Kim D, 2020, JAMA-J AM MED ASSOC, V323, P2085, DOI 10.1001/jama.2020.6266
   Korber B, 2020, SPIKE MUTATION PIPEL, DOI [10.1101/2020.04.29.069054, DOI 10.1101/2020.04.29.069054]
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Medel Carlos Hernandez, 2008, International Journal of Navigation and Observation, DOI 10.1155/2008/178927
   Mellan T. A, 2020, REPORT 21 ESTIMATING, DOI [10.1101/2020.05.09.20096701, DOI 10.1101/2020.05.09.20096701]
   Miller MJ, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008265
   Munayco CV, 2020, INFECT DIS MODEL, V5, P338, DOI 10.1016/j.idm.2020.05.001
   Nouvellet P., 2020, REPORT 26 REDUCTION
   Park SY, 2020, EMERG INFECT DIS, V26, P1666, DOI 10.3201/eid2608.201274
   Pereira R. H, 2020, 14 IPEA DIR EST POL
   Rivett L, 2020, ELIFE, V9, DOI 10.7554/eLife.58728
   Croda JHR, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/S1679-49742020000100021, 10.5123/s1679-49742020000100021]
   Silveira M., 2020, REPEATED POPULATION, DOI [10.1101/2020.05.01.20087205, DOI 10.1101/2020.05.01.20087205]
   Sy Karla Therese L, 2020, medRxiv, DOI 10.1101/2020.05.28.20115949
   Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035
   Wolfel R, 2020, NATURE, DOI 10.1038/s41586-020-2196-x
   World Health Organization, 2020, COR DIS COVID 2019 S
   Wu XJ, 2020, EMERG INFECT DIS, V26, P1324, DOI 10.3201/eid2606.200299
   Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726
   Zheng X, 2020, J INFECTION, V81, pE128, DOI 10.1016/j.jinf.2020.05.041
NR 51
TC 2
Z9 2
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 2397-3374
J9 NAT HUM BEHAV
JI Nat. Hum. Behav.
PD AUG
PY 2020
VL 4
IS 8
BP 856
EP +
DI 10.1038/s41562-020-0928-4
EA JUL 2020
PG 21
WC Psychology, Biological; Multidisciplinary Sciences; Neurosciences;
   Psychology, Experimental
SC Psychology; Science & Technology - Other Topics; Neurosciences &
   Neurology
GA NA5SE
UT WOS:000555068900001
PM 32737472
OA Bronze
DA 2020-09-29
ER

PT J
AU Mavian, C
   Pond, SK
   Marini, S
   Magalis, BR
   Vandamme, AM
   Dellicour, S
   Scarpino, SV
   Houldcroft, C
   Villabona-Arenas, J
   Paisie, TK
   Trovao, NS
   Boucher, C
   Zhang, Y
   Scheuermann, RH
   Gascuel, O
   Lam, TTY
   Suchard, MA
   Abecasis, A
   Wilkinson, E
   de Oliveira, TD
   Bento, AI
   Schmidt, HA
   Martin, D
   Hadfield, J
   Faria, N
   Grubaugh, ND
   Neher, RA
   Baele, G
   Lemey, P
   Stadler, T
   Albert, J
   Crandall, KA
   Leitner, T
   Stamatakis, A
   Prosperi, M
   Salemi, M
AF Mavian, Carla
   Pond, Sergei Kosakovsky
   Marini, Simone
   Magalis, Brittany Rife
   Vandamme, Anne-Mieke
   Dellicour, Simon
   Scarpino, Samuel V.
   Houldcroft, Charlotte
   Villabona-Arenas, Julian
   Paisie, Taylor K.
   Trovao, Nidia S.
   Boucher, Christina
   Zhang, Yun
   Scheuermann, Richard H.
   Gascuel, Olivier
   Lam, Tommy Tsan-Yuk
   Suchard, Marc A.
   Abecasis, Ana
   Wilkinson, Eduan
   de Oliveira, Tulio
   Bento, Ana I.
   Schmidt, Heiko A.
   Martin, Darren
   Hadfield, James
   Faria, Nuno
   Grubaugh, Nathan D.
   Neher, Richard A.
   Baele, Guy
   Lemey, Philippe
   Stadler, Tanja
   Albert, Jan
   Crandall, Keith A.
   Leitner, Thomas
   Stamatakis, Alexandros
   Prosperi, Mattia
   Salemi, Marco
TI Sampling bias and incorrect rooting make phylogenetic network tracing of
   SARS-COV-2 infections unreliable
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Letter
C1 [Mavian, Carla; Marini, Simone; Magalis, Brittany Rife; Paisie, Taylor K.; Prosperi, Mattia; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32609 USA.
   [Mavian, Carla; Magalis, Brittany Rife; Paisie, Taylor K.; Salemi, Marco] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.
   [Pond, Sergei Kosakovsky] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA.
   [Marini, Simone; Prosperi, Mattia] Univ Florida, Dept Epidmiol, Gainesville, FL 32610 USA.
   [Vandamme, Anne-Mieke; Dellicour, Simon; Baele, Guy; Lemey, Philippe] Katholieke Univ Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium.
   [Vandamme, Anne-Mieke; Abecasis, Ana] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Global Hlth & Trop Med, P-1349008 Lisbon, Portugal.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidmiol Lab, B-1050 Brussels, Belgium.
   [Scarpino, Samuel V.] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA.
   [Houldcroft, Charlotte] Univ Cambridge, Dept Med, Cambridge CB2 3QG, England.
   [Villabona-Arenas, Julian] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1E 7HT, England.
   [Villabona-Arenas, Julian] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
   [Trovao, Nidia S.] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Boucher, Christina] Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL 32611 USA.
   [Zhang, Yun; Scheuermann, Richard H.] Craig Venter Inst, Dept Informat, La Jolla, CA 92037 USA.
   [Scheuermann, Richard H.] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.
   [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.
   [Gascuel, Olivier] CNRS, USR 3756, Ctr Bioinformat Biostat & Biol Integrat C3BI, Unite Bioinformat Evolut, F-75015 Paris, France.
   [Gascuel, Olivier] Inst Pasteur, F-75015 Paris, France.
   [Lam, Tommy Tsan-Yuk] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Wilkinson, Eduan; de Oliveira, Tulio] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform, ZA-4041 Durban, South Africa.
   [Bento, Ana I.] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA.
   [Schmidt, Heiko A.] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna CIBIV, Max F Perutz Labs, A-1030 Vienna, Austria.
   [Martin, Darren] Univ Cape Town, Dept Integrat Biomed Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.
   [Hadfield, James] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Faria, Nuno] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Neher, Richard A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Stadler, Tanja] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
   [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.
   [Crandall, Keith A.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Biostat & Bioinformat, Computat Biol Inst, Washington, DC 20052 USA.
   [Leitner, Thomas] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA.
   [Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Computat Mol Evolut Grp, D-69118 Heidelberg, Germany.
   [Stamatakis, Alexandros] Karlsruhe Inst Technol, Inst Theoret Informat, D-76131 Karlsruhe, Germany.
RP Mavian, C; Prosperi, M; Salemi, M (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32609 USA.; Mavian, C; Salemi, M (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.; Prosperi, M (corresponding author), Univ Florida, Dept Epidmiol, Gainesville, FL 32610 USA.
EM cmavian@ufl.edu; m.prosperi@ufl.edu; salemi@pathology.ufl.edu
RI Houldcroft, Charlotte/L-2497-2019; Dellicour, Simon/AAE-9054-2020;
   Faria, Nuno R/I-2975-2012
OI Houldcroft, Charlotte/0000-0002-1833-5285; Dellicour,
   Simon/0000-0001-9558-1052; Faria, Nuno R/0000-0001-8839-2798; Sequeira
   Trovao, Nidia/0000-0002-2106-1166; Paisie, Taylor/0000-0002-6024-2744;
   Schmidt, Heiko/0000-0002-2311-8592; Zhang, Yun/0000-0002-1180-275X
FU NSF Division of Environmental Biology Award [2028221]; NIH National
   Institute of Allergy and Infectious Diseases Award [1R21AI138815-01]
FX We are grateful to Paul Sharp, Andrew Rambaut, and Nicola De Maio for
   their insightful suggestions and critical reading of our manuscript.
   C.M., B.R.M., M.P., and M.S. were, in part, supported by NSF Division of
   Environmental Biology Award 2028221 and NIH National Institute of
   Allergy and Infectious Diseases Award 1R21AI138815-01. The contents of
   this article are solely the responsibility of the authors and do not
   necessarily represent the official views of the National Institutes of
   Health.
CR Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117
   Frost SDW, 2015, EPIDEMICS-NETH, V10, P88, DOI 10.1016/j.epidem.2014.09.001
   Grubaugh ND, 2020, NAT MICROBIOL, DOI 10.1038/s41564-020-0690-4
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1
   Mavian C., 2020, SNAPSHOT SARS COV 2, DOI 10.1101/ 2020.04.01.020594
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Weaver S., 2020, STATE GISAID COVID 1
NR 9
TC 4
Z9 4
U1 1
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 9
PY 2020
VL 117
IS 23
BP 12522
EP 12523
DI 10.1073/pnas.2007295117
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MG3QD
UT WOS:000545947700008
PM 32381734
OA Other Gold, Green Published
DA 2020-09-29
ER

PT J
AU Lu, J
   du Plessis, L
   Liu, Z
   Hill, V
   Kang, M
   Lin, HF
   Sun, JF
   Francois, S
   Kraemer, MUG
   Faria, NR
   McCrone, JT
   Peng, JJ
   Xiong, QL
   Yuan, RY
   Zeng, LL
   Zhou, PP
   Liang, CM
   Yi, LN
   Liu, J
   Xiao, JP
   Hu, JX
   Liu, T
   Ma, WJ
   Li, W
   Su, J
   Zheng, HY
   Peng, B
   Fang, SS
   Su, WZ
   Li, KB
   Sun, RL
   Bai, R
   Tang, X
   Liang, MF
   Quick, J
   Song, T
   Rambaut, A
   Loman, N
   Raghwani, J
   Pybus, OG
   Ke, CW
AF Lu, Jing
   du Plessis, Louis
   Liu, Zhe
   Hill, Verity
   Kang, Min
   Lin, Huifang
   Sun, Jiufeng
   Francois, Sarah
   Kraemer, Moritz U. G.
   Faria, Nuno R.
   McCrone, John T.
   Peng, Jinju
   Xiong, Qianling
   Yuan, Runyu
   Zeng, Lilian
   Zhou, Pingping
   Liang, Chumin
   Yi, Lina
   Liu, Jun
   Xiao, Jianpeng
   Hu, Jianxiong
   Liu, Tao
   Ma, Wenjun
   Li, Wei
   Su, Juan
   Zheng, Huanying
   Peng, Bo
   Fang, Shisong
   Su, Wenzhe
   Li, Kuibiao
   Sun, Ruilin
   Bai, Ru
   Tang, Xi
   Liang, Minfeng
   Quick, Josh
   Song, Tie
   Rambaut, Andrew
   Loman, Nick
   Raghwani, Jayna
   Pybus, Oliver G.
   Ke, Changwen
TI Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China
SO CELL
LA English
DT Article
ID READ ALIGNMENT; PERFORMANCE; VIRUS; ZIKA
AB Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 infection and was first reported in central China in December 2019. Extensive molecular surveillance in Guangdong, China's most populous province, during early 2020 resulted in 1,388 reported RNA-positive cases from 1.6 million tests. In order to understand the molecular epidemiology and genetic diversity of SARS-CoV-2 in China, we generated 53 genomes from infected individuals in Guangdong using a combination of metagenomic sequencing and tiling amplicon approaches. Combined epidemiological and phylogenetic analyses indicate multiple independent introductions to Guangdong, although phylogenetic clustering is uncertain because of low virus genetic variation early in the pandemic. Our results illustrate how the timing, size, and duration of putative local transmission chains were constrained by national travel restrictions and by the province's large-scale intensive surveillance and intervention measures. Despite these successes, COVID-19 surveillance in Guangdong is still required, because the number of cases imported from other countries has increased.
C1 [Lu, Jing; Liu, Zhe; Lin, Huifang; Sun, Jiufeng; Peng, Jinju; Xiong, Qianling; Yuan, Runyu; Zeng, Lilian; Zhou, Pingping; Liang, Chumin; Yi, Lina; Xiao, Jianpeng; Hu, Jianxiong; Liu, Tao; Ma, Wenjun] Guangdong Prov Inst Publ Hlth, Guangzhou 511430, Peoples R China.
   [Lu, Jing; Liu, Zhe; Kang, Min; Lin, Huifang; Sun, Jiufeng; Peng, Jinju; Xiong, Qianling; Yuan, Runyu; Zeng, Lilian; Zhou, Pingping; Liang, Chumin; Yi, Lina; Liu, Jun; Xiao, Jianpeng; Liu, Tao; Ma, Wenjun; Li, Wei; Su, Juan; Zheng, Huanying; Song, Tie; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Peoples R China.
   [du Plessis, Louis; Francois, Sarah; Kraemer, Moritz U. G.; Faria, Nuno R.; Raghwani, Jayna; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
   [Hill, Verity; McCrone, John T.; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH8 9YL, Midlothian, Scotland.
   [Peng, Bo; Fang, Shisong] Shenzhen Ctr Dis Control & Prevent, Shenzhen 518055, Peoples R China.
   [Su, Wenzhe; Li, Kuibiao] Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Peoples R China.
   [Sun, Ruilin; Bai, Ru] Guangdong Prov Second Peoples Hosp, Guangzhou 510320, Peoples R China.
   [Tang, Xi; Liang, Minfeng] Foshan First Peoples Hosp, Foshan 528000, Peoples R China.
   [Quick, Josh; Loman, Nick] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
RP Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Peoples R China.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
EM oliver.pybus@zoo.ox.ac.uk; kecw1965@aliyun.com
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Francois, Sarah/0000-0002-1138-8800; Hill, Verity/0000-0002-3509-8146
FU Guangdong Provincial Novel Coronavirus Scientific and Technological
   Project [2020111107001]; Science and Technology Planning Project of
   Guangdong [2018B020207006]; Key Research and Development Program of
   Guangdong Province [2019B111103001]; Oxford Martin School; Biotechnology
   and Biological Sciences Research Council (BBSRC)Biotechnology and
   Biological Sciences Research Council (BBSRC) [BB/M010996/1]; Wellcome
   TrustWellcome Trust; Royal Society Sir Henry Dale Fellowship
   [204311/Z/16/Z]; Medical Research CouncilMedical Research Council UK
   (MRC); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [MR/S0195/1]; UK Research and Innovation Future Leaders
   Fellowship; European Research CouncilEuropean Research Council (ERC)
   [725422-ReservoirDOCS]; Wellcome Trust ARTIC network [206298/Z/17/Z]
FX LWe gratefully acknowledge the efforts of local CDCs, hospitals, and the
   thirdparty detection institutions in epidemiological investigations,
   sample collection, and detection. We would like to thank all the authors
   who have kindly deposited and shared genome data on GISAID. A table with
   genome sequence acknowledgments can be found in Table S1.4. This work
   was supported by grants from Guangdong Provincial Novel Coronavirus
   Scientific and Technological Project (2020111107001), Science and
   Technology Planning Project of Guangdong (2018B020207006), and the Key
   Research and Development Program of Guangdong Province (2019B111103001).
   O.G.P., M.U.G.K., and L.d.P. were supported by the Oxford Martin School.
   V.H. is supported by the Biotechnology and Biological Sciences Research
   Council (BBSRC) (BB/M010996/1). N.R.F. acknowledges funding from a
   Wellcome Trust and Royal Society Sir Henry Dale Fellowship
   (204311/Z/16/Z) and from a Medical Research Council and FAPESP award
   (MR/S0195/1). J.Q. is funded by a UK Research and Innovation Future
   Leaders Fellowship. A.R. is supported by the European Research Council
   (725422-ReservoirDOCS). This work was supported by the Wellcome Trust
   ARTIC network (Collaborators Award206298/Z/17/Z).
CR Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Flightradar24, 2020, AIR TRAFF CHIN BUS A
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Itokawa K., 2020, BIORXIV, DOI [10.1101/2020.03.10.985150, DOI 10.1101/2020.03.10.985150]
   Kang M, 2020, EVIDENCE CHARACTERIS, DOI [10.1101/2020.02.03.20019141, DOI 10.1101/2020.02.03.20019141]
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Ladner JT, 2019, NAT MED, V25, P206, DOI 10.1038/s41591-019-0345-2
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Quick J., 2020, ARTIC NCOV2019 PRIME
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A., 2020, PHYLODYNAMIC ANAL 17
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   World Health Organization, 2020, COR DIS COVID 2019 S
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 31
TC 13
Z9 13
U1 5
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 28
PY 2020
VL 181
IS 5
BP 997
EP +
DI 10.1016/j.cell.2020.04.023
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LT9QF
UT WOS:000537399500008
PM 32359424
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Kraemer, MUG
   Yang, CH
   Gutierrez, B
   Wu, CH
   Klein, B
   Pigott, DM
   du Plessis, L
   Faria, NR
   Li, RR
   Hanage, WP
   Brownstein, JS
   Layan, M
   Vespignani, A
   Tian, HY
   Dye, C
   Pybus, OG
   Scarpino, SV
AF Kraemer, Moritz U. G.
   Yang, Chia-Hung
   Gutierrez, Bernardo
   Wu, Chieh-Hsi
   Klein, Brennan
   Pigott, David M.
   du Plessis, Louis
   Faria, Nuno R.
   Li, Ruoran
   Hanage, William P.
   Brownstein, John S.
   Layan, Maylis
   Vespignani, Alessandro
   Tian, Huaiyu
   Dye, Christopher
   Pybus, Oliver G.
   Scarpino, Samuel V.
CA Open COVID-19 Data Working Grp
TI The effect of human mobility and control measures on the COVID-19
   epidemic in China
SO SCIENCE
LA English
DT Article
ID REGRESSION-MODELS; DISEASE; WUHAN
AB The ongoing coronavirus disease 2019 (COVID-19) outbreak expanded rapidly Throughout China. Major behavioral, clinical, and state interventions were undertaken to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide. It remains unclear how these unprecedented interventions, including travel restrictions, affected COVID-19 spread in China. We used real-time mobility data from Wuhan and detailed case data including travel history to elucidate the role of case importation in transmission in cities across China and to ascertain the impact of control measures. Early on, the spatial distribution of COVID-19 cases in China was explained well by human mobility data. After the implementation of control measures, this correlation dropped and growth rates became negative in most locations, although shifts in the demographics of reported cases were still indicative of local chains of transmission outside of Wuhan. This study shows that the drastic control measures implemented in China substantially mitigated the spread of COVID-19.
C1 [Kraemer, Moritz U. G.; Gutierrez, Bernardo; du Plessis, Louis; Faria, Nuno R.; Dye, Christopher; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, Moritz U. G.; Brownstein, John S.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.; Brownstein, John S.] Boston Childrens Hosp, Boston, MA 02115 USA.
   [Yang, Chia-Hung; Klein, Brennan; Vespignani, Alessandro; Scarpino, Samuel V.] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA.
   [Gutierrez, Bernardo] Univ San Francisco Quito USFQ, Sch Biol & Environm Sci, Quito, Ecuador.
   [Wu, Chieh-Hsi] Univ Southampton, Math Sci, Southampton, Hants, England.
   [Pigott, David M.] Univ Washington, Dept Hlth Metr, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Li, Ruoran; Hanage, William P.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Layan, Maylis] CNRS, Inst Pasteur, UMR2000, Math Modelling Infect Dis Unit, Paris, France.
   [Layan, Maylis] Sorbonne Univ, Paris, France.
   [Vespignani, Alessandro] ISI Fdn, Turin, Italy.
   [Tian, Huaiyu] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.
   [Pybus, Oliver G.] Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England.
RP Kraemer, MUG; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Kraemer, MUG (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.; Scarpino, SV (corresponding author), Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA.; Pybus, OG (corresponding author), Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England.
EM moritz.kraemer@zoo.ox.ac.uk; oliver.pybus@zoo.ox.ac.uk;
   s.scarpino@northeastern.edu
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012; Wang,
   Lin/B-4145-2013; du Plessis, Louis/K-1667-2013
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Wang, Lin/0000-0002-5371-2138; Gutierrez, Bernardo/0000-0002-9220-2739;
   Klein, Brennan/0000-0001-8326-5044; Pigott, David/0000-0002-6731-4034;
   du Plessis, Louis/0000-0003-0352-6289; Wu,
   Chieh-Hsi/0000-0001-9386-725X; Vespignani,
   Alessandro/0000-0003-3419-4205
FU Oxford Martin School; Branco Weiss Fellowship; Universities of Academic
   Excellence Scholarship Program of the Secretariat for Higher Education,
   Science, Technology, and Innovation of the Republic of Ecuador
   [ARSEQ-BEC-003163-2017]; Sir Henry Dale Fellowship; National Institute
   of General Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U54GM088558]
FX H.T., O.G.P., and M.U.G.K. acknowledge support from the Oxford Martin
   School. M.U.G.K. is supported by a Branco Weiss Fellowship. B.G. is
   supported by a Universities of Academic Excellence Scholarship Program
   of the Secretariat for Higher Education, Science, Technology, and
   Innovation of the Republic of Ecuador (grant no. ARSEQ-BEC-003163-2017).
   N.R.F. is supported by a Sir Henry Dale Fellowship. W.P.H. is supported
   by the National Institute of General Medical Sciences (grant no.
   U54GM088558). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Ai S, 2020, POPULATION MOVEMENT, DOI [10.1101/2020.02.04.20020339, DOI 10.1101/2020.02.04.20020339]
   Aurora Big Data, 2017, MOB MAP APP RES REP
   Backer J.A., 2020, EUROSURVEILLANCE, V25, P20, DOI DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9
   Du ZW, 2020, EMERG INFECT DIS, V26, P1049, DOI 10.3201/eid2605.200146
   Du ZQ, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4855-9
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Goldstein E, 2017, EPIDEMIOLOGY, V28, P136, DOI 10.1097/EDE.0000000000000571
   Hastie TJ, 1992, STAT MODELS S, P195
   Heinzl H, 2003, COMPUT STAT DATA AN, V44, P253, DOI 10.1016/S0167-9473(03)00062-8
   Jin G, 2020, IMPACT TRAFFIC ISOLA, DOI [10.1101/2020.02.04.20020438, DOI 10.1101/2020.02.04.20020438, 10.1101/2020.02.04.20020438.]
   Keeling MJ, 2004, ECOLOGY GENETICS EVO, P415, DOI [10.1016/B978-012323448-3/50019-2, DOI 10.1016/13978-017371448-3/50019-7]
   Kraemer M. U. G., 2020, ZENODO, DOI [10.5281/zenodo.3714914., DOI 10.5281/ZENODO.3714914]
   Kraemer M. U. G., 2020, ZENODO, DOI [10.5281/zenodo.3714914., DOI 10.5281/ZENODO.3714914.]
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Li Q., 2020, N ENGL J MED NEJMOA2, V2001316, DOI [10.1056/NEJMoa2001316 Medline, DOI 10.1056/NEJMOA2001316MEDLINE]
   Li R., 2020, SUBSTANTIAL UNDOCUME, DOI DOI 10.1101/2020.02.14.20023127.
   Li R., 2020, SCIENCE, DOI [10.1126/science.aba9757, DOI 10.1126/SCIENCE.ABA9757]
   McDonald J., 2014, HDB BIOL STAT
   McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018
   Ramshaw RE, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0330-0
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Ripley B, 2019, R PACKAGE VERSION, V7, P3
   Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500
   Surveillances V., 2020, ZHONGHUA LIU XING BI, V2, P113, DOI DOI 10.3760/CMA.J.ISSN.0254-6450.2020.02.003
   Tian H, 2020, IMPACT TRANSMISSION
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   Tuite AR, 2020, ANN INTERN MED
   Tuite AR, 2020, ANN INTERN MED, V172, P567, DOI 10.7326/M20-0358
   Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102
   WHO, 2020, REP WHO CHIN JOINT M
   World Health Organization, 2020, 27 WHO
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Wu Z., 2019, JAMA-J AM MED ASSOC, V2020, P17
   Wu Z., 2019, JAMA-J AM MED ASSOC, V2020, P17
   Xu B, 2020, LANCET INFECT DIS, V3099, P30119, DOI DOI 10.1016/S1473-3099(20)30119-5
   Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0
   Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08
   Zhao S, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa022
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 46
TC 98
Z9 98
U1 79
U2 79
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAY 1
PY 2020
VL 368
IS 6490
BP 493
EP +
DI 10.1126/science.abb4218
PG 35
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LK9KT
UT WOS:000531178400041
PM 32213647
OA Green Published
DA 2020-09-29
ER

PT J
AU Cunha, MS
   Faria, NR
   Caleiro, GS
   Candido, DS
   Hill, SC
   Claro, IM
   da Costa, AC
   Nogueira, JS
   Maeda, AY
   da Silva, FG
   de Souza, RP
   Spinola, R
   Tubaki, RM
   de Menezes, RMT
   Abade, L
   Mucci, LF
   Timenetsky, MDST
   Sabino, E
AF Cunha, Mariana Sequetin
   Faria, Nuno Rodrigues
   Caleiro, Giovana Santos
   Candido, Darlan Silva
   Hill, Sarah C.
   Claro, Ingra Morales
   da Costa, Antonio Charlys
   Nogueira, Juliana Silva
   Maeda, Adriana Yurika
   da Silva, Fernanda Gisele
   de Souza, Renato Pereira
   Spinola, Roberta
   Tubaki, Rosa Maria
   Tironi de Menezes, Regiane Maria
   Abade, Leandro
   Mucci, Luis Filipe
   Sampaio Tavares Timenetsky, Maria do Carmo
   Sabino, Esther
TI Genomic evidence of yellow fever virus in Aedes scapularis, southeastern
   Brazil, 2016
SO ACTA TROPICA
LA English
DT Article
DE Yellow fever virus; Surveillance; Brazil; Aedes
ID SAO-PAULO; CULICIDAE; STATE
AB The southeastern region of Brazil has recently experienced the largest yellow fever disease outbreak in decades. Since July 2016 epizootic events were reported in Sao Paulo state's north region, where 787 Culicidae were captured as part of public health surveillance efforts and tested using real-time quantitative PCR. One Aedes scapularis pool collected in November 2016 in an agriculture area in Urupes city tested positive for YFV-RNA. Using a validated multiplex PCR approach we were able to recover a complete virus genome sequence from this pool. Phylogenetic analysis of the novel strain and publicly available data indicates that the belongs to the South American genotype 1 clade circulating in Sao Paulo state and is basal to the recent outbreak clade in southeast Brazil. Our findings highlight the need of additional studies, including vector competence studies, to disentangle the role of Aedes scapularis in yellow fever transmission in the Americas.
C1 [Cunha, Mariana Sequetin; Caleiro, Giovana Santos; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva, Fernanda Gisele; de Souza, Renato Pereira; Sampaio Tavares Timenetsky, Maria do Carmo] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Faria, Nuno Rodrigues; Candido, Darlan Silva; Hill, Sarah C.; Abade, Leandro] Univ Oxford, Dept Zool, Oxford, England.
   [Caleiro, Giovana Santos; Claro, Ingra Morales; da Costa, Antonio Charlys; Sabino, Esther] Univ Sao Paulo, Inst Trop Med, Sao Paulo, SP, Brazil.
   [Tubaki, Rosa Maria; Tironi de Menezes, Regiane Maria] Superintendence Control Endem Dis, Sao Paulo, SP, Brazil.
   [Spinola, Roberta] Ctr Vigilancia Epidemiol Prof Alexandre Vranjac, Sao Paulo, SP, Brazil.
   [Mucci, Luis Filipe] Superintendence Control Endem Dis, Taubate, SP, Brazil.
RP Cunha, MS (corresponding author), Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
EM masequetin@gmail.com
RI Tubaki, Rosa Maria/D-9602-2011; Faria, Nuno R/I-2975-2012; da-Costa,
   Antonio Charlys/G-1548-2010; Mucci, Luis Filipe/M-9130-2013
OI Tubaki, Rosa Maria/0000-0002-9688-5266; Faria, Nuno
   R/0000-0001-8839-2798; da-Costa, Antonio Charlys/0000-0001-5516-5177;
   Mucci, Luis Filipe/0000-0002-7766-7597; Hill, Sarah/0000-0002-2995-2596;
   Pereira de Souza, Renato/0000-0003-1315-7085
FU Secretaria de Estado de Saude [FAPESP 2017/00021-9, FAPESP
   2016/01735-2]; FAPESP-MRCgrant (CADDE) [FAPESP 2018/14389-0]; Wellcome
   TrustWellcome Trust [204311/Z/16/Z]; Royal Society Sir Henry Dale
   Fellowship [204311/Z/16/Z]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [400354/2016-0]; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/01735-2]; Oxford
   Martin School
FX This Research was made possible with support from the Secretaria de
   Estado de Saude, FAPESP 2017/00021-9, FAPESP 2016/01735-2, by the
   FAPESP-MRCgrant (CADDE, FAPESP 2018/14389-0), a Wellcome Trust and Royal
   Society Sir Henry Dale Fellowship(grant 204311/Z/16/Z), by CNPq
   #400354/2016-0 and FAPESP #2016/01735-2, and by the Oxford Martin
   School.
CR Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CDC Centers for Disease Control and Prevention; CDC, 2009, CDC PROT REALT RT PC, V1, P7
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   de Souza R.P., 2019, BIORXIV
   de Souza RP, 2011, REV INST MED TROP SP, V53, P133, DOI 10.1590/S0036-46652011000300004
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Forattini O P, 1978, Rev Saude Publica, V12, P297, DOI 10.1590/S0034-89101978000300005
   Gubler DJ, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay097
   Ho YL, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz040
   Ministerio Da Saude, 2017, GUIA VIGILANCIA EP P
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/S0037-86822011005000041, 10.1590/s0037-86822011005000041]
   Mucci LF, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0005-z
   Pan American Health Organization/World Health Organization, 2019, EP UPD YELL FEV
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002
   Vasconcelos P.F., 2003, REV SOC BRASILEIRA M, P275
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2020
VL 205
AR 105390
DI 10.1016/j.actatropica.2020.105390
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LD1OM
UT WOS:000525801200030
PM 32044285
DA 2020-09-29
ER

PT J
AU Candido, DD
   Watts, A
   Abade, L
   Kraemer, MUG
   Pybus, OG
   Croda, J
   de Oliveira, W
   Khan, K
   Sabino, EC
   Faria, NR
AF Candido, Darlan Da S.
   Watts, Alexander
   Abade, Leandro
   Kraemer, Moritz U. G.
   Pybus, Oliver G.
   Croda, Julio
   de Oliveira, Wanderson
   Khan, Kamran
   Sabino, Ester C.
   Faria, Nuno R.
TI Routes for COVID-19 importation in Brazil
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Editorial Material
C1 [Candido, Darlan Da S.; Abade, Leandro; Kraemer, Moritz U. G.; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [Watts, Alexander; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Watts, Alexander; Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Grp, Boston, MA USA.
   [Pybus, Oliver G.] Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England.
   [Croda, Julio; de Oliveira, Wanderson] Minist Saude, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Croda, Julio] Fundacao Univ Fed Grande Dourados, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.
   [Croda, Julio] Fundacao Oswaldo Cruz Campo Grande, Campo Grande, MS, Brazil.
   [Sabino, Ester C.; Faria, Nuno R.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Faria, Nuno R.] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Faria, NR (corresponding author), Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.; Faria, NR (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.
EM nuno.faria@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; Oliveira,
   Wanderson/D-7140-2016
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   da Silva Candido, Darlan/0000-0002-5080-3130; Oliveira,
   Wanderson/0000-0002-9662-1930
FU Medical Research CouncilMedical Research Council UK (MRC); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo CADDE partnership award
   [MR/S0195/1]; John Fell Research Fund [005166]; Sir Henry Dale
   Fellowship [204311/Z/16/Z]; Clarendon Fund; Oxford University Zoology
   Department
FX This work was supported by a Medical Research Council and Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo CADDE partnership award
   (MR/S0195/1) and a John Fell Research Fund (grant 005166). N.R.F. is
   supported by a Sir Henry Dale Fellowship (204311/Z/16/Z). D.D.S.C. is
   supported by the Clarendon Fund and by the Oxford University Zoology
   Department.
CR de Jesus JG, 2020, VIROLOGICAL
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Ministerio da Saude B, 2020, BRAS AMPL MON COR
   WHO, TECHN GUID 2020
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 5
TC 8
Z9 8
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD APR
PY 2020
VL 27
IS 3
AR taaa042
DI 10.1093/jtm/taaa042
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA LU1KU
UT WOS:000537521800012
PM 32211799
OA Green Published, Other Gold
DA 2020-09-29
ER

PT J
AU Rezende, HR
   Romano, CM
   Claro, IM
   Caleiro, GS
   Sabino, EC
   Felix, AC
   Bissoli, J
   Hill, S
   Faria, NR
   da Silva, TCC
   Santos, APB
   Cerutti, C
   Vicente, CR
AF Rezende, Helder Ricas
   Romano, Camila Malta
   Claro, Ingra Morales
   Caleiro, Giovana Santos
   Sabino, Ester Cerdeira
   Felix, Alvina Clara
   Bissoli, Jefferson
   Hill, Sarah
   Faria, Nuno Rodrigues
   Cardoso da Silva, Theresa Cristina
   Brioschi Santos, Ana Paula
   Cerutti Junior, Crispim
   Vicente, Creuza Rachel
TI First report of Aedes albopictus infected by Dengue and Zika virus in a
   rural outbreak in Brazil
SO PLOS ONE
LA English
DT Article
ID TIME RT-PCR; DIPTERA-CULICIDAE; VECTOR; STATE; CONTAINERS; TYPE-1; CITY
AB In Brazil, Dengue (DENV) and Zika (ZIKV) viruses are reported as being transmitted exclusively by Aedes aegypti in urban settings. This study established the vectors and viruses involved in an arbovirus outbreak that occurred in 2019 in a rural area of Espi ' rito Santo state, Brazil. Mosquitoes collected were morphologically identified, sorted in samples, and submitted to molecular analysis for arboviruses detection. Phylogenetic reconstruction was performed for the viral sequence obtained. All 393 mosquitoes were identified as Aedes albopictus. DENV-1 genotype V was present in one sample and another sample was positive for ZIKV. The DENV-1 clustered with viruses that have circulated in previous years in large urban centers of different regions in Brazil. This is the first report of A. albopictus infected by DENV and ZIKV during an outbreak in a rural area in Brazil, indicating its involvement in arboviral transmission. The DENV-1 strain found in the A. albopictus was not new in Brazil, being involved previously in epidemics related to A. aegypti, suggesting the potential to A. albopictus in transmitting viruses already circulating in the Brazilian population. This finding also indicates the possibility of these viruses to disperse across urban and rural settings, imposing additional challenges for the control of the diseases.
C1 [Rezende, Helder Ricas] Secretaria Estado Saude Espirito Santo, Nucleo Entomol & Malacol, Serra, ES, Brazil.
   [Romano, Camila Malta] Univ Sao Paulo, Hosp Clin HCFMUSP LIM52, Fac Med, Sao Paulo, SP, Brazil.
   [Claro, Ingra Morales; Sabino, Ester Cerdeira] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil.
   [Caleiro, Giovana Santos; Felix, Alvina Clara] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil.
   [Bissoli, Jefferson] Secretaria Municipal Saude Linhares, Vigilancia Saude, Linhares, ES, Brazil.
   [Hill, Sarah; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Cardoso da Silva, Theresa Cristina; Brioschi Santos, Ana Paula] Secretaria Estado Sande Espirito Santo, Vigilancia Saude, Vitoria, ES, Brazil.
   [Cerutti Junior, Crispim; Vicente, Creuza Rachel] Univ Fed Espirito Santo, Dept Med Social, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil.
RP Vicente, CR (corresponding author), Univ Fed Espirito Santo, Dept Med Social, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil.
EM vicentecrachel@gmail.com
RI Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798; Hill, Sarah/0000-0002-2995-2596
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/05958-3,
   18/14389-0]
FX This research was supported by Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [grants number 15/05958-3, CMR; and 18/14389-0,
   ECS]. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abilio AP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006692
   Auteri M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3098575
   Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bezerra JMT, 2016, ACTA TROP, V164, P431, DOI 10.1016/j.actatropica.2016.10.010
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brasil, 2019, GUIA VIG SAUD
   Brasil. Ministerio da Saude, 2015, PLAN NAC EP DENG
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Cecilio AB, 2009, BRAZ J BIOL, V69, P123, DOI 10.1590/S1519-69842009000100015
   Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   da Silva VC, 2006, REV SAUDE PUBL, V40, P1106, DOI [10.1590/S0034-89102006000700021, 10.1590/s0034-89102006000700021]
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Albuquerque C M, 2000, Rev Saude Publica, V34, P314
   de Almeida PS, 2006, REV SAUDE PUBL, V40, P1094, DOI 10.1590/S0034-89102006000700019
   de Brito M, 2004, REV SAUDE PUBL, V38, P209, DOI 10.1590/S0034-89102004000200009
   de Bruycker-Nogueira F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35622-x
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Custodio JMD, 2019, REV INST MED TROP SP, V61, DOI [10.1590/S1678-9946201961018, 10.1590/s1678-9946201961018]
   DONALISIO MR, 2017, REV SAUDE PUBL, V51, DOI DOI 10.1590/S1518-8787
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Ferreira Neto J. A., 1987, Cadernos de Saude Publica, V3, P56, DOI 10.1590/S0102-311X1987000100006
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Gomes AC, 2005, REV SAUDE PUBL, V39, P106
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Heinisch MRS, 2019, ACTA TROP, V189, P104, DOI 10.1016/j.actatropica.2018.09.011
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Montagner FRG, 2018, BRAZ J BIOL, V78, P233, DOI 10.1590/1519-6984.04416
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Pan American Health Organization, 2017, TOOL DIAGN CAR PAT S
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Scolari F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02036
   SERUFO JC, 1993, MEM I OSWALDO CRUZ, V88, P503, DOI 10.1590/S0074-02761993000300025
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   TRPIS M, 1968, MOSQ NEWS, V28, P647
   WHO, 2019, ZIK EP UPD
   World Health Organization, 2009, CDC PROT REAL TIME R
NR 51
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 12
PY 2020
VL 15
IS 3
AR e0229847
DI 10.1371/journal.pone.0229847
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ9AF
UT WOS:000535288600027
PM 32163449
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Gutierrez, B
   Wise, EL
   Pullan, ST
   Logue, CH
   Bowden, TA
   Escalera-Zamudio, M
   Trueba, G
   Nunes, MRT
   Faria, NR
   Pybus, OG
AF Gutierrez, Bernardo
   Wise, Emma L.
   Pullan, Steven T.
   Logue, Christopher H.
   Bowden, Thomas A.
   Escalera-Zamudio, Marina
   Trueba, Gabriel
   Nunes, Marcio R. T.
   Faria, Nuno R.
   Pybus, Oliver G.
TI Evolutionary Dynamics of Oropouche Virus in South America
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Oropouche virus; arbovirus; bunyavirus; emerging infectious diseases;
   evolutionary biology; phylogenetic analysis
ID VALLEY FEVER VIRUS; NONSTRUCTURAL PROTEIN NSM; AMINO-ACID SITES;
   PHYLOGENETIC ANALYSIS; TERMINAL REGION; REASSORTMENT; TRANSMISSION;
   DISEASE; IDENTIFICATION; EPIDEMIOLOGY
AB The Amazon basin is home to numerous arthropod-borne viral pathogens that cause febrile disease in humans. Among these, Oropouche orthobunyavirus (OROV) is a relatively understudied member of the genus Orthobunyavirus, family Peribuoyaviridae, that causes periodic outbreaks in human populations in Brazil and other South American countries. Although several studies have described the genetic diversity of the virus, the evolutionary processes that shape the OROV genome remain poorly understood. Here, we present a comprehensive study of the genomic dynamics of OROV that encompasses phylogenetic analysis, evolutionary rate estimates, inference of natural selective pressures, recombination and reassortment, and structural analysis of OROV variants. Our study includes all available published sequences, as well as a set of new OROV genome sequences obtained from patients in Ecuador, representing the first set of genomes from this country. Our results show differing evolutionary processes on the three segments that comprise the viral genome. We infer differing times of the most recent common ancestors of the genome segments and propose that this can be explained by cryptic reassortment. We also present the discovery of previously unobserved putative N-linked glycosylation sites, as well as codons that evolve under positive selection on the viral surface proteins, and discuss the potential role of these features in the evolution of OROV through a combined phylogenetic and structural approach.
   IMPORTANCE The emergence and reemergence of pathogens such as Zika virus, chikungunya virus, and yellow fever virus have drawn attention toward other cocirculating arboviruses in South America. Oropouche virus (OROV) is a poorly studied pathogen responsible for over a dozen outbreaks since the early 1960s and represents a public health burden to countries such as Brazil, Panama, and Peru. OROV is likely underreported since its symptomatology can be easily confounded with other febrile illnesses (e.g., dengue fever and leptospirosis) and point-of-care testing for the virus is still uncommon. With limited data, there is a need to optimize the information currently available. Analysis of OROV genomes can help us understand how the virus circulates in nature and can reveal the evolutionary forces that shape the genetic diversity of the virus, which has implications for molecular diagnostics and the design of potential vaccines.
C1 [Gutierrez, Bernardo; Escalera-Zamudio, Marina; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Gutierrez, Bernardo] USFQ, Sch Biol & Environm Sci, Quito, Ecuador.
   [Wise, Emma L.] Univ Plymouth, Plymouth, Devon, England.
   [Wise, Emma L.; Pullan, Steven T.; Logue, Christopher H.] Publ Hlth England, Natl Infect Serv, Porton Down, England.
   [Logue, Christopher H.; Trueba, Gabriel] USFQ, Microbiol Inst, Quito, Ecuador.
   [Bowden, Thomas A.] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford, England.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil.
   [Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM oliver.pybus@zoo.ox.ac.uk
RI Faria, Nuno R/I-2975-2012; Wise, Emma/AAX-8268-2020; Pybus, Oliver
   G/B-2640-2012; Trueba, Gabriel/F-9707-2015
OI Faria, Nuno R/0000-0001-8839-2798; Wise, Emma/0000-0002-0279-3900;
   Pybus, Oliver G/0000-0002-8797-2667; Gutierrez,
   Bernardo/0000-0002-9220-2739; Bowden, Thomas/0000-0002-8066-8785;
   Escalera-Zamudio, Marina/0000-0002-4773-2773; Trueba,
   Gabriel/0000-0003-2617-9021; Pullan, Steven/0000-0002-8983-599X
FU Public Health England; Universidad San Francisco de Quito; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L009528/1];
   FAPESP-MRC grant (CADDE) [FAPESP 2018/14389-0]; EMBO Long Term
   FellowshipEuropean Molecular Biology Organization (EMBO) [ALTF376-2017];
   Leverhulme Trust ECR Fellowship [ECF-2019-542]; 2017 Universities of
   Academic Excellence Scholarship Program of the Secretariat for Higher
   Education, Science, Technology, and Innovation of the Republic of
   Ecuador [ARSEQ-BEC-003163-2017]; CNPq (National Council for Scientific
   and Technological Development) grantNational Council for Scientific and
   Technological Development (CNPq) [302584/20115-3]; Wellcome
   TrustWellcome Trust [204311/Z/16/Z]; Royal SocietyRoyal Society of
   London [204311/Z/16/Z]; European Union Seventh Framework Program
   (FP7/2007-2013)/European Research Council [614725-PATHPHYLODYN]; 
   [203141/Z/16/Z]
FX The work leading to the generation of the sequences from these samples
   was funded by Public Health England as part of a PHE-funded Ph.D.
   studentship awarded to E.L.W., C.H.L., and S.T.P. and by the Universidad
   San Francisco de Quito. This study was supported by the Medical Research
   Council (MR/L009528/1 to T.A.B.) and by a FAPESP-MRC grant (CADDE,
   FAPESP 2018/14389-0 to N.R.F.). The Wellcome Centre for Human Genetics
   is supported by grant 203141/Z/16/Z. M.E.-Z. is supported by an EMBO
   Long Term Fellowship (ALTF376-2017) and a Leverhulme Trust ECR
   Fellowship (ECF-2019-542). B.G. is supported by the 2017 Universities of
   Academic Excellence Scholarship Program of the Secretariat for Higher
   Education, Science, Technology, and Innovation of the Republic of
   Ecuador (ARSEQ-BEC-003163-2017) and by Universidad San Francisco de
   Quito. M.R.T.N. is supported by CNPq (National Council for Scientific
   and Technological Development) grant 302584/20115-3. N.R.F. is supported
   by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (grant
   204311/Z/16/Z). O.G.P. is supported by the European Union Seventh
   Framework Program (FP7/2007-2013)/European Research Council
   (614725-PATHPHYLODYN).
CR Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Allen ER, 2018, CELL REP, V25, P3750, DOI 10.1016/j.celrep.2018.12.001
   Alvarez-Falconi Pedro P., 2010, Rev. gastroenterol. Perú, V30, P334
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093
   Bowden TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003374
   Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05
   Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030
   Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Crabtree MB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001639
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Eifan S, 2013, VIRUSES-BASEL, V5, P2447, DOI 10.3390/v5102447
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Freire CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11353
   Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Gutierrez B, 2018, BIORXIV, DOI [10.1101/682559, DOI 10.1101/682559]
   Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hart TJ, 2009, ZOONOSES PUBLIC HLTH, V56, P285, DOI 10.1111/j.1863-2378.2008.01166.x
   Hellert J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08832-8
   IROEGBU CU, 1981, J VIROL, V37, P383, DOI 10.1128/JVI.37.1.383-394.1981
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Lam TTY, 2013, EPIDEMICS-NETH, V5, P1, DOI 10.1016/j.epidem.2012.09.002
   Lemey P, 2012, BIOINFORMATICS, V28, P3248, DOI 10.1093/bioinformatics/bts580
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li S, 2016, CELL REP, V16, P278, DOI 10.1016/j.celrep.2016.06.039
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Murray GGR, 2016, METHODS ECOL EVOL, V7, P80, DOI 10.1111/2041-210X.12466
   Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Navarro JC, 2016, AM J TROP MED HYG, V95, P328, DOI 10.4269/ajtmh.15-0679
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081
   PHOENIX I, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/V8050149
   Pollitt E, 2006, VIROLOGY, V348, P224, DOI 10.1016/j.virol.2005.12.026
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rissanen I, 2017, J VIROL, V91, DOI 10.1128/JVI.00378-17
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Romero-Alvarez D, 2018, MICROBES INFECT, V20, P135, DOI 10.1016/j.micinf.2017.11.013
   Romero-Alvarez D, 2017, MEM I OSWALDO CRUZ, V112, P292, DOI 10.1590/0074-02760160415
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   Sakkas H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040175
   Schrodinger LLC, 2015, PYMOL MOL GRAPH SYST
   Seabright GE, 2019, J MOL BIOL, V431, P2223, DOI 10.1016/j.jmb.2019.04.016
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005
   Shi XH, 2006, J VIROL, V80, P8089, DOI 10.1128/JVI.00579-06
   Shi XH, 2016, P NATL ACAD SCI USA, V113, P8825, DOI 10.1073/pnas.1603364113
   Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2019, INFECT GENET EVOL, V68, P16, DOI 10.1016/j.meegid.2018.11.020
   Terasaki K, 2013, J VIROL, V87, P676, DOI 10.1128/JVI.02192-12
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   URQUIDI V, 1992, J GEN VIROL, V73, P2255, DOI 10.1099/0022-1317-73-9-2255
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Watanabe Y, 2018, P NATL ACAD SCI USA, V115, P7320, DOI 10.1073/pnas.1803990115
   Watts DM, 1997, AM J TROP MED HYG, V56, P148, DOI 10.4269/ajtmh.1997.56.148
   Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335
   Wernike K, 2017, SCI REP-UK, V7, DOI 10.1038/srep42500
   Wise EL, 2019, BIORXIV, DOI [10.1101/683953, DOI 10.1101/683953]
   Wise EL, 2018, EMERG INFECT DIS, V24, P935, DOI 10.3201/eid2405.171569
   Wohl S, 2016, ANNU REV VIROL, V3, P173, DOI 10.1146/annurev-virology-110615-035747
   Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07
   Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06
NR 85
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 5
AR e01127-19
DI 10.1128/JVI.01127-19
PG 17
WC Virology
SC Virology
GA KN1BN
UT WOS:000514575000001
PM 31801869
OA Other Gold, Green Published
DA 2020-09-29
ER

PT J
AU Nazziwa, J
   Faria, NR
   Chaplin, B
   Rawizza, H
   Kanki, P
   Dakum, P
   Abimiku, A
   Charurat, M
   Ndembi, N
   Esbjornsson, J
AF Nazziwa, Jamirah
   Faria, Nuno Rodrigues
   Chaplin, Beth
   Rawizza, Holly
   Kanki, Phyllis
   Dakum, Patrick
   Abimiku, Alash'le
   Charurat, Man
   Ndembi, Nicaise
   Esbjornsson, Joakim
TI Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin,
   Diversity, Demography and Geographic Spread
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NAIVE PREGNANT-WOMEN; DRUG-RESISTANCE; DISEASE PROGRESSION;
   ANTIRETROVIRAL THERAPY; POPULATION-DYNAMICS; SEQUENCE-ANALYSIS; TYPE-1
   SUBTYPE; HOT-SPOTS; POL GENE; RECOMBINATION
AB Nigeria has the highest number of AIDS-related deaths in the world. In this study, we characterised the HIV-1 molecular epidemiology by analysing 1442 HIV-1 pol sequences collected 1999-2014 from four geopolitical zones in Nigeria using state-of-the-art maximum-likelihood and Bayesian phylogenetic analyses. The main circulating forms were the circulating recombinant form (CRF) 02_AG (44% of the analysed sequences), CRF43_02G (16%), and subtype G (8%). Twenty-three percent of the sequences represented unique recombinant forms (URFs), whereof 37 (11%) could be grouped into seven potentially novel CRFs. Bayesian phylodynamic analysis suggested that five major Nigerian HIV-1 sub-epidemics were introduced in the 1960s and 1970s, close to the Nigerian Civil War. The analysis also indicated that the number of effective infections decreased in Nigeria after the introduction of free antiretroviral treatment in 2006. Finally, Bayesian phylogeographic analysis suggested gravity-like dynamics in which virus lineages first emerge and expand within large urban centers such as Abuja and Lagos, before migrating towards smaller rural areas. This study provides novel insight into the Nigerian HIV-1 epidemic and may have implications for future HIV-1 prevention strategies in Nigeria and other severely affected countries.
C1 [Nazziwa, Jamirah; Esbjornsson, Joakim] Lund Univ, Dept Translat Med, Lund, Sweden.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Chaplin, Beth; Rawizza, Holly; Kanki, Phyllis] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Dakum, Patrick; Abimiku, Alash'le; Ndembi, Nicaise] Inst Human Virol Nigeria, Abuja, Nigeria.
   [Dakum, Patrick; Abimiku, Alash'le; Charurat, Man; Ndembi, Nicaise] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
   [Esbjornsson, Joakim] Univ Oxford, Nuffield Dept Med, Oxford, England.
RP Esbjornsson, J (corresponding author), Lund Univ, Dept Translat Med, Lund, Sweden.; Esbjornsson, J (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.
EM joakim.esbjornsson@med.lu.se
RI Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798; Esbjornsson,
   Joakim/0000-0002-3822-4953; Nazziwa, Jamirah/0000-0001-9029-7976
FU Swedish Research CouncilSwedish Research Council [350-2012-6628,
   2016-01417]; Swedish Society of Medical Research [SA-2016]; Medical
   Faculty at Lund University; US NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI147331-01
   (RAI147331A)]; US Centers for Disease Control and PreventionUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA [5U2GGH000925]; Lund University
FX We thank all the study participants, the collaborating health centers in
   Nigeria, Federal Ministry of Health and the National Agency for the
   Control of AIDS (NACA) in Nigeria. The study was supported by the
   Swedish Research Council (No. 350-2012-6628 and 2016-01417), Swedish
   Society of Medical Research (SA-2016), the Medical Faculty at Lund
   University, the US NIH R01 AI147331-01 (RAI147331A), and the US Centers
   for Disease Control and Prevention to the Institute of Human Virology
   Nigeria (5U2GGH000925). Open access funding provided by Lund University.
CR Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09
   Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2
   Ajoge HO, 2012, AIDS RES HUM RETROV, V28, P115, DOI [10.1089/aid.2011.0115, 10.1089/AID.2011.0115]
   Ajoge HO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017865
   Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Chaplin B, 2011, AIDS RES HUM RETROV, V27, P71, DOI 10.1089/aid.2010.0050
   Charurat M, 2012, J INFECT DIS, V205, P1239, DOI 10.1093/infdis/jis103
   Delatorre E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098908
   Diallo K, 2015, AIDS RES HUM RETROV, V31, P564, DOI [10.1089/aid.2014.0168, 10.1089/AID.2014.0168]
   Drummond A. J., 2017, BAYESIAN EVOLUTIONAR
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010
   Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025
   Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Galli A, 2008, J GEN VIROL, V89, P3119, DOI 10.1099/vir.0.2008/003418-0
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401
   Granich R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131353
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9
   Hassan AS, 2017, AIDS, V31, P1211, DOI 10.1097/QAD.0000000000001470
   Howard TM, 1996, AIDS RES HUM RETROV, V12, P1413, DOI 10.1089/aid.1996.12.1413
   Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]
   Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]
   Kaleebu P, 2001, AIDS, V15, P293, DOI 10.1097/00002030-200102160-00001
   Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kassambara A., 2017, FACTOEXTRA EXTRACT V
   Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811
   Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0
   Laga M, 2013, LANCET GLOB HEALTH, V1, pE243, DOI 10.1016/S2214-109X(13)70096-2
   Laher F, 2017, J VIROL, V91, DOI [10.1128/JVI.02477-16, 10.1128/jvi.02477-16]
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Magiorkinis G, 2003, J GEN VIROL, V84, P2715, DOI 10.1099/vir.0.19180-0
   Mild M, 2013, INFECT GENET EVOL, V19, P369, DOI 10.1016/j.meegid.2013.05.004
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Mir D, 2016, INFECT GENET EVOL, V46, P190, DOI 10.1016/j.meegid.2016.05.017
   (NACA) N.A.F.T.C.O.A., 2015, GLOB AIDS RESP COUNT
   Naidoo VL, 2017, J VIROL, V91, DOI 10.1128/JVI.00518-17
   Ojesina AI, 2006, AIDS RES HUM RETROV, V22, P770, DOI 10.1089/aid.2006.22.770
   Palm AA, 2014, J INFECT DIS, V209, P721, DOI 10.1093/infdis/jit416
   Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Rambaut A., 2014, TRACER V1 6
   Rambaut A., 2016, VIRUS EVOL, V2
   Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d
   ROGERS AR, 1992, MOL BIOL EVOL, V9, P552
   Senkaali D, 2004, AIDS RES HUM RETROV, V20, P932, DOI 10.1089/aid.2004.20.932
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   SLATKIN M, 1991, GENETICS, V129, P555
   Smyth RP, 2014, J VIROL, V88, P2891, DOI 10.1128/JVI.03014-13
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Team R. C., 2013, R LANG ENV STAT COMP
   Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892
   Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293
   UNAIDS, 2018, UNAIDS DAT 2018
   UNAIDS, 2017, UNAIDS GLOB REP UNAI
   Volz EM, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex014
   Wang HZ, 2011, R J, V3, P29, DOI 10.32614/rj-2011-015
   Yamaguchi J, 2008, AIDS RES HUM RETROV, V24, P1327, DOI 10.1089/aid.2008.0101
   Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002
   Zwickl D.J., 2006, THESIS
NR 73
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 26
PY 2020
VL 10
IS 1
AR 3468
DI 10.1038/s41598-020-59944-x
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NF3PH
UT WOS:000563209800005
PM 32103028
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Giovanetti, M
   Faria, NR
   Lourenco, J
   de Jesus, JG
   Xavier, J
   Claro, IM
   Kraemer, MUG
   Fonseca, V
   Dellicour, S
   Theze, J
   Salles, FD
   Graf, T
   Silveira, PP
   do Nascimento, VA
   de Souza, VC
   Iani, FCD
   Castilho-Martins, EA
   Cruz, LN
   Wallau, G
   Fabri, A
   Levy, F
   Quick, J
   de Azevedo, V
   Aguiar, RS
   de Oliveira, T
   de Menezes, CB
   Castilho, MD
   Terra, TM
   da Silva, MS
   de Filippis, AMB
   de Abreu, AL
   Oliveira, WK
   Croda, J
   de Albuquerque, CFC
   Nunes, MRT
   Sabino, EC
   Loman, N
   Naveca, FG
   Pybus, OG
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Lourenco, Jose
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   Claro, Ingra Morales
   Kraemer, Moritz U. G.
   Fonseca, Vagner
   Dellicour, Simon
   Theze, Julien
   Salles, Flavia da Silva
   Graf, Tiago
   Silveira, Paola Paz
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   de Melo Iani, Felipe Campos
   Castilho-Martins, Emerson Augusto
   Cruz, Laura Nogueira
   Wallau, Gabriel
   Fabri, Allison
   Levy, Flavia
   Quick, Joshua
   de Azevedo, Vasco
   Aguiar, Renato Santana
   de Oliveira, Tulio
   de Menezes, Camila Botto
   Castilho, Marcia da Costa
   Terra, Tirza Matos
   da Silva, Marineide Souza
   Bispo de Filippis, Ana Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Croda, Julio
   Campelo de Albuquerque, Carlos F.
   Nunes, Marcio R. T.
   Sabino, Ester Cerdeira
   Loman, Nicholas
   Naveca, Felipe Gomes
   Pybus, Oliver G.
   Alcantara, Luiz Carlos
TI Genomic and Epidemiological Surveillance of Zika Virus in the Amazon
   Region
SO CELL REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; TRANSMISSION; OUTBREAK; SPREAD; BRAZIL;
   OROPOUCHE; REVEALS; MODELS; ANGOLA; FEVER
AB Zika virus (ZIKV) has caused an explosive epidemic linked to severe clinical outcomes in the Americas. As of June 2018, 4,929 ZIKV suspected infections and 46 congenital syndrome cases had been reported in Manaus, Amazonas, Brazil. Although Manaus is a key demographic hub in the Amazon region, little is known about the ZIKV epidemic there, in terms of both transmission and viral genetic diversity. Using portable virus genome sequencing, we generated 59 ZIKV genomes in Manaus. Phylogenetic analyses indicated multiple introductions of ZIKV from northeastern Brazil to Manaus. Spatial genomic analysis of virus movement among six areas in Manaus suggested that populous northern neighborhoods acted as sources of virus transmission to other neighborhoods. Our study revealed how the ZIKV epidemic was ignited and maintained within the largest urban metropolis in the Amazon. These results might contribute to improving the public health response to outbreaks in Brazil.
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Fabri, Allison; Levy, Flavia; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Faria, Nuno Rodrigues; Xavier, Joilson; Fonseca, Vagner; de Melo Iani, Felipe Campos; de Azevedo, Vasco; Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Kraemer, Moritz U. G.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Claro, Ingra Morales; Salles, Flavia da Silva; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, ZA-4001 Durban, South Africa.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium.
   [Dellicour, Simon] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Graf, Tiago; Silveira, Paola Paz; Aguiar, Renato Santana] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [de Melo Iani, Felipe Campos] Fundacao Ezequiel Dias, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Castilho-Martins, Emerson Augusto] Univ Fed Amapa, Fac Med, Macapa, Brazil.
   [Cruz, Laura Nogueira; de Abreu, Andre Luiz] Minist Saude CGLAB SVS MS, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, Brasilia, DF, Brazil.
   [Wallau, Gabriel] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Quick, Joshua; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [de Menezes, Camila Botto] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tirza Matos; da Silva, Marineide Souza] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Oliveira, Wanderson Kleber] MS, SVS, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil.
RP Alcantara, LC (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Faria, NR; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.; Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM nuno.faria@zoo.ox.ac.uk; oliver.pybus@zoo.ox.ac.uk;
   luiz.alcantara@ioc.fiocruz.br
RI Wallau, Gabriel Luz/B-5911-2008; Fonseca, Vagner/R-5813-2019; Faria,
   Nuno R/I-2975-2012; Nascimento, Valdinete Alves do/AAV-1879-2020;
   Dellicour, Simon/AAE-9054-2020; Pybus, Oliver G/B-2640-2012; Graf,
   Tiago/S-8535-2019; Oliveira, Wanderson/D-7140-2016; Castilho-Martins,
   Emerson Augusto/I-2094-2014
OI Wallau, Gabriel Luz/0000-0002-1419-5713; Fonseca,
   Vagner/0000-0001-5521-6448; Faria, Nuno R/0000-0001-8839-2798;
   Nascimento, Valdinete Alves do/0000-0002-7786-4718; Dellicour,
   Simon/0000-0001-9558-1052; Pybus, Oliver G/0000-0002-8797-2667; Graf,
   Tiago/0000-0003-4921-7975; Oliveira, Wanderson/0000-0002-9662-1930; da
   Silva Sales, Flavia Cristina/0000-0002-9048-0030; Castilho-Martins,
   Emerson Augusto/0000-0003-0542-4294; Alcantara,
   Luiz/0000-0002-6769-9931; Xavier, Joilson/0000-0003-3916-2018;
   /0000-0002-8529-4022
FU Decit/SCTIE/MoH; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/2016-00, 88881.130825/2016-00, 88887.130823/201600];
   European Union (EU) Horizon 2020 Programme through ZIKAllianceEuropean
   Union (EU) [PRES-005-FEX-17-4-2-33]; Oxford Martin School; Branco Weiss
   Fellowship - Society in Science; Google Faculty Award; Training Grant
   from the National Institute of Child Health and Human Development
   [T32HD040128]; Fonds National de la Recherche Scientifique (FNRS;
   Belgium)Fonds de la Recherche Scientifique - FNRS; FaperjCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/2002.930/2016]; International Development Research Centre
   (IDRC) Canada [108411-001]; EU Horizon 2020 Programme through ZikaPlan
   and ZikAction [734584, 734857]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX We thank Oxford Nanopore Technologies for technical support and QIAGEN
   for support of the ZIBRA-2 (Zika in Brazil Real Time Analyses-Second
   Round) project with reagents and equipment. This work was supported by
   Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7); by CAPES
   (88887.130716/2016-00, 88881.130825/2016-00, and 88887.130823/201600);
   by the European Union (EU) Horizon 2020 Programme through ZIKAlliance
   (PRES-005-FEX-17-4-2-33); and by the Oxford Martin School. M.U.G.K. is
   supported by The Branco Weiss Fellowship - Society in Science,
   administered by ETH Zurich, and acknowledges funding from a Google
   Faculty Award and a Training Grant from the National Institute of Child
   Health and Human Development (T32HD040128). S.D. is supported by Fonds
   National de la Recherche Scientifique (FNRS; Belgium). The activities of
   the A.M.B.F. laboratory were supported by the Faperj under the grant no.
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada under the grant 108411-001) and the EU Horizon 2020
   Programme through ZikaPlan and ZikAction (grants 734584 and 734857).
   M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ).
CR Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chaves BA, 2019, J MED ENTOMOL, V56, P1739, DOI 10.1093/jme/tjz110
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Fonseca V., 2019, PLOS NEGLECT TROP D, V213, P72
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Izquierdo-Suzan M, 2019, EMERG INFECT DIS, V25, P1477, DOI 10.3201/eid2508.181533
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kraemer MUG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41192-3
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Lourenco J., 2017, ELIFE, V6, P290
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Oboist U, 2019, METHODS ECOL EVOL, V10, P1357, DOI 10.1111/2041-210X.13205
   Perez-Guzman P.N., 2018, PLOS CURR, V10, P16
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2019, B EPIDEMIOLOGICO
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Vasconcelos L., 2001, P 1 WORLD PLANN C AC, V32, P11
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Wickham H., 2016, ELEGANT GRAPHICS DAT
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 64
TC 0
Z9 0
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 18
PY 2020
VL 30
IS 7
BP 2275
EP 2283
DI 10.1016/j.celrep.2020.01.085
PG 9
WC Cell Biology
SC Cell Biology
GA KN4QZ
UT WOS:000514824500019
PM 32075736
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Deng, XD
   Achari, A
   Federman, S
   Yu, GX
   Somasekar, S
   Bartolo, I
   Yagi, S
   Mbala-Kingebeni, P
   Kapetshi, J
   Ahuka-Mundeke, S
   Muyembe-Tamfum, JJ
   Ahmed, AA
   Ganesh, V
   Tamhankar, M
   Patterson, JL
   Ndembi, N
   Mbanya, D
   Kaptue, L
   McArthur, C
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Lopez, S
   Arias, CF
   Arevalo, S
   Miller, S
   Stone, M
   Busch, M
   Hsieh, K
   Messenger, S
   Wadford, DA
   Rodgers, M
   Cloherty, G
   Faria, NR
   Theze, J
   Pybus, OG
   Neto, Z
   Morais, J
   Taveira, N
   Hackett, JR
   Chiu, CY
AF Deng, Xianding
   Achari, Asmeeta
   Federman, Scot
   Yu, Guixia
   Somasekar, Sneha
   Bartolo, Ines
   Yagi, Shigeo
   Mbala-Kingebeni, Placide
   Kapetshi, Jimmy
   Ahuka-Mundeke, Steve
   Muyembe-Tamfum, Jean-Jacques
   Ahmed, Asim A.
   Ganesh, Vijay
   Tamhankar, Manasi
   Patterson, Jean L.
   Ndembi, Nicaise
   Mbanya, Dora
   Kaptue, Lazare
   McArthur, Carole
   Munoz-Medina, Jose E.
   Gonzalez-Bonilla, Cesar R.
   Lopez, Susana
   Arias, Carlos F.
   Arevalo, Shaun
   Miller, Steve
   Stone, Mars
   Busch, Michael
   Hsieh, Kristina
   Messenger, Sharon
   Wadford, Debra A.
   Rodgers, Mary
   Cloherty, Gavin
   Faria, Nuno R.
   Theze, Julien
   Pybus, Oliver G.
   Neto, Zoraima
   Morais, Joana
   Taveira, Nuno
   Hackett, John R.
   Chiu, Charles Y.
TI Metagenomic sequencing with spiked primer enrichment for viral
   diagnostics and genomic surveillance
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ZIKA VIRUS; EBOLA-VIRUS; REAL-TIME; TRANSMISSION; DIVERSITY; DEPLETION;
   IMPACT; BRAZIL; BAHIA; AIDS
AB Metagenomic next-generation sequencing (mNGS), the shotgun sequencing of RNA and DNA from clinical samples, has proved useful for broad-spectrum pathogen detection and the genomic surveillance of viral outbreaks. An additional target enrichment step is generally needed for high-sensitivity pathogen identification in low-titre infections, yet available methods using PCR or capture probes can be limited by high cost, narrow scope of detection, lengthy protocols and/or cross-contamination. Here, we developed metagenomic sequencing with spiked primer enrichment (MSSPE), a method for enriching targeted RNA viral sequences while simultaneously retaining metagenomic sensitivity for other pathogens. We evaluated MSSPE for 14 different viruses, yielding a median tenfold enrichment and mean 47% (+/- 16%) increase in the breadth of genome coverage over mNGS alone. Virus detection using MSSPE arboviral or haemorrhagic fever viral panels was comparable in sensitivity to specific PCR, demonstrating 95% accuracy for the detection of Zika, Ebola, dengue, chikungunya and yellow fever viruses in plasma samples from infected patients. Notably, sequences from re-emerging and/or co-infecting viruses that have not been specifically targeted a priori, including Powassan and Usutu, were successfully enriched using MSSPE. MSSPE is simple, low cost, fast and deployable on either benchtop or portable nanopore sequencers, making this method directly applicable for diagnostic laboratory and field use.
   This study describes a new method that improves the sensitivity of viral detection compared with next-generation sequencing and enables the detection of emerging flaviviruses not specifically targeted a priori. Metagenomic sequencing with spiked primer enrichment is simple, low cost, fast and deployable on either benchtop or portable nanopore sequencers, making it applicable for diagnostic laboratory and field use.
C1 [Deng, Xianding; Achari, Asmeeta; Federman, Scot; Yu, Guixia; Somasekar, Sneha; Arevalo, Shaun; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Deng, Xianding; Achari, Asmeeta; Federman, Scot; Yu, Guixia; Somasekar, Sneha; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.
   [Bartolo, Ines] Univ Lisbon, Med Res Inst, Fac Pharm, Lisbon, Portugal.
   [Yagi, Shigeo; Hsieh, Kristina; Messenger, Sharon; Wadford, Debra A.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA USA.
   [Mbala-Kingebeni, Placide; Kapetshi, Jimmy; Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Ahmed, Asim A.] Boston Childrens Hosp, Boston, MA USA.
   [Ahmed, Asim A.] Harvard Med Sch, Boston, MA 02115 USA.
   [Ganesh, Vijay] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Tamhankar, Manasi; Patterson, Jean L.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA.
   [Ndembi, Nicaise] Inst Human Virol Nigeria, Abuja, Nigeria.
   [Ndembi, Nicaise] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
   [Mbanya, Dora] Univ Yaounde I, Yaounde, Cameroon.
   [Mbanya, Dora] Univ Bamenda, Bamenda, Cameroon.
   [Kaptue, Lazare] Univ Montagnes, Bangangte, Cameroon.
   [McArthur, Carole] Univ Missouri, Kansas City, MO 64110 USA.
   [Munoz-Medina, Jose E.; Gonzalez-Bonilla, Cesar R.] Inst Mexicano Seguro Social, Mexico City, DF, Mexico.
   [Lopez, Susana; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Stone, Mars; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA.
   [Rodgers, Mary; Cloherty, Gavin; Hackett, John R.] Abbott Labs, Abbott Pk, IL 60064 USA.
   [Faria, Nuno R.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Neto, Zoraima; Morais, Joana] Angolan Natl Inst Hlth Res, Luanda, Angola.
   [Taveira, Nuno] IUEM, Monte De Caparica, Portugal.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.
EM charles.chiu@ucsf.edu
RI NDEMBI, Nicaise/AAE-4383-2020; Pybus, Oliver G/B-2640-2012; Faria, Nuno
   R/I-2975-2012; Bartolo, Ines/A-7477-2014; Lopez, Susana/H-6661-2017;
   Taveira, Nuno/A-6252-2014
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Bartolo, Ines/0000-0002-2022-8921; Lopez, Susana/0000-0001-6336-9209;
   Taveira, Nuno/0000-0003-0176-5585
FU Abbott LaboratoriesAbbott Laboratories; NIH from the NIAID
   [R33-AI129455]; NIH from the National Heart, Lung, and Blood
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01-HL105704]; California Initiative to Advance
   Precision Medicine; Charles and Helen Schwab Foundation; Steven and
   Alexandra Cohen Foundation; United States Department of DefenseUnited
   States Department of Defense [W81XWH-17-1-0681]; Wellcome TrustWellcome
   Trust; Royal Society/Sir Henry Dale Fellowship [204311/Z/16/Z]; Global
   Challenges Research Fund [005073]; Oxford John Fell Research Fund
   [005166]; Africa Oxford grant [AfiOx-48]
FX We thank N. Loman and J. Quick at the University of Birmingham for
   providing ZIKV tiling multiplex PCR primers. The following viral RNA
   extracts were obtained through Biodefense and Emerging Infections
   Resources, the National Institute of Allergy and Infectious Diseases
   (NIAID) and the National Institutes of Health (NIH): CCHFV, IbAr10200,
   NR-37382; LASV, Josiah, NR-31821; Rift Valley Fever Virus, ZH501,
   NR-37379; MeV, Edmonston strain, NR-44104. This work was also funded in
   part by Abbott Laboratories (C.Y.C.), NIH grant no. R33-AI129455
   (C.Y.C.) from the NIAID, NIH grant no. R01-HL105704 (C.Y.C.) from the
   National Heart, Lung, and Blood Institute, the California Initiative to
   Advance Precision Medicine (C.Y.C.), the Charles and Helen Schwab
   Foundation (C.Y.C.), the Steven and Alexandra Cohen Foundation (C.Y.C.),
   United States Department of Defense award W81XWH-17-1-0681 (C.Y.C.), the
   Wellcome Trust and Royal Society/Sir Henry Dale Fellowship grant no.
   204311/Z/16/Z (N.R.F.), the Global Challenges Research Fund grant no.
   005073 (N.R.F.), the Oxford John Fell Research Fund grant no. 005166
   (N.R.F.) and Africa Oxford grant no. AfiOx-48 (N.R.F.).
CR Nguyen AT, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0580-9
   Berg Michael G, 2016, J Clin Microbiol, V54, P868, DOI 10.1128/JCM.02479-15
   Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Cherpillod P, 2016, J CLIN VIROL, V77, P9, DOI 10.1016/j.jcv.2016.01.017
   Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7
   Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064
   Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5
   Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15
   Kafetzopoulou LE, 2019, SCIENCE, V363, P74, DOI 10.1126/science.aau9343
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Koehler JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107007
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lorenz TC, 2012, JOVE-J VIS EXP, DOI 10.3791/3998
   Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219
   Metsky HC, 2019, NAT BIOTECHNOL, V37, P160, DOI 10.1038/s41587-018-0006-x
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miller S, 2019, GENOME RES, V29, P831, DOI 10.1101/gr.238170.118
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Pollock NR, 2017, J CLIN MICROBIOL, V55, P1255, DOI [10.1128/jcm.00053-17, 10.1128/JCM.00053-17]
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rasmussen AL, 2016, CELL HOST MICROBE, V19, P611, DOI 10.1016/j.chom.2016.04.016
   Reperant LA, 2017, VACCINE, V35, P4470, DOI 10.1016/j.vaccine.2017.04.082
   ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Shorten RJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004948
   Simner PJ, 2018, CLIN INFECT DIS, V66, P778, DOI 10.1093/cid/cix881
   Song HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04217-5
   Sovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11307
   Sozhamannan S, 2015, VIRUSES-BASEL, V7, P3130, DOI 10.3390/v7062763
   Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005
   Strong MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004437
   Temmam S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139810
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5
   Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
NR 54
TC 7
Z9 7
U1 5
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAR
PY 2020
VL 5
IS 3
BP 443
EP 454
DI 10.1038/s41564-019-0637-9
EA JAN 2020
PG 12
WC Microbiology
SC Microbiology
GA KQ0XE
UT WOS:000508513600001
PM 31932713
OA Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU de Jesus, JG
   Wallau, GD
   Maia, ML
   Xavier, J
   Lima, MAO
   Fonseca, V
   de Abreu, AS
   Tosta, SFD
   do Amaral, HR
   Lima, IAB
   Silva, PV
   dos Santos, DC
   de Oliveira, AS
   de Souza, SC
   Falcao, MB
   Cerqueira, E
   Machado, LC
   Sobral, MC
   Rezende, TMT
   Pereira, MR
   Pereira, FM
   Maia, ZPG
   Franca, RFD
   de Abreu, AL
   Melo, CFCDE
   Faria, NR
   da Cunha, RV
   Giovanetti, M
   Alcantara, LCJ
AF de Jesus, Jaqueline Goes
   Wallau, Gabriel da Luz
   Maia, Maricelia Lima
   Xavier, Joilson
   Oliveira Lima, Maria Aparecida
   Fonseca, Vagner
   de Abreu, Alvaro Salgado
   de Oliveira Tosta, Stephane Fraga
   do Amaral, Helineide Ramos
   Barbosa Lima, Italo Andrade
   Silva, Paloma Viana
   dos Santos, Daiana Carlos
   de Oliveira, Aline Sousa
   de Souza, Siane Campos
   Falcao, Melissa Barreto
   Cerqueira, Erenilde
   Machado, Lais Ceschini
   Sobral, Mariana Carolina
   Teodoro Rezende, Tatiana Maria
   Pereira, Mylena Ribeiro
   Pereira, Felicidade Mota
   Gusmao Maia, Zuinara Pereira
   de Oliveira Franca, Rafael Freitas
   de Abreu, Andre Luiz
   de Albuquerque e Melo, Carlos Frederico Campelo
   Faria, Nuno Rodrigues
   da Cunha, Rivaldo Venancio
   Giovanetti, Marta
   Junior Alcantara, Luiz Carlos
TI Persistence of chikungunya ECSA genotype and local outbreak in an upper
   medium class neighborhood in Northeast Brazil
SO PLOS ONE
LA English
DT Article
ID INDIAN-OCEAN; VIRUS; REEMERGENCE; POPULATION; GENOME; ZIKA
AB The chikungunya East/Central/South/Africa virus lineage (CHIKV-ECSA) was first detected in Brazil in the municipality of Feira de Santana (FS) by mid 2014. Following that, a large number of CHIKV cases have been notified in FS, which is the second-most populous city in Bahia state, northeastern Brazil, and plays an important role on the spread to other Brazilian states due to climate conditions and the abundance of competent vectors. To better understand CHIKV dynamics in Bahia state, we generated 5 complete genome sequences from a local outbreak raised in Serraria Brasil, a neighbourhood in FS, by next-generation sequencing using Illumina approach. Phylogenetic reconstructions revealed that the new FS genomes belongs to the ECSA genotype and falls within a single strongly supported monophyletic clade that includes other older CHIKV sequences from the same location, suggesting the persistence of the virus during distinct epidemic seasons. We also performed minor variants analysis and found a small number of SNPs per sample (b_29L and e_45SR = 16 SNPs, c_29SR = 29 and d_45PL and f_45FL = 21 SNPs). Out of the 93 SNPs found, 71 are synonymous, 21 are non-synonymous and one generated a stop codon. Although those mutations are not related to the increase of virus replication and/or infectivity, some SNPs were found in non-structural proteins which may have an effect on viral evasion from the mammal immunological system. These findings reinforce the needing of further studies on those variants and of continued genomic surveillance strategies to track viral adaptations and to monitor CHIKV epidemics for improved public health control.
C1 [de Jesus, Jaqueline Goes; Barbosa Lima, Italo Andrade; Silva, Paloma Viana; dos Santos, Daiana Carlos; de Oliveira, Aline Sousa; de Souza, Siane Campos] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Wallau, Gabriel da Luz; Machado, Lais Ceschini; Sobral, Mariana Carolina; Teodoro Rezende, Tatiana Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
   [Maia, Maricelia Lima; Oliveira Lima, Maria Aparecida; do Amaral, Helineide Ramos; Cerqueira, Erenilde] Univ Estadual Feira De Santana, Feira De Santana, BA, Brazil.
   [Maia, Maricelia Lima; Falcao, Melissa Barreto] Minist Saude, Secretaria Sande Feira De Santana, Feira De Santana, BA, Brazil.
   [Xavier, Joilson; Fonseca, Vagner; de Abreu, Alvaro Salgado; de Oliveira Tosta, Stephane Fraga; Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Pereira, Mylena Ribeiro; de Oliveira Franca, Rafael Freitas] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Pereira, Felicidade Mota; Gusmao Maia, Zuinara Pereira] Lab Cent Saude Publ Bahia, Salvador, BA, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Labs Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [de Albuquerque e Melo, Carlos Frederico Campelo] Org Mundial Sande OPAS OMS, Org Pan Amer Saude, Brasilia, DF, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Dept Clin Medica, Fac Med, Campo Grande, MS, Brazil.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
RP Giovanetti, M; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.; Giovanetti, M; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
EM giovanetti.marta@gmail.com; luiz.alcantara@ioc.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Wallau, Gabriel Luz/B-5911-2008; Fonseca,
   Vagner/R-5813-2019; Maia, Zuinara/M-7713-2019
OI Faria, Nuno R/0000-0001-8839-2798; Wallau, Gabriel
   Luz/0000-0002-1419-5713; Fonseca, Vagner/0000-0001-5521-6448; Xavier,
   Joilson/0000-0003-3916-2018; Andrade Barbosa Lima,
   Italo/0000-0002-7113-7579
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Horizon 2020
   [PRES-005-FEX-17-4-2-33]
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00), and by Horizon 2020
   (PRES-005-FEX-17-4-2-33) to LCJA. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   [Anonymous], 2016, B EP MON CAS DENG FE, V47, P7
   [Anonymous], 2017, B EP MON CAS DENG FE, V48
   [Anonymous], 2019, B EP ARB BAH 2019
   [Anonymous], 2017, IBGE CID FEIR SANT
   Brasil. Ministerio da Saude. OPAS, 2015, OPAS DIV DAD LEV
   Brasil. Ministerio da Saude. Secretaria de Vigilacia em Saude, 2017, SECR VIG SAUD SECR A
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   European Centre for Disease Prevention and Control, 2014, GUID SURV NAT MOSQ E, DOI [10.2900/37227, DOI 10.2900/37227]
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fonseca V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007231
   Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13
   Fu JYL, 2019, J GEN VIROL, V100, P1541, DOI 10.1099/jgv.0.001338
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Huits R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196630
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lima MM, 2018, ORG YVANNA CARLA SOU, V2
   Morrison CR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0017-2016
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Pathak H, 2019, CLIN MED, V19, P381, DOI 10.7861/clinmed.2019-0035
   Peres RC, 2013, J VECTOR ECOL, V38, P190, DOI 10.1111/j.1948-7134.2013.12027.x
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rodas JD, 2016, AM J TROP MED HYG, V95, P639, DOI 10.4269/ajtmh.16-0091
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Xavier J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217871
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
NR 49
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 8
PY 2020
VL 15
IS 1
AR e0226098
DI 10.1371/journal.pone.0226098
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5DK
UT WOS:000534337700012
PM 31914137
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU de Jesus, JG
   Dutra, KR
   Sales, FCD
   Claro, IM
   Terzian, AC
   Candido, DD
   Hill, SC
   Theze, J
   Torres, C
   D'Agostini, TL
   Felix, AC
   Reis, AFN
   Alcantar, LC
   de Abreu, AL
   Croda, JHR
   de Oliveira, WK
   de Filipis, AMB
   Camis, MDRD
   Romano, CM
   Loman, NJ
   Pybus, OG
   Sabino, EC
   Nogueira, ML
   Faria, NR
AF de Jesus, Jaqueline Goes
   Dutra, Karina Rocha
   da Silva Sales, Flavia Cristina
   Claro, Ingra Morales
   Terzian, Ana Carolina
   Candido, Darlan da Silva
   Hill, Sarah C.
   Theze, Julien
   Torres, Celeste
   D'Agostini, Tatiana Lang
   Felix, Alvina Clara
   Negri Reis, Andreia F.
   Alcantar, Luiz Carlos Junior
   de Abreu, Andre L.
   Croda, Julio H. R.
   de Oliveira, Wanderson K.
   Bispo de Filipis, Ana Maria
   Rodrigues dos Santos Camis, Maria do Carmo
   Romano, Camila Malta
   Loman, Nick J.
   Pybus, Oliver G.
   Sabino, Ester Cerdeira
   Nogueira, Mauricio L.
   Faria, Nuno Rodrigues
TI Genomic detection of a virus lineage replacement event of dengue virus
   serotype 2 in Brazil, 2019
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue 2; outbreak; genomic surveillance; lineage replacement; Brazil
ID ZIKA VIRUS; CIRCULATION
AB BACKGROUND Despite efforts to mitigate the impact of dengue virus (DENV) epidemics, the virus remains a public health problem in tropical and subtropical regions around the world. Most DENV cases in the Americas between January and July 2019 were reported in Brazil. Sao Paulo State in the southeast of Brazil has reported nearly half of all DENV infections in the country.
   OBJECTIVES To understand the origin and dynamics of the 2019 DENV outbreak.
   METHODS Here using portable nanopore sequencing we generated20 new DENV genome sequences from viremic patients with suspected dengue infection residing in two of the most-affected municipalities of Sao Paulo State, Araraquara and Sao Jose do Rio Preto. We conducted a comprehensive phylogenetic analysis with 1,630 global DENV strains to better understand the evolutionary history of the DENV lineages that currently circulate in the region.
   FINDINGS The new outbreak strains were classified as DENV2 genotype III (American/Asian genotype). Our analysis shows that the 2019 outbreak is the result of a novel DENV lineage that was recently introduced to Brazil from the Caribbean region. Dating phylogeographic analysis suggests that DENV2-III BR-4 was introduced to Brazil in or around early 2014, possibly from the Caribbean region.
   MAIN CONCLUSIONS Our study describes the early detection of a newly introduced and rapidly-expanding DENV2 virus lineage in Brazil.
C1 [de Jesus, Jaqueline Goes; da Silva Sales, Flavia Cristina; Claro, Ingra Morales; Felix, Alvina Clara; Romano, Camila Malta; Sabino, Ester Cerdeira; Faria, Nuno Rodrigues] Univ Sao Paulo, Inst Med Trop, Sao Paulo, SP, Brazil.
   [Dutra, Karina Rocha; Terzian, Ana Carolina; Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [Candido, Darlan da Silva; Hill, Sarah C.; Theze, Julien; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Torres, Celeste; Alcantar, Luiz Carlos Junior; Bispo de Filipis, Ana Maria] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [D'Agostini, Tatiana Lang; Rodrigues dos Santos Camis, Maria do Carmo] Coordenadoria Controle Doencas Sao Paulo, Ctr Vigilancia Epidemiol Prof Alexandre Vranjac, Secretaria Estado Saude, Sao Paulo, SP, Brazil.
   [Negri Reis, Andreia F.] Secretaria Municipal Saude, Sao Jose Do Rio Preto, SP, Brazil.
   [Alcantar, Luiz Carlos Junior] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [de Abreu, Andre L.; Croda, Julio H. R.; de Oliveira, Wanderson K.] Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Minist Saude, Brasilia, DF, Brazil.
   [Croda, Julio H. R.] Fundacao Univ Fed Grande Dourados, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.
   [Croda, Julio H. R.] Fiocruz MS, Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
   [Romano, Camila Malta] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, SP, Brazil.
   [Loman, Nick J.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
RP Faria, NR (corresponding author), Univ Sao Paulo, Inst Med Trop, Sao Paulo, SP, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM nuno.faria@zoo.ox.ac.uk
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Hill, Sarah/0000-0002-2995-2596; Reis, AlessanRSS/0000-0001-8486-7469;
   da Silva Candido, Darlan/0000-0002-5080-3130
FU FAPESP-MRC grant (CADDE) [FAPESP 2018/14389-0]; Wellcome TrustWellcome
   Trust; Royal Society Sir Henry Dale Fellowship [204311/Z/16/Z];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0, 440685/2016-8, 440856/2016-7]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/01735-2, 13/21719-3,
   15/12295-0, 15/14313-6]; Oxford Martin School; Decit/SCTIE/MoH;
   CAPESCAPES [88887.130716/201600, 88881.130825/2016-00,
   88887.130823/2016-00]; EU's Horizon 2020 Programme through ZIKAlliance
   [PRES-005-FEX-17-4-2-33]
FX Financial support: The research was supported by the FAPESP-MRC grant
   (CADDE, FAPESP 2018/14389-0), a Wellcome Trust and Royal Society Sir
   Henry Dale Fellowship (grant 204311/Z/16/Z), and by a CNPq
   #400354/2016-0 and FAPESP #2016/01735-2, and by the Oxford Martin
   School; Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7);
   CAPES (88887.130716/201600, 88881.130825/2016-00 and
   88887.130823/2016-00); EU's Horizon 2020 Programme through ZIKAlliance
   (PRES-005-FEX-17-4-2-33).; MLN is supported by FAPESP (grant
   #13/21719-3); ACBT and KRD receive FAPESP Scholarships (grants
   #15/12295-0 and 15/14313-6, respectively); MLN and ECS are CNPq Research
   Fellows (PQ).
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   de Bruycker-Nogueira F, 2016, INFECT GENET EVOL, V45, P454, DOI 10.1016/j.meegid.2016.09.025
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fonseca V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007231
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Nunes PCG, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6641-4
   Hill SC, 2019, EMERG INFECT DIS, V25, P784, DOI 10.3201/eid2504.180958
   Kanakaratne N, 2009, EMERG INFECT DIS, V15, P192, DOI 10.3201/eid1502.080926
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Mir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098519
   MS-Ministerio da Saude, 2019, MON CAS ARB ROS URB
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Ortiz-Baez AS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180251
   PAHO /WHO-Pan American Health Organization/World Health Organization, 2019, EP UPD YELL FEV
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
NR 28
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e190423
DI 10.1590/0074-02760190423
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LT4TX
UT WOS:000537066200001
PM 32428189
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU de Jesus, JG
   Sacchi, C
   Candido, DD
   Claro, IM
   Sale, FCS
   Manuli, ER
   da Silva, DBB
   de Paiva, TM
   Pinho, MAB
   Santos, KCD
   Hill, SC
   Aguiar, RS
   Romero, F
   dos Santos, FCP
   Goncalves, CR
   Timenetsky, MD
   Quick, J
   Croda, JHR
   de Oliveira, W
   Rambaut, A
   Pybus, OG
   Loman, NJ
   Sabino, EC
   Faria, NR
AF de Jesus, Jaqueline Goes
   Sacchi, Claudio
   Candido, Darlan da Silva
   Claro, Ingra Morales
   Silva Sale, Flavia Cristina
   Manuli, Erika Regina
   Borges da Silva, Daniela Bernardes
   de Paiva, Terezinha Maria
   Benega Pinho, Margarete Aparecida
   de Oliveira Santos, Katia Correa
   Hill, Sarah Catherine
   Aguiar, Renato Santana
   Romero, Filipe
   Pereira dos Santos, Fabiana Cristina
   Goncalves, Claudia Regina
   Timenetsky, Maria do Carmo
   Quick, Joshua
   Rosa Croda, Julio Henrique
   de Oliveira, Wanderson
   Rambaut, Andrew
   Pybus, Oliver G.
   Loman, Nicholas J.
   Sabino, Ester Cerdeira
   Faria, Nuno Rodrigues
TI Importation and early local transmission of COVID-19 in Brazil, 2020
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Public health surveillance; COVID-19; SARS-CoV-2
ID EVOLUTION
AB We conducted the genome sequencing and analysis of the first confirmed COVID-19 infections in Brazil. Rapid sequencing coupled with phylogenetic analyses in the context of travel history corroborate multiple independent importations from Italy and local spread during the initial stage of COVID-19 transmission in Brazil.
C1 [de Jesus, Jaqueline Goes; Claro, Ingra Morales; Silva Sale, Flavia Cristina; Manuli, Erika Regina; Sabino, Ester Cerdeira; Faria, Nuno Rodrigues] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil.
   [Sacchi, Claudio; Goncalves, Claudia Regina] Adolfo Lutz Inst, Lab Estrateg, Sao Paulo, SP, Brazil.
   [Candido, Darlan da Silva; Hill, Sarah Catherine; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3SY, England.
   [Borges da Silva, Daniela Bernardes; de Paiva, Terezinha Maria; Benega Pinho, Margarete Aparecida; de Oliveira Santos, Katia Correa; Pereira dos Santos, Fabiana Cristina; Timenetsky, Maria do Carmo] Adolfo Lutz Inst, Ctr Virol, Sao Paulo, SP, Brazil.
   [Aguiar, Renato Santana; Romero, Filipe] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Quick, Joshua; Loman, Nicholas J.] Univ Birmingham, Birmingham, W Midlands, England.
   [Rosa Croda, Julio Henrique; de Oliveira, Wanderson] Minist Saude Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, Brasilia, DF, Brazil.
   [Rosa Croda, Julio Henrique] Fundacao Univ Fed Grande Dourados, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.
   [Rosa Croda, Julio Henrique] Fundacao Osvaldo Cruz Campo Grande, Campo Grande, MS, Brazil.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Faria, Nuno Rodrigues] Imperial Coll, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3SY, England.
EM nuno.fana@zoo.ox.ac.uk
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Goncalves, Claudia Regina/0000-0002-4287-0560; da Silva Sales, Flavia
   Cristina/0000-0002-9048-0030; Manuli, Erika/0000-0003-2376-8488; De
   Jesus, Jaqueline/0000-0002-5404-272X; Hill, Sarah/0000-0002-2995-2596;
   da Silva Candido, Darlan/0000-0002-5080-3130
FU Medical Research CouncilMedical Research Council UK (MRC) [MR/S0195/1];
   FAPESP CADDE partnership award [MR/S0195/1]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2018/14389-0]; John Fell
   Research Fund [005166]; Wellcome TrustWellcome Trust [204311/Z/16/Z];
   Royal Society Sir Henry Dale Fellowship [204311/Z/16/Z]; Clarendon Fund;
   Oxford University Zoology Department
FX This work was supported by a Medical Research Council and FAPESP CADDE
   partnership award (MR/S0195/1), FAPESP grant N degrees 2018/14389-0, and
   a John Fell Research Fund (grant N degrees 005166). NRF is supported by
   a Wellcome Trust and Royal Society Sir Henry Dale Fellowship
   (204311/Z/16/Z). DDSC is supported by the Clarendon Fund and by the
   Oxford University Zoology Department.
CR Andersen KG, 2020, NAT MED, DOI 10.1038/s41591-020-0820-9
   Brasil. Ministerio da Saude, NOT CAS DOENC PEL CO
   Candido DS, 2020, J TRAVEL MED
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, 2020, NAT MICROBIOL
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Rambaut A., PHYLOGENETIC ANAL NC
   WHO, COR DIS COVID 2019 S
   World Health Organization, CRIT PREP READ RESP
NR 13
TC 3
Z9 3
U1 5
U2 5
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2020
VL 62
AR e30
DI 10.1590/S1678-9946202062030
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LQ7YL
UT WOS:000535214700008
PM 32401959
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Maia, ZPG
   Pereira, FM
   Said, RFD
   Fonseca, V
   Graf, T
   Nogueira, FD
   Nardy, VB
   Xavier, J
   Maia, ML
   Abreu, AL
   de Albuquerque, CFC
   Oliveira, WK
   Croda, J
   de Filippis, AMB
   Cunha, RV
   Lourenco, J
   de Oliveira, T
   Faria, NR
   Alcantara, LCJ
   Giovanetti, M
AF Pereira Gusmao Maia, Zuinara
   Mota Pereira, Felicidade
   do Carmo Said, Rodrigo Fabiano
   Fonseca, Vagner
   Graef, Tiago
   de Bruycker Nogueira, Fernanda
   Brandao Nardy, Vanessa
   Xavier, Joilson
   Lima Maia, Maricelia
   Abreu, Andre L.
   Campelo de Albuquerque, Carlos F.
   Kleber Oliveira, Wanderson
   Croda, Julio
   de Filippis, Ana Maria Bispo
   Venancio Cunha, Rivaldo
   Lourenco, Jose
   de Oliveira, Tulio
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
   Giovanetti, Marta
TI Return of the founder Chikungunya virus to its place of introduction
   into Brazil is revealed by genomic characterization of exanthematic
   disease cases
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Chikungunya; East-Central-South-African genotype; Northeast Brazil;
   surveillance; portable genome sequencing
ID ZIKA
AB Between June 2017 and August 2018, several municipalities located in Bahia state (Brazil) reported a large increase in the number of patients presenting with febrile illness similar to that of arboviral infections. Using a combination of portable whole genome sequencing, molecular clock and epidemiological analyses, we revealed the return of the CHIKV-ECSA genotype into Bahia. Our results show local persistence of lineages in some municipalities and the re-introduction of new epidemiological strains from different Brazilian regions, highlighting a complex dynamic of transmission between epidemic seasons and sampled locations. Estimated climate-driven transmission potential of CHIKV remained at similar levels throughout the years, such that large reductions in the total number of confirmed cases suggests a slow, but gradual accumulation of herd-immunity over the 4 years of the epidemic in Bahia after its introduction in 2014. Bahia remains a reservoir of the genetic diversity of CHIKV in the Americas, and genomic surveillance strategies are essential to assist in monitoring and understanding arboviral transmission and persistence both locally and over large distances.
C1 [Pereira Gusmao Maia, Zuinara; Mota Pereira, Felicidade; Brandao Nardy, Vanessa] Dept Virol, Lab Cent Saude Publ, Salvador, BH, Brazil.
   [do Carmo Said, Rodrigo Fabiano; Giovanetti, Marta] Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Graef, Tiago] Fiocruz MS, Lab Patol Expt, Inst Goncalo Moniz, Salvador, BH, Brazil.
   [de Bruycker Nogueira, Fernanda; de Filippis, Ana Maria Bispo; Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Lima Maia, Maricelia] Univ Estadual Feira de Santana, Feira De Santana, BA, Brazil.
   [Lima Maia, Maricelia] Secretaria Saude Feira de Santana, Feira De Santana, BA, Brazil.
   [Abreu, Andre L.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, CGLAB SVS MS, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Kleber Oliveira, Wanderson] Minist Saude SVS MS, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Venancio Cunha, Rivaldo] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.
   [Venancio Cunha, Rivaldo] Fundacao Oswaldo Cruz, Coordinat Hlth Surveillance & Reference Labs, Rio De Janeiro, RJ, Brazil.
   [Lourenco, Jose; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Alcantara, LCJ; Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
EM luiz.alcantara@ioc.fiocruz.br; giovanetti.marta@gmail.com
RI Maia, Zuinara Pereira Gusmao/AAA-6737-2020; Graf, Tiago/S-8535-2019;
   Faria, Nuno R/I-2975-2012; Fonseca, Vagner/R-5813-2019; Maia,
   Zuinara/M-7713-2019; Giovanetti, Marta/AAK-7408-2020
OI Maia, Zuinara Pereira Gusmao/0000-0003-0224-4335; Graf,
   Tiago/0000-0003-4921-7975; Faria, Nuno R/0000-0001-8839-2798; Fonseca,
   Vagner/0000-0001-5521-6448; Alcantara, Luiz/0000-0002-6769-9931; Xavier,
   Joilson/0000-0003-3916-2018
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; Horizon 2020 Framework Programme
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; EU's Horizon 2020 Framework Programme through
   ZikaPlan [734584, 734857]; EU's Horizon 2020 Framework Programme through
   ZikAction [734584, 734857]; Department of Zoology, University of Oxford;
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This work was supported by the ZiBRA2 project, supported by the
   Brazilian Ministry of Health (SVS-MS) and the Pan American Organization
   (OPAS) and founded by CNPq [grant number 440685/2016-8 and
   440856/2016-7]; by CAPES [grant number 88887.130716/2016-00,
   88881.130825/2016-00 and 88887.130823/2016-00]; by Horizon 2020
   Framework Programme [grant number PRES-005-FEX-17-4-2-33]. The
   Flavivirus Laboratory activities were also supported by Faperj (Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)
   under the [grant number E-26/2002.930/2016], by the International
   Development Research Centre (IDRC) Canada over the [grant number
   108411-001] and EU's Horizon 2020 Framework Programme through ZikaPlan
   and ZikAction under the [grant number 734584 and 734857]. JL was
   supported by a lectureship from the Department of Zoology, University of
   Oxford. MG is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro - FAPERJ; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior.
CR Brasil, 2019, B EPIDEMIOLOGICO MON
   Fonseca V, 2019, PLOS NEGLECT TROP D, V8, P13
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lourenco J, 2017, ELIFE, V9, P6
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2019, PLOS NEGLECT TROP D, V7, P13
   Obolski U., 2019, METHODS ECOL EVOL, V1, P1
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Xavier J, 2019, PLOS ONE, V11, P14
NR 14
TC 0
Z9 1
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 53
EP 57
DI 10.1080/22221751.2019.1701954
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA JZ6DG
UT WOS:000505191100001
PM 31880218
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Giovanetti, M
   de Mendonca, MCL
   Fonseca, V
   Mares-Guia, MA
   Fabri, A
   Xavier, J
   de Jesus, JG
   Graf, T
   Rodrigues, CDD
   dos Santos, CC
   Sampaio, SA
   Chalhoub, FLL
   Nogueira, FD
   Theze, J
   Romano, APM
   Ramos, DG
   de Abreu, AL
   Oliveira, WK
   Said, RFD
   de Alburque, CFC
   de Oliveira, T
   Fernandes, CA
   Aguiar, SF
   Chieppe, A
   Sequeira, PC
   Faria, NR
   Cunha, RV
   Alcantara, LCJ
   de Filippis, AMB
AF Giovanetti, Marta
   Lima de Mendonca, Marcos Cesar
   Fonseca, Vagner
   Mares-Guia, Maria Angelica
   Fabri, Allison
   Xavier, Joilson
   de Jesus, Jaqueline Goes
   Graf, Tiago
   dos Santos Rodrigues, Cintia Damasceno
   dos Santos, Carolina Cardoso
   Sampaio, Simone Alves
   Levy Chalhoub, Flavia Lowen
   Nogueira, Fernanda de Bruycker
   Theze, Julien
   Martins Romano, Alessandro Pecego
   Ramos, Daniel Garkauskas
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   do Carmo Said, Rodrigo Fabiano
   Campelo de Alburque, Carlos F.
   de Oliveira, Tulio
   Fernandes, Carlos Augusto
   Aguiar, Shirlei Ferreira
   Chieppe, Alexandre
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Cunha, Rivaldo Venancio
   Junior Alcantara, Luiz Carlos
   Bispo de Filippis, Ana Maria
TI Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE yellow fever; outbreak; Southeast Brazil; genomic surveillance; outbreak
   response
ID PHYLOGENETIC ANALYSIS; DENGUE; ZIKA
AB The recent reemergence of yellow fever virus (YFV) in Brazil has raised serious concerns due to the rapid dissemination of the virus in the southeastern region. To better understand YFV genetic diversity and dynamics during the recent outbreak in southeastern Brazil, we generated 18 complete and nearly complete genomes from the peak of the epidemic curve from nonhuman primates (NHPs) and human infected cases across the Espirito Santo and Rio de Janeiro states. Genomic sequencing of 18 YFV genomes revealed the estimated timing, source, and likely routes of yellow fever virus transmission and dispersion during one of the largest outbreaks ever registered in Brazil. We showed that during the recent epidemic, YFV was reintroduced from Minas Gerais to the Espirito Santo and Rio de Janeiro states multiple times between 2016 and 2019. The analysis of data from portable sequencing could identify the corridor of spread of YFV. These findings reinforce the idea that continued genomic surveillance strategies can provide information on virus genetic diversity and transmission dynamics that might assist in understanding arbovirus epidemics.
   IMPORTANCE Arbovirus infections in Brazil, including yellow fever, dengue, zika, and chikungunya, result in considerable morbidity and mortality and are pressing public health concerns. However, our understanding of these outbreaks is hampered by the limited availability of genomic data. In this study, we investigated the genetic diversity and spatial distribution of YFV during the current outbreak by analyzing genomic data from areas in southeastern Brazil not covered by other previous studies. To gain insights into the routes of YFV introduction and dispersion, we tracked the virus by sequencing YFV genomes sampled from nonhuman primates and infected patients from the southeastern region. Our study provides an understanding of how YFV initiates transmission in new Brazilian regions and illustrates that genomics in the field can augment traditional approaches to infectious disease surveillance and control.
C1 [Giovanetti, Marta; Lima de Mendonca, Marcos Cesar; Mares-Guia, Maria Angelica; Fabri, Allison; dos Santos Rodrigues, Cintia Damasceno; dos Santos, Carolina Cardoso; Sampaio, Simone Alves; Levy Chalhoub, Flavia Lowen; Nogueira, Fernanda de Bruycker; Sequeira, Patricia Carvalho; Junior Alcantara, Luiz Carlos; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [de Jesus, Jaqueline Goes; Graf, Tiago] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Theze, Julien] Univ Oxford, Dept Zool, Oxford, England.
   [Martins Romano, Alessandro Pecego; Ramos, Daniel Garkauskas] Minist Saude, Coordenacao Geral Vigilancia Arboviroses CGARB, CGLAB SVS MS, Brasilia, DF, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Minist Saude,CGLAB SVS MS, Brasilia, DF, Brazil.
   [Oliveira, Wanderson Kleber] Minist Saude, SVS, Brasilia, DF, Brazil.
   [Campelo de Alburque, Carlos F.] Lab Cent Saude Publ Noel Nutels LACEN RJ, Rio De Janeiro, Brazil.
   [Fernandes, Carlos Augusto] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Chieppe, Alexandre] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Cunha, Rivaldo Venancio] Univ Fed Mato Grosso, Fac Med, Campo Grande, MS, Brazil.
RP Giovanetti, M (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
EM giovanetti.marta@gmail.com
RI Fonseca, Vagner/R-5813-2019; Giovanetti, Marta/AAK-7408-2020; Graf,
   Tiago/S-8535-2019; Faria, Nuno R/I-2975-2012
OI Fonseca, Vagner/0000-0001-5521-6448; Graf, Tiago/0000-0003-4921-7975;
   Faria, Nuno R/0000-0001-8839-2798; Xavier, Joilson/0000-0003-3916-2018;
   Alcantara, Luiz/0000-0002-6769-9931
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; EU's Horizon 2020 program through ZIKAlliance
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; Horizon 2020 through ZikaPlan [734584, 734857];
   Horizon 2020 through ZikAction [734584, 734857]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX We thank all personnel from Health Surveillance System in Rio de Janeiro
   that coordinated surveillance and helped with data collection and
   assembly. We also thank Ronaldo Lapa e Solange Regina Conceicao from the
   Instituto Oswaldo Cruz (Fiocruz, Rio de Janeiro) for their support.;
   This work was supported by the ZiBRA2 project supported by the Brazilian
   Ministry of Health (SVS-MS) and the Pan American Organization (OPAS) and
   founded by Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7);
   by CAPES (88887.130716/2016-00, 88881.130825/2016-00, and
   88887.130823/2016-00); and by EU's Horizon 2020 program through
   ZIKAlliance (PRES-005-FEX-17-4-2-33). The Flavivirus Laboratory
   activities was also supported by Faperj (Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro) under grant number
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada over the grant 108411-001 and Horizon 2020 through
   ZikaPlan and ZikAction under the grant's agreement numbers 734584 and
   734857. M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ).
CR Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Brazilian Ministry of Health, 2017, EP UPD YELL FEV
   Brazilian Ministry of Health, 2018, EP UPD YELL FEV
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   Degallier Nicolas, 1992, Ciencia e Cultura (Sao Paulo), V44, P143
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   deSouza RP, 2019, BIORXIV, DOI [10.1101/645341, DOI 10.1101/645341]
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Giovanetti M, 2019, BIORXIV, DOI [10.1101/711994, DOI 10.1101/711994]
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mondet B, 1996, B SOC PATHOL EXOT, V89, P107
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ribeiro AF, 2019, AM J TROP MED HYG, V101, P180, DOI 10.4269/ajtmh.18-0882
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Secretaria de Vigilancia em Saude, 2019, MON PER SAZ FEBR AM
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Souza Renato Pereira de, 2011, Rev. Inst. Med. trop. S. Paulo, V53, P133, DOI 10.1590/S0036-46652011000300004
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
NR 36
TC 3
Z9 3
U1 5
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 1
AR e01623-19
DI 10.1128/JVI.01623-19
PG 12
WC Virology
SC Virology
GA JX6LP
UT WOS:000503844300009
PM 31597773
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Faria, NR
   Vidal, N
   Lourenco, J
   Raghwani, J
   Sigaloff, KCE
   Tatem, AJ
   van de Vijver, DAM
   Pineda-Pena, AC
   Rose, R
   Wallis, CL
   Ahuka-Mundeke, S
   Muyembe-Tamfum, JJ
   Muwonga, J
   Suchard, MA
   de Wit, TFR
   Hamers, RL
   Ndembi, N
   Baele, G
   Peeters, M
   Pybus, OG
   Lemey, P
   Dellicour, S
AF Faria, Nuno R.
   Vidal, Nicole
   Lourenco, Jose
   Raghwani, Jayna
   Sigaloff, Kim C. E.
   Tatem, Andy J.
   van de Vijver, David A. M.
   Pineda-Pena, Andrea-Clemencia
   Rose, Rebecca
   Wallis, Carole L.
   Ahuka-Mundeke, Steve
   Muyembe-Tamfum, Jean-Jacques
   Muwonga, Jeremie
   Suchard, Marc A.
   de Wit, Tobias F. Rinke
   Hamers, Raph L.
   Ndembi, Nicaise
   Baele, Guy
   Peeters, Martine
   Pybus, Oliver G.
   Lemey, Philippe
   Dellicour, Simon
TI Distinct rates and patterns of spread of the major HIV-1 subtypes in
   Central and East Africa
SO PLOS PATHOGENS
LA English
DT Article
ID ANTIRETROVIRAL DRUG-RESISTANCE; HUMAN-IMMUNODEFICIENCY-VIRUS; DISTANCE
   TRUCK DRIVERS; NAIVE INDIVIDUALS; TYPE-1; INFECTION; ORIGIN;
   SURVEILLANCE; TRANSMISSION; EPIDEMIC
AB Author summary Since it emerged in human populations in the Democratic Republic of Congo (DRC) around 1920, HIV diversified in several virus lineages that spread across sub-Saharan Africa and beyond. While some lineages are rare and remain geographically confined to certain regions, e.g. subtypes H and J, others expanded rapidly across sub-Saharan Africa, e.g. subtype C. Here we conducted a spatial genetic analysis of the three main HIV-1 virus lineages, subtypes, A1, C and D, that co-circulate across 20 locations in central and East Africa, to investigate their spatial and temporal origins and their mode of spread across comparable geographic areas. We find that subtype C, currently the dominant lineage in sub-Saharan Africa, emerged in the southern DRC mining region, and spread 3-fold faster than other co-circulating lineages. Our study uncovers distinct patterns of spread of the main HIV-1 subtypes in a region that covers nearly half of all infected individuals in sub-Saharan Africa.
   Since the ignition of the HIV-1 group M pandemic in the beginning of the 20th century, group M lineages have spread heterogeneously throughout the world. Subtype C spread rapidly through sub-Saharan Africa and is currently the dominant HIV lineage worldwide. Yet the epidemiological and evolutionary circumstances that contributed to its epidemiological expansion remain poorly understood. Here, we analyse 346 novel pol sequences from the DRC to compare the evolutionary dynamics of the main HIV-1 lineages, subtypes A1, C and D. Our results place the origins of subtype C in the 1950s in Mbuji-Mayi, the mining city of southern DRC, while subtypes A1 and D emerged in the capital city of Kinshasa, and subtypes H and J in the less accessible port city of Matadi. Following a 15-year period of local transmission in southern DRC, we find that subtype C spread at least three-fold faster than other subtypes circulating in Central and East Africa. In conclusion, our results shed light on the origins of HIV-1 main lineages and suggest that socio-historical rather than evolutionary factors may have determined the epidemiological fate of subtype C in sub-Saharan Africa.
C1 [Faria, Nuno R.; Lourenco, Jose; Raghwani, Jayna; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Vidal, Nicole] INSERM, Inst Rech Dev, TransVIHMI, Montpellier, France.
   [Sigaloff, Kim C. E.; de Wit, Tobias F. Rinke; Hamers, Raph L.] Univ Montpellier, Montpellier, France.
   [Sigaloff, Kim C. E.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.
   [Tatem, Andy J.] Univ Amsterdam, VU Univ, Med Ctr, Dept Internal Med,Sect Infect Dis, Amsterdam, Netherlands.
   [Tatem, Andy J.] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England.
   [van de Vijver, David A. M.] Flowminder Fdn, Stockholm, Sweden.
   [Pineda-Pena, Andrea-Clemencia] Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
   [Pineda-Pena, Andrea-Clemencia] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal.
   [Rose, Rebecca] Univ Rosario, Mol Biol & Immunol Dept, Fdn Inst Inmunol Colombia, Dept Basic Sci, Bogota, Colombia.
   [Wallis, Carole L.] Bioinfoexperts LLC, Thibodaux, LA USA.
   [Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques] Lancet Labs, Dept Mol Pathol, Johannesburg, South Africa.
   [Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques] BARC SA, Johannesburg, South Africa.
   [Muwonga, Jeremie] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques] Clin Univ Kinshasa, Microbiol Serv, Kinshasa, DEM REP CONGO.
   [Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques] Clin Univ Kinshasa, AIDS Natl Lab, Kinshasa, DEM REP CONGO.
   [Ahuka-Mundeke, Steve] Clin Univ Kinshasa, Microbiol Serv, Kinshasa, DEM REP CONGO.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Ndembi, Nicaise] UCLA, Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA.
   [Ndembi, Nicaise] Inst Human Virol, Abuja, Nigeria.
   [Baele, Guy; Lemey, Philippe; Dellicour, Simon] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab, Bruxels, Belgium.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM nuno.faria@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Dellicour, Simon/AAE-9054-2020; Faria, Nuno
   R/I-2975-2012; NDEMBI, Nicaise/AAE-4383-2020; Vidal, Nicole/L-4130-2017;
   Pineda-Pena, Andrea-Clemencia/N-9809-2015
OI Pybus, Oliver G/0000-0002-8797-2667; Dellicour,
   Simon/0000-0001-9558-1052; Faria, Nuno R/0000-0001-8839-2798; Lourenco,
   Jose/0000-0002-9318-2581; Raghwani, Jayna/0000-0001-8538-4995; Vidal,
   Nicole/0000-0001-7022-2643; Pineda-Pena,
   Andrea-Clemencia/0000-0003-1937-0506
FU Sir Henry Dale Fellowship (Wellcome Trust/Royal Society)
   [204311/Z/16/Z]; European Research Council under the European Union's
   Seventh Framework Programme (FP7/2007-2013)/ERCEuropean Research Council
   (ERC) [268904, 614725]; European Union's Horizon 2020 research and
   innovation programme [725422-ReservoirDOCS]; Wellcome TrustWellcome
   Trust [206298/Z/17/Z, 204613/Z/16/Z]; European Research Council award
   ReservoirDOCS; National Science FoundationNational Science Foundation
   (NSF) [DMS 1264153]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI107034, AI135995]; European Funds through grant 'Bio-Molecular
   and Epidemiological Surveillance of HIV Transmitted Drug Resistance,
   Hepatitis Co-Infections and Ongoing Transmission Patterns in Europe
   (BEST HOPE) (project HIVERA: Harmonizing Integrating Vitalizing European
   Re [249697]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1182408, OPP1106427, 1032350, OPP1134076]; Clinton Health
   Access Initiative; Wellcome Trust Sustaining Health GrantWellcome Trust
   [106866/Z/15/Z]; DFID; NOW-WOTRO; Netherlands Regional AIDS Program in
   Southern Africa; Abbott (ISR) [212620]; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven [C14/18/094]; Research Foundation
   -Flanders (FWO)FWO; Flemish Government -department EWI; Special Research
   Fund, KU Leuven (Bijzonder Onderzoeksfonds, KU Leuven) [OT/14/115];
   Research Foundation -Flanders (Fonds voor Wetenschappelijk Onderzoek
   -Vlaanderen)FWO [G066215N, G0D5117N, G0B9317N]; WienerAnspach
   Foundation; Fonds Wetenschappelijk Onderzoek (FWO, Belgium)FWO; Fonds
   National de la Recherche Scientifique (FNRS, Belgium)Fonds de la
   Recherche Scientifique - FNRS
FX NRF is funded by a Sir Henry Dale Fellowship (Wellcome Trust/Royal
   Society Grant 204311/Z/16/Z). JL was funded by the European Research
   Council under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant agreement no. 268904 -DIVERSITY. The research
   leading to these results has received funding from the European Research
   Council under the European Union's Horizon 2020 research and innovation
   programme (grant agreement no. 725422-ReservoirDOCS). MAS and PL
   acknowledge funding from the Wellcome Trust Collaborative Award,
   206298/Z/17/Z and the European Research Council award ReservoirDOCS. MAS
   acknowledges funding from the National Science Foundation through grant
   DMS 1264153 and the National Institutes of Health through grants
   AI107034 and AI135995. ACPP was supported by European Funds through
   grant 'Bio-Molecular and Epidemiological Surveillance of HIV Transmitted
   Drug Resistance, Hepatitis Co-Infections and Ongoing Transmission
   Patterns in Europe (BEST HOPE) (project funded through HIVERA:
   Harmonizing Integrating Vitalizing European Research on HIV/Aids, grant
   249697). AJT is supported by funding from the Bill & Melinda Gates
   Foundation (OPP1182408, OPP1106427, 1032350, OPP1134076), the Clinton
   Health Access Initiative, National Institutes of Health, a Wellcome
   Trust Sustaining Health Grant (106866/Z/15/Z), and funds from DFID and
   the Wellcome Trust (204613/Z/16/Z). TFRW received funding from NOW-WOTRO
   and the Netherlands Regional AIDS Program in Southern Africa. NN
   received funding from Abbott (ISR#212620). GB acknowledges support from
   the Interne Fondsen KU Leuven/Internal Funds KU Leuven under grant
   agreement C14/18/094, and the computational resources and services
   provided by the VSC (Flemish Supercomputer Center), funded by the
   Research Foundation -Flanders (FWO) and the Flemish Government
   -department EWI. OGP received funding from the European Research Council
   under the European Union's Seventh Framework Programme (FP7/2007
   -2013)/ERC grant agreement no. 614725 -PATHPHYLODYN. PL acknowledges
   support by the Special Research Fund, KU Leuven (Bijzonder
   Onderzoeksfonds, KU Leuven, OT/14/115), and the Research Foundation
   -Flanders (Fonds voor Wetenschappelijk Onderzoek -Vlaanderen, G066215N,
   G0D5117N and G0B9317N). SD was supported by the WienerAnspach Foundation
   and the Fonds Wetenschappelijk Onderzoek (FWO, Belgium), and is
   currently funded by the Fonds National de la Recherche Scientifique
   (FNRS, Belgium). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007
   Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07
   Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09
   [Anonymous], 2013, GER HIST, V30, P239
   [Anonymous], 2017, JLSRF, V3, pA104
   [Anonymous], 2012, TOPICS HETEROCYCLIC, V29, P347
   [Anonymous], 2012, DIABETES OBES METAB, V14, P83
   [Anonymous], 2013, N ENGL J MED, V368, pe36
   [Anonymous], 2016, HIV LOS ALAMOS SEQUE
   [Anonymous], 1997, AIDS, V11, pS13
   [Anonymous], 2013, N ENGL J MED, V368, pe36
   [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001
   Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594
   Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bartolo I, 2016, AIDS RES HUM RETROV, V32, P822, DOI [10.1089/aid.2016.0084, 10.1089/AID.2016.0084]
   Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003
   Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391
   Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548
   Delatorre E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098908
   Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074072
   Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448
   Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904
   Dellicour S, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey023
   Dellicour S, 2016, BIOINFORMATICS, V32, P3204, DOI 10.1093/bioinformatics/btw384
   Dennis AM, 2014, JAIDS-J ACQ IMM DEF, V67, P181, DOI 10.1097/QAI.0000000000000271
   Djoko CF, 2011, AIDS RES HUM RETROV, V27, P323, DOI 10.1089/aid.2010.0201
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Eshleman SH, 2009, AIDS, V23, P845, DOI 10.1097/QAD.0b013e328327957a
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   Ferguson AG, 2007, HEALTH PLACE, V13, P504, DOI 10.1016/j.healthplace.2006.05.009
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104
   Gale CV, 2006, AIDS RES HUM RETROV, V22, P985, DOI 10.1089/aid.2006.22.985
   Galluzzo CM, 2007, AIDS RES HUM RETROV, V23, P1449, DOI 10.1089/aid.2007.0109
   Giles-Vernick T, 2013, J AFR HIST, V54, P11, DOI 10.1017/S0021853713000029
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9
   Hazlewood A, 1964, RAIL ROAD E AFRICA T, Vxiii
   Hemelaar J, 2019, LANCET INFECT DIS, V19, P143, DOI 10.1016/S1473-3099(18)30647-9
   Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93
   Hogan CA, 2016, J INFECT DIS, V214, P353, DOI 10.1093/infdis/jiw009
   Hue S, 2012, AIDS RES HUM RETROV, V28, P220, DOI 10.1089/aid.2011.0048
   Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68
   Huybrechts A., 1970, TRANSPORTS STRUCTURE
   Iversen AKN, 2005, AIDS, V19, P990, DOI 10.1097/01.aids.0000171418.91786.ad
   Kalish ML, 2004, EMERG INFECT DIS, V10, P1227
   Katoh Kazutaka, 2005, Genome Inform, V16, P22
   Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08
   Koehler AB, 2001, INT J FORECASTING, V17, P269, DOI 10.1016/S0169-2070(01)00081-4
   Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789
   Kuhnert D, 2016, MOL BIOL EVOL, V33, P2102, DOI 10.1093/molbev/msw064
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2012, BIOINFORMATICS, V28, P3248, DOI 10.1093/bioinformatics/bts580
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Li GD, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0148-6
   Lihana RW, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-215
   Mbugua GG, 1995, E AFR MED J, V72, P515
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Mosha F, 2011, AIDS RES HUM RETROV, V27, P377, DOI 10.1089/aid.2010.0113
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Muwonga J, 2011, JAIDS-J ACQ IMM DEF, V57, pS27, DOI 10.1097/QAI.0b013e31821f596c
   Nazziwa J, 2013, AIDS RES HUM RETROV, V29, P788, DOI [10.1089/aid.2012.0123, 10.1089/AID.2012.0123]
   Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Pepin J, 2013, J EPIDEMIOL COMMUN H, V67, P473, DOI 10.1136/jech-2012-201423
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Raghwani J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007167
   Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179
   Rambaut A., 2014, PATH O GEN V1 4
   Schneider WH, 2009, MED HIST, V53, P193, DOI 10.1017/S002572730000363X
   SEIBERT SA, 1995, MOL BIOL EVOL, V12, P803
   Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P833, DOI [10.1089/aid.2011.0348, 10.1089/AID.2011.0348]
   Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022
   Somi GR, 2008, ANTIVIR THER, V13, P77
   Ssemwanga D, 2012, CLIN INFECT DIS, V54, pS339, DOI 10.1093/cid/cir937
   Stadler T, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0420
   Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904
   Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020
   UNAIDS, 2019, GLOB AIDS UPD 2019
   UNAIDS, 2013, GLOB REP UNAIDS REP
   Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000
   Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94
   Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126
   Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001
   Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4
   Wilkinson E, 2016, INFECT GENET EVOL, V46, P200, DOI 10.1016/j.meegid.2016.07.008
   Wilkinson E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16897
   Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390
   Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Yebra G, 2015, J GEN VIROL, V96, P1890, DOI 10.1099/vir.0.000107
   Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400
NR 111
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD DEC
PY 2019
VL 15
IS 12
AR e1007976
DI 10.1371/journal.ppat.1007976
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA KC7BG
UT WOS:000507327900026
PM 31809523
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Hill, SC
   Vasconcelos, J
   Neto, Z
   Jandondo, D
   Ze-Ze, L
   Aguiar, RS
   Xavier, J
   Theze, J
   Mirandela, M
   Candido, ALM
   Vaz, F
   Sebastiao, CD
   Wu, CH
   Kraemer, MUG
   Melo, A
   Schamber-Reis, BLF
   de Azevedo, GS
   Tanuri, A
   Higa, LM
   Clemente, C
   da Silva, SP
   Candido, DD
   Claro, IM
   Quibuco, D
   Domingos, C
   Pocongo, B
   Watts, AG
   Khan, K
   Alcantara, LCJ
   Sabino, EC
   Lackritz, E
   Pybus, OG
   Alves, MJ
   Afonso, J
   Faria, NR
AF Hill, Sarah C.
   Vasconcelos, Jocelyne
   Neto, Zoraima
   Jandondo, Domingos
   Ze-Ze, Libia
   Aguiar, Renato Santana
   Xavier, Joilson
   Theze, Julien
   Mirandela, Marinela
   Micolo Candido, Ana Luisa
   Vaz, Filipa
   Sebastiao, Cruz dos Santos
   Wu, Chieh-Hsi
   Kraemer, Moritz U. G.
   Melo, Adriana
   Schamber-Reis, Bruno L. F.
   de Azevedo, Girlene S.
   Tanuri, Amilcar
   Higa, Luiza M.
   Clemente, Carina
   da Silva, Sara Pereira
   Candido, Darlan da Silva
   Claro, Ingra M.
   Quibuco, Domingos
   Domingos, Cristovao
   Pocongo, Barbara
   Watts, Alexander G.
   Khan, Kamran
   Junior Alcantara, Luiz Carlos
   Sabino, Ester C.
   Lackritz, Eve
   Pybus, Oliver G.
   Alves, Maria-Joao
   Afonso, Joana
   Faria, Nuno R.
TI Emergence of the Asian lineage of Zika virus in Angola: an outbreak
   investigation
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION; AFRICA
AB Background Zika virus infections and suspected microcephaly cases have been reported in Angola since late 2016, but no data are available about the origins, epidemiology, and diversity of the virus. We aimed to investigate the emergence and circulation of Zika virus in Angola.
   Methods Diagnostic samples collected by the Angolan Ministry of Health as part of routine arboviral surveillance were tested by real-time reverse transcription PCR by the Instituto Nacional de Investigacao em Saude (Ministry of Health, Luanda, Angola). To identify further samples positive for Zika virus and appropriate for genomic sequencing, we also tested samples from a 2017 study of people with HIV in Luanda. Portable sequencing was used to generate Angolan Zika virus genome sequences from three people positive for Zika virus infection by real-time reverse transcription PCR, including one neonate with microcephaly. Genetic and mobility data were analysed to investigate the date of introduction and geographical origin of Zika virus in Angola. Brain CT and MRI, and serological assays were done on a child with microcephaly to confirm microcephaly and assess previous Zika virus infection.
   Findings Serum samples from 54 people with suspected acute Zika virus infection, 76 infants with suspected microcephaly, 24 mothers of infants with suspected microcephaly, 336 patients with suspected dengue virus or chikungunya virus infection, and 349 samples from the HIV study were tested by real-time reverse transcription PCR. Four cases identified between December, 2016, and June, 2017, tested positive for Zika virus. Analyses of viral genomic and human mobility data suggest that Zika virus was probably introduced to Angola from Brazil between July, 2015, and June, 2016. This introduction probably initiated local circulation of Zika virus in Angola that continued until at least June, 2017. The infant with microcephaly in whom CT and MRI were done had brain abnormalities consistent with congenital Zika syndrome and serological evidence for Zika virus infection.
   Interpretation Our analyses show that autochthonous transmission of the Asian lineage of Zika virus has taken place in Africa. Zika virus surveillance and surveillance of associated cases of microcephaly throughout the continent is crucial.
C1 [Hill, Sarah C.; Theze, Julien; Kraemer, Moritz U. G.; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Wu, Chieh-Hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Vasconcelos, Jocelyne; Neto, Zoraima; Jandondo, Domingos; Mirandela, Marinela; Micolo Candido, Ana Luisa; Vaz, Filipa; Sebastiao, Cruz dos Santos; Afonso, Joana] Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
   [Ze-Ze, Libia; Alves, Maria-Joao] Inst Nacl Saude Doutor Ricardo Jorge, Aguas De Moura, Portugal.
   [Ze-Ze, Libia] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.
   [Aguiar, Renato Santana; Tanuri, Amilcar; Higa, Luiza M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato Santana; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Dept Genet Ecol & Evolucao, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Sebastiao, Cruz dos Santos] Univ Agostinho Neto, Inst Super Ciencias Saude, Luanda, Angola.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA 02115 USA.
   [Melo, Adriana; de Azevedo, Girlene S.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Brazil.
   [Schamber-Reis, Bruno L. F.] Ctr Univ Unifacisa, Dept Human Genet, Campina Grande, Brazil.
   [Clemente, Carina; da Silva, Sara Pereira] Cligest Clin, Luanda, Angola.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Quibuco, Domingos] Hosp Pediat David Bernardino, Luanda, Angola.
   [Domingos, Cristovao; Pocongo, Barbara] Inst Nacl Luta SIDA, Luanda, Angola.
   [Watts, Alexander G.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Watts, Alexander G.; Khan, Kamran] BlueDot, Toronto, ON, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Junior Alcantara, Luiz Carlos] IOC Fundacao Oswaldo Cruz MS, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Lackritz, Eve] WHO, Geneva, Switzerland.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.; Afonso, J (corresponding author), Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
EM jfm.morais9@gmail.com; nuno.faria@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Ze-Ze, Libia Maria Marques/U-5730-2017;
   Aguiar, Renato S/G-3542-2015; Melo, Adriana S O/H-5650-2016; Faria, Nuno
   R/I-2975-2012; Higa, Luiza/W-2698-2019; Sabino, Ester
   Cerdeira/F-7750-2010
OI Pybus, Oliver G/0000-0002-8797-2667; Ze-Ze, Libia Maria
   Marques/0000-0001-7258-1439; Aguiar, Renato S/0000-0001-5180-3717;
   Faria, Nuno R/0000-0001-8839-2798; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Xavier, Joilson/0000-0003-3916-2018; da
   Silva Candido, Darlan/0000-0002-5080-3130; Hill,
   Sarah/0000-0002-2995-2596; Alves, Maria Joao/0000-0003-0065-9000;
   Alcantara, Luiz/0000-0002-6769-9931
FU Sir Henry Dale Fellowship [204311/Z/16/Z]; internal Higher Education
   Funding Council for England Global Challenges Research Fund [005073];
   Africa Oxford Initiative [AfiOx-48, AfiOx-60]; John Fell Research Fund
   [005166]; Medical Research CouncilMedical Research Council UK (MRC)
   [MR/S0195/1, 2018/14389-0]; O Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [440900/2016-6, 440685/2016-8];
   Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [88881.130757/2016-01, 88887.130716/2016-00,
   88881.130728/2016-01]; European Research CouncilEuropean Research
   Council (ERC) [614725-PATHPHYLODYN]; Oxford Martin School; UK Medical
   Research CouncilMedical Research Council UK (MRC); Cancer Research
   UKCancer Research UK [ANR00310]
FX We thank the participants who participated in this study and the WHO
   Angolan country office for sharing information about suspected Zika and
   microcephaly cases. This research was supported by a Sir Henry Dale
   Fellowship (204311/Z/16/Z), internal Higher Education Funding Council
   for England Global Challenges Research Fund (005073), the Africa Oxford
   Initiative (AfiOx-48 and AfiOx-60), John Fell Research Fund (005166),
   and by the Medical Research Council (MR/S0195/1 and 2018/14389-0), O
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (440900/2016-6 and 440685/2016-8), Fundacao Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (88881.130757/2016-01,
   88887.130716/2016-00, and 88881.130728/2016-01), the European Research
   Council (FP7 grant agreement 614725-PATHPHYLODYN), and the Oxford Martin
   School. C-HW is supported by the UK Medical Research Council and Cancer
   Research UK (ANR00310). We thank Patricia Alvarez Baptista and Antonio
   Gomes Pinto Ferreira (Fundacao Oswaldo Cruz, Instituto de Tecnologia em
   Imunobiologicos Bio-Manguinhos, Rio de Janeiro, Brazil) for donating
   Bio-Manguinhos reagents, and Jorge Munoz-Jordan and Gilberto Santiago
   (CDC) for donating real-time reverse transcription PCR reagents.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hill SC, 2019, EMERG INFECT DIS, V25, P784, DOI 10.3201/eid2504.180958
   Lourenco J, 2018, PLOS CURR OUTBREAKS
   Melo AS, 2016, JAMA NEUROL
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Pan American Health Organization, 2018, DIG ZIK CAS INC RAT
   Pan American Health Organization WHO, 2018, ZIK CAS CONG SYNDR A
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Sharp TM, 2013, MMWR-MORBID MORTAL W, V62, P504
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Taiwan Centers for Disease Control, TRAV VIS RET ZIK AFF
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   WHO, 2017, WEEK, V48
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2007, WHO CHILD GROWTH STA
   World Health Organization rapid advice guideline, 2016, SCREEN ASS MAN NEON
NR 32
TC 10
Z9 10
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2019
VL 19
IS 10
BP 1138
EP 1147
DI 10.1016/S1473-3099(19)30293-2
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA JA4ST
UT WOS:000487824300040
PM 31559967
OA Green Published, Other Gold, Green Accepted
DA 2020-09-29
ER

PT J
AU Candido, DD
   Pybus, OG
   Faria, NR
AF Candido, Darlan da Silva
   Pybus, Oliver G.
   Faria, Nuno Rodrigues
TI Genomic epidemiology quantifies gaps in Aedes-borne virus transmission
   in the Americas
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Candido, Darlan da Silva] Univ Oxford, Radcliffe Dept Med, Oxford, England.
   [Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A38
BP S12
EP S12
DI 10.1093/ve/vez002.037
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600039
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   Joshua, Q
   Claro, IM
   Xavier, J
   Hill, SC
   Renato, S
   Paz, P
   Lourenco, J
   Dellicour, S
   Sabino, E
   Loman, NJ
   Naveca, F
   Pybus, OG
   Faria, NR
   Alcantara, LCJ
AF Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Joshua, Quick
   Claro, Ingra Morales
   Xavier Junior, Joilson
   Hill, Sarah C.
   Renato, Souza
   Paz, Paola
   Lourenco, Jose
   Dellicour, Simon
   Sabino, Esther
   Loman, Nicholas J.
   Naveca, Felipe
   Pybus, Oliver G.
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
TI Genomic surveillance of Zika virus transmission in the Amazonas State,
   Brazil
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier Junior, Joilson; Junior Alcantara, Luiz Carlos] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Joshua, Quick; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, Ingra Morales; Sabino, Esther] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Hill, Sarah C.; Lourenco, Jose; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Renato, Souza; Paz, Paola] Univ Fed Rio de Janeiro, Inst Pasteur, Lab Clin & Epidemiol Virol, Rio De Janeiro, Brazil.
   [Dellicour, Simon] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
   [Naveca, Felipe] Fiocruz MS, Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
RI Pybus, Oliver G/B-2640-2012; Dellicour, Simon/AAE-9054-2020; Faria, Nuno
   R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020
OI Pybus, Oliver G/0000-0002-8797-2667; Dellicour,
   Simon/0000-0001-9558-1052; Faria, Nuno R/0000-0001-8839-2798; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A32
BP S10
EP S10
DI 10.1093/ve/vez002.031
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600033
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Oboist, U
   Perez, PN
   Villabona-Arenas, CJ
   Theze, J
   Faria, NR
   Lourenco, J
AF Oboist, Uri
   Perez, Pablo N.
   Villabona-Arenas, Christian J.
   Theze, Julien
   Faria, Nuno R.
   Lourenco, Jose
TI MVSE: An R-package that estimates a climate-driven mosquito-borne viral
   suitability index
SO METHODS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE community ecology; community ecological modelling; disease ecology;
   disease ecological modelling; microbial ecology; mosquitoes;
   mosquito-borne Viral Suitability Estimator; viruses
ID AEDES-AEGYPTI; ZIKA VIRUS; JAPANESE ENCEPHALITIS; WEST-NILE; DENGUE;
   TEMPERATURE; CULICIDAE; OUTBREAK; DIPTERA; VECTOR
AB Viruses, such as dengue, Zika, yellow fever and chikungunya, depend on mosquitoes for transmission. Their epidemics typically present periodic patterns, linked to the underlying mosquito population dynamics, which are known to be driven by natural climate fluctuations. Understanding how climate dictates the timing and potential of viral transmission is essential for preparedness of public health systems and design of control strategies. While various alternative approaches have been proposed to estimate local transmission potential of such viruses, few open-source, ready to use and freely available software tools exist. We developed the Mosquito-borne Viral Suitability Estimator (MVSE) software package for the R programming environment. MVSE estimates the index P, a novel suitability index based on a climate-driven mathematical expression for the basic reproductive number of mosquito-borne viruses. By accounting for local humidity and temperature, as well as viral, vector and human priors, the index P can be estimated for specific host and viral species in different regions of the globe. We describe the background theory, empirical support and biological interpretation of the index P. Using real-world examples spanning multiple epidemiological contexts, we further demonstrate MVSE's basic functionality, research and educational potentials.
C1 [Oboist, Uri] Tel Aviv Univ, Sch Publ Hlth, Tel Aviv, Israel.
   [Oboist, Uri] Tel Aviv Univ, Porter Sch Environm & Earth Sci, Tel Aviv, Israel.
   [Perez, Pablo N.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England.
   [Villabona-Arenas, Christian J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London, England.
   [Theze, Julien; Faria, Nuno R.; Lourenco, Jose] Univ Oxford, Dept Zool, Oxford, England.
RP Lourenco, J (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM jose.lourenco@zoo.ox.ac.uk
RI Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798; Lourenco, Jose/0000-0002-9318-2581;
   Villabona Arenas, Christian Julian/0000-0001-9928-3968
FU Higher Education Funding Council for EnglandHigher Education Funding
   Council for England [005073]; John Fell Fund, University of Oxford
   [005166]; European Molecular Biology OrganizationEuropean Molecular
   Biology Organization (EMBO); Wellcome TrustWellcome Trust
   [204311/Z/16/Z]; Royal SocietyRoyal Society of London [204311/Z/16/Z];
   H2020 European Research Council [757688]; FP7 Ideas: European Research
   Council [268904, 614725]
FX Higher Education Funding Council for England, Grant/Award Number:
   005073; John Fell Fund, University of Oxford, Grant/Award Number:
   005166; European Molecular Biology Organization; Wellcome Trust and
   Royal Society, Grant/Award Number: 204311/Z/16/Z; H2020 European
   Research Council, Grant/Award Number: ERC-2017-STG and 757688; FP7
   Ideas: European Research Council, Grant/Award Number: 268904 -DIVERSITY
   and 614725 -PATHPHYLODYN
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034651
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dickerson CZ, 2007, EFFECTS TEMPERATURE
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dutta P, 2010, J ENVIRON BIOL, V31, P781
   Ezeakacha N., 2015, THESIS, P131
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS, V8
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92
   Guzzetta G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005918
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, P1
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006284
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Jaenisch Thomas, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2010.140487
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer M. U. G., 2016, LANCET INFECT DIS, V3099, P1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Louren<comma>co J., 2019, MVSE DATA COLLECTION, DOI [10.6084/m9.figshare.c.4485503, DOI 10.6084/M9.FIGSHARE.C.4485503]
   Lourenco J, 2018, EVOL APPL, V11, P516, DOI 10.1111/eva.12554
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/eLife.29820, 10.7554/elife.29820]
   Lourenco J, 2016, EPIDEMICS-NETH, V16, P40, DOI 10.1016/j.epidem.2016.05.003
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Macdonald G., 1957, EPIDEMIOLOGY CONTROL
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Madeira NG, 2002, MEM I OSWALDO CRUZ, V97, P415, DOI 10.1590/S0074-02762002000300025
   MAGALHAES T, 2017, PLOS NEGLECT TROP D, V26, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Monteiro LCC, 2007, NEOTROP ENTOMOL, V36, P966, DOI 10.1590/S1519-566X2007000600021
   Mordecai E. A., 2017, PLOS NEGLECT TROP D, V11, P1
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oo TT, 2011, TROP BIOMED, V28, P302
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Perez-Guzman Pablo Noel, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.7a6c64436a3085ebba37e5329ba169e6
   ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143
   ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P1251, DOI 10.1016/0022-1910(68)90018-8
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0
   Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Williams CR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000922
   Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yanoviak SP, 2006, ECOL APPL, V16, P1854, DOI 10.1890/1051-0761(2006)016[1854:DAPHAA]2.0.CO;2
   Yasuno M., 1960, POPULATION ENGLISH E, V43, P319
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
NR 78
TC 1
Z9 1
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2041-210X
EI 2041-2096
J9 METHODS ECOL EVOL
JI Methods Ecol. Evol.
PD AUG
PY 2019
VL 10
IS 8
BP 1357
EP 1370
DI 10.1111/2041-210X.13205
PG 14
WC Ecology
SC Environmental Sciences & Ecology
GA IO1AD
UT WOS:000479111100022
PM 32391139
OA Green Published, Other Gold, Green Accepted
DA 2020-09-29
ER

PT J
AU Vasylyeva, TI
   du Plessis, L
   Pineda-Pena, AC
   Kuhnert, D
   Lemey, P
   Vandamme, AM
   Gomes, P
   Camacho, RJ
   Pybus, OG
   Abecasis, AB
   Faria, NR
AF Vasylyeva, Tetyana I.
   du Plessis, Louis
   Pineda-Pena, Andrea C.
   Kuehnert, Denise
   Lemey, Philippe
   Vandamme, Anne-Mieke
   Gomes, Perpetua
   Camacho, Ricardo J.
   Pybus, Oliver G.
   Abecasis, Ana B.
   Faria, Nuno R.
TI Tracing the Impact of Public Health Interventions on HIV-1 Transmission
   in Portugal Using Molecular Epidemiology
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE HIV; Portugal; phylodynamics; epidemiology; reproductive number;
   transmission groups; harm reduction
ID DRUG-RESISTANCE; INJECT DRUGS; HEPATITIS-C; NON-B; NETWORKS; SPREAD;
   PREVALENCE; INFECTION; PEOPLE; SEX
AB Background. Estimation of temporal changes in human immunodeficiency virus (HIV) transmission patterns can help to elucidate the impact of preventive strategies and public health policies.
   Methods. Portuguese HIV-1 subtype B and G pol genetic sequences were appended to global reference data sets to identify country-specific transmission clades. Bayesian birth-death models were used to estimate subtype-specific effective reproductive numbers (R-e). Discrete trait analysis (DTA) was used to quantify mixing among transmission groups.
   Results. We identified 5 subtype B Portuguese clades (26-79 sequences) and a large monophyletic subtype G Portuguese clade (236 sequences). We estimated that major shifts in HIV-1 transmission occurred around 1999 (95% Bayesian credible interval [BCI], 1998-2000) and 2000 (95% BCI, 1998-2001) for subtypes B and G, respectively. For subtype B, R-e dropped from 1.91 (95% BCI, 1.73-2.09) to 0.62 (95% BCI,. 52-. 72). For subtype G, R-e decreased from 1.49 (95% BCI, 1.39-1.59) to 0.72 (95% BCI,.63-. 8). The DTA suggests that people who inject drugs (PWID) and heterosexuals were the source of most (>80%) virus lineage transitions for subtypes G and B, respectively.
   Conclusions. The estimated declines in R-e coincide with the introduction of highly active antiretroviral therapy and the scale-up of harm reduction for PWID. Inferred transmission events across transmission groups emphasize the importance of prevention efforts for bridging populations.
C1 [Vasylyeva, Tetyana I.; du Plessis, Louis; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
   [Vasylyeva, Tetyana I.] Univ Oxford, New Coll, Oxford, England.
   [Pineda-Pena, Andrea C.; Vandamme, Anne-Mieke; Abecasis, Ana B.] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Global Hlth & Trop Med, Lisbon, Portugal.
   [Gomes, Perpetua] Ctr Hosp Lisboa Ocidental, Hosp Egas Moniz, Lab Mol Biol, LMCBM,SPC, Lisbon, Portugal.
   [Gomes, Perpetua] CiiEM, Ctr Interdisciplinary Res Egas Moniz, Almada, Portugal.
   [Pineda-Pena, Andrea C.] Univ Rosario, Mol Biol & Immunol Dept, Fdn Inst Inmunol Colombia, Bogota, Colombia.
   [Pineda-Pena, Andrea C.] Univ Rosario, Basic Sci Dept, Bogota, Colombia.
   [Kuehnert, Denise] Max Planck Inst Sci Human Hist, Jena, Germany.
   [Lemey, Philippe; Vandamme, Anne-Mieke; Camacho, Ricardo J.] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
EM nuno.faria@zoo.ox.ac.uk
RI Pineda-Pena, Andrea-Clemencia/N-9809-2015; Pybus, Oliver G/B-2640-2012;
   Vandamme, Anne-Mieke/I-4127-2012; Faria, Nuno R/I-2975-2012; du Plessis,
   Louis/K-1667-2013; Abecasis, Ana/B-6295-2009
OI Pineda-Pena, Andrea-Clemencia/0000-0003-1937-0506; Pybus, Oliver
   G/0000-0002-8797-2667; Vandamme, Anne-Mieke/0000-0002-6594-2766; Faria,
   Nuno R/0000-0001-8839-2798; du Plessis, Louis/0000-0003-0352-6289;
   Vasylyeva, Tetyana/0000-0002-9736-7022; Kuhnert,
   Denise/0000-0002-5657-018X; Abecasis, Ana/0000-0002-3903-5265
FU New College of the University of Oxford; Royal SocietyRoyal Society of
   London [204311/Z/16/Z]; Wellcome TrustWellcome Trust [204311/Z/16/Z];
   European Research Council, under the European Commission Seventh
   Framework Programme (FP7/2007-2013)/European Research Council
   [614725-PATHPHYLODYN]; Max Planck SocietyMax Planck SocietyFoundation
   CELLEX; European Funds (grant 'Bio-Molecular and Epidemiological
   Surveillance of HIV Transmitted Drug Resistance, Hepatitis Co-Infections
   and Ongoing Transmission Patterns in Europe-BEST HOPE-[HIVERA:
   Harmonizing Integrating Vitalizing European Research on HIV/AID
   [249697]; L'Oreal Portugal Medals of Honor for Women in Science 2012
   (L'Oreal Portugal); L'Oreal Portugal Medals of Honor for Women in
   Science 2012 (Comissao Nacional da Unesco); L'Oreal Portugal Medals of
   Honor for Women in Science 2012 (Fundacao para a Ciencia e Tecnologia
   [FCT]); FCTPortuguese Foundation for Science and Technology
   [GHTMUID/Multi/04413/2013]; MigrantHIV project - FCT
   [PTDC/DTP-EPI/7066/2014]; Gilead Genese HIVLatePresenters; Research
   Foundation FlandersFWO [FWO G.0692.14]; VIROGENESIS project from the
   European Union's Horizon 2020 Research and Innovation Programme [634650]
FX This work was supported by the New College of the University of Oxford
   (Juliana Cuyler Matthews Junior Research Fellowship to T. I. V.); the
   Royal Society and Wellcome Trust (Sir Henry Dale Fellowship [grant
   204311/Z/16/Z] to N. R. F.); the European Research Council, under the
   European Commission Seventh Framework Programme (FP7/2007-2013)/European
   Research Council (grant agreement 614725-PATHPHYLODYN; to O. G. P and L.
   d. P.); the Max Planck Society (to D. K.); European Funds (grant
   'Bio-Molecular and Epidemiological Surveillance of HIV Transmitted Drug
   Resistance, Hepatitis Co-Infections and Ongoing Transmission Patterns in
   Europe-BEST HOPE-[project funded through HIVERA: Harmonizing Integrating
   Vitalizing European Research on HIV/AIDS; grant 249697]); L'Oreal
   Portugal Medals of Honor for Women in Science 2012 (financed through
   L'Oreal Portugal, Comissao Nacional da Unesco and Fundacao para a
   Ciencia e Tecnologia [FCT]); by FCT for funds to
   GHTMUID/Multi/04413/2013; by the MigrantHIV project (financed by FCT;
   PTDC/DTP-EPI/7066/2014); by Gilead Genese HIVLatePresenters; the
   Research Foundation Flanders (FWO G.0692.14); and the VIROGENESIS
   project, which receives funding from the European Union's Horizon 2020
   Research and Innovation Programme (grant agreement 634650).
CR Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7
   Amaral JA, 2005, J APPL STAT, V32, P127, DOI 10.1080/02664760500054160
   [Anonymous], 2014, TRANSFORD GETTING DR
   [Anonymous], 2019, DRUG TREATMENT PROFI
   Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130
   Bezemer D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001898
   Bezemer D, 2014, AIDS RES HUM RETROV, V30, P118, DOI [10.1089/aid.2013.0171, 10.1089/AID.2013.0171]
   Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082
   Boskova V, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex044
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Carvalho A, 2015, J CLIN MICROBIOL, V53, P1506, DOI 10.1128/JCM.03611-14
   Chaillon A, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0339-4
   Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262
   Chan PA, 2015, JAIDS-J ACQ IMM DEF, V70, P428, DOI 10.1097/QAI.0000000000000786
   Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326
   Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010
   Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568
   Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089
   European Centre for Disease Prevention and Control WROfE, 2015, HIV AIDS SURV EUR SU
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Fernandes RM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4210-2
   GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005
   Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963
   Hue S, 2014, AIDS, V28, P1967, DOI 10.1097/QAD.0000000000000383
   INSA DdDaId, 2015, INF VIH SIDA SIT POR
   Kuhnert D, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006895
   Kuiken Carla, 2003, AIDS Reviews, V5, P52
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Loo MV, 2002, ANN AM ACAD POLIT SS, V582, P49
   MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009
   Parczewski M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172473
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Patino-Galindo JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171062
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Poon AFY, 2016, LANCET HIV, V3, pE231, DOI 10.1016/S2352-3018(16)00046-1
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077
   Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Stadler T, 2012, MOL BIOL EVOL, V29, P347, DOI 10.1093/molbev/msr217
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Vasylyeva TI, 2016, AIDS, V30, P2885, DOI 10.1097/QAD.0000000000001291
   Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001
NR 49
TC 4
Z9 4
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2019
VL 220
IS 2
BP 233
EP 243
DI 10.1093/infdis/jiz085
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IS7VN
UT WOS:000482357500009
PM 30805610
OA Other Gold, Green Published
DA 2020-09-29
ER

PT J
AU De Jesus, JG
   Giovanetti, M
   Faria, NR
   Alcantara, LC
AF De Jesus, Jaqueline Goes
   Giovanetti, Marta
   Faria, Nuno Rodrigues
   Alcantara, Luiz Carlos Junior
TI Acute Vector-Borne Viral Infection:Zika and MinION Surveillance
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID ZIKA VIRUS-INFECTIONS; YELLOW-FEVER; ARBOVIRUS INFECTIONS;
   NUCLEOTIDE-SEQUENCE; EPIDEMIC; OUTBREAK; TRANSMISSION; CHIKUNGUNYA;
   ANTIBODIES; MOSQUITOS
AB The MinION sequencer was launched by the Oxford Nanopore Technologies start-up as a disruptive technology for genome sequencing based on single-molecule synthesis. Its characteristics as a portable device, low cost, and simple library preparation have made it a good candidate for field researchers. MinION has been used to sequence a number of microorganisms, such as bacteria, viruses, and fungi. Based on the experience that characterized the Ebola virus genetic diversity in Guinea during the 2014-2015 outbreak, the ZiBRA (Zika in Brazil Real-time Analysis) project aimed to sequence a large number of Zika virus genomes during a mobile laboratory trip in northeast Brazil to provide important epidemiological information about the spread of this disease in this country. In response to the positive and rapid results obtained by the ZiBRA project, the Brazilian Ministry of Health and many leading institutions, such as the Pan American Health Organization and WHO, have shown interest in expanding the strategy used in this project to other countries dealing with arbovirus infection.
C1 [De Jesus, Jaqueline Goes] Fundacao Oswaldo Cruz, Lab Expt Pathol, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com
RI Giovanetti, Marta/AAK-7408-2020; Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798; Alcantara, Luiz/0000-0002-6769-9931
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Ambardar S, 2016, INDIAN J MICROBIOL, V56, P394, DOI 10.1007/s12088-016-0606-4
   Antwerpen MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123298
   Balasubramanian S, 2011, CHEM COMMUN, V47, P7281, DOI 10.1039/c1cc11078k
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V21, P27
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V6, P47
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003
   HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laver T, 2015, Biomol Detect Quantif, V3, P1
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   Meinel DM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.08.010
   Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751
   Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324
   Min Jou W, 1972, Nature, V237, P82
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nilakanta Haema, 2014, BMC Res Notes, V7, P830, DOI 10.1186/1756-0500-7-830
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003
   Plesivkova D, 2019, WIRES FORENSIC SCI, V1, pe1323, DOI [10.1002/wfs2.1323, DOI 10.1002/wfs2.1323]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0
   SANGER F., 1965, J MOL BIOL, V13, P373
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P376
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Vogel G, 2016, SCIENCE, V352, P1152, DOI 10.1126/science.352.6290.1152
   Walter MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/j.jbiotec.2016.12.006
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   World Health Organization, 2016, ZIK VIR MICR GUILL B
   WU R, 1968, J MOL BIOL, V35, P523, DOI 10.1016/S0022-2836(68)80012-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 1
Z9 1
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JUL
PY 2019
VL 7
IS 4
AR AME-0008-2019
DI 10.1128/microbiolspec.AME-0008-2019
PG 11
WC Microbiology
SC Microbiology
GA IT2VO
UT WOS:000482711900003
PM 31400093
OA Bronze
DA 2020-09-29
ER

PT J
AU Xavier, J
   Giovanetti, M
   Fonseca, V
   Theze, J
   Graf, T
   Fabri, A
   de Jesus, JG
   de Mendonca, MCL
   Rodrigues, CDD
   Mares-Guia, MA
   dos Santos, CC
   Tosta, SFD
   Candido, D
   Nogueira, RMR
   de Abreu, AL
   Oliveira, WK
   de Albuquerque, CFC
   Chieppe, A
   de Oliveira, T
   Brasil, P
   Calvet, G
   Sequeira, PC
   Faria, NR
   de Filippis, AMB
   Alcantara, LCJ
AF Xavier, Joilson
   Giovanetti, Marta
   Fonseca, Vagner
   Theze, Julien
   Graf, Tiago
   Fabri, Allison
   de Jesus, Jaqueline Goes
   Lima de Mendonca, Marcos Cesar
   dos Santos Rodrigues, Cintia Damasceno
   Mares-Guia, Maria Angelica
   dos Santos, Carolina Cardoso
   de Oliveira Tosta, Stephane Fraga
   Candido, Darlan
   Ribeiro Nogueira, Rita Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Campelo de Albuquerque, Carlos F.
   Chieppe, Alexandre
   de Oliveira, Tulio
   Brasil, Patricia
   Calvet, Guilherme
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Bispo de Filippis, Ana Maria
   Junior Alcantara, Luiz Carlos
TI Circulation of chikungunya virus East/Central/South African lineage in
   Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; POPULATION; MODEL; ZIKA
AB The emergence of chikungunya virus (CHIKV) has raised serious concerns due to the virus' rapid dissemination into new geographic areas and the clinical features associated with infection. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. Our phylogenetic reconstructions indicated the circulation of the East-Central-South-African (ECSA) lineage in Rio de Janeiro. Time-measured phylogenetic analysis combined with CHIKV notified case numbers revealed the ECSA lineage was introduced in Rio de Janeiro around June 2015 (95% Bayesian credible interval: May to July 2015) indicating the virus was circulating unnoticed for 5 months before the first reports of CHIKV autochthonous transmissions in Rio de Janeiro, in November 2015. These findings reinforce that continued genomic surveillance strategies are needed to assist in the monitoring and understanding of arbovirus epidemics, which might help to attenuate public health impact of infectious diseases.
C1 [Xavier, Joilson; de Jesus, Jaqueline Goes] Fiocruz MS, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Xavier, Joilson; Giovanetti, Marta; Fabri, Allison; Lima de Mendonca, Marcos Cesar; dos Santos Rodrigues, Cintia Damasceno; Mares-Guia, Maria Angelica; dos Santos, Carolina Cardoso; Ribeiro Nogueira, Rita Maria; Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; de Oliveira Tosta, Stephane Fraga; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Theze, Julien; Candido, Darlan; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Graf, Tiago; Fabri, Allison] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Abreu, Andre Luiz; Oliveira, Wanderson Kleber] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Chieppe, Alexandre] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Brasil, Patricia; Calvet, Guilherme] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP de Filippis, AMB; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM abispo@ioc.fiocruz.br; luiz.alcantara@ioc.fiocruz.br
RI Graf, Tiago/S-8535-2019; Calvet, GA/G-6959-2013; Faria, Nuno
   R/I-2975-2012; Fonseca, Vagner/R-5813-2019; Oliveira,
   Wanderson/AAF-5182-2019; Giovanetti, Marta/AAK-7408-2020
OI Graf, Tiago/0000-0003-4921-7975; Calvet, GA/0000-0002-3545-5238; Faria,
   Nuno R/0000-0001-8839-2798; Fonseca, Vagner/0000-0001-5521-6448;
   Oliveira, Wanderson/0000-0002-9662-1930; Xavier,
   Joilson/0000-0003-3916-2018; De Jesus, Jaqueline/0000-0002-5404-272X;
   Alcantara, Luiz/0000-0002-6769-9931
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro /FaperjCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.930/2016]; Coordenacao de Vigilancia em Saude e Laboratorios
   de Referencia da Fundacao Oswaldo Cruz
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00). Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro /Faperj over the grant number E-26/202.930/2016
   and by the Coordenacao de Vigilancia em Saude e Laboratorios de
   Referencia da Fundacao Oswaldo Cruz.
CR Bastos MLA, 2018, BRAZ J INFECT DIS, V22, P248, DOI 10.1016/j.bjid.2018.05.002
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Brasil, 2018, B EP MON CAS DENG FE
   Brasil, 2016, B EP ARB CEN EP DENG
   Brasil, 2019, B EP MON CAS DENG FE
   Brasil, 2015, B EP MON CAS DED FEB
   Brasil. Boletim Epidemiologico, 2017, B EP MON CAS DENG FE
   de Albuquerque IGC, 2012, REV SOC BRAS MED TRO, V45, P128, DOI 10.1590/S0037-86822012000100026
   Collado D, 2018, J VIROL
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Katoh K, 2017, BRIEF BIOINFORM
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lessa-Aquino C, 2018, EPIDEMIOL INFECT, V146, P2056, DOI 10.1017/S0950268818002467
   Mascarenhas M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207554
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   PAHO/WHO, 2017, NUM CAS REP CHIK PAI
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Souza TMA, 2017, PLOS CURR, V9
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 46
TC 3
Z9 3
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2019
VL 14
IS 6
AR e0217871
DI 10.1371/journal.pone.0217871
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC4XB
UT WOS:000470970000023
PM 31185030
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Hanke, K
   Faria, NR
   Kuhnert, D
   Yousef, KP
   Hauser, A
   Meixenberger, K
   Hofmann, A
   Bremer, V
   Bartmeyer, B
   Pybus, O
   Kucherer, C
   von Kleist, M
   Bannert, N
AF Hanke, Kirsten
   Faria, Nuno Rodrigues
   Kuehnert, Denise
   Yousef, Kaveh Pouran
   Hauser, Andrea
   Meixenberger, Karolin
   Hofmann, Alexandra
   Bremer, Viviane
   Bartmeyer, Barbara
   Pybus, Oliver
   Kuecherer, Claudia
   von Kleist, Max
   Bannert, Norbert
TI Reconstruction of the Genetic History and the Current Spread of HIV-1
   Subtype A in Germany
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Germany; HIV-1; phylogeography; reproduction numbers; risk groups;
   spread; subtype A; transmission cluster
ID INJECTION-DRUG USERS; NON-B SUBTYPES; MOLECULAR EPIDEMIOLOGY;
   TRANSMISSION NETWORKS; TYPE-1 EPIDEMIC; VIRAL STRAINS; DIVERSITY; SEX;
   MEN; INFECTIONS
AB HIV-1 non-B infections have been increasing in Europe for several years. In Germany, subtype A belongs to the most abundant non-B subtypes showing an increasing prevalence of 8.3% among new infections in 2016. Here we trace the origin and examine the current spread of the German HIV-1 subtype A epidemic. Bayesian coalescence and birth-death analyses were performed with 180 German HIV-1 pot sequences and 528 related and publicly available sequences to reconstruct the population dynamics and fluctuations for each of the transmission groups. Our reconstructions indicate two distinct sources of the German subtype A epidemic, with an Eastern European and an Eastern African lineage both cocirculating in the country. A total of 13 German-origin clusters were identified; among these, 6 clusters showed recent activity. Introductions leading to further countrywide spread originated predominantly from Eastern Africa when introduced before 2005. Since 2005, however, spreading introductions have occurred exclusively within the Eastern European Glade. Moreover, we observed changes in the main route of subtype A transmission. The beginning of the German epidemic (1985 to 1995) was dominated by heterosexual transmission of the Eastern African lineage. Since 2005, transmissions among German men who have sex with men (MSM) have been increasing and have been associated with the Eastern European lineage. Infections among people who inject drugs dominated between 1998 and 2005. Our findings on HIV-1 subtype A infections provide new insights into the spread of this virus and extend the understanding of the HIV epidemic in Germany.
   IMPORTANCE HIV-1 subtype A is the second most prevalent subtype worldwide, with a high prevalence in Eastern Africa and Eastern Europe. However, an increase of non-B infections, including subtype A infections, has been observed in Germany and other European countries. There has simultaneously been an increased flow of refugees into Europe and especially into Germany, raising the question of whether the surge in non-B infections resulted from this increased immigration or whether German transmission chains are mainly involved. This study is the first comprehensive subtype A study from a western European country analyzing in detail its phylogenetic origin, the impact of various transmission routes, and its current spread. The results and conclusions presented provide new and substantial insights for virologists, epidemiologists, and the general public health sector. In this regard, they should be useful to those authorities responsible for developing public health intervention strategies to combat the further spread of HIV/AIDS.
C1 [Hanke, Kirsten; Hauser, Andrea; Meixenberger, Karolin; Kuecherer, Claudia; Bannert, Norbert] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany.
   [Faria, Nuno Rodrigues; Pybus, Oliver] Univ Oxford, Dept Zool, Oxford, England.
   [Kuehnert, Denise] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.
   [Yousef, Kaveh Pouran; von Kleist, Max] Free Univ Berlin, Math Inst, Dept Math & Comp Sci, Berlin, Germany.
   [Hofmann, Alexandra; Bremer, Viviane; Bartmeyer, Barbara] Robert Koch Inst, Div HIV AIDS STI & Blood Borne Infect, Berlin, Germany.
   [Hofmann, Alexandra] Charite Univ Med Berlin, Berlin, Germany.
   [Bannert, Norbert] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
RP Hanke, K; Bannert, N (corresponding author), Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany.; Bannert, N (corresponding author), Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
EM hankek@rki.de; bannertn@rki.de
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012; von Kleist,
   Max/K-3023-2016
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Kuhnert, Denise/0000-0002-5657-018X; Hofmann,
   Alexandra/0000-0002-9915-3482; von Kleist, Max/0000-0001-6587-6394
FU Bundesgesundheitsministerium/German Federal Ministry of Health
   [IIA5-2013-2513AUK375]
FX This study was part of the MASTER HIV/HEP project funded by the
   Bundesgesundheitsministerium/German Federal Ministry of Health
   (https://www.bundesgesund heitsministerium.de/en/en.html; grant number
   IIA5-2013-2513AUK375).
CR Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7
   Avise J., 2000, PHYLOGEOGRAPHY HIST
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Baalwa J, 2013, VIROLOGY, V436, P33, DOI 10.1016/j.virol.2012.10.009
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Balode D, 2004, AIDS RES HUM RETROV, V20, P245, DOI 10.1089/088922204773004978
   Barin F, 1997, AIDS, V11, P1503, DOI 10.1097/00002030-199712000-00015
   Beloukas A, 2016, INFECT GENET EVOL, V46, P180, DOI 10.1016/j.meegid.2016.06.033
   Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724
   Beyrer C, 2009, AIDS RES HUM RETROV, V25, P853, DOI 10.1089/aid.2008.0206
   Bezemer D, 2014, AIDS RES HUM RETROV, V30, P118, DOI [10.1089/aid.2013.0171, 10.1089/AID.2013.0171]
   Bielejec F, 2014, SYST BIOL, V63, P493, DOI 10.1093/sysbio/syu015
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bobkov A, 1997, AIDS RES HUM RETROV, V13, P1195, DOI 10.1089/aid.1997.13.1195
   Bobkov AF, 2004, J MED VIROL, V74, P191, DOI 10.1002/jmv.20177
   Bobkova M, 2013, AIDS REV, V15, P204
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Brand D, 2014, J CLIN MICROBIOL, V52, P4010, DOI 10.1128/JCM.01141-14
   Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024
   Caplinskas S, 2013, AIDS RES HUM RETROV, V29, P732, DOI [10.1089/aid.2012.0312, 10.1089/AID.2012.0312]
   Chaix ML, 2013, CLIN INFECT DIS, V56, P880, DOI 10.1093/cid/cis999
   Chan PA, 2015, JAIDS-J ACQ IMM DEF, V70, P428, DOI 10.1097/QAI.0000000000000786
   Collinson-Streng AN, 2009, AIDS RES HUM RETROV, V25, P1045, DOI 10.1089/aid.2009.0127
   Diez-Fuertes F, 2015, INFECT GENET EVOL, V33, P197, DOI 10.1016/j.meegid.2015.05.003
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   ECDC, 2018, EUR CTR DIS PREV CON
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b
   Gavryushkina A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003919
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61
   GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079
   Hauser A, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.2.30436
   Hauser A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206234
   Hauser A, 2018, J VIROL METHODS, V259, P32, DOI 10.1016/j.jviromet.2018.05.013
   Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93
   Hofmann A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2585-4
   Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963
   Hue S, 2012, AIDS RES HUM RETROV, V28, P220, DOI 10.1089/aid.2011.0048
   Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590
   Kuhnert D, 2016, MOL BIOL EVOL, V33, P2102, DOI 10.1093/molbev/msw064
   Laga V, 2015, CURR HIV RES, V13, P219, DOI 10.2174/1570162X13666150407142834
   Lai A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146097
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lapovok I. A., 2015, Voprosy Virusologii, V60, P29
   Lihana RW, 2012, AIDS REV, V14, P83
   Magiorkinis G, 2016, INFECT GENET EVOL, V46, P169, DOI 10.1016/j.meegid.2016.05.041
   Mbanya Dora, 2008, Int J Environ Res Public Health, V5, P378
   Meixenberger K, 2014, J CLIN MICROBIOL, V52, P2977, DOI 10.1128/JCM.03289-13
   Novitsky VA, 1998, AIDS RES HUM RETROV, V14, P1079, DOI 10.1089/aid.1998.14.1079
   Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677
   Parczewski M, 2014, INFECT GENET EVOL, V27, P121, DOI 10.1016/j.meegid.2014.07.004
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Ragonnet-Cronin M, 2016, J INFECT DIS, V213, P1410, DOI 10.1093/infdis/jiv758
   Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317
   Rambaut A., 2014, TRACER V1 6
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Robert Koch Institute, 2018, EPID B
   Ryom L, 2016, HIV MED, V17, P83, DOI 10.1111/hiv.12322
   Saad MD, 2006, AIDS RES HUM RETROV, V22, P796, DOI 10.1089/aid.2006.22.796
   Saad MD, 2006, AIDS RES HUM RETROV, V22, P709, DOI 10.1089/aid.2006.22.709
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   Sanchez JL, 2006, DRUG ALCOHOL DEPEN, V82, pS15, DOI 10.1016/S0376-8716(06)80003-7
   Ssemwanga D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071768
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Tamalet C, 2015, J MED VIROL, V87, P1327, DOI 10.1002/jmv.24184
   Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9
   UNAIDS, 2017, FACT SHEET
   Vinogradova A, 2010, AIDS RES HUM RETROV, V26, P395, DOI 10.1089/aid.2009.0205
   Wang XC, 2015, CLIN INFECT DIS, V61, P1462, DOI 10.1093/cid/civ526
   Yousef KP, 2016, JAIDS-J ACQ IMM DEF, V73, P356, DOI 10.1097/QAI.0000000000001122
   Zarandia M, 2006, AIDS RES HUM RETROV, V22, P470, DOI 10.1089/aid.2006.22.470
   Zeh C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147436
   Zetterberg V, 2004, AIDS RES HUM RETROV, V20, P1148, DOI 10.1089/aid.2004.20.1148
NR 75
TC 1
Z9 1
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2019
VL 93
IS 12
AR e02238-18
DI 10.1128/JVI.02238-18
PG 17
WC Virology
SC Virology
GA IA1ZC
UT WOS:000469360000019
PM 30944175
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Kraemer, MUG
   Reiner, RC
   Brady, O
   Messina, JP
   Gilbert, M
   Pigott, DM
   Yi, D
   Johnson, K
   Earl, L
   Marczak, LB
   Shirude, S
   Weaver, N
   Bisanzio, D
   Perkins, TA
   Lai, SJ
   Lu, X
   Jones, P
   Coelho, GE
   Carvalho, RG
   Van Bortel, W
   Marsboom, C
   Hendrickx, G
   Schaffner, F
   Moore, CG
   Nax, HH
   Bengtsson, L
   Wetter, E
   Tatem, AJ
   Brownstein, JS
   Smith, DL
   Lambrechts, L
   Cauchemez, S
   Linard, C
   Faria, NR
   Pybus, OG
   Scott, TW
   Liu, Q
   Yu, H
   Wint, GRW
   Hay, SI
   Golding, N
AF Kraemer, Moritz U. G.
   Reiner, Robert C., Jr.
   Brady, Oliverj
   Messina, Jane P.
   Gilbert, Marius
   Pigott, David M.
   Yi, Dingdong
   Johnson, Kimberly
   Earl, Lucas
   Marczak, Laurie B.
   Shirude, Shreya
   Weaver, NicoleDavis
   Bisanzio, Donal
   Perkins, T. Alex
   Lai, Shengjie
   Lu, Xin
   Jones, Peter
   Coelho, Giovanini E.
   Carvalho, Roberta G.
   Van Bortel, Wim
   Marsboom, Cedric
   Hendrickx, Guy
   Schaffner, Francis
   Moore, Chester G.
   Nax, Heinrich H.
   Bengtsson, Linus
   Wetter, Erik
   Tatem, Andrew J.
   Brownstein, John S.
   Smith, David L.
   Lambrechts, Louis
   Cauchemez, Simon
   Linard, Catherine
   Faria, Nuno R.
   Pybus, Oliver G.
   Scott, Thomas W.
   Liu, Qiyong
   Yu, Hongjie
   Wint, G. R. William
   Hay, Simon, I
   Golding, Nick
TI Past and future spread of the arbovirus vectors Aedes aegypti and Aedes
   albopictus
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ZIKA VIRUS; UNITED-STATES; NICHE SHIFTS; CULICIDAE; MOSQUITO; DIPTERA;
   ESTABLISHMENT; TRANSMISSION; COMPETITION; INTENSITY
AB The global population at risk from mosquito-borne diseases-including dengue, yellow fever, chikungunya and Zika-is expanding in concert with changes in the distribution of two key vectors: Aedes aegypti and Aedes albopictus. The distribution of these species is largely driven by both human movement and the presence of suitable climate. Using statistical mapping techniques, we show that human movement patterns explain the spread of both species in Europe and the United States following their introduction. We find that the spread of Ae. aegypti is characterized by long distance importations, while Ae. albopictus has expanded more along the fringes of its distribution. We describe these processes and predict the future distributions of both species in response to accelerating urbanization, connectivity and climate change. Global surveillance and control efforts that aim to mitigate the spread of chikungunya, dengue, yellow fever and Zika viruses must consider the so far unabated spread of these mosquitos. Our maps and predictions offer an opportunity to strategically target surveillance and control programmes and thereby augment efforts to reduce arbovirus burden in human populations globally.
C1 [Kraemer, Moritz U. G.; Faria, Nuno R.; Pybus, Oliver G.; Wint, G. R. William] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, Moritz U. G.; Brownstein, John S.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.; Brownstein, John S.] Boston Childrens Hosp, Boston, MA 02115 USA.
   [Reiner, Robert C., Jr.; Pigott, David M.; Johnson, Kimberly; Earl, Lucas; Marczak, Laurie B.; Shirude, Shreya; Weaver, NicoleDavis; Smith, David L.; Hay, Simon, I] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Brady, Oliverj] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Brady, Oliverj] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Messina, Jane P.] Univ Oxford, Sch Geog & Environm, Oxford, England.
   [Messina, Jane P.] Univ Oxford, Oxford Sch Global & Area Studies, Oxford, England.
   [Gilbert, Marius; Linard, Catherine] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium.
   [Gilbert, Marius] Fonds Natl Rech Sci, Brussels, Belgium.
   [Yi, Dingdong] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Bisanzio, Donal] RTI Int, Washington, DC USA.
   [Bisanzio, Donal] Univ Nottingham, Sch Med, Epidemiol & Publ Hlth Div, Nottingham, England.
   [Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Lai, Shengjie; Yu, Hongjie] Fudan Univ, Sch Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.
   [Lai, Shengjie; Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England.
   [Lai, Shengjie; Bengtsson, Linus; Wetter, Erik; Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden.
   [Lu, Xin] Cent S Univ, Sch Business, Changsha, Hunan, Peoples R China.
   [Lu, Xin] Natl Univ Def Technol, Coll Syst Engn, Changsha, Hunan, Peoples R China.
   [Lu, Xin] Southwestern Univ Finance & Econ, Sch Business Adm, Chengdu, Sichuan, Peoples R China.
   [Jones, Peter] Waen Associates Ltd, Dolgellau, Gwynedd, Wales.
   [Coelho, Giovanini E.] PAHO, Washington, DC USA.
   [Carvalho, Roberta G.] Minist Hlth, Natl Dengue Control Program, Brasilia, DF, Brazil.
   [Van Bortel, Wim] European Ctr Dis Prevent & Control, Stockholm, Sweden.
   [Van Bortel, Wim] Inst Trop Med, Antwerp, Belgium.
   [Marsboom, Cedric; Hendrickx, Guy] Avia GIS, Zoersel, Belgium.
   [Schaffner, Francis] Francis Schaffner Consultancy, Riehen, Switzerland.
   [Moore, Chester G.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Nax, Heinrich H.] Swiss Fed Inst Technol, Computat Social Sci, Zurich, Switzerland.
   [Bengtsson, Linus] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Wetter, Erik] Stockholm Sch Econ, Stockholm, Sweden.
   [Lambrechts, Louis] Inst Pasteur, Insect Virus Interact Unit, UMR2000, CNRS, Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, UMR2000, CNRS, Paris, France.
   [Linard, Catherine] Univ Namur, Dept Geog, Namur, Belgium.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.
   [Liu, Qiyong] Shandong Univ, Climate Change & Hlth Ctr, Sch Publ Hlth, Jinan, Shandong, Peoples R China.
   [Liu, Qiyong] WHO Collaborating Ctr Vector Surveillance & Manag, Beijing, Peoples R China.
   [Liu, Qiyong] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China.
   [Wint, G. R. William] Univ Oxford, Dept Zool, ERGO, Oxford, England.
   [Golding, Nick] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
RP Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Kraemer, MUG (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.; Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.; Golding, N (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
EM moritz.kraemer@zoo.ox.ac.uk; sihay@uw.edu;
   nick.golding.research@gmail.com
RI lu, xin/C-1940-2009; Faria, Nuno R/I-2975-2012; Pybus, Oliver
   G/B-2640-2012; Hay, Simon I/F-8967-2015; Smith, David/L-8850-2013
OI lu, xin/0000-0002-3547-6493; Faria, Nuno R/0000-0001-8839-2798; Pybus,
   Oliver G/0000-0002-8797-2667; Hay, Simon I/0000-0002-0611-7272; Davis
   Weaver, Nicole/0000-0002-7205-9621; Lai, Shengjie/0000-0001-9781-8148;
   Smith, David/0000-0003-4367-3849; Moore, Chester/0000-0002-1837-7266;
   Van Bortel, Wim/0000-0002-6644-518X
FU Society in Science; Branco Weiss Fellowship; National Institute of Child
   Health and Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD040128]; International Research Consortium on Dengue Risk
   Assessment Management and Surveillance (IDAMS; European Commission 7th
   Framework Programme) [21893]; Sir Henry Wellcome Fellowship - Wellcome
   TrustWellcome Trust [206471/Z/17/Z]; Bill and Melinda Gates
   FoundationBill & Melinda Gates Foundation [OP1183567]; Research for
   Health in Humanitarian Crises (R2HC) Programme [13468]; Department of
   International Development (DFiD); Wellcome TrustWellcome Trust [95066];
   Bill & Melinda Gates FoundationBill & Melinda Gates Foundation
   [OPP1106023, OPP1093011, OPP1132415, OPP1159934]; American people
   through the US Agency for International Development Emerging Pandemic
   Threats Program-2 PREDICT-2 [AID-OAA-A-14-00102]; National Library of
   Medicine of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Library of Medicine (NLM) [R01LM010812, R01LM011965]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; National Institute of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U10AI089674];
   European Commission through the European Research Council [324247];
   French Government's Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; French Agence
   Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-16-CE35-0004]; City of Paris Emergence(s) programme in Biomedical
   Research; European Union's Horizon 2020 research and innovation
   programme under ZikaPLAN grant [734584]; AXA Research Fund;
   Investissement d'Avenir programFrench National Research Agency (ANR);
   Laboratoire d'Excellence Integrative Biology of Emerging Infectious
   Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious Disease
   Agent Study of the National Institute of General Medical Sciences;
   INCEPTION project [PIA/ANR-16-CONV-0005]; European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant [734548];
   University of Melbourne McKenzie fellowship; VBORNET, an ECDC;
   VectorNet, an ECDC; EFSA [ECDC/09/018, OC/EFSA/AHAW/2013/02]; National
   Institutes of Health Program Project grantUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [P01
   AI098670]; Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71771213, 71522014, 71725001, 91846301,
   71790615]
FX The authors thank S. Ray for providing comments during the revision
   process. M.U.G.K. acknowledges funding from the Society in Science, The
   Branco Weiss Fellowship, administered by the ETH Zurich. M.U.G.K. also
   acknowledges funding from the Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128). M.U.G.K., S.I.H.,
   J.P.M., N.G., O.J.B. and G.R.W.W. acknowledge funding from the
   International Research Consortium on Dengue Risk Assessment Management
   and Surveillance (IDAMS; European Commission 7th Framework Programme no.
   21893). O.B.J. was funded by a Sir Henry Wellcome Fellowship funded by
   the Wellcome Trust (grant number 206471/Z/17/Z) and a grant from the
   Bill and Melinda Gates Foundation (OP1183567). S.I.H. received a grant
   from the Research for Health in Humanitarian Crises (R2HC) Programme,
   managed by Enhancing Learning and Research for Humanitarian Assistance
   (ELRHA; no. 13468), which also supported M.U.G.K. and N.G. The R2HC
   programme aims to improve health outcomes by strengthening the evidence
   base for public health interventions in humanitarian crises. The 8 pound
   million R2HC programme is funded equally by the Wellcome Trust and
   Department of International Development (DFiD), with ELRHA overseeing
   the programme's execution and management. S. I. H. was also funded by a
   Senior Research Fellowship from the Wellcome Trust (no. 95066) and
   grants from the Bill & Melinda Gates Foundation (OPP1106023, OPP1093011,
   OPP1132415 and OPP1159934). This study was made possible by the support
   of the American people through the US Agency for International
   Development Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative
   Agreement number AID-OAA-A-14-00102), which also supported M.U.G.K.
   J.S.B. is supported by the National Library of Medicine of the National
   Institutes of Health (R01LM010812 and R01LM011965), which also supports
   M.U.G.K. D.L.S. is funded by the National Institutes of Health and
   National Institute of Allergy and Infectious Diseases (no. U10AI089674).
   H. H. N. was funded by the European Commission through the European
   Research Council Advanced Investigator Grant 'Momentum' 324247. L.L.
   received funding from the French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases (grant ANR-10-LABX-62-IBEID), the French Agence
   Nationale de la Recherche (grant ANR-16-CE35-0004), the City of Paris
   Emergence(s) programme in Biomedical Research, and the European Union's
   Horizon 2020 research and innovation programme under ZikaPLAN grant
   agreement No. 734584. S.C. received funding from the AXA Research Fund,
   the Investissement d'Avenir program, the Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program (Grant
   ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent Study of
   the National Institute of General Medical Sciences, the INCEPTION
   project (PIA/ANR-16-CONV-0005), and the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement No
   734548. N.G. is supported by a University of Melbourne McKenzie
   fellowship. W.V.B., G.H. and F.S. acknowledge funding from VBORNET and
   VectorNet, an ECDC and EFSA-funded project (no. ECDC/09/018 and
   OC/EFSA/AHAW/2013/02), and thank all contributing VBORNET and VectorNet
   experts for data sharing. T.W.S., R.C.R. and L.L. received funding from
   the National Institutes of Health Program Project grant (no. P01
   AI098670). X.L.; is supported by the Natural Science Foundation of China
   (71771213, 71522014, 71725001, 91846301 and 71790615). This work was
   also partially supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement no. 734548.
CR Armbruster PA, 2016, J MED ENTOMOL, V53, P1013, DOI 10.1093/jme/tjw037
   Behrens JJW, 2013, INT J APPL GEOSPAT R, V4, P9, DOI 10.4018/jagr.2013040102
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   BERMAN M, 1989, J ROY STAT SOC B MET, V51, P81
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Canali M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040444
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Golding N., 2014, STREAMLINED FUNCTION
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hastie T., 1990, GEN ADDITIVE MODELS
   HAWLEY WA, 1989, J MED ENTOMOL, V26, P122, DOI 10.1093/jmedent/26.2.122
   Jongejans E, 2015, THEOR ECOL-NETH, V8, P207, DOI 10.1007/s12080-014-0245-5
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer M. U. G, 2015, MOVEMENT FUNCTIONS A
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Leisnham PT, 2009, ECOLOGY, V90, P2405, DOI 10.1890/08-1569.1
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3
   Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2
   Osorio HC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040820
   Padilla DK, 1996, GLOBAL ECOL BIOGEOGR, V5, P353, DOI 10.2307/2997590
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Prinzing A, 2002, ECOGRAPHY, V25, P721, DOI 10.1034/j.1600-0587.2002.250608.x
   R Core Team, 2016, R LANG ENV COMP
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Ruktanonchai NW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004846
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Samir KC, 2014, POPUL ENVIRON, V35, P243, DOI 10.1007/s11111-014-0205-4
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x
   Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324
   Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904
   Tisseuil C, 2016, ECOGRAPHY, V39, P409, DOI 10.1111/ecog.01393
   Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716
   United Nations Framework on Climate Change (UNFCCC), 2015, PAR AGR 21 C PART
   United Nations Population Division, 2014, WORLD URB PROSP 2014
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e
   Wesolowski A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004267
   Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431
NR 73
TC 88
Z9 89
U1 16
U2 26
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAY
PY 2019
VL 4
IS 5
BP 854
EP 863
DI 10.1038/s41564-019-0376-y
PG 10
WC Microbiology
SC Microbiology
GA HU7QL
UT WOS:000465477000018
PM 30833735
OA Green Published, Green Accepted, Other Gold
DA 2020-09-29
ER

PT J
AU Fonseca, V
   Libin, PJK
   Theys, K
   Faria, NR
   Nunes, MRT
   Restovic, MI
   Freire, M
   Giovanetti, M
   Cuypers, L
   Nowe, A
   Abecasis, A
   Deforche, K
   Santiago, GA
   de Siqueira, IC
   San, EJ
   Machado, KCB
   Azevedo, V
   Bispo-de Filippis, AM
   da Cunha, RV
   Pybus, OG
   Vandamme, AM
   Alcantara, LCJ
   de Oliveira, T
AF Fonseca, Vagner
   Libin, Pieter J. K.
   Theys, Kristof
   Faria, Nuno R.
   Nunes, Marcio R. T.
   Restovic, Maria I.
   Freire, Murilo
   Giovanetti, Marta
   Cuypers, Lize
   Nowe, Ann
   Abecasis, Ana
   Deforche, Koen
   Santiago, Gilberto A.
   de Siqueira, Isadora C.
   San, Emmanuel J.
   Machado, Kaliane C. B.
   Azevedo, Vasco
   Bispo-de Filippis, Ana Maria
   da Cunha, Rivaldo Venancio
   Pybus, Oliver G.
   Vandamme, Anne-Mieke
   Alcantara, Luiz C. J.
   de Oliveira, Tulio
TI A computational method for the identification of Dengue, Zika and
   Chikungunya virus species and genotypes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOLECULAR EPIDEMIOLOGY; LARGE PHYLOGENIES; PERFORMANCE; ACCURATE;
   BURDEN; SYSTEM; HIV-1
AB In recent years, an increasing number of outbreaks of Dengue, Chikungunya and Zika viruses have been reported in Asia and the Americas. Monitoring virus genotype diversity is crucial to understand the emergence and spread of outbreaks, both aspects that are vital to develop effective prevention and treatment strategies. Hence, we developed an efficient method to classify virus sequences with respect to their species and sub-species (i.e. serotype and/or genotype). This tool provides an easy-to-use software implementation of this new method and was validated on a large dataset assessing the classification performance with respect to whole-genome sequences and partial-genome sequences. Available online: http://krisp.org.za/tools.php.
   Author summary Dengue (DENV), Chikungunya (CHIKV) and Zika (ZIKV) are considered major public health challenges. In addition to the epidemic caused by DENV, which has been described in many tropical countries, the introduction of CHIKV and ZIKV in these countries is a major public health concern. These arboviruses are primarily transmitted by mosquitoes of the species Ae. Aegypti and its related diseases result in increased financial costs associated with diagnosis and treatment. To support the design of efficient diagnosis, prevention and treatment strategies, a bioinformatics tool has been developed for the genotyping of these viruses based on appropriate evolutionary models in an automatic, accurate and rapid manner. A set of virus reference sequences was obtained from GenBank and used for the development of the tools. This process involved the alignment of the reference sequences followed by phylogenetic tree reconstructions. To assign the genotypes uploaded by the user, the tool analyses the sequences one by one, genotypes through identification, alignment and phylogenetic reconstruction. This computational method allows the high-throughput classification of these virus species and genotypes in seconds. As shown experimentally, genotypes are classified most confidently using the envelope gene or complete genome sequences.
C1 [Fonseca, Vagner; Giovanetti, Marta; Bispo-de Filippis, Ana Maria; Alcantara, Luiz C. J.] Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Fonseca, Vagner; San, Emmanuel J.; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Fonseca, Vagner; Azevedo, Vasco; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Libin, Pieter J. K.; Nowe, Ann] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium.
   [Libin, Pieter J. K.; Theys, Kristof; Cuypers, Lize; Vandamme, Anne-Mieke] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Restovic, Maria I.; Freire, Murilo; de Siqueira, Isadora C.; Machado, Kaliane C. B.] Fundacao Oswaldo Cruz, Lab Patol Expt, Salvador, BA, Brazil.
   [Abecasis, Ana; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, Ctr Global Hlth & Trop Med, Lisbon, Portugal.
   [Deforche, Koen] EMWEB Private Co, Herent, Belgium.
   [Santiago, Gilberto A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Coordenacao Vigilancia Saude & Lab Referencias, Rio De Janeiro, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com; tuliodna@gmail.com
RI Fonseca, Vagner/R-5813-2019; Pybus, Oliver G/B-2640-2012; Giovanetti,
   Marta/AAK-7408-2020; de Siqueira, Isadora Cristina/R-9953-2016; Faria,
   Nuno R/I-2975-2012; Azevedo, Vasco A/B-1556-2019; Abecasis,
   Ana/B-6295-2009
OI Fonseca, Vagner/0000-0001-5521-6448; Pybus, Oliver
   G/0000-0002-8797-2667; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Faria, Nuno R/0000-0001-8839-2798;
   Azevedo, Vasco A/0000-0002-4775-2280; Nowe, Ann/0000-0001-6346-4564;
   Abecasis, Ana/0000-0002-3903-5265; Alcantara, Luiz/0000-0002-6769-9931
FU South African Medical Re-search Council [MRC-RFA-UFSP-01-2013/UKZN
   HIVEPI]; Royal Society Newton Advanced Fellowship; VIROGENESIS project -
   European Union's Horizon 2020 Research and Innovation Programme
   [634650]; National Institutes of Health Common FundUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U24HG006941]; FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen)FWO; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/201600, 88881.130825/2016-00, 88887.130823/2016-00]; EU's
   Horizon 2020 Programme through ZIKAlliance [PRES-005-FEX-17-4-2-33];
   Fundacao para a Ciencia e Tecnologia (FCT)Portuguese Foundation for
   Science and Technology [GHTM-UID/Multi/04413/2013]; Decit/SCTIE/MoH
FX Supported by a research Flagship grant from the South African Medical
   Re-search Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI), a Royal Society
   Newton Advanced Fellowship (TdO), the VIROGENESIS project receives
   funding from the European Union's Horizon 2020 Research and Innovation
   Programme (under Grant Agreement no. 634650) and the National Institutes
   of Health Common Fund, grant number U24HG006941. Pieter Libin was
   supported by a PhD grant of the FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen). This work was supported by Decit/SCTIE/MoH and CNPq
   (440685/2016-8 and 440856/2016-7); by CAPES (88887.130716/201600,
   88881.130825/2016-00 and 88887.130823/2016-00); and by EU's Horizon 2020
   Programme through ZIKAlliance (PRES-005-FEX-17-4-2-33). Ana Abecasis was
   supported by Fundacao para a Ciencia e Tecnologia (FCT) through funds to
   GHTM-UID/Multi/04413/2013. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altschul SF, 1990, BASIC LOCAL ALIGNMEN
   [Anonymous], 2018, STROKE, V49, pe233
   Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Benson Dennis A, 2013, Nucleic Acids Res, V41, pD36, DOI 10.1093/nar/gks1195
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765
   Cuypers L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100569
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Ha Schmidt, 2002, BIOINFORMATICS, V18, P502, DOI [10.1093/bioinformatics/18.3.502, DOI 10.1093/BIOINFORMATICS/18.3.502]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Libin P., 2018, BIOINFORMATICS OXFOR
   Libin P, 2017, BIOINFORMATICS, V33, P3993, DOI 10.1093/bioinformatics/btx535
   Libin P, 2013, BIOINFORMATICS, V29, P1477, DOI 10.1093/bioinformatics/btt162
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Morens DM, 2016, J INFECT DIS, V214, pS434, DOI 10.1093/infdis/jiw291
   Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salemi M., 2003, PHYLOGENETIC HDB PRA
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theys K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006528
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 45
TC 6
Z9 6
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007231
DI 10.1371/journal.pntd.0007231
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100009
PM 31067235
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Hill, SC
   de Vasconcelos, JN
   Granja, BG
   Theze, J
   Jandondo, D
   Neto, Z
   Mirandela, M
   Sebastiao, CD
   Candido, ALM
   Clemente, C
   da Silva, SP
   de Oliveira, T
   Pybus, OG
   Faria, NR
   Afonso, JM
AF Hill, Sarah C.
   de Vasconcelos, Jocelyne Neto
   Granja, Bernardo Gutierrez
   Theze, Julien
   Jandondo, Domingos
   Neto, Zoraima
   Mirandela, Marinela
   Sebastiao, Cruz dos Santos
   Micolo Candido, Ana Lulsa
   Clemente, Carina
   da Silva, Sara Pereira
   de Oliveira, Tulio
   Pybus, Oliver G.
   Faria, Nuno R.
   Afonso, Joana Morals
TI Early Genomic Detection of Cosmopolitan Genotype of Dengue Virus
   Serotype 2, Angola, 2018
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OUTBREAK; ZIKA
AB We used portable genome sequencing to investigate reported dengue virus transmission in Angola. Our results show that autochthonous transmission of dengue serotype 2 (cosmopolitan genotype) occurred in January 2018.
C1 [Hill, Sarah C.; Granja, Bernardo Gutierrez; Theze, Julien; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Oxford, England.
   [de Vasconcelos, Jocelyne Neto; Jandondo, Domingos; Neto, Zoraima; Mirandela, Marinela; Sebastiao, Cruz dos Santos; Micolo Candido, Ana Lulsa; Afonso, Joana Morals] Inst Nacl Invest Saude, Luanda, Angola.
   [Granja, Bernardo Gutierrez] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Quito, Ecuador.
   [Clemente, Carina; da Silva, Sara Pereira] Cligest, Luanda, Angola.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Durban, South Africa.
RP Afonso, JM (corresponding author), Inst Nacl Invest Saude, Luanda, Angola.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, Peter Medawar Bldg, Oxford OX1 3SY, England.
EM nuno.faria@zoo.ox.ac.uk; jinafonso.7@gmail.com
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Hill, Sarah/0000-0002-2995-2596
FU Wellcome TrustWellcome Trust; Royal Society Sir Henry Dale Fellowship
   [204311/Z/16/Z]; Higher Education Funding Council for England's Global
   Challenges Research Fund [005073]; John Fell Research Fund [005166];
   Africa-Oxford Travel Grants [AfiOx-48, AfiOx-60]
FX This study was made possible by funding from the Wellcome Trust and
   Royal Society Sir Henry Dale Fellowship (grant no. 204311/Z/16/Z), the
   Higher Education Funding Council for England's Global Challenges
   Research Fund (grant no. 005073), and the John Fell Research Fund (grant
   no. 005166). Travel to Angola by S.C.H. and N.R.F. was supported by
   Africa-Oxford Travel Grants (grant nos. AfiOx-48 and AfiOx-60).
CR Abreu C, 2016, J CLIN VIROL, V79, P77, DOI 10.1016/j.jcv.2016.04.011
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Schwartz E., 2013, Eurosurveillance, V18, P20488
   Sharp TM, 2013, MMWR-MORBID MORTAL W, V62, P504
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
NR 12
TC 7
Z9 8
U1 2
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2019
VL 25
IS 4
BP 784
EP 787
DI 10.3201/eid2504.180958
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HP3UZ
UT WOS:000461604500020
PM 30882320
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Kraemer, MUG
   Golding, N
   Bisanzio, D
   Bhatt, S
   Pigott, DM
   Ray, SE
   Brady, OJ
   Brownstein, JS
   Faria, NR
   Cummings, DAT
   Pybus, OG
   Smith, DL
   Tatem, AJ
   Hay, SI
   Reiner, RC
AF Kraemer, M. U. G.
   Golding, N.
   Bisanzio, D.
   Bhatt, S.
   Pigott, D. M.
   Ray, S. E.
   Brady, O. J.
   Brownstein, J. S.
   Faria, N. R.
   Cummings, D. A. T.
   Pybus, O. G.
   Smith, D. L.
   Tatem, A. J.
   Hay, S. I.
   Reiner, R. C., Jr.
TI Utilizing general human movement models to predict the spread of
   emerging infectious diseases in resource poor settings
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EBOLA-VIRUS DISEASE; ZOONOTIC NICHE; TIME-SERIES; ZIKA VIRUS;
   TRANSMISSION; LIBERIA; EPIDEMIC; DYNAMICS; OUTBREAK; MOBILITY
AB Human mobility is an important driver of geographic spread of infectious pathogens. Detailed information about human movements during outbreaks are, however, difficult to obtain and may not be available during future epidemics. The Ebola virus disease (EVD) outbreak in West Africa between 2014-16 demonstrated how quickly pathogens can spread to large urban centers following one cross-species transmission event. Here we describe a flexible transmission model to test the utility of generalised human movement models in estimating EVD cases and spatial spread over the course of the outbreak. A transmission model that includes a general model of human mobility significantly improves prediction of EVD's incidence compared to models without this component. Human movement plays an important role not only to ignite the epidemic in locations previously disease free, but over the course of the entire epidemic. We also demonstrate important differences between countries in population mixing and the improved prediction attributable to movement metrics. Given their relative rareness, locally derived mobility data are unlikely to exist in advance of future epidemics or pandemics. Our findings show that transmission patterns derived from general human movement models can improve forecasts of spatio-temporal transmission patterns in places where local mobility data is unavailable.
C1 [Kraemer, M. U. G.; Faria, N. R.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.; Brownstein, J. S.] Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, M. U. G.; Brownstein, J. S.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.
   [Golding, N.] Univ Melbourne, Dept BioSci, Parkville, Vic, Australia.
   [Bisanzio, D.] RTI Int, Washington, DC USA.
   [Bisanzio, D.] Univ Nottingham, Sch Med, Epidemiol & Publ Hlth Div, Nottingham, England.
   [Bhatt, S.] Imperial Coll London, London, England.
   [Pigott, D. M.; Ray, S. E.; Smith, D. L.; Hay, S. I.; Reiner, R. C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Brady, O. J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Cummings, D. A. T.] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Cummings, D. A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Smith, D. L.] Sanaria Inst Global Hlth & Trop Med, Rockville, MD USA.
   [Tatem, A. J.] Univ Southampton, Dept Geog & Environm Sci, WorldPop, Southampton, Hants, England.
   [Tatem, A. J.] Flowminder Fdn, Stockholm, Sweden.
RP Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Kraemer, MUG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.; Hay, SI; Reiner, RC (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
EM moritz.kraemer@zoo.ox.ac.uk; sihay@uw.edu; bcreiner@uw.edu
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012; Hay, Simon
   I/F-8967-2015; Smith, David/L-8850-2013
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Hay, Simon I/0000-0002-0611-7272; Ray, Sarah/0000-0002-5775-8344;
   Golding, Nick/0000-0001-8916-5570; Bhatt, Samir/0000-0002-0891-4611;
   Smith, David/0000-0003-4367-3849
FU Research for Health in Humanitarian Crises (R2HC) programme managed by
   ELRHA; Wellcome TrustWellcome Trust; Department of International
   Development (DFID); The Branco Weiss Fellowship -Society in Science;
   National Institute of Child Health and Human DevelopmentUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [T32HD040128]; National Library of Medicine of
   the National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Library of Medicine (NLM) [R01LM010812, R01LM011965]; Bill & Melinda
   Gates FoundationBill & Melinda Gates Foundation [OPP1119467, OPP1093011,
   OPP1106023, OPP1132415]; Discovery Early Career Researcher Award from
   the Australian Research CouncilAustralian Research Council
   [DE180100635]; NIH/National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U10AI089674]; Wellcome Trust Sustaining
   Health [10688/Z/15/Z]; RAPIDD programme of the Science & Technology
   Directorate, Department of Homeland Security; Fogarty International
   Center (FIC)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC);
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; US NIH MIDAS
   programUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U54-GM088491]; Sir Henry Wellcome
   Fellowship - Wellcome TrustWellcome Trust [206471/Z/17/Z]; Oxford Martin
   School
FX MUGK is funded by the Research for Health in Humanitarian Crises (R2HC)
   programme managed by ELRHA (to SIH). The R2HC programme is funded
   equally by the Wellcome Trust and the Department of International
   Development (DFID). MUGK is also supported by The Branco Weiss
   Fellowship -Society in Science, administered by the ETH Zurich and
   acknowledges funding from a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128) and the National
   Library of Medicine of the National Institutes of Health (R01LM010812,
   R01LM011965). NG, DB and DMP received funding from the Bill & Melinda
   Gates Foundation (#OPP10937011, #OPP1068048). NG was supported by a
   Discovery Early Career Researcher Award from the Australian Research
   Council (DE180100635). DLS and AJT are funded by the NIH/National
   Institute of Allergy and Infectious Diseases (#U10AI089674), and the
   Bill & Melinda Gates Foundation (AJT #OPP1106427, #1032350, DLS
   #OPP1110495). AJT is also supported by a Wellcome Trust Sustaining
   Health Grant (#10688/Z/15/Z). SIH is funded by a Senior Research
   Fellowship from the Wellcome Trust (#095066), and grants from the Bill &
   Melinda Gates Foundation (#OPP1119467, #OPP1093011, #OPP1106023 and
   #OPP1132415). DLS, AJT, SIH and RCR also acknowledge funding support
   from the RAPIDD programme of the Science & Technology Directorate,
   Department of Homeland Security, and the Fogarty International Center
   (FIC), National Institutes of Health (NIH). D.A.T.C. was supported by US
   NIH MIDAS program (U54-GM088491). OJB was funded by a Sir Henry Wellcome
   Fellowship funded by the Wellcome Trust (grant number 206471/Z/17/Z).
   This research received funding from the Oxford Martin School. Funding:
   Wellcome Trust.
CR Ajelli M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0678-3
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Backer JA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005210
   Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106
   Bharti N, 2011, SCIENCE, V334, P1424, DOI 10.1126/science.1210554
   Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Currie J, 2016, SCIENCE, V351, P815, DOI 10.1126/science.aad8521
   D'Silva JP, 2017, J THEOR BIOL, V428, P65, DOI 10.1016/j.jtbi.2017.05.034
   de Montjoye Y.-A., 2014, ARXIV14074885V2
   Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111
   Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062
   du Plessis L, 2015, TRENDS MICROBIOL, V23, P383, DOI 10.1016/j.tim.2015.04.007
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471
   Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8
   Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108
   Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113
   Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guarani V, 2016, ELIFE, V5, DOI 10.7554/eLife.17163
   Halloran ME, 2014, SCIENCE, V346, P433, DOI 10.1126/science.346.6208.433-a
   Hastie T., 1990, GEN ADDITIVE MODELS
   Jongejans E, 2015, THEOR ECOL-NETH, V8, P207, DOI 10.1007/s12080-014-0245-5
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer M. U. G, 2015, MOVEMENT FUNCTIONS A
   Kraemer MUG, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0144-x
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kramer AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160294
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lessler J., 2014, PLOS CURR OUTBREAKS, V2
   Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/s1473-3099(14)70995-8, 10.1016/S1473-3099(14)70995-8]
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6
   Mylne A, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.42
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Nocedal J., 2013, NUMERICAL OPTIMIZATI, V11, DOI [10.5194/bgd-11-12733-2014, DOI 10.5194/BGD-11-12733-2014]
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Rambaut A., PHYLOGEOGRAPHY 2014
   Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268
   Reiner RC, 2012, P NATL ACAD SCI USA, V109, P2033, DOI 10.1073/pnas.1108438109
   Rivers C, 2014, NATURE, V515, P493, DOI 10.1038/515492a
   Ruktanonchai NW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1315-5
   Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Sorichetta A, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.66
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716
   Uchida H., 2008, AGGLOMERATION INDEX
   Valdez LD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12172
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   Wesolowski A., 2014, PLOS CURR OUTBREAKS, V29
   Wesolowski A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02064-4
   Wesolowski A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004267
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   WHO, 2016, EB SIT REP
   Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x
   Yang W, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0536
NR 75
TC 7
Z9 7
U1 2
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 26
PY 2019
VL 9
AR 5151
DI 10.1038/s41598-019-41192-3
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ3GN
UT WOS:000462298600038
PM 30914669
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU Naveca, FG
   Claro, I
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Iani, FCD
   do Nascimento, VA
   de Souza, VC
   Silveira, PP
   Lourenco, J
   Santillana, M
   Kraemer, MUG
   Quick, J
   Hill, SC
   Theze, J
   Carvalho, RDD
   Azevedo, V
   Salles, FCD
   Nunes, MRT
   Lemos, PD
   Candido, DD
   Pereira, GD
   Oliveira, MAA
   Meneses, CAR
   Maito, RM
   Cunha, CRS
   Campos, DPD
   Castilho, MD
   Siqueira, TCD
   Terra, TM
   de Albuquerque, CFC
   da Cruz, LN
   de Abreu, AL
   Martins, DV
   Simoes, DSDV
   de Aguiar, RS
   Luz, SLB
   Loman, N
   Pybus, OG
   Sabino, EC
   Okumoto, O
   Alcantara, LCJ
   Faria, NR
AF Naveca, Felipe Gomes
   Claro, Ingra
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   de Melo Iani, Felipe Campos
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Silveira, Paola Paz
   Lourenco, Jose
   Santillana, Mauricio
   Kraemer, Moritz U. G.
   Quick, Josh
   Hill, Sarah C.
   Theze, Julien
   de Oliveira Carvalho, Rodrigo Dias
   Azevedo, Vasco
   da Silva Salles, Flavia Cristina
   Teixeira Nunes, Marcio Roberto
   Lemos, Poliana da Silva
   Candido, Darlan da Silva
   Pereira, Glauco de Carvalho
   Assuncao Oliveira, Marluce Aparecida
   Ribeiro Meneses, Catia Alexandra
   Maito, Rodrigo Melo
   Santa Brigida Cunha, Claudeth Rocha
   de Sousa Campos, Daniela Palha
   Castilho, Marcia da Costa
   da Silva Siqueira, Thalita Caroline
   Terra, Tiza Matos
   Campelo de Albuquerque, Carlos F.
   da Cruz, Laura Nogueira
   de Abreu, Andre Luis
   Martins, Divino Valerio
   de Moraes Vanlume Simoes, Daniele Silva
   de Aguiar, Renato Santana
   Bessa Luz, Sergio Luiz
   Loman, Nicholas
   Pybus, Oliver G.
   Sabino, Ester C.
   Okumoto, Osnei
   Junior Alcantara, Luiz Carlos
   Faria, Nuno Rodrigues
TI Genomic, epidemiological and digital surveillance of Chikungunya virus
   in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAYARO VIRUS; POPULATION-DYNAMICS; MATO-GROSSO; ZIKA VIRUS; OUTBREAK;
   INFERENCE; EMERGENCE; OROPOUCHE; DISEASE; ILLNESS
AB Background Since its first detection in the Caribbean in late 2013, chikungunya virus (CHIKV) has affected 51 countries in the Americas. The CHIKV epidemic in the Americas was caused by the CHIKV-Asian genotype. In August 2014, local transmission of the CHIKV-Asian genotype was detected in the Brazilian Amazon region. However, a distinct lineage, the CHIKV-East-Central-South-America (ECSA)-genotype, was detected nearly simultaneously in Feira de Santana, Bahia state, northeast Brazil. The genomic diversity and the dynamics of CHIKV in the Brazilian Amazon region remains poorly understood despite its importance to better understand the epidemiological spread and public health impact of CHIKV in the country.
   Methodology/Principal findings We report a large CHIKV outbreak (5,928 notified cases between August 2014 and August 2018) in Boa vista municipality, capital city of Roraima's state, located in the Brazilian Amazon region. We generated 20 novel CHIKV-ECSA genomes from the Brazilian Amazon region using MinION portable genome sequencing. Phylogenetic analyses revealed that despite an early introduction of the Asian genotype in 2015 in Roraima, the large CHIKV outbreak in 2017 in Boa Vista was caused by an ECSA-lineage most likely introduced from northeastern Brazil. Epidemiological analyses suggest a basic reproductive number of R-0 of 1.66, which translates in an estimated 39 (95% CI: 36 to 45) % of Roraima's population infected with CHIKV-ECSA. Finally, we find a strong association between Google search activity and the local laboratory-confirmed CHIKV cases in Roraima.
   Conclusions/Significance This study highlights the potential of combining traditional surveillance with portable genome sequencing technologies and digital epidemiology to inform public health surveillance in the Amazon region. Our data reveal a large CHIKV-ECSA outbreak in Boa Vista, limited potential for future CHIKV outbreaks, and indicate a replacement of the Asian genotype by the ECSA genotype in the Amazon region.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa; Bessa Luz, Sergio Luiz] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; de Melo Iani, Felipe Campos; de Oliveira Carvalho, Rodrigo Dias; Azevedo, Vasco; Pereira, Glauco de Carvalho; Assuncao Oliveira, Marluce Aparecida; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [de Jesus, Jaqueline Goes; Xavier, Joilson] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [de Melo Iani, Felipe Campos] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Silveira, Paola Paz; de Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Lourenco, Jose; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
   [Santillana, Mauricio] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Santillana, Mauricio] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Quick, Josh; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Teixeira Nunes, Marcio Roberto; Lemos, Poliana da Silva] Brazilian Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Ribeiro Meneses, Catia Alexandra; Maito, Rodrigo Melo; Santa Brigida Cunha, Claudeth Rocha] Lab Cent Saude Publ, Boa Vista, Roraima, Brazil.
   [de Sousa Campos, Daniela Palha; da Silva Siqueira, Thalita Caroline] Secretaria Municipal Saude Boa Vista, Superintendencia Vigilancia Saude, Roraima, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tiza Matos] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [da Cruz, Laura Nogueira; de Abreu, Andre Luis; Martins, Divino Valerio; de Moraes Vanlume Simoes, Daniele Silva; Okumoto, Osnei] MS, SVS, Brasilia, DF, Brazil.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
EM luiz.alcantara@ioc.fiocruz.br; nuno.faria@zoo.ox.ac.uk
RI Nascimento, Valdinete Alves do/AAV-1879-2020; Aguiar, Renato
   S/G-3542-2015; Giovanetti, Marta/AAK-7408-2020; Sabino, Ester
   Cerdeira/F-7750-2010; Pybus, Oliver G/B-2640-2012; Azevedo, Vasco
   A/B-1556-2019; Loman, Nicholas/Z-1573-2019; Faria, Nuno R/I-2975-2012
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Aguiar, Renato
   S/0000-0001-5180-3717; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   Pybus, Oliver G/0000-0002-8797-2667; Azevedo, Vasco
   A/0000-0002-4775-2280; Faria, Nuno R/0000-0001-8839-2798; Lourenco,
   Jose/0000-0002-9318-2581; da Silva Candido, Darlan/0000-0002-5080-3130;
   /0000-0002-8529-4022; Carvalho, Rodrigo/0000-0003-0216-7173; da Silva
   Sales, Flavia Cristina/0000-0002-9048-0030; Iani,
   Felipe/0000-0002-3629-8529; Souza, Victor Costa de/0000-0002-3869-1519;
   Alcantara, Luiz/0000-0002-6769-9931; Hill, Sarah/0000-0002-2995-2596;
   Luz, Sergio Luiz Bessa/0000-0001-5887-7372; Xavier,
   Joilson/0000-0003-3916-2018
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440685/2016-8, 440856/2016-7]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88887.130716/2016-00,
   88881.130825/2016-00, 88887.130823/2016-00]; EU's Horizon 2020 Programme
   through ZIKAlliance [PRES-005-FEX-17-4-2-33]; Royal SocietyRoyal Society
   of London; Wellcome Trust Sir Henry Dale Fellowship [204311/Z/16/Z];
   John Fell Research Fund [005166]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN]; National Institute of General Medical Sciences of
   the NIH (USA) [R01GM130668]; internal GCRF grant [005073]
FX The ZIBRA-2 project is funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 440685/2016-8) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   88887.130716/2016-00). FGN is funded by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br, grant
   440856/2016-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br, grants 88881.130825/2016-00 and
   88887.130823/2016-00). L.C.J.A. is supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant PRES-005-FEX-17-4-2-33). N.R.F. is
   funded by a Royal Society and Wellcome Trust Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN). MS was partially supported by the
   National Institute of General Medical Sciences of the NIH (USA) under
   award number R01GM130668. The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR [Anonymous], 2015, PUBMED, V7, pe141
   [Anonymous], 2017, EMERGING INFECTIOUS, V23, ps6
   [Anonymous], 2015, PUBMED, V31, P43
   [Anonymous], 2016, PLOS CURRENTS OUTBRE, V39, pS1, DOI 10.2337/dc16-S001
   [Anonymous], 2015, PUBMED, V4, pA1
   [Anonymous], 2010, EURO SURVEILLANCE, V15, pe1936
   [Anonymous], 2016, PUBMED, V44, pD7
   [Anonymous], 2016, EVOLUTION, V2, pA49
   [Anonymous], 2016, PUBMED, V21, piii
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrillo FB, 2019, J VIROL, V93, DOI 10.1128/JVI.01622-18
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Freitas Andre Ricardo Ribas, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.14608e586cd321d8d5088652d7a0d884
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/eLife.29820, 10.7554/elife.29820]
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Obolski U, 2018, MVSE R PACKAGE ESTIM, DOI [10.1101/360701, DOI 10.1101/360701]
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Organization PAWH, 2017, NUMB REP CAS CHIK FE
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Receveur M. C., 2010, EUROSURVEILLANCE, V15, P18
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TM, 2017, PLOS CURRENTS, V9, DOI [10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727, DOI 10.1371/CURRENTS.OUTBREAKS.4200119978D62CCAA454599CD27357]
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Team RC, 2014, R LANG ENV COMP
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 79
TC 12
Z9 12
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007065
DI 10.1371/journal.pntd.0007065
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300007
PM 30845267
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Vasylyeva, TI
   Liulchuk, M
   du Plessis, L
   Fearnhill, E
   Zadorozhna, V
   Babii, N
   Scherbinska, A
   Novitsky, V
   Pybus, OG
   Faria, NR
AF Vasylyeva, Tetyana I.
   Liulchuk, Mariia
   du Plessis, Louis
   Fearnhill, Esther
   Zadorozhna, Victoriia
   Babii, Nataliia
   Scherbinska, Alla
   Novitsky, Vladimir
   Pybus, Oliver G.
   Faria, Nuno R.
TI The Changing Epidemiological Profile of HIV-1 Subtype B Epidemic in
   Ukraine
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
DE HIV-1; B-FSU; Ukraine; molecular epidemiology; people who inject drugs
ID INJECTING DRUG-USERS; FORMER SOVIET-UNION; MOLECULAR EPIDEMIOLOGY;
   TYPE-1; PEOPLE; EUROPE; PERFORMANCE; SEX
AB While HIV-1 subtype B has caused a large epidemic in the Western world, its transmission in Ukraine remains poorly understood. We assessed the genetic diversity of HIV-1 subtype B viruses circulating in Ukraine, characterized the transmission group structure, and estimated key evolutionary and epidemiological parameters. We analyzed 120 HIV-1 subtype B pol sequences (including 46 newly generated) sampled from patients residing in 11 regions of Ukraine between 2002 and 2017. Phylogenies were estimated using maximum likelihood and Bayesian phylogenetic methods. A Bayesian molecular clock coalescent analysis was used to estimate effective population size dynamics and date the most recent common ancestors of identified clades. A phylodynamic birth-death model was used to estimate the effective reproductive number (R-e) of these clades. We identified two phylogenetically distinct predominantly Ukrainian (>= 75%) clades of HIV-1 subtype B. We found no significant transmission group structure for either clade, suggesting frequent mixing among transmission groups. The estimated dates of origin of both subtype B clades were around early 1970s, similar to the introduction of HIV-1 subtype A into Ukraine. R-e was estimated to be 1.42 [95% highest posterior density (HPD) 1.26-1.56] for Clade 1 and 1.69 (95% HPD 1.49-1.84) for Clade 2. Evidently, the subtype B epidemic in the country is no longer concentrated in specific geographical regions or transmission groups. The study results highlight the necessity for strengthening preventive and monitoring efforts to reduce the further spread of HIV-1 subtype B.
C1 [Vasylyeva, Tetyana I.; du Plessis, Louis; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Peter Medawar Bldg,South Parks Rd, Oxford OX1 3SY, England.
   [Liulchuk, Mariia; Zadorozhna, Victoriia; Babii, Nataliia; Scherbinska, Alla] Natl Acad Sci Ukraine, LV Gromashevskij Inst Epidemiol & Infect Dis, Kiev, Ukraine.
   [Fearnhill, Esther] UCL, Inst Global Hlth, London, England.
   [Novitsky, Vladimir] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
RP Vasylyeva, TI (corresponding author), Univ Oxford, Dept Zool, Peter Medawar Bldg,South Parks Rd, Oxford OX1 3SY, England.
EM tetyana.vasylyeva@zoo.ox.ac.uk
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012; du Plessis,
   Louis/K-1667-2013
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   du Plessis, Louis/0000-0003-0352-6289; Vasylyeva,
   Tetyana/0000-0002-9736-7022
FU Wellcome TrustWellcome Trust [204311/Z/16/Z] Funding Source: Medline
CR Aibekova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191891
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Barcal Katerina, 2005, Harm Reduct J, V2, P16, DOI 10.1186/1477-7517-2-16
   Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724
   Bobkov A, 1998, AIDS RES HUM RETROV, V14, P669, DOI 10.1089/aid.1998.14.669
   Bobkova M, 2013, AIDS REV, V15, P204
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Dehne KL, 1999, J DRUG ISSUES, V29, P729, DOI 10.1177/002204269902900402
   Diez-Fuertes F, 2015, INFECT GENET EVOL, V33, P197, DOI 10.1016/j.meegid.2015.05.003
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010
   European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2016, HIV AIDS SURV EUR 20
   Fearnhill E, 2017, CLIN INFECT DIS, V65, P1127, DOI 10.1093/cid/cix499
   Ferdinandy B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004093
   Gelman A, 1998, STAT SCI, V13, P163
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hue S, 2014, AIDS, V28, P1967, DOI 10.1097/QAD.0000000000000383
   Karamov E, 2018, AIDS RES HUM RETROV, V34, P629, DOI [10.1089/aid.2018.0055, 10.1089/AID.2018.0055]
   Kazennova E, 2017, AIDS RES HUM RETROV, V33, P1061, DOI [10.1089/aid.2017.0078, 10.1089/AID.2017.0078]
   Kazennova E, 2014, AIDS RES HUM RETROV, V30, P742, DOI [10.1089/aid.2013.0194, 10.1089/AID.2013.0194]
   Kiriazova T, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2885-4
   Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195
   Kuiken Carla, 2003, AIDS Reviews, V5, P52
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023
   Malta M, 2014, CURR HIV-AIDS REP, V11, P52, DOI 10.1007/s11904-013-0196-2
   MoH, 2017, OP INF OFF ERG CAS H
   Nabatov AA, 2002, AIDS RES HUM RETROV, V18, P891, DOI 10.1089/08892220260190380
   Nikolopoulos GK, 2016, INFECT GENET EVOL, V46, P256, DOI 10.1016/j.meegid.2016.06.017
   Novitsky VA, 1998, AIDS RES HUM RETROV, V14, P1079, DOI 10.1089/aid.1998.14.1079
   Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Saad MD, 2006, AIDS RES HUM RETROV, V22, P796, DOI 10.1089/aid.2006.22.796
   Saad MD, 2006, AIDS RES HUM RETROV, V22, P709, DOI 10.1089/aid.2006.22.709
   Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Simmons R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157179
   Simmons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137062
   Stadler T, 2012, MOL BIOL EVOL, V29, P347, DOI 10.1093/molbev/msr217
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739
   van de Laar TJ, 2017, TRANSFUSION, V57, P1235, DOI 10.1111/trf.14097
   Vasylyeva TI, 2018, P NATL ACAD SCI USA, V115, P1051, DOI 10.1073/pnas.1701447115
   Vasylyeva TI, 2016, AIDS, V30, P2885, DOI 10.1097/QAD.0000000000001291
   Vitek CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103657
   Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085
NR 51
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD FEB 1
PY 2019
VL 35
IS 2
BP 155
EP 163
DI 10.1089/aid.2018.0167
PG 9
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA HR2AW
UT WOS:000462938900007
PM 30430838
OA Green Published, Other Gold
DA 2020-09-29
ER

PT J
AU Kraemer, MUG
   Cummings, DAT
   Funk, S
   Reiner, RC
   Faria, NR
   Pybus, OG
   Cauchemez, S
AF Kraemer, M. U. G.
   Cummings, D. A. T.
   Funk, S.
   Reiner, R. C., Jr.
   Faria, N. R.
   Pybus, O. G.
   Cauchemez, S.
TI Reconstruction and prediction of viral disease epidemics
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Review
DE Geographic spread; real-time prediction; viral epidemics
ID RESPIRATORY SYNDROME CORONAVIRUS; A H1N1 VIRUS; ZIKA VIRUS;
   YELLOW-FEVER; EBOLA-VIRUS; REAL-TIME; HOUSEHOLD TRANSMISSION; ZOONOTIC
   NICHE; SOUTH-KOREA; INFLUENZA
AB A growing number of infectious pathogens are spreading among geographic regions. Some pathogens that were previously not considered to pose a general threat to human health have emerged at regional and global scales, such as Zika and Ebola Virus Disease. Other pathogens, such as yellow fever virus, were previously thought to be under control but have recently re-emerged, causing new challenges to public health organisations. A wide array of new modelling techniques, aided by increased computing capabilities, novel diagnostic tools, and the increased speed and availability of genomic sequencing allow researchers to identify new pathogens more rapidly, assess the likelihood of geographic spread, and quantify the speed of human-to-human transmission. Despite some initial successes in predicting the spread of acute viral infections, the practicalities and sustainability of such approaches will need to be evaluated in the context of public health responses.
C1 [Kraemer, M. U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.
   [Kraemer, M. U. G.; Faria, N. R.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Cummings, D. A. T.] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Cummings, D. A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Funk, S.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Funk, S.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Reiner, R. C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, S.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Cauchemez, S.] CNRS, UMR2000 Genom Evolut Modelisat & Sante, Paris, France.
RP Kraemer, MUG (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM moritz.kraemer@zoo.ox.ac.uk
RI Funk, Stefan/B-7629-2015; Faria, Nuno R/I-2975-2012; Pybus, Oliver
   G/B-2640-2012
OI Funk, Stefan/0000-0002-2012-0080; Faria, Nuno R/0000-0001-8839-2798;
   Pybus, Oliver G/0000-0002-8797-2667; Funk, Sebastian/0000-0002-2842-3406
FU BrancoWeiss Fellowship Society in Science; National Institute of Child
   Health and Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD040128]; National Library of Medicine of the National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM010812, R01LM011965]; Oxford Martin School; Investissement
   d'Avenir programFrench National Research Agency (ANR); Laboratoire
   d'Excellence Integrative Biology of Emerging Infectious Diseases program
   [ANR-10-LABX-62-IBEID]; Models of Infectious Disease Agent Study of the
   National Institute of General Medical Sciences; AXA Research Fund; Sir
   Henry Dale Fellowship [204311/Z/16/Z]; internal GCRF grant [005073];
   John Fell Fund grant [005166]; Wellcome Trust Senior Research Fellowship
   in Basic Biomedical ScienceWellcome Trust [210758/Z/18/Z]
FX MUGK is supported by The BrancoWeiss Fellowship Society in Science,
   administered by the ETH Zurich and acknowledges funding from a Training
   Grant from the National Institute of Child Health and Human Development
   (T32HD040128) and the National Library of Medicine of the National
   Institutes of Health (R01LM010812, R01LM011965). OGP acknowledges
   support from the Oxford Martin School. SC acknowledges financial support
   from the Investissement d'Avenir program, the Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program (Grant
   ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent Study of
   the National Institute of General Medical Sciences, the AXA Research
   Fund. NRF is supported by a Sir Henry Dale Fellowship (204311/Z/16/Z),
   internal GCRF grant 005073 and John Fell Fund grant 005166. SF was
   supported by a Wellcome Trust Senior Research Fellowship in Basic
   Biomedical Science (210758/Z/18/Z).
CR Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170
   ANDERSON R M, 1991
   Andronico A, 2017, AM J EPIDEMIOL, V186, P1194, DOI 10.1093/aje/kwx008
   [Anonymous], 2018, JAMA-J AM MED ASSOC, V319, P1973, DOI 10.1001/jama.2018.5711
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Baele G, 2017, SYST BIOL, V66, pE47, DOI 10.1093/sysbio/syw054
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggerstaff M, 2018, EPIDEMICS-NETH, V24, P26, DOI 10.1016/j.epidem.2018.02.003
   Blumberg S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004452
   Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Bromham L, 2018, BIOL REV, V93, P1165, DOI 10.1111/brv.12390
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Camacho A., 2015, PLOS CURR OUTBREAKS, V7, P1, DOI DOI 10.1371/CURRENTS.OUTBREAKS.406AE55E83EC0B5193E3085
   Cauchemez S, 2006, EMERG INFECT DIS, V12, P110
   Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399
   Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108
   Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Churcher TS, 2014, SCIENCE, V344, P1230, DOI 10.1126/science.1251449
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   Dellicour S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03763-2
   Dellicour S, 2017, MOL BIOL EVOL, V34, P2563, DOI 10.1093/molbev/msx176
   Dellicour S, 2016, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-016-0924-x
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.31257, 10.7554/elife.37324, 10.7554/eLife.37324]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017
   Fisman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114548
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guarani V, 2016, ELIFE, V5, DOI 10.7554/eLife.17163
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Held L, 2017, STAT MED, V36, P3443, DOI 10.1002/sim.7363
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Khan K, 2013, PLOS CURRENT OUTBREA
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0144-x
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kramer AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160294
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lau MSY, 2017, P NATL ACAD SCI USA, V114, P2337, DOI 10.1073/pnas.1614595114
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Ma Johansson, 2014, PLOS ONE, V9
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Metcalf CJE, 2015, TRENDS IMMUNOL, V36, P753, DOI 10.1016/j.it.2015.10.004
   Metcalf CJE, 2016, LANCET, V6736, P5
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pigott DM, 2016, ELIFE, V5, DOI 10.7554/eLife.16412
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Poon LLM, 2016, NAT GENET, V48, P195, DOI 10.1038/ng.3479
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Reiner RC, 2015, ELIFE, V4, DOI 10.7554/eLife.09520
   Rivers C, 2014, NATURE, V515, P493, DOI 10.1038/515492a
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tsang TK, 2016, TRENDS MICROBIOL, V24, P123, DOI 10.1016/j.tim.2015.10.012
   Tsang TK, 2014, J INFECT DIS, V210, P684, DOI 10.1093/infdis/jiu186
   Viboud C, 2018, EPIDEMICS-NETH, V22, P1, DOI 10.1016/j.epidem.2017.10.003
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   World Health Organization, 2016, SITUATION REPORT
   Zhao S, 2018, PLOS NEGLECT TROP D, V12, P1, DOI DOI 10.1371/J0URNAL.PNTD.0006158
NR 103
TC 11
Z9 11
U1 4
U2 17
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR e34
DI 10.1017/S0950268818002881
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HG9OV
UT WOS:000455339100033
PM 30394230
OA Green Accepted, Other Gold, Green Published
DA 2020-09-29
ER

PT J
AU Flammer, PG
   Dellicour, S
   Preston, SG
   Rieger, D
   Warren, S
   Tan, CKW
   Nicholson, R
   Prichystalova, R
   Bleicher, N
   Wahl, J
   Faria, NR
   Pybus, OG
   Pollard, M
   Smith, AL
AF Flammer, Patrik G.
   Dellicour, Simon
   Preston, Stephen G.
   Rieger, Dirk
   Warren, Sylvia
   Tan, Cedric K. W.
   Nicholson, Rebecca
   Prichystalova, Renata
   Bleicher, Niels
   Wahl, Joachim
   Faria, Nuno R.
   Pybus, Oliver G.
   Pollard, Mark
   Smith, Adrian L.
TI Molecular archaeoparasitology identifies cultural changes in the
   Medieval Hanseatic trading centre of Lubeck
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE ancient DNA; genetics; parasitology; archaeology; diet; trade
ID ANCIENT DNA; MITOCHONDRIAL-DNA; PLEISTOCENE SEDIMENTS; INTESTINAL
   PARASITES; YERSINIA-PESTIS; CHAGAS-DISEASE; TUBERCULOSIS; MUMMY;
   FALCIPARUM; SEQUENCES
AB Throughout history, humans have been afflicted by parasitic worms, and eggs are readily detected in archaeological deposits. This study integrated parasitological and ancient DNA methods with a large sample set dating between Neolithic and Early Modern periods to explore the utility of molecular archaeoparasitology as a new approach to study the past. Molecular analyses provided unequivocal species-level parasite identification and revealed location-specific epidemiological signatures. Faecal-oral transmitted nematodes (Ascaris lumbricoides and Trichuris trichiura) were ubiquitous across time and space. By contrast, high numbers of food-associated cestodes (Diphyllobothrium latum and Taenia saginata) were restricted to medieval Lubeck. The presence of these cestodes and changes in their prevalence at approximately 1300 CE indicate substantial alterations in diet or parasite availability. Trichuris trichiura ITS-1 sequences grouped into two clades; one ubiquitous and one restricted to medieval Lubeck and Bristol. The high sequence diversity of T.t.ITS-1 detected in Lubeck is consistent with its importance as a Hanseatic trading centre. Collectively, these results introduce molecular archaeoparasitology as an artefact-independent source of historical evidence.
C1 [Flammer, Patrik G.; Dellicour, Simon; Preston, Stephen G.; Warren, Sylvia; Tan, Cedric K. W.; Faria, Nuno R.; Pybus, Oliver G.; Smith, Adrian L.] Univ Oxford, Dept Zool, Peter Medawar Bldg Pathogen Res, Oxford OX1 3SY, England.
   [Flammer, Patrik G.; Pollard, Mark] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England.
   [Dellicour, Simon] KU Leuven Univ Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.
   [Rieger, Dirk] Archaol & Denkmalpflege Hansestadt Lubeck, D-23566 Lubeck, Germany.
   [Nicholson, Rebecca] Oxford Archaeol Ltd, Janus House, Oxford OX2 0ES, England.
   [Prichystalova, Renata] Masaryk Univ Brno, Brno 60177, Czech Republic.
   [Bleicher, Niels] Hochbauamt Stadt Zurich, Abt Unterwasserarchaol, CH-8008 Zurich, Switzerland.
   [Wahl, Joachim] Univ Tubingen, D-72070 Tubingen, Germany.
   [Wahl, Joachim] Landesamt Denkmalpflege, Regierungsprasidium Stuttgart, D-78467 Constance, Germany.
RP Smith, AL (corresponding author), Univ Oxford, Dept Zool, Peter Medawar Bldg Pathogen Res, Oxford OX1 3SY, England.
EM adrian.smith@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; Dellicour,
   Simon/AAE-9054-2020
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Dellicour, Simon/0000-0001-9558-1052; Flammer,
   Patrik/0000-0002-3153-3411; Prichystalova, Renata/0000-0002-2257-8212
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PBSKP3-140149/PBSKP3-145846]; Sir Henry Dale Fellowship
   (Wellcome Trust/Royal Society) [204311/Z/16/Z]; Fonds Wetenschappelijk
   Onderzoek (FWO)FWO; Wiener-Anspach Foundation; BBSRCBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/K004468/1,
   BB/K001388/1]; John Fell OUP Research Fund; DEFRADepartment for
   Environment, Food & Rural Affairs (DEFRA)
FX P.G.F. received funding from the Swiss National Science Foundation
   (PBSKP3-140149/PBSKP3-145846). N.R.F. is funded by a Sir Henry Dale
   Fellowship (Wellcome Trust/Royal Society 204311/Z/16/Z). S.D. is a
   post-doctoral research fellow funded by the Fonds Wetenschappelijk
   Onderzoek (FWO) and the Wiener-Anspach Foundation. A.L.S. is funded by
   BBSRC (BB/K004468/1 and BB/K001388/1), the John Fell OUP Research Fund
   and DEFRA.
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   [Anonymous], 1843, CODEX DIPLOMATICUS L
   Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Barrett JH, 2011, J ARCHAEOL SCI, V38, P1516, DOI 10.1016/j.jas.2011.02.017
   Berndt H, 1968, ARCHAEOLOGICA LUDENS, P78
   Biagini P, 2012, NEW ENGL J MED, V367, P2057, DOI 10.1056/NEJMc1208124
   Bleicher N., 2015, ZURICH PARKHAUS OPER
   Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591
   Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549
   Bouwman AS, 2012, P NATL ACAD SCI USA, V109, P18511, DOI 10.1073/pnas.1209444109
   Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852
   Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295
   Cooper A, 2000, SCIENCE, V289, P1139
   Cote NML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146230
   Cutillas C, 2009, ACTA TROP, V111, P299, DOI 10.1016/j.actatropica.2009.05.011
   Dabernat H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089877
   Dellicour S, 2014, MOL ECOL RESOUR, V14, P647, DOI 10.1111/1755-0998.12200
   Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637
   EXCOFFIER L, 1992, GENETICS, V131, P479
   Fehring GP, 1991, LUBECKER SCHRIFTEN A, V21, P183
   Fehring GP, 1984, LUBECKER SCHRIFTEN A
   Fehring GP, 1980, LUBECKER SCHRIFTEN A, P202
   Ferreira LF, 2000, ACTA TROP, V75, P79, DOI 10.1016/S0001-706X(99)00095-9
   Gelabert P, 2016, P NATL ACAD SCI USA, V113, P11495, DOI 10.1073/pnas.1611017113
   Glaser M., 2002, LUBECKER SCHRIFTEN A, P552
   Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134
   Harbeck M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003349
   Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616
   Herrmann B, 1986, LUBECKER SCHRIFTEN A, V12
   Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426
   Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071
   Horreo JL, 2013, J SCI FOOD AGR, V93, P354, DOI 10.1002/jsfa.5766
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lampen A., 2000, VSWG VIERTELJAHRSCHR, V3, P281
   Legant G., 2010, THESIS HAMBURG
   Liu WQ, 2007, ACTA TROP, V101, P91, DOI 10.1016/j.actatropica.2006.08.010
   Loreille O, 2001, INT J PARASITOL, V31, P1101, DOI 10.1016/S0020-7519(01)00214-4
   Mardulyn P, 2009, EVOLUTION, V63, P2717, DOI 10.1111/j.1558-5646.2009.00755.x
   McCullagh P, 1992, GEN LINEAR MODELS, VXIX
   Mitchell PD, 2013, LANCET, V382, P888, DOI 10.1016/S0140-6736(13)61757-2
   Muller R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3236
   NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269
   Nerlich AG, 2008, EMERG INFECT DIS, V14, P1317, DOI 10.3201/eid1408.080235
   Newfield TP, 2009, AGR HIST REV, V57, P155
   Oh CS, 2010, J ARCHAEOL SCI, V37, P1269, DOI 10.1016/j.jas.2009.12.029
   Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214
   Sallares R, 2004, MED HIST, V48, P311, DOI 10.1017/S0025727300007651
   Seo M, 2007, J PARASITOL, V93, P589, DOI 10.1645/GE-905R3.1
   Slon V, 2017, SCIENCE, V356, P605, DOI 10.1126/science.aam9695
   Soe MJ, 2015, J PARASITOL, V101, P57, DOI 10.1645/14-650.1
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   WHARTON D, 1980, PARASITOLOGY, V81, P447, DOI 10.1017/S003118200005616X
   Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114
   Yeh HY, 2014, J ARCHAEOL SCI, V49, P83, DOI 10.1016/j.jas.2014.05.001
   Zimmerling D., 1976, HANSE HANDELSMACHT Z
NR 56
TC 3
Z9 3
U1 0
U2 4
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD OCT 10
PY 2018
VL 285
IS 1888
AR 20180991
DI 10.1098/rspb.2018.0991
PG 10
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA GW4EQ
UT WOS:000446864300003
PM 30282648
OA Green Published, Other Gold
DA 2020-09-29
ER

PT J
AU do Rosario, MS
   Giovanetti, M
   de Jesus, PAP
   Farias, DS
   Faria, NR
   de Lima, CPS
   da Silva, SP
   Nunes, MR
   Alcantara, LC
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Giovanetti, Marta
   Pereira de Jesus, Pedro Antonio
   Farias, Daniel Santana
   Faria, Nuno R.
   de Lima, Clayton Pereira S.
   da Silva, Sandro Patroca
   Nunes, Marcio Roberto
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and
   dengue virus co-infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Opsoclonus; Chikungunya; Dengue
ID NEUROLOGICAL MANIFESTATIONS; INFECTION; DIAGNOSIS
AB Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare neurological disorder characterized by irregular multidirectional eye movements, myoclonus, cerebellar ataxia, sleep disturbances, and cognitive dysfunction. Although most commonly related to paraneoplastic syndrome, this condition has occasionally been described following infectious illnesses. This article reports the first case of OMAS in association with chikungunya and dengue virus co-infection. The genetic analysis identified chikungunya virus of East/Central/South African genotype and dengue serotype 4 virus of genotype II. This report represents an unusual clinical syndrome associated with viral co-infection and reinforces the need for clinical vigilance with regard to neurological syndromes in the context of emergent arboviruses. (c) 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [do Rosario, Mateus Santana; Giovanetti, Marta; Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Pereira de Jesus, Pedro Antonio] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [de Lima, Clayton Pereira S.; da Silva, Sandro Patroca; Nunes, Marcio Roberto] Inst Evandro Chagas, Ctr Tecnol & Inovacao, Ananindeua, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020; de Siqueira,
   Isadora Cristina/R-9953-2016
OI Faria, Nuno R/0000-0001-8839-2798; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Jesus, Pedro Antonio/0000-0003-1211-2272;
   Alcantara, Luiz/0000-0002-6769-9931; do Rosario,
   Mateus/0000-0001-7404-6392
FU CNPq-National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [302584/2015-3]; MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology [04160060-00/2016]
FX CNPq-National Council for Scientific and Technological Development
   (302584/2015-3) and MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology (04160060-00/2016)
CR Bintner M, 2015, NEUROLOGY, P2005
   Blaes F, 2008, J NEUROIMMUNOL, V201, P221, DOI 10.1016/j.jneuroim.2008.05.033
   Cao-Lormeau V. M., 2016, LANCET
   Chiam CW, 2013, DIAGN MICR INFEC DIS, V77, P133, DOI 10.1016/j.diagmicrobio.2013.06.018
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gorman MP, 2010, CURR OPIN PEDIATR, V22, P745, DOI 10.1097/MOP.0b013e32833fde3f
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tan AH, 2014, PARKINSONISM RELAT D, V20, P1309, DOI 10.1016/j.parkreldis.2014.09.002
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
NR 15
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2018
VL 75
BP 11
EP 14
DI 10.1016/j.ijid.2018.07.019
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA GV6IS
UT WOS:000446213000003
PM 30076990
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   de Maia, ML
   Junior, JX
   Amarante, MFC
   Viana, P
   Barreto, FK
   de Cerqueira, EM
   Santos, NP
   Falcao, MB
   Costa, MCM
   Faical, AVB
   de Melo, ALA
   Amorim, LS
   de Siqueira, IC
   Macarenhas, DL
   de Filippis, AMB
   Faria, NR
   Acosta, AX
   Alcantara, LCJ
AF Giovanetti, M.
   Goes de Jesus, J.
   Lima de Maia, M.
   Junior, J. X.
   Castro Amarante, M. F.
   Viana, P.
   Khouri Barreto, F.
   de Cerqueira, E. M.
   Pedreira Santos, N.
   Barreto Falcao, M.
   Machado Costa, M. C.
   Barros Faical, A. V.
   Andrade de Melo, A. L.
   Santos Amorim, L.
   de Siqueira, I. C.
   Macarenhas, D. L.
   Bispo de Filippis, A. M.
   Faria, N. Rodrigues
   Xavier Acosta, A.
   Junior Alcantara, L. C.
TI Genetic evidence of Zika virus in mother's breast milk and body fluids
   of a newborn with severe congenital defects
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Giovanetti, M.; Goes de Jesus, J.; Junior, J. X.; Castro Amarante, M. F.; Viana, P.; Khouri Barreto, F.; Santos Amorim, L.; Junior Alcantara, L. C.] Inst Goncalo Moniz Salvador, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, M.; Bispo de Filippis, A. M.; Junior Alcantara, L. C.] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lima de Maia, M.; de Cerqueira, E. M.] Univ Estadual Feira de Santana, Salvador, BA, Brazil.
   [Lima de Maia, M.; Pedreira Santos, N.; Barreto Falcao, M.; Machado Costa, M. C.; Andrade de Melo, A. L.; Macarenhas, D. L.] Secretaria Saude Feira Santana, Salvador, BA, Brazil.
   [Barreto Falcao, M.; Xavier Acosta, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Faria, N. Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Fundac Oswaldo Cruz, Rio De Janeiro, Brazil.
EM lalcan@bahia.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020; de Siqueira,
   Isadora Cristina/R-9953-2016
OI Faria, Nuno R/0000-0001-8839-2798; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Alcantara, Luiz/0000-0002-6769-9931;
   Xavier, Joilson/0000-0003-3916-2018
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX Supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). All authors report no conflicts of interest
   relevant to this article.
CR de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dupont-Rouzeyrol M, 2016, LANCET LOND ENGL, V387, P1051
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 5
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2018
VL 24
IS 10
BP 1111
EP 1112
DI 10.1016/j.cmi.2018.06.008
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GU0EY
UT WOS:000444923000026
PM 29906587
OA Bronze
DA 2020-09-29
ER

PT J
AU Faria, NR
   Kraemer, MUG
   Hill, SC
   de Jesus, JG
   Aguiar, RS
   Iani, FCM
   Xavier, J
   Quick, J
   du Plessis, L
   Dellicour, S
   Theze, J
   Carvalho, RDO
   Baele, G
   Wu, CH
   Silveira, PP
   Arruda, MB
   Pereira, MA
   Pereira, GC
   Lourenco, J
   Obolski, U
   Abade, L
   Vasylyeva, TI
   Giovanetti, M
   Yi, D
   Weiss, DJ
   Wint, GRW
   Shearer, FM
   Funk, S
   Nikolay, B
   Fonseca, V
   Adelino, TER
   Oliveira, MAA
   Silva, MVF
   Sacchetto, L
   Figueiredo, PO
   Rezende, IM
   Mello, EM
   Said, RFC
   Santos, DA
   Ferraz, ML
   Brito, MG
   Santana, LF
   Menezes, MT
   Brindeiro, RM
   Tanuri, A
   dos Santos, FCP
   Cunha, MS
   Nogueira, JS
   Rocco, IM
   da Costa, AC
   Komninakis, SCV
   Azevedo, V
   Chieppe, AO
   Araujo, ESM
   Mendonca, MCL
   dos Santos, CC
   dos Santos, CD
   Mares-Guia, AM
   Nogueira, RMR
   Sequeira, PC
   Abreu, RG
   Garcia, MHO
   Abreu, AL
   Okumoto, O
   Kroon, EG
   de Albuquerque, CFC
   Lewandowski, K
   Pullan, ST
   Carroll, M
   de Oliveira, T
   Sabino, EC
   Souza, RP
   Suchard, MA
   Lemey, P
   Trindade, GS
   Drumond, BP
   Filippis, AMB
   Loman, NJ
   Cauchemez, S
   Alcantara, LCJ
   Pybus, OG
AF Faria, N. R.
   Kraemer, M. U. G.
   Hill, S. C.
   de Jesus, J. Goes
   Aguiar, R. S.
   Iani, F. C. M.
   Xavier, J.
   Quick, J.
   du Plessis, L.
   Dellicour, S.
   Theze, J.
   Carvalho, R. D. O.
   Baele, G.
   Wu, C. -H.
   Silveira, P. P.
   Arruda, M. B.
   Pereira, M. A.
   Pereira, G. C.
   Lourenco, J.
   Obolski, U.
   Abade, L.
   Vasylyeva, T. I.
   Giovanetti, M.
   Yi, D.
   Weiss, D. J.
   Wint, G. R. W.
   Shearer, F. M.
   Funk, S.
   Nikolay, B.
   Fonseca, V.
   Adelino, T. E. R.
   Oliveira, M. A. A.
   Silva, M. V. F.
   Sacchetto, L.
   Figueiredo, P. O.
   Rezende, I. M.
   Mello, E. M.
   Said, R. F. C.
   Santos, D. A.
   Ferraz, M. L.
   Brito, M. G.
   Santana, L. F.
   Menezes, M. T.
   Brindeiro, R. M.
   Tanuri, A.
   dos Santos, F. C. P.
   Cunha, M. S.
   Nogueira, J. S.
   Rocco, I. M.
   da Costa, A. C.
   Komninakis, S. C. V.
   Azevedo, V.
   Chieppe, A. O.
   Araujo, E. S. M.
   Mendonca, M. C. L.
   dos Santos, C. C.
   dos Santos, C. D.
   Mares-Guia, A. M.
   Nogueira, R. M. R.
   Sequeira, P. C.
   Abreu, R. G.
   Garcia, M. H. O.
   Abreu, A. L.
   Okumoto, O.
   Kroon, E. G.
   de Albuquerque, C. F. C.
   Lewandowski, K.
   Pullan, S. T.
   Carroll, M.
   de Oliveira, T.
   Sabino, E. C.
   Souza, R. P.
   Suchard, M. A.
   Lemey, P.
   Trindade, G. S.
   Drumond, B. P.
   Filippis, A. M. B.
   Loman, N. J.
   Cauchemez, S.
   Alcantara, L. C. J.
   Pybus, O. G.
TI Genomic and epidemiological monitoring of yellow fever virus
   transmission potential
SO SCIENCE
LA English
DT Article
ID SPREAD; BRAZIL; ANGOLA
AB The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.
C1 [Faria, N. R.; Kraemer, M. U. G.; Hill, S. C.; du Plessis, L.; Theze, J.; Lourenco, J.; Obolski, U.; Abade, L.; Vasylyeva, T. I.; Wint, G. R. W.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, M. U. G.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [de Jesus, J. Goes; Xavier, J.; Giovanetti, M.; Araujo, E. S. M.; Mendonca, M. C. L.; dos Santos, C. C.; dos Santos, C. D.; Mares-Guia, A. M.; Nogueira, R. M. R.; Sequeira, P. C.; de Oliveira, T.; Filippis, A. M. B.; Alcantara, L. C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Aguiar, R. S.; Silveira, P. P.; Arruda, M. B.; Menezes, M. T.; Brindeiro, R. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Iani, F. C. M.; Pereira, M. A.; Pereira, G. C.; Adelino, T. E. R.; Oliveira, M. A. A.; Silva, M. V. F.] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Iani, F. C. M.; Carvalho, R. D. O.; Giovanetti, M.; Fonseca, V.; Sacchetto, L.; Figueiredo, P. O.; Rezende, I. M.; Mello, E. M.; Azevedo, V.; Kroon, E. G.; Trindade, G. S.; Drumond, B. P.; Alcantara, L. C. J.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Dellicour, S.; Baele, G.; Lemey, P.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford, England.
   [Abade, L.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Yi, D.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Weiss, D. J.; Shearer, F. M.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England.
   [Funk, S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Ctr Bioinformat, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, CNRS, Genom Evolut Modelisat & Sante UMR2000, Paris, France.
   [Fonseca, V.; de Oliveira, T.] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Durban, South Africa.
   [Said, R. F. C.; Santos, D. A.; Ferraz, M. L.; Brito, M. G.; Santana, L. F.] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [dos Santos, F. C. P.; Cunha, M. S.; Nogueira, J. S.; Rocco, I. M.; Souza, R. P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Sch Med ABC FMABC, Clin Immunol Lab, Santo Andre, SP, Brazil.
   [Chieppe, A. O.] Coordenacao Vigilancia Epidemiol Estado Rio de Ja, Rio De Janeiro, Brazil.
   [Abreu, R. G.; Garcia, M. H. O.] Minist Saude, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Abreu, A. L.; Okumoto, O.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
   [de Albuquerque, C. F. C.] OMS, OPAS, Brasilia, DF, Brazil.
   [Lewandowski, K.; Pullan, S. T.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Carroll, M.] Publ Hlth England, NIHR HPRU Emerging & Zoonot Infect, London, England.
   [de Oliveira, T.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Human Genet, Los Angeles, CA 90095 USA.
RP Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM nuno.faria@zoo.ox.ac.uk; luiz.alcantara@ioc.fiocruz.br;
   oliver.pybus@zoo.ox.ac.uk
RI Rezende, Izabela Mauricio/AAL-5766-2020; Dellicour, Simon/AAE-9054-2020;
   Azevedo, Vasco A/B-1556-2019; da-Costa, Antonio Charlys/G-1548-2010;
   Aguiar, Renato S/G-3542-2015; Sabino, Ester Cerdeira/F-7750-2010; Loman,
   Nicholas/Z-1573-2019; Giovanetti, Marta/AAK-7408-2020; Kroon,
   Erna/V-5444-2019; Komninakis, Shirley V/B-2915-2010; Pybus, Oliver
   G/B-2640-2012; Faria, Nuno R/I-2975-2012; Sacchetto, Livia/B-8841-2019;
   Funk, Stefan/B-7629-2015; Azevedo, Vasco A.C/F-4315-2011; Fonseca,
   Vagner/R-5813-2019; Baele, Guy/R-8157-2017; du Plessis,
   Louis/K-1667-2013
OI Rezende, Izabela Mauricio/0000-0003-2616-6300; Dellicour,
   Simon/0000-0001-9558-1052; Azevedo, Vasco A/0000-0002-4775-2280;
   da-Costa, Antonio Charlys/0000-0001-5516-5177; Aguiar, Renato
   S/0000-0001-5180-3717; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   Komninakis, Shirley V/0000-0001-7784-3418; Pybus, Oliver
   G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798; Sacchetto,
   Livia/0000-0001-9716-6899; Funk, Stefan/0000-0002-2012-0080; Azevedo,
   Vasco A.C/0000-0002-4775-2280; Fonseca, Vagner/0000-0001-5521-6448;
   Baele, Guy/0000-0002-1915-7732; du Plessis, Louis/0000-0003-0352-6289;
   Vasylyeva, Tetyana/0000-0002-9736-7022; Pereira de Souza,
   Renato/0000-0003-1315-7085; Alcantara, Luiz/0000-0002-6769-9931; Funk,
   Sebastian/0000-0002-2842-3406; Iani, Felipe/0000-0002-3629-8529; Pullan,
   Steven/0000-0002-8983-599X; Hill, Sarah/0000-0002-2995-2596; Carvalho,
   Rodrigo/0000-0003-0216-7173; Xavier, Joilson/0000-0003-3916-2018; De
   Jesus, Jaqueline/0000-0002-5404-272X; Wu, Chieh-Hsi/0000-0001-9386-725X
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2, 2017/00021-9]; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; internal GCRF grant [005073]; John Fell Research Fund
   [005166]; ERCEuropean Research Council (ERC) [614725-PATHPHYLODYN];
   Oxford Martin School; Branco Weiss Fellowship; National Institute of
   Child Health and Human DevelopmentUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [T32HD040128]; National Library of Medicine of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM011965]; Fonds Wetenschappelijk
   Onderzoek (FWO, Flanders, Belgium)FWO; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven; EU's Horizon 2020 Programme through
   ZIKAlliance [734548]; Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of
   Infectious Disease Agent Study of the National Institute of General
   Medical Sciences; AXA Research Fund; Association Robert Debre; European
   Research CouncilEuropean Research Council (ERC) [725422-ReservoirDOCS];
   Wellcome TrustWellcome Trust [206298/Z/17/Z]; Research Foundation,
   Flanders (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen)FWO
   [G066215N, G0D5117N, G0B9317N]
FX This work was supported in part by CNPq 400354/2016-0 and FAPESP
   2016/01735-2. N.R.F. is supported by a Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN) and from the Oxford Martin School.
   M.U.G.K. acknowledges funding from a Branco Weiss Fellowship,
   administered by ETH Zurich, a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128), and the National
   Library of Medicine of the National Institutes of Health (R01LM010812
   and R01LM011965). S.D. is funded by the Fonds Wetenschappelijk Onderzoek
   (FWO, Flanders, Belgium). G.B. acknowledges support from the Interne
   Fondsen KU Leuven/Internal Funds KU Leuven. A.C.d.C. is funded by FAPESP
   2017/00021-9. B.B.N. and S.C. are supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant 734548), the Investissement
   d'Avenir program, the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, the AXA Research Fund, and the Association
   Robert Debre. P.L. and M.A.S. acknowledge funding from the European
   Research Council (grant agreement 725422-ReservoirDOCS) and from the
   Wellcome Trust Collaborative Award 206298/Z/17/Z. P.L. acknowledges
   support from the Research Foundation, Flanders (Fonds voor
   Wetenschappelijk Onderzoek, Vlaanderen, G066215N, G0D5117N, and
   G0B9317N).
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil, 2017, B EPIDEMIOLOGICO, V48
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.31257, 10.7554/elife.37324, 10.7554/eLife.37324]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   Franco O., 1969, HIST FEBRE AMARELA B
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   PAHO, 2009, OUTBR YELL FEV PAR
   Pan American Health Organization/World Health Organization, 2018, EP UPD YELL FEV 16 F
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Segura M. N. O., 2007, ATLAS CULICIDEOS AMA, V167
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vainio J, 1998, YELLOW FEVER
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
NR 49
TC 70
Z9 71
U1 1
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 31
PY 2018
VL 361
IS 6405
BP 894
EP +
DI 10.1126/science.aat7115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3UB
UT WOS:000443547000033
PM 30139911
OA Green Accepted, Bronze
DA 2020-09-29
ER

PT J
AU Theze, J
   Li, T
   du Plessis, L
   Bouquet, J
   Kraemer, MUG
   Somasekar, S
   Yu, GX
   de Cesare, M
   Balmaseda, A
   Kuan, G
   Harris, E
   Wu, CH
   Ansari, MA
   Bowden, R
   Faria, NR
   Yagi, S
   Messenger, S
   Brooks, T
   Stone, M
   Bloch, EM
   Busch, M
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Wolinsky, S
   Lopez, S
   Arias, CF
   Bonsall, D
   Chiu, CY
   Pybus, OG
AF Theze, Julien
   Li, Tony
   du Plessis, Louis
   Bouquet, Jerome
   Kraemer, Moritz U. G.
   Somasekar, Sneha
   Yu, Guixia
   de Cesare, Mariateresa
   Balmaseda, Angel
   Kuan, Guillermina
   Harris, Eva
   Wu, Chieh-hsi
   Ansari, M. Azim
   Bowden, Rory
   Faria, Nuno R.
   Yagi, Shigeo
   Messenger, Sharon
   Brooks, Trevor
   Stone, Mars
   Bloch, Evan M.
   Busch, Michael
   Munoz-Medina, Jose E.
   Gonzalez-Bonilla, Cesar R.
   Wolinsky, Steven
   Lopez, Susana
   Arias, Carlos F.
   Bonsall, David
   Chiu, Charles Y.
   Pybus, Oliver G.
TI Genomic Epidemiology Reconstructs the Introduction and Spread of Zika
   Virus in Central America and Mexico
SO CELL HOST & MICROBE
LA English
DT Article
ID SEXUAL TRANSMISSION; MOLECULAR SEQUENCES; CLINICAL-SAMPLES; GENERATION;
   DENGUE; CHIKUNGUNYA; ACCURATE; PROTEIN; BRAZIL; EVOLUTION
AB The Zika virus (ZIKV) epidemic in the Americas established ZIKV as a major public health threat and uncovered its association with severe diseases, including microcephaly. However, genetic epidemiology in some at-risk regions, particularly Central America and Mexico, remains limited. We report 61 ZIKV genomes from this region, generated using metagenomic sequencing with ZIKV-specific enrichment, and combine phylogenetic, epidemiological, and environmental data to reconstruct ZIKV transmission. These analyses revealed multiple independent ZIKV introductions to Central America and Mexico. One introduction, likely from Brazil via Honduras, led to most infections and the undetected spread of ZIKV through the region from late 2014. Multiple lines of evidence indicate biannual peaks of ZIKV transmission in the region, likely driven by varying local environmental conditions for mosquito vectors and herd immunity. The spatial and temporal heterogeneity of ZIKV transmission in Central America and Mexico challenges arbovirus surveillance and disease control measures.
C1 [Theze, Julien; du Plessis, Louis; Kraemer, Moritz U. G.; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Li, Tony; Bouquet, Jerome; Somasekar, Sneha; Yu, Guixia; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Li, Tony; Bouquet, Jerome; Somasekar, Sneha; Yu, Guixia; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [de Cesare, Mariateresa; Bowden, Rory] Univ Oxford, Oxford Genom Ctr, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Salud, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Wu, Chieh-hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Ansari, M. Azim; Bonsall, David] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Yagi, Shigeo; Messenger, Sharon] Calif Dept Publ Hlth, Richmond, CA USA.
   [Brooks, Trevor; Stone, Mars; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA.
   [Bloch, Evan M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Munoz-Medina, Jose E.; Gonzalez-Bonilla, Cesar R.] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA.
   [Lopez, Susana; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Chiu, Charles Y.] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA.
EM charles.chiu@ucsf.edu; oliver.pybus@zoo.ox.ac.uk
RI Arias, Carlos/O-4036-2019; Esteban, Munoz Medina Jose/B-6186-2015;
   Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; Lopez,
   Susana/H-6661-2017; Wolinsky, Steven/B-2893-2012; du Plessis,
   Louis/K-1667-2013
OI Arias, Carlos/0000-0003-3130-4501; Esteban, Munoz Medina
   Jose/0000-0002-1289-4457; Pybus, Oliver G/0000-0002-8797-2667; Faria,
   Nuno R/0000-0001-8839-2798; Lopez, Susana/0000-0001-6336-9209; Ansari,
   M. Azim/0000-0003-2790-8353; bonsall, david/0000-0003-2187-0550;
   Gonzalez Bonilla, Cesar/0000-0002-2225-5069; Bowden,
   Rory/0000-0001-8596-0366; Bouquet, Jerome/0000-0001-8077-6025; du
   Plessis, Louis/0000-0003-0352-6289; Wu, Chieh-Hsi/0000-0001-9386-725X
FU European Research Council under the European Commission Seventh
   Framework Program (FP7)/European Research Council grant
   [614725-PATHPHYLODYN]; Oxford Martin School; Society in Science Branco
   Weiss Fellowship; National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128];
   National Library of Medicine of the NIH [R01LM010812, R01LM011965];
   Wellcome TrustWellcome Trust; Royal SocietyRoyal Society of London
   [204311/Z/16/Z]; Abbott LaboratoriesAbbott Laboratories; NIH from the
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI099631, P01AI106695, U19 AI118610, R21AI129455]; NIH from the
   National Heart, Lung, and Blood InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01 HL105704]; Wellcome
   Trust core awardWellcome Trust [203141/Z/16/Z]
FX We thank Marco A. Espinoza for processing the Mexican ZIKV serum
   samples. We thank Magelda Montoya and Juan Carlos Mercado for their
   invaluable assistance in providing samples from Nicaragua. Wealso thank
   Prof. Nicholas Loman and Joshua Quick for their feedback on the
   manuscript. We are grateful to past and present members of the team at
   the Centro de Salud Socrates Flores Vivas, the National Virology
   Laboratory in the Centro Nacional de Diagnostico y Referencia, and the
   Sustainable Sciences Institute in Nicaragua for their dedication and
   high-quality work, as well as the children who participated in the
   studies and their families. We thank Philippe Lemey for providing the
   script to analyze viral transmissions among locations. We thank Paul
   Klenerman, who supported sequencing of the Nicaragua samples through the
   Oxford Viromics initiative. This work was supported by the European
   Research Council under the European Commission Seventh Framework Program
   (FP7/2007-2013)/European Research Council grant agreement
   614725-PATHPHYLODYN and by the Oxford Martin School. M.U.G.K. is
   supported by the Society in Science Branco Weiss Fellowship,
   administered by the ETH Zurich, and acknowledges funding from a training
   grant from the National Institute of Child Health and Human Development
   (T32HD040128) and the National Library of Medicine of the NIH
   (R01LM010812, R01LM011965). N.R.F. is supported by the Wellcome Trust
   and the Royal Society (204311/Z/16/Z). This work was also funded in part
   by Abbott Laboratories (C.Y.C.), NIH grants R01AI099631 (A.B.),
   P01AI106695 (E.H.), U19 AI118610 (S.W. and E.H.), and R21AI129455
   (C.Y.C.) from the National Institute of Allergy and Infectious Diseases,
   and NIH grant R01 HL105704 (C.Y.C.) from the National Heart, Lung, and
   Blood Institute. This work was also supported by the Wellcome Trust core
   award (203141/Z/16/Z).
CR Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonsall David, 2015, F1000Res, V4, P1062, DOI 10.12688/f1000research.7111.1
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Brooks T, 2017, EMERG INFECT DIS, V23, P1360, DOI 10.3201/eid2308.161944
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Koehler JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107007
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li H, 2013, ARXIVQBIOGN13033997
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/eLife.29820, 10.7554/elife.29820]
   Luk KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141723
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
NR 67
TC 34
Z9 35
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 13
PY 2018
VL 23
IS 6
BP 855
EP +
DI 10.1016/j.chom.2018.04.017
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GM7WT
UT WOS:000438408600023
PM 29805095
OA Green Published, Green Accepted, Other Gold
DA 2020-09-29
ER

PT J
AU Dellicour, S
   Baele, G
   Dudas, G
   Faria, NR
   Pybus, OG
   Suchard, MA
   Rambaut, A
   Lemey, P
AF Dellicour, Simon
   Baele, Guy
   Dudas, Gytis
   Faria, Nuno R.
   Pybus, Oliver G.
   Suchard, Marc A.
   Rambaut, Andrew
   Lemey, Philippe
TI Phylodynamic assessment of intervention strategies for the West African
   Ebola virus outbreak
SO NATURE COMMUNICATIONS
LA English
DT Article
ID REAL-TIME; DYNAMICS; EVOLUTION; SPREAD; TRANSMISSION; EPIDEMIOLOGY;
   SURVEILLANCE; SEQUENCES; INFERENCE; MODEL
AB Genetic analyses have provided important insights into Ebola virus spread during the recent West African outbreak, but their implications for specific intervention scenarios remain unclear. Here, we address this issue using a collection of phylodynamic approaches. We show that long-distance dispersal events were not crucial for epidemic expansion and that preventing viral lineage movement to any given administrative area would, in most cases, have had little impact. However, major urban areas were critical in attracting and disseminating the virus: preventing viral lineage movement to all three capitals simultaneously would have contained epidemic size to one-third. We also show that announcements of border closures were followed by a significant but transient effect on international virus dispersal. By quantifying the hypothetical impact of different intervention strategies, as well as the impact of barriers on dispersal frequency, our study illustrates how phylodynamic analyses can help to address specific epidemiological and outbreak control questions.
C1 [Dellicour, Simon; Baele, Guy; Lemey, Philippe] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Herestr 49, B-3000 Leuven, Belgium.
   [Dudas, Gytis] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Suchard, Marc A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Kings Bldg, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
RP Dellicour, S (corresponding author), Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Herestr 49, B-3000 Leuven, Belgium.
EM simon.dellicour@kuleuven.be
RI Rambaut, Andrew/B-2481-2009; Faria, Nuno R/I-2975-2012; Dudas,
   Gytis/H-5968-2019; Pybus, Oliver G/B-2640-2012; Dellicour,
   Simon/AAE-9054-2020; Lemey, Philippe/C-3755-2018; Baele, Guy/R-8157-2017
OI Rambaut, Andrew/0000-0003-4337-3707; Faria, Nuno R/0000-0001-8839-2798;
   Dudas, Gytis/0000-0002-0227-4158; Pybus, Oliver G/0000-0002-8797-2667;
   Dellicour, Simon/0000-0001-9558-1052; Lemey,
   Philippe/0000-0003-2826-5353; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X; Baele, Guy/0000-0002-1915-7732
FU Fonds Wetenschappelijk Onderzoek (FWO, Belgium)FWO; Fonds National de la
   Recherche Scientifique (FNRS, Belgium)Fonds de la Recherche Scientifique
   - FNRS; European Community's Seventh Framework ProgrammeEuropean Union
   (EU) [278433-PREDEMICS]; European Research Council under the European
   Union's Horizon 2020 research and innovation programmeEuropean Research
   Council (ERC) [725422-ReservoirDOCS]; Wellcome Trust Collaborative
   AwardWellcome Trust [206298/Z/17/Z]; European Union's Seventh Framework
   Programme/European Research Council [614725-PATH-PHYLODYN]; Oxford
   Martin School Programme on Pandemic Genomics; Special Research Fund, KU
   Leuven ('Bijzonder Onderzoeksfonds,' KU Leuven) [OT/14/115]; Research
   Foundation-Flanders ('Fonds voor Wetenschappelijk
   Onderzoek-Vlaanderen,')FWO [G066215N, G0D5117N, G0B9317N]; Sir Henry
   Dale Fellowship [204311/Z/16/Z]; National Science FoundationNational
   Science Foundation (NSF) [DMS1264153]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 LM012080]; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven; Mahan Postdoctoral Fellowship at Fred
   Hutchinson Cancer Research Center; European Union's Horizon 2020
   research and innovation program [634650]; Research Foundation-Flanders
   (FWO)FWO; Flemish Government department EWI
FX S.D. is a postdoctoral research fellow funded by the Fonds
   Wetenschappelijk Onderzoek (FWO, Belgium) and by the Fonds National de
   la Recherche Scientifique (FNRS, Belgium). P.L., G.B. and A.R.
   acknowledge funding from the European Community's Seventh Framework
   Programme (FP7/2007-2013) under Grant Agreement no. 278433-PREDEMICS.
   P.L., A.R. and M.A.S. acknowledge funding from the European Research
   Council under the European Union's Horizon 2020 research and innovation
   programme (grant agreement no. 725422-ReservoirDOCS) and from the
   Wellcome Trust Collaborative Award, 206298/Z/17/Z. O.G.P. is supported
   by the European Union's Seventh Framework Programme
   (FP7/2007-2013)/European Research Council (614725-PATH-PHYLODYN) and by
   the Oxford Martin School Programme on Pandemic Genomics. P.L.
   acknowledges support by the Special Research Fund, KU Leuven ('Bijzonder
   Onderzoeksfonds,' KU Leuven, OT/14/115), and the Research
   Foundation-Flanders ('Fonds voor Wetenschappelijk Onderzoek-Vlaanderen,'
   G066215N, G0D5117N and G0B9317N). N.R.F. is funded by a Sir Henry Dale
   Fellowship (grant 204311/Z/16/Z). M.A.S. acknowledges funding through
   the National Science Foundation grant no. DMS1264153 and National
   Institutes of Health grant no. R01 LM012080. G.B. acknowledges support
   from the Interne Fondsen KU Leuven/Internal Funds KU Leuven. G.D. is
   supported by the Mahan Postdoctoral Fellowship at Fred Hutchinson Cancer
   Research Center. The VIROGENESIS project receives funding from the
   European Union's Horizon 2020 research and innovation program under
   grant agreement no. 634650. The computational resources and services
   used in this work were provided by the VSC (Flemish Supercomputer
   Center), funded by the Research Foundation-Flanders (FWO) and the
   Flemish Government department EWI.
CR [Anonymous], 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.28, 10.1038/nmicrobiol.2016.28]
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Backer JA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005210
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Bielejec F, 2014, SYST BIOL, V63, P493, DOI 10.1093/sysbio/syu015
   Blackwood JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29262
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Dellicour S, 2017, MOL BIOL EVOL, V34, P2563, DOI 10.1093/molbev/msx176
   Dellicour S, 2016, BIOINFORMATICS, V32, P3204, DOI 10.1093/bioinformatics/btw384
   Dellicour S, 2016, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-016-0924-x
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gelman A, 1996, STAT SINICA, V6, P733
   Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kramer AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160294
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lau MSY, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005798
   Lau MSY, 2017, P NATL ACAD SCI USA, V114, P2337, DOI 10.1073/pnas.1614595114
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lycett SJ, 2016, SCIENCE, V354, P213, DOI 10.1126/science.aaf8852
   MENG XL, 1994, ANN STAT, V22, P1142, DOI 10.1214/aos/1176325622
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935
   Nouvellet P, 2015, NATURE, V528, pS109, DOI 10.1038/nature16041
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Ratmann O, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad1863
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f
   Streicker DG, 2016, P NATL ACAD SCI USA, V113, P10926, DOI 10.1073/pnas.1606587113
   Swofford D, 2002, PAUP PHYLOGENETIC AN
   Trovao NS, 2015, MOL BIOL EVOL, V32, P3264, DOI 10.1093/molbev/msv185
   Volz Erik, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.6f7025f1271821d4c815385b08f5f80e
   Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e
   Wishart J, 1928, BIOMETRIKA, V20A, P32, DOI 10.1093/biomet/20A.1-2.32
   Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191
   World Health Organization, EB SIT REP
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Zinszer K, 2015, LANCET INFECT DIS, V15, P1005, DOI 10.1016/S1473-3099(15)00234-0
NR 60
TC 18
Z9 18
U1 3
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 8
PY 2018
VL 9
AR 2222
DI 10.1038/s41467-018-03763-2
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI6WN
UT WOS:000434644000001
PM 29884821
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Lourenco, J
   Tennant, W
   Faria, NR
   Walker, A
   Gupta, S
   Recker, M
AF Lourenco, Jose
   Tennant, Warren
   Faria, Nuno R.
   Walker, Andrew
   Gupta, Sunetra
   Recker, Mario
TI Challenges in dengue research: A computational perspective
SO EVOLUTIONARY APPLICATIONS
LA English
DT Review
DE computation; dengue; epidemiology; evolution; models
ID ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL ANTIGENIC SIN; VIRUS SEROTYPE
   4; T-CELL RESPONSES; HEMORRHAGIC-FEVER; PUERTO-RICO; MOLECULAR
   EVOLUTION; DISEASE SEVERITY; CROSS-IMMUNITY; SHOCK SYNDROME
AB The dengue virus is now the most widespread arbovirus affecting human populations, causing significant economic and social impact in South America and South-East Asia. Increasing urbanization and globalization, coupled with insufficient resources for control, misguided policies or lack of political will, and expansion of its mosquito vectors are some of the reasons why interventions have so far failed to curb this major public health problem. Computational approaches have elucidated on dengue's population dynamics with the aim to provide not only a better understanding of the evolution and epidemiology of the virus but also robust intervention strategies. It is clear, however, that these have been insufficient to address key aspects of dengue's biology, many of which will play a crucial role for the success of future control programmes, including vaccination. Within a multiscale perspective on this biological system, with the aim of linking evolutionary, ecological and epidemiological thinking, as well as to expand on classic modelling assumptions, we here propose, discuss and exemplify a few major computational avenuesreal-time computational analysis of genetic data, phylodynamic modelling frameworks, within-host model frameworks and GPU-accelerated computing. We argue that these emerging approaches should offer valuable research opportunities over the coming years, as previously applied and demonstrated in the context of other pathogens.
C1 [Lourenco, Jose; Faria, Nuno R.; Walker, Andrew; Gupta, Sunetra] Univ Oxford, Dept Zool, Oxford, England.
   [Tennant, Warren; Recker, Mario] Univ Exeter, Ctr Math & Environm, Penryn, England.
RP Lourenco, J (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM jose.lourenco@zoo.ox.ac.uk
RI Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798; Tennant, Warren/0000-0001-5822-6887;
   Lourenco, Jose/0000-0002-9318-2581; Recker, Mario/0000-0001-9489-1315
FU European Research Council under the European Union's Seventh Framework
   Programme / ERCEuropean Research Council (ERC) [268904 - DIVERSITY];
   Royal Society University Research FellowshipRoyal Society of London;
   Wellcome TrustWellcome Trust; Royal SocietyRoyal Society of London
   [204311/Z/16/Z]; Engineering and Physical Sciences Research Council
   (EPSRC)Engineering & Physical Sciences Research Council (EPSRC)
FX JL, AW and SG received funding from the European Research Council under
   the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC
   grant agreement no. 268904 - DIVERSITY. MR was supported by a Royal
   Society University Research Fellowship. NRF by a Sir Henry Dale
   Fellowship jointly funded by the Wellcome Trust and the Royal Society
   (grant number 204311/Z/16/Z). WT has received funding from a doctoral
   scholarship from the Engineering and Physical Sciences Research Council
   (EPSRC) Doctoral Training Partnership.
CR Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   Adams B, 2006, J THEOR BIOL, V242, P337, DOI 10.1016/j.jtbi.2006.03.002
   Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Aguiar M, 2008, MATH MODEL NAT PHENO, V3, P48, DOI 10.1051/mmnp:2008070
   AIKEN SR, 1978, T I BRIT GEOGR, V3, P476, DOI 10.2307/622125
   Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192
   Amarilla AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-113
   Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Ansari NA, 2012, APPL MATH, V3, P177, DOI [10.4236/am.2012.32028, DOI 10.4236/am.2012.32028]
   Auguste AJ, 2010, J VIROL, V84, P9967, DOI 10.1128/JVI.00588-10
   Aziz AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-258
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Bedford T., 2014, ELIFE, V2014, P1
   Bedford T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-220
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Ben-Shachar R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005194
   Ben-Shachar R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0886
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Bhoomiboonchoo P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1590-z
   Bin Ghouth AS, 2012, AM J TROP MED HYG, V86, P1072, DOI 10.4269/ajtmh.2012.11-0723
   BOSIO CF, 1992, J MED ENTOMOL, V29, P985, DOI 10.1093/jmedent/29.6.985
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campbell KM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003957
   Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005
   Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169
   Chao DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076044
   Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876
   Chew CH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3496-9
   Choudhury D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133842
   Clapham HE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004951
   Clapham HE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0094
   Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244
   Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dorigatti I, 2015, VACCINE, V33, P3746, DOI 10.1016/j.vaccine.2015.05.059
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0196
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, P1
   Francis TJ, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806
   Franco L, 2010, EUROSURVEILLANCE, V15, P5
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gautret P, 2010, EUROSURVEILLANCE, V15, P2
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gujarati TP, 2014, J MATH BIOL, V69, P1773, DOI 10.1007/s00285-013-0749-4
   Guzman MG, 2008, T ROY SOC TROP MED H, V102, P522, DOI 10.1016/j.trstmh.2008.03.001
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead S. B., 2011, REV INFECT DIS S4, V11, pS830
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hladish T. J., 2016, PLOS NEGLECT TROP D, V10, P1
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Hu K, 2013, J THEOR BIOL, V319, P62, DOI 10.1016/j.jtbi.2012.11.021
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   Issack M. I., 2010, EMERG INFECT DIS, V16, P3
   Jaenisch T., 2014, EMERGING INFECT DIS, V20
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Ke RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003193
   Khan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147416
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Kochel TJ, 2005, J INFECT DIS, V191, P1000, DOI 10.1086/427511
   Kochel TJ, 2002, LANCET, V360, P310, DOI 10.1016/S0140-6736(02)09522-3
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Larrieu S, 2012, EUROSURVEILLANCE, V17, P4
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/eLife.29820, 10.7554/elife.29820]
   Lourenco J, 2016, EPIDEMICS-NETH, V16, P40, DOI 10.1016/j.epidem.2016.05.003
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lourenco J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003308
   Lourenco J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000894
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Magnus C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002900
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Martin E, 2016, VIRUS RES, V213, P23, DOI 10.1016/j.virusres.2015.11.009
   Minayev P, 2009, J R SOC INTERFACE, V6, P989, DOI 10.1098/rsif.2008.0467
   Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nagao Y, 2008, EPIDEMIOL INFECT, V136, P843, DOI 10.1017/S0950268807008990
   Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105
   Nikin-Beers R, 2015, MATH BIOSCI, V263, P83, DOI 10.1016/j.mbs.2015.02.004
   Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Nuraini N, 2009, MATH COMPUT MODEL, V49, P1148, DOI 10.1016/j.mcm.2008.06.016
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Parreira R, 2014, EUROSURVEILLANCE, V19, P7
   Perez-Sautu U, 2011, EMERG INFECT DIS, V17, P734, DOI 10.3201/eid1704.101169
   Perkins T. A., 2016, P ROY SOC LOND B BIO, V283, P36
   Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642
   Poblap Thaval, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P899
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rasmussen DA, 2014, MOL BIOL EVOL, V31, P258, DOI 10.1093/molbev/mst203
   Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198
   Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Rodriguez-Barraquer I, 2014, VACCINE, V32, P514, DOI 10.1016/j.vaccine.2013.11.020
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616
   Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017
   Schwartz IB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066201
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Seidahmed OME, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001821
   Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999
   Sierra Beatriz, 2002, International Journal of Infectious Diseases, V6, P125, DOI 10.1016/S1201-9712(02)90073-1
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Tang YX, 2010, AM J TROP MED HYG, V83, P1156, DOI 10.4269/ajtmh.2010.10-0052
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11
   Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Thomas DL, 2016, EMERG INFECT DIS, V22, P1002, DOI 10.3201/eid2206.152000
   Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985
   Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Tsuzuki A, 2009, ACTA TROP, V111, P325, DOI 10.1016/j.actatropica.2009.05.010
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10
   Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947
   Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757
   Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099
   Waman VP, 2016, PEERJ, V4, DOI 10.7717/peerj.2326
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996
   Williams CR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000922
   Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 188
TC 6
Z9 6
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1752-4571
J9 EVOL APPL
JI Evol. Appl.
PD APR
PY 2018
VL 11
IS 4
SI SI
BP 516
EP 533
DI 10.1111/eva.12554
PG 18
WC Evolutionary Biology
SC Evolutionary Biology
GA GB9TZ
UT WOS:000429418200011
PM 29636803
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Grubaugh, ND
   Faria, NR
   Andersen, KG
   Pybus, OG
AF Grubaugh, Nathan D.
   Faria, Nuno R.
   Andersen, Kristian G.
   Pybus, Oliver G.
TI Genomic Insights into Zika Virus Emergence and Spread
SO CELL
LA English
DT Editorial Material
ID INFECTIVITY; BRAZIL
AB The emergence and spread of Zika virus in the Americas continues to challenge our disease surveillance systems. Virus genome sequencing during the epidemic uncovered the timescale of Zika virus transmission and spread. Yet, we are only beginning to explore how genomics can enhance our responses to emerging viruses.
C1 [Grubaugh, Nathan D.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM andersen@scripps.edu; oliver.pybus@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Grubaugh, Nathan/0000-0003-2031-1933
FU NIH training grantUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5T32AI007244-33];
   Wellcome TrustWellcome Trust; Royal Society Sir Henry Dale Fellowship
   [204311/Z/16/Z]; NIH NCATS CTSAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR001114]; Ray
   Thomas Foundation; European Union's Seventh Framework Programme
   (FP7)/European Research Council [614725-PATHPHYLODYN]; Oxford Martin
   School
FX We thank the clinicians, epidemiologists, and biologists at the front
   lines of the epidemic and the many laboratories worldwide that shared
   protocols and data ahead of print. N.D.G. is supported by NIH training
   grant 5T32AI007244-33. N.R.F. is funded by a Wellcome Trust and Royal
   Society Sir Henry Dale Fellowship (grant 204311/Z/16/Z). K.G.A. is a Pew
   Biomedical Scholar and is supported by NIH NCATS CTSA UL1TR001114 and
   The Ray Thomas Foundation. O.G.P. is supported by the European Union's
   Seventh Framework Programme (FP7/2007-2013)/European Research Council
   (614725-PATHPHYLODYN) and by the Oxford Martin School.
CR de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Souza AD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064615
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 15
TC 21
Z9 22
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 8
PY 2018
VL 172
IS 6
BP 1160
EP 1162
DI 10.1016/j.cell.2018.02.027
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FZ3IX
UT WOS:000427482100017
PM 29522736
OA Bronze
DA 2020-09-29
ER

PT J
AU Vasylyeva, TI
   Liulchuk, M
   Friedman, SR
   Sazonova, I
   Faria, NR
   Katzourakis, A
   Babii, N
   Scherbinska, A
   Theze, J
   Pybus, OG
   Smyrnov, P
   Mbisa, JL
   Paraskevis, D
   Hatzakis, A
   Magiorkinis, G
AF Vasylyeva, Tetyana I.
   Liulchuk, Mariia
   Friedman, Samuel R.
   Sazonova, Iana
   Faria, Nuno R.
   Katzourakis, Aris
   Babii, Nataliia
   Scherbinska, Alla
   Theze, Julien
   Pybus, Oliver G.
   Smyrnov, Pavlo
   Mbisa, Jean L.
   Paraskevis, Dimitrios
   Hatzakis, Angelos
   Magiorkinis, Gkikas
TI Molecular epidemiology reveals the role of war in the spread of HIV in
   Ukraine
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE HIV; Ukraine; war; people who inject drugs; phylogeography
ID INJECTING DRUG-USERS; HIV/AIDS EPIDEMIC; PEOPLE; CONFLICT; IMPACT;
   INTERVENTIONS; SUBSTITUTION; PREVENTION; SEQUENCES; SUBTYPE
AB Ukraine has one of the largest HIV epidemics in Europe, historically driven by people who inject drugs (PWID). The epidemic showed signs of stabilization in 2012, but the recent war in eastern Ukraine may be reigniting virus spread. We investigated the movement of HIV-infected people within Ukraine before and during the conflict. We analyzed HIV-1 subtype-A pol nucleotide sequences sampled during 2012-2015 from 427 patients of 24 regional AIDS centers and used phylogeographic analysis to reconstruct virus movement among different locations in Ukraine. We then tested for correlations between reported PWID behaviors and reconstructed patterns of virus spread. Our analyses suggest that Donetsk and Lugansk, two cities not controlled by the Ukrainian government in eastern Ukraine, were significant exporters of the virus to the rest of the country. Additional analyses showed that viral dissemination within the country changed after 2013. Spearman correlation analysis showed that incoming virus flow was correlated with the number of HIV-infected internally displaced people. Additionally, there was a correlation between more intensive virus movement and locations with a higher proportion of PWID practicing risky sexual behaviors. Our findings suggest that effective prevention responses should involve internally displaced people and people who frequently travel to war-affected regions. Scale-up of harm reduction services for PWID will be an important factor in preventing new local HIV outbreaks in Ukraine.
C1 [Vasylyeva, Tetyana I.; Faria, Nuno R.; Katzourakis, Aris; Theze, Julien; Pybus, Oliver G.; Magiorkinis, Gkikas] Univ Oxford, Dept Zool, Oxford OX2 6GG, England.
   [Liulchuk, Mariia; Babii, Nataliia; Scherbinska, Alla] Natl Acad Sci Ukraine, LV Gromashevskij Inst Epidemiol & Infect Dis, UA-03680 Kiev, Ukraine.
   [Friedman, Samuel R.] Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY 10010 USA.
   [Sazonova, Iana; Smyrnov, Pavlo] Alliance Publ Hlth, UA-03680 Kiev, Ukraine.
   [Mbisa, Jean L.; Magiorkinis, Gkikas] Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London NW9 5HT, England.
   [Paraskevis, Dimitrios; Hatzakis, Angelos; Magiorkinis, Gkikas] Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens 11527, Greece.
RP Vasylyeva, TI; Magiorkinis, G (corresponding author), Univ Oxford, Dept Zool, Oxford OX2 6GG, England.; Magiorkinis, G (corresponding author), Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London NW9 5HT, England.; Magiorkinis, G (corresponding author), Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens 11527, Greece.
EM tetyana.vasylyeva@zoo.ox.ac.uk; gmagi@med.uoa.gr
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; Paraskevis,
   Dimitrios/H-5835-2019
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Paraskevis, Dimitrios/0000-0001-6167-7152; Sazonova,
   Iana/0000-0001-5192-5669; Friedman, Sam/0000-0003-2083-1226;
   Katzourakis, Aris/0000-0003-3328-6204; Liulchuk,
   Mariia/0000-0001-7689-4002; Vasylyeva, Tetyana/0000-0002-9736-7022;
   Mbisa, Jean/0000-0002-0348-9679
FU Clarendon Fund; Hertford College of the University of Oxford; NIH
   National Institute on Drug AbuseUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Drug Abuse (NIDA) [DP1DA034989]; Medical Research
   CouncilMedical Research Council UK (MRC) [MR/K010565/1]; Medical
   Research Council/Wellcome Trust/Newton Fund [MC_PC_15100/ZK/16-078];
   Ukrainian Institute for Social Research (UISR) after O. Yaremenko (UISR)
   under International Charitable Foundation Contract "Alliance for Public
   Health."
FX We thank Louis du Plessis (Department of Zoology, University of Oxford)
   for assistance. T.I.V. is supported by the Clarendon Fund and Hertford
   College of the University of Oxford; S.R.F. is supported by NIH National
   Institute on Drug Abuse Grant DP1DA034989; G.M. is supported by Medical
   Research Council Clinician Scientist Fellowship MR/K010565/1; and N.R.F.
   is supported by the Medical Research Council/Wellcome Trust/Newton Fund
   (Grant MC_PC_15100/ZK/16-078). IBBS data collection was administered by
   the Ukrainian Institute for Social Research (UISR) after O. Yaremenko
   (UISR) under International Charitable Foundation Contract "Alliance for
   Public Health."
CR Alliance for Public Health, 2015, ANN REPORT
   Balakirieva O., 2014, SUMMARY ANAL REPORT
   Balakiryeva OM, 2012, ANAL REPORT BEHAV MO
   Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0
   Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2
   Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724
   Berleva G, 2012, ANAL REPORT ESTIMATI
   Betsi NA, 2006, AIDS CARE, V18, P356, DOI 10.1080/09540120500200856
   Bielejec F, 2014, SYST BIOL, V63, P493, DOI 10.1093/sysbio/syu015
   Bobkov A, 1997, AIDS RES HUM RETROV, V13, P1195, DOI 10.1089/aid.1997.13.1195
   Booth RE, 2006, DRUG ALCOHOL DEPEN, V82, pS49, DOI 10.1016/S0376-8716(06)80009-8
   Dehne KL, 1999, J DRUG ISSUES, V29, P729, DOI 10.1177/002204269902900402
   del Rio Carlos, 2006, Top HIV Med, V14, P102
   DESJARLAIS DC, 2012, PLOS ONE, V0007
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duchenko A, 2017, DRUGS ALCOHOL TODAY, V17, P149, DOI 10.1108/DAT-03-2017-0013
   European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2016, HIV AIDS SURV EUR 20
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Filippovych S, 2015, INT J DRUG POLICY, V26, P3, DOI 10.1016/j.drugpo.2014.11.005
   Friedman SR, 2000, AM J EPIDEMIOL, V152, P913, DOI 10.1093/aje/152.10.913
   Gelman A, 1998, STAT SCI, V13, P163
   Graw F, 2012, EPIDEMICS-NETH, V4, P104, DOI 10.1016/j.epidem.2012.04.002
   Internal Displacement Monitoring Centre, 2017, UKR COUNTR INF 2015
   Jeffreys H., 1961, THEOR PROB, P447
   Khan B, 2013, DISCRETE DYN NAT SOC, DOI 10.1155/2013/720818
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001
   Mills EJ, 2006, INT J STD AIDS, V17, P713, DOI 10.1258/095646206778691077
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Ministry of Health, 2017, OV NUMB PEOPL REC AR
   Ministry of Health of Ukraine, 2014, MIN HLTH UKR INF B N, V44
   Ministry of Health of Ukraine, 2016, MIN HLTH UKR INF B N, VN46
   Ministry of Health of Ukraine, 2016, REP MON EV EFF NAT P
   Ministry of Health of Ukraine, 2014, MIN HLTH UKR INF B N, V41
   Mock NB, 2004, EMERG THEMES EPIDEMI, V1, P1, DOI DOI 10.1186/1742-7622-1-6
   Niccolai LM, 2009, J URBAN HEALTH, V86, pS131, DOI 10.1007/s11524-009-9369-0
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Owczarzak J, 2015, INT J DRUG POLICY, V26, P6, DOI 10.1016/j.drugpo.2014.11.009
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Pizzi M, 2015, WAR UKRAINE THREATEN
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ruane Peter J, 2004, MedGenMed, V6, P31
   Simmons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137062
   Smal V, 2016, INTERNALLY DISPLACED
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   State Service for Statistics of Ukraine, 2016, ALL UKR POP SERV
   State Statistics Service of Ukraine, 2016, STAT 2016
   Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739
   Swofford D, 2002, PAUP PHYLOGENETIC AN
   Thomson MM, 2007, AIDS RES HUM RETROV, V23, P1599, DOI 10.1089/aid.2007.0166
   Toussova O, 2009, J URBAN HEALTH, V86, pS121, DOI 10.1007/s11524-009-9364-5
   Tripodi Paolo, 2004, Med Confl Surviv, V20, P195, DOI 10.1080/1362369042000248802
   UN High Commissioner for Refugees, 2014, PREL AN NEEDS ASS IN
   UNAIDS, 2015, UKR GLOB AIDS RESP P
   UNAIDS, 2016, OP RES SYST SERV PRE
   UNAIDS Office on AIDS and Humanitarian Response, 2003, HIV AIDS CONFL
   Vasylyeva TI, 2016, AIDS, V30, P2885, DOI 10.1097/QAD.0000000000001291
   Vitek CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103657
   WHO, 2014, GOOD PRACT EUR HIV P
   Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085
   Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628
NR 65
TC 16
Z9 16
U1 1
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 30
PY 2018
VL 115
IS 5
BP 1051
EP 1056
DI 10.1073/pnas.1701447115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU3CZ
UT WOS:000423728800066
PM 29339468
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Faria, NR
   da Costa, AC
   Lourenco, J
   Loureiro, P
   Lopes, ME
   Ribeiro, R
   Alencar, CS
   Kraemer, MUG
   Villabona-Arenas, CJ
   Wu, CH
   Theze, J
   Khan, K
   Brent, SE
   Romano, C
   Delwart, E
   Custer, B
   Busch, MP
   Pybus, OG
   Sabino, EC
AF Faria, Nuno R.
   da Costa, Antonio Charlys
   Lourenco, Jose
   Loureiro, Paula
   Lopes, Maria Esther
   Ribeiro, Roberto
   Alencar, Cecilia Salete
   Kraemer, Moritz U. G.
   Villabona-Arenas, Christian J.
   Wu, Chieh-Hsi
   Theze, Julien
   Khan, Kamran
   Brent, Shannon E.
   Romano, Camila
   Delwart, Eric
   Custer, Brian
   Busch, Michael P.
   Pybus, Oliver G.
   Sabino, Ester C.
CA NHLBI Recipient Epidemiology
   Donor Evaluation Study
TI Genomic and epidemiological characterisation of a dengue virus outbreak
   among blood donors in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RIO-DE-JANEIRO; AEDES-AEGYPTI; ZIKA VIRUS; REPRODUCTIVE NUMBER;
   POPULATION-DYNAMICS; CO-CIRCULATION; SEROTYPE 4; SAO-PAULO; STATE;
   SPREAD
AB Outbreaks caused by Dengue, Zika and Chikungunya viruses can spread rapidly in immunologically naive populations. By analysing 92 newly generated viral genome sequences from blood donors and recipients, we assess the dynamics of dengue virus serotype 4 during the 2012 outbreak in Rio de Janeiro. Phylogenetic analysis indicates that the outbreak was caused by genotype II, although two isolates of genotype I were also detected for the first time in Rio de Janeiro. Evolutionary analysis and modelling estimates are congruent, indicating a reproduction number above 1 between January and June, and at least two thirds of infections being unnoticed. Modelling analysis suggests that viral transmission started in early January, which is consistent with multiple introductions, most likely from the northern states of Brazil, and with an increase in within-country air travel to Rio de Janeiro. The combination of genetic and epidemiological data from blood donor banks may be useful to anticipate epidemic spread of arboviruses.
C1 [Faria, Nuno R.; Lourenco, Jose; Kraemer, Moritz U. G.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [da Costa, Antonio Charlys; Ribeiro, Roberto; Romano, Camila; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [da Costa, Antonio Charlys; Ribeiro, Roberto; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, LIM46, Sao Paulo, Brazil.
   [Loureiro, Paula] Fundacao Hemope, Fac Ciencias Med, Recife, PE, Brazil.
   [Lopes, Maria Esther] Fundacao Hemorio, Rio De Janeiro, Brazil.
   [Alencar, Cecilia Salete] Hosp Clin Sao Paulo, Lab Invest Med LIM03, Sao Paulo, Brazil.
   [Villabona-Arenas, Christian J.] Univ Montpellier, Inst Rech Dev, Montpellier, France.
   [Wu, Chieh-Hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Khan, Kamran; Brent, Shannon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Khan, Kamran] Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   [Delwart, Eric; Custer, Brian; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA.
   [Delwart, Eric; Custer, Brian; Busch, Michael P.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP da Costa, AC; Sabino, EC (corresponding author), Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.; da Costa, AC; Sabino, EC (corresponding author), Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, LIM46, Sao Paulo, Brazil.
EM charlysbr@yahoo.com.br; sabinoec@usp.br
RI Pybus, Oliver G/B-2640-2012; Loureiro, Paula/A-2965-2013; Faria, Nuno
   R/I-2975-2012; Romano, Camila M/C-8185-2013; da-Costa, Antonio
   Charlys/G-1548-2010; Sabino, Ester Cerdeira/F-7750-2010
OI Pybus, Oliver G/0000-0002-8797-2667; Loureiro,
   Paula/0000-0003-1849-0047; Faria, Nuno R/0000-0001-8839-2798; Romano,
   Camila M/0000-0003-4550-1987; da-Costa, Antonio
   Charlys/0000-0001-5516-5177; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   Wu, Chieh-Hsi/0000-0001-9386-725X; Lourenco, Jose/0000-0002-9318-2581
FU Sir Henry Dale Fellowship [204311/Z/16/Z]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2012/03417-8, 2014/03417-7,
   2017/00021-9, 2016/01735-2, 2011/18955-1]; European Research Council
   under European Union's Seventh Framework Programme/ERCEuropean Research
   Council (ERC) [268904 - DIVERSITY]; Society in Science, The Branco Weiss
   Fellowship; National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128];
   National Library of Medicine of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM010812,
   R01LM011965]; European Research Council under European Union's Seventh
   Framework Programme/European Research Council [614725-PATHPHYLODYN]
FX N.R.F. is funded by a Sir Henry Dale Fellowship (grant 204311/Z/16/Z).
   ACC is funded by FAPESP #2012/03417-8, 2014/03417-7 and 2017/00021-9. JL
   received funding from the European Research Council under the European
   Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement
   no. 268904 - DIVERSITY. MUGK is supported by the Society in Science, The
   Branco Weiss Fellowship, administered by the ETH Zurich and acknowledges
   funding from a Training Grant from the National Institute of Child
   Health and Human Development (T32HD040128) and the National Library of
   Medicine of the National Institutes of Health (R01LM010812,
   R01LM011965). We thank Shirley Cavalcante Vasconcelos Komninakis
   (UNIFESP), Luciano Monteiro da Silva and Lucy Santos Vilas Boas,
   (IMT-USP) and Paulo Brito, director from SEOMA/RJ, for daily
   meteorological data from Rio de Janeiro municipality. This work was
   funded by FAPESP # 2016/01735-2 and 2011/18955-1, and the European
   Research Council under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/European Research Council grant agreement number
   614725-PATHPHYLODYN.
CR Acosta POA, 2011, EMERG INFECT DIS, V17, P1979, DOI 10.3201/eid1710.110776
   Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Degener CM, 2014, MEM I OSWALDO CRUZ, V109, P1030, DOI 10.1590/0074-0276140234
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS OUTBRE, V1
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gouy M, 2008, BIOCHIMIE, V90, P555, DOI 10.1016/j.biochi.2007.07.003
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Janeiro S. d. E. d. S. d. R. d., 2015, B EP 07 2015 DENG CE
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lourenco J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003308
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Musso D, 2014, EURO SURVEILL, V19
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rambaut A., 2014, PATH O GEN V1 4
   Rasmussen DA, 2014, MOL BIOL EVOL, V31, P258, DOI 10.1093/molbev/mst203
   Rocco IM, 2012, REV INST MED TROP SP, V54, P49, DOI 10.1590/S0036-46652012000100009
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Saude S. d. V. e. S. M. d., 2016, B EPIDEMIOLOGICO
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Stadler T, 2012, MOL BIOL EVOL, V29, P347, DOI 10.1093/molbev/msr217
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Villabona-Arenas CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1892
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 73
TC 16
Z9 16
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 9
PY 2017
VL 7
AR 15216
DI 10.1038/s41598-017-15152-8
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM2JK
UT WOS:000414810800039
PM 29123142
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU da Costa, AC
   Theze, J
   Komninakis, SCV
   Sanz-Duro, RL
   Felinto, MRL
   Moura, LCC
   Barroso, IMD
   Santos, LEC
   Nunes, MADL
   Moura, AA
   Lourenco, J
   Deng, XT
   Delwart, EL
   Guimaraes, MRDS
   Pybus, OG
   Sabino, EC
   Faria, NR
AF da Costa, Antonio Charlys
   Theze, Julien
   Komninakis, Shirley Cavalcante Vasconcelos
   Sanz-Duro, Rodrigo Lopes
   Lemos Felinto, Marta Rejane
   Correa Moura, Lucia Cristina
   de Oliveira Barroso, Ivoneide Moreira
   Correia Santos, Lucineide Eliziario
   de Lemos Nunes, Mardjane Alves
   Moura, Adriana Avila
   Lourenco, Jose
   Deng, Xutao
   Delwart, Eric L.
   dos Anjos Silva Guimaraes, Maria Raquel
   Pybus, Oliver G.
   Sabino, Ester C.
   Faria, Nuno R.
TI Spread of Chikungunya Virus East/Central/South African Genotype in
   Northeast Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We investigated an outbreak of exanthematous illness in Maceio by using molecular surveillance; 76% of samples tested positive for chikungunya virus. Genetic analysis of 23 newly generated genomes identified the East/Central/South African genotype, suggesting that this lineage has persisted since mid-2014 in Brazil and may spread in the Americas and beyond.
C1 [da Costa, Antonio Charlys] Univ Sao Paulo, Inst Trop Med, Ave Dr Eneas Carvalho de Aguiar 470, BR-05403000 Sao Paulo, Brazil.
   [Sabino, Ester C.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Theze, Julien; Lourenco, Jose; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Oxford, England.
   [Komninakis, Shirley Cavalcante Vasconcelos] Sch Med ABC FMABC, Santo Andre, Brazil.
   [Komninakis, Shirley Cavalcante Vasconcelos; Sanz-Duro, Rodrigo Lopes] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Lemos Felinto, Marta Rejane; Correa Moura, Lucia Cristina] Secretaria Estado Saude Paraiba, Lab Cent Saude Publ Dra Telma Lobo, Joao Pessoa, Paraiba, Brazil.
   [de Oliveira Barroso, Ivoneide Moreira; Correia Santos, Lucineide Eliziario; dos Anjos Silva Guimaraes, Maria Raquel] Hosp Unimed Maceio, Alagoas, Brazil.
   [de Lemos Nunes, Mardjane Alves; Moura, Adriana Avila] Hosp Escola Dr Helvio Auto, Alagoas, Brazil.
   [Moura, Adriana Avila] Univ Fed Alagoas, Maceio, Brazil.
   [Deng, Xutao; Delwart, Eric L.] Blood Syst Res Inst, San Francisco, CA USA.
   [Deng, Xutao; Delwart, Eric L.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP Sabino, EC (corresponding author), Univ Sao Paulo, Inst Trop Med, Ave Dr Eneas Carvalho de Aguiar 470, BR-05403000 Sao Paulo, Brazil.; Faria, NR (corresponding author), Peter Medawar Bldg,South Parks Rd, Oxford OX1 3SY, England.
EM sabinoec@gmail.com; nuno.faria@zoo.ox.ac.uk
RI da-Costa, Antonio Charlys/G-1548-2010; Faria, Nuno R/I-2975-2012; Pybus,
   Oliver G/B-2640-2012; Komninakis, Shirley V/B-2915-2010; Sabino, Ester
   Cerdeira/F-7750-2010
OI da-Costa, Antonio Charlys/0000-0001-5516-5177; Faria, Nuno
   R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667; Komninakis,
   Shirley V/0000-0001-7784-3418; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Lourenco, Jose/0000-0002-9318-2581; Lopes
   Sanz Duro, Rodrigo/0000-0001-8579-2091
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2016/01735-2, 2012/03417-7, 2017/00021-9]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [400354/2016-0]; Sir
   Henry Dale Fellowship (Wellcome Trust/Royal Society) [204311/Z/16/Z];
   ERC under the European Union's Seventh Framework Programme
   [614725-PATHPHYLODYN]; US Agency for International DevelopmentUnited
   States Agency for International Development (USAID) [AID-OAA-A-14-00102]
FX This work was supported by FAPESP #2016/01735-2 and CNPq #400354/2016-0.
   A.C.dC. is funded by FAPESP #2012/03417-7 and 2017/00021-9. N.R.F. is
   funded by a Sir Henry Dale Fellowship (Wellcome Trust/Royal Society
   Grant 204311/Z/16/Z). This research received funding from the ERC under
   the European Union's Seventh Framework Programme (FP7/2007-2013), grant
   agreement no. 614725-PATHPHYLODYN; and the US Agency for International
   Development Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative
   Agreement No. AID-OAA-A-14-00102).
CR Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS OUTBRE, V1
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Ministerio da Saude, 2017, SITUACAO EPIDEMIOLGI, V48, P16
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
NR 10
TC 33
Z9 33
U1 0
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2017
VL 23
IS 10
BP 1742
EP 1744
DI 10.3201/eid2310.170307
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FH4PC
UT WOS:000411137100028
PM 28930031
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Dellicour, S
   Rose, R
   Faria, NR
   Vieira, LFP
   Bourhy, H
   Gilbert, M
   Lemey, P
   Pybus, OG
AF Dellicour, Simon
   Rose, Rebecca
   Faria, Nuno Rodrigues
   Vieira, Luiz Fernando Pereira
   Bourhy, Herve
   Gilbert, Marius
   Lemey, Philippe
   Pybus, Oliver G.
TI Using Viral Gene Sequences to Compare and Explain the Heterogeneous
   Spatial Dynamics of Virus Epidemics
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE phylodynamics; viral phylogeography; molecular epidemiology; relaxed
   random walk; RABV; spread
ID RABIES VIRUS; PHYLOGEOGRAPHY; LIKELIHOOD; EXPANSION; EVOLUTION; AFRICA;
   STATES
AB Rabies is an important zoonotic disease distributed worldwide. A key question in rabies epidemiology is the identification of factors that impact virus dispersion. Here we apply new analytical methods, based on phylogeographic reconstructions of viral lineage movement, to undertake a comparative evolutionary-epidemiological study of the spatial dynamics of rabies virus (RABV) epidemics in different hosts and habitats. We compiled RABV data sets from skunk, raccoon, bat and domestic dog populations in order to investigate the viral diffusivity of different RABV epidemics, and to detect and compare the environmental factors that impact the velocity of viral spread in continuous spatial landscapes. We build on a recently developed statistical framework that uses spatially-and temporally-referenced phylogenies. We estimate several spatial statistics of virus spread, which reveal a higher diffusivity of RABV in domestic dogs compared with RABV in other mammals. This finding is explained by subsequent analyses of environmental heterogeneity, which indicate that factors relating to human geography play a significant role in RABV dispersion in domestic dogs. More generally, our results suggest that human-related factors are important worldwide in explaining RABV dispersion in terrestrial host species. Our study shows that phylogenetically informed viral movements can be used to elucidate the factors that impact virus dispersal, opening new opportunities for a better understanding of the impact of host species and environmental conditions on the spatial dynamics of rapidly evolving populations.
C1 [Dellicour, Simon; Lemey, Philippe] KU Leuven Univ Leuven, Clin & Epidemiol Virol, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Rose, Rebecca] BioInfoExperts LLC, Thibodaux, LA USA.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Vieira, Luiz Fernando Pereira] Inst Agr & Forest Def Espirito Santo IDAF, Dept Laboratorial Diag, Vitoria, Brazil.
   [Bourhy, Herve] Inst Pasteur, WHO Collaborating Ctr Reference & Res Rabies, Lyssavirus Dynam & Host Adaptat Unit, Paris, France.
   [Gilbert, Marius] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium.
RP Dellicour, S (corresponding author), KU Leuven Univ Leuven, Clin & Epidemiol Virol, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
EM simon.dellicour@kuleuven.be
RI Faria, Nuno R/I-2975-2012; Lemey, Philippe/C-3755-2018; Dellicour,
   Simon/AAE-9054-2020; Pybus, Oliver G/B-2640-2012
OI Faria, Nuno R/0000-0001-8839-2798; Lemey, Philippe/0000-0003-2826-5353;
   Dellicour, Simon/0000-0001-9558-1052; Pybus, Oliver
   G/0000-0002-8797-2667
FU Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium)FWO;
   Wiener-Anspach Foundation; Medical Research CouncilMedical Research
   Council UK (MRC) [99204]; Sir Henry Dale Fellowship (Welcome Trust-Royal
   Society) [204311/Z/16/Z]; European Research Council under the European
   Community's Seventh Framework Programme/ERC [278433-PREDEMICS]; European
   Research Council under the European Community's Seventh Framework
   Programme under ERC [260864-ViralPhylogeography]; European Research
   Council under the European Union's Seventh Framework
   Programme/ERCEuropean Research Council (ERC) [614725-PATHPHYLODYN]
FX We thank two anonymous reviewers as well as Bram Vrancken for their
   helpful comments on this study. S.D. is a postdoctoral research fellow
   funded by the Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium)
   and previously funded by the Wiener-Anspach Foundation. R.R. received
   funding from the Medical Research Council under a Methodology Research
   Fellowship grant agreement no. 99204. N.R.F. is funded by a Sir Henry
   Dale Fellowship (Welcome Trust-Royal Society Grant 204311/Z/16/Z). MG is
   a Senior Research Associate of the Fonds National de la Recherche
   Scientifique (FNRS, Brussels, Belgium). HB and PL acknowledge funding by
   European Research Council under the European Community's Seventh
   Framework Programme (FP7/2007-2013)/ERC grant agreement no.
   278433-PREDEMICS. PL also acknowledges funding from the European
   Research Council under the European Community's Seventh Framework
   Programme (FP7/2007-2013) under ERC Grant agreement no.
   260864-ViralPhylogeography. O.G.P. received funding from the European
   Research Council under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant agreement no. 614725-PATHPHYLODYN.
CR Baele G, 2017, SYST BIOL, V66, pE47, DOI 10.1093/sysbio/syw054
   Benavides JA, 2016, P R SOC B, V283, P1
   Biek R, 2007, P NATL ACAD SCI USA, V104, P7993, DOI 10.1073/pnas.0700741104
   Blanton JD, 2012, JAVMA-J AM VET MED A, V241, P712, DOI 10.2460/javma.241.6.712
   Bourhy H, 2008, J GEN VIROL, V89, P2673, DOI 10.1099/vir.0.2008/003913-0
   Bourhy H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005525
   Carnieli P, 2011, ARCH VIROL, V156, P1007, DOI 10.1007/s00705-011-0942-y
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   de Thoisy B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004378
   Dellicour S, 2016, BIOINFORMATICS, V32, P3204, DOI 10.1093/bioinformatics/btw384
   Dellicour S, 2016, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-016-0924-x
   Dijkstra E., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390
   Dodet B, 2008, VACCINE, V26, P6295, DOI 10.1016/j.vaccine.2008.04.087
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   Fusaro A, 2013, INFECT GENET EVOL, V17, P202, DOI [10.1016/j.meegid.2013.03.051, 10.1016/j.meegid.2013.03.05]
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709
   Hayman DTS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001001
   Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x
   Horton DL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003569
   Jeffreys H, 1961, THEORY PROBABILITY
   Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360
   Kuzmina NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082348
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1
   McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x
   Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138
   Mundt CC, 2009, AM NAT, V173, P456, DOI 10.1086/597220
   Murray GGR, 2016, METHODS ECOL EVOL, V7, P80, DOI 10.1111/2041-210X.12466
   Navascues M, 2010, MOL ECOL RESOUR, V10, P760, DOI 10.1111/j.1755-0998.2010.02895.x
   Vieira LFP, 2013, VIRUS GENES, V46, P330, DOI 10.1007/s11262-012-0866-y
   Picard-Meyer E, 2012, ARCH VIROL, V157, P1689, DOI 10.1007/s00705-012-1351-6
   Pinero C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001635
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x
   Seetahal JFR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002365
   Silva SR, 2013, BIOLOGICALS, V41, P217, DOI 10.1016/j.biologicals.2013.04.002
   Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Talbi C, 2009, J GEN VIROL, V90, P783, DOI 10.1099/vir.0.007765-0
   Tohma K, 2014, INFECT GENET EVOL, V23, P86, DOI 10.1016/j.meegid.2014.01.026
   Torres C, 2014, MOL ECOL, V23, P2340, DOI 10.1111/mec.12728
   Troupin C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006041
   Trovao NS, 2015, MOL BIOL EVOL, V32, P3264, DOI 10.1093/molbev/msv185
   Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9
   WHO, 2005, WHO TECH REP SER, V931, P1
   Zieger U, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003251
NR 50
TC 18
Z9 18
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD OCT
PY 2017
VL 34
IS 10
BP 2563
EP 2571
DI 10.1093/molbev/msx176
PG 9
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA FI2XJ
UT WOS:000411814800010
PM 28651357
OA Bronze
DA 2020-09-29
ER

PT J
AU Lourenco, J
   de Lima, MM
   Faria, NR
   Walker, A
   Kraemer, MUG
   Villabona-Arenas, CJ
   Lambert, B
   de Cerqueira, EM
   Pybus, OG
   Alcantara, LCJ
   Recker, M
AF Lourenco, Jose
   de Lima, Maricelia Maia
   Faria, Nuno Rodrigues
   Walker, Andrew
   Kraemer, Moritz U. G.
   Villabona-Arenas, Christian Julian
   Lambert, Ben
   de Cerqueira, Erenilde Marques
   Pybus, Oliver G.
   Alcantara, Luiz C. J.
   Recker, Mario
TI Epidemiological and ecological determinants of Zika virus transmission
   in an urban setting
SO ELIFE
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; AEDES-AEGYPTI; DENGUE; TEMPERATURE;
   INFECTION; MODEL; POPULATION; SURVEILLANCE; CULICIDAE; OUTBREAK
AB The Zika virus has emerged as a global public health concern. Its rapid geographic expansion is attributed to the success of Aedes mosquito vectors, but local epidemiological drivers are still poorly understood. Feira de Santana played a pivotal role in the Chikungunya epidemic in Brazil and was one of the first urban centres to report Zika infections. Using a climate-driven transmission model and notified Zika case data, we show that a low observation rate and high vectorial capacity translated into a significant attack rate during the 2015 outbreak, with a subsequent decline in 2016 and fade-out in 2017 due to herd-immunity. We find a potential Zika-related, low risk for microcephaly per pregnancy, but with significant public health impact given high attack rates. The balance between the loss of herd-immunity and viral re-importation will dictate future transmission potential of Zika in this urban setting.
C1 [Lourenco, Jose; Faria, Nuno Rodrigues; Walker, Andrew; Kraemer, Moritz U. G.; Lambert, Ben; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [de Lima, Maricelia Maia; Alcantara, Luiz C. J.] Fiocruz MS, Lab Haematol Genet & Computat Biol, SalvadorBahia, Brazil.
   [Villabona-Arenas, Christian Julian] Univ Montreal, INSERM, UMI 233, Inst Rech Dev,U1175, Montpellier, France.
   [Villabona-Arenas, Christian Julian] Univ Montreal, LIRMM, Inst Biol Computat, Montpellier, France.
   [de Cerqueira, Erenilde Marques] Univ Estadual Feira de Santana, Dept Hlth, Ctr PostGrad Collect Hlth, Feira De SantanaBahia, Brazil.
   [Recker, Mario] Univ Exeter, Ctr Math & Environm, Penryn, England.
RP Lourenco, J (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM jose.lourenco@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Lourenco, Jose/0000-0002-9318-2581; Villabona Arenas, Christian
   Julian/0000-0001-9928-3968; Recker, Mario/0000-0001-9489-1315;
   Alcantara, Luiz/0000-0002-6769-9931
FU European Research CouncilEuropean Research Council (ERC) [268904 -
   DIVERSITY, 614725-PATHPHYLODYN]; Wellcome TrustWellcome Trust
   [204311/Z/16/Z]; Royal SocietyRoyal Society of London [204311/Z/16/Z];
   International Development Emerging Pandemic Threats Program-2
   [AID-OAA-A-14-00102]; Labex EpiGenMed [ANR-10-LABX-12-01]; Engineering
   and Physical Sciences Research CouncilEngineering & Physical Sciences
   Research Council (EPSRC); Royal SocietyRoyal Society of London
FX Funder Grant reference number Author; European Research Council 268904 -
   DIVERSITY Jose Lourenco Andrew Walker; Wellcome Trust and Royal Society
   204311/Z/16/Z Nuno Rodrigues Faria; International Development Emerging
   Pandemic Threats Program-2 AID-OAA-A-14-00102 Moritz UG Kraemer; Labex
   EpiGenMed ANR-10-LABX-12-01 Christian Julian Villabona-Arenas;
   Engineering and Physical Sciences Research Council Ben Lambert; European
   Research Council 614725-PATHPHYLODYN Oliver G Pybus; Royal Society Mario
   Recker; The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Bewick S., 2016, ZIKA VIRUS ENDEMIC V
   Bicout DJ, 2004, VECTOR-BORNE ZOONOT, V4, P33, DOI 10.1089/153036604773082979
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil BDMEP, 1961, BANC DAD MET ENS PES
   Brazil SINAN, 2016, SIST INF AGR NOT
   Brazil ZG, 2016, NAT GUID ZIK VIR PAT
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chowell G., 2016, PLOS CURRENTS, V8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   Dickerson CZ., 2007, DOCTOR OF PHILOS
   Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EUROCAT, 2003, EUR SURV CONG AN FIN
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS, V8
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feldstein LR, 2015, T ROY SOC TROP MED H, V109, P303, DOI 10.1093/trstmh/trv012
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Golden Gate Weather Services, 2017, NIN NIN YEARS INT BA
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Jaenisch T, 2016, B WORLD HEALTH ORGAN, P1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lampoudi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3074302
   Xuan LTT, 2014, GLOBAL HEALTH ACTION, V7, P52, DOI 10.3402/gha.v7.23119
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lounibos LP, 2008, J AM MOSQUITO CONTR, V24, P11, DOI 10.2987/5656.1
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lourenco J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003308
   Madeira NG, 2002, MEM I OSWALDO CRUZ, V97, P415, DOI 10.1590/S0074-02762002000300025
   Maxian  O., 2017, EPIDEMICS
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Mordecai E, 2016, TEMPERATURE DETERMIN
   Mourya DT, 2004, AM J TROP MED HYG, V70, P346, DOI 10.4269/ajtmh.2004.70.346
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Rodrigues LC, 2016, LANCET INFECT DIS
   Rossi MM, 2015, ANN BIOMETRICS BIOST, V2, P1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   WHO, 2016, MOSQ VECT CONTR EM R
   WHO, 2016, WHO BRAZ STAT
   WHO, 2016, WHO DIR GEN SUMM OUT
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2016, PROJECTED SPREAD ZIK
   ZIBRA, 2016, ZIK BRAZ REAL TIM AN
NR 91
TC 23
Z9 23
U1 0
U2 19
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD SEP 9
PY 2017
VL 6
AR e29820
DI 10.7554/elife.29820
PG 25
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FJ9HC
UT WOS:000413083000001
PM 28887877
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU Tian, HY
   Sun, Z
   Faria, NR
   Yang, J
   Cazelles, B
   Huang, SQ
   Xu, B
   Yang, QQ
   Pybus, OG
   Xu, B
AF Tian, Huaiyu
   Sun, Zhe
   Faria, Nuno Rodrigues
   Yang, Jing
   Cazelles, Bernard
   Huang, Shanqian
   Xu, Bo
   Yang, Qiqi
   Pybus, Oliver G.
   Xu, Bing
TI Increasing airline travel may facilitate co-circulation of multiple
   dengue virus serotypes in Asia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GLOBAL DISTRIBUTION; SPREAD; FEVER; EPIDEMIOLOGY; POPULATION;
   STRATEGIES; EVOLUTION; INFECTION; AIRCRAFT; DYNAMICS
AB The incidence of dengue has grown dramatically in recent decades worldwide, especially in Southeast Asia and the Americas with substantial transmission in 2014-2015. Yet the mechanisms underlying the spatio-temporal circulation of dengue virus (DENV) serotypes at large geographical scales remain elusive. Here we investigate the co-circulation in Asia of DENV serotypes 1-3 from 1956 to 2015, using a statistical framework that jointly estimates migration history and quantifies potential predictors of viral spatial diffusion, including socioeconomic, air transportation and maritime mobility data. We find that the spread of DENV-1, -2 and -3 lineages in Asia is significantly associated with air traffic. Our analyses suggest the network centrality of air traffic hubs such as Thailand and India contribute to seeding dengue epidemics, whilst China, Cambodia, Indonesia, and Singapore may establish viral diffusion links with multiple countries in Asia. Phylogeographic reconstructions help to explain how growing air transportation networks could influence the dynamics of DENV circulation.
C1 [Tian, Huaiyu; Yang, Jing; Huang, Shanqian; Yang, Qiqi; Xu, Bing] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.
   [Sun, Zhe; Xu, Bo; Xu, Bing] Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modeling, Dept Earth Syst Sci,Sch Environm, Beijing, Peoples R China.
   [Faria, Nuno Rodrigues; Huang, Shanqian; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Cazelles, Bernard] UPMC ENS, Ecol & Evolut, UMR 7625, Paris, France.
   [Cazelles, Bernard] UMMISCO UMI 209 IRD UPMC, Bondy, France.
RP Xu, B (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Xu, B (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modeling, Dept Earth Syst Sci,Sch Environm, Beijing, Peoples R China.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM oliver.pybus@zoo.ox.ac.uk; bingxu@tsinghua.edu.cn
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; Cazelles,
   Bernard/B-1572-2013
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Cazelles, Bernard/0000-0002-7972-361X; Tian, Huaiyu/0000-0002-4466-0858;
   /0000-0002-5030-0963
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81673234]; Fundamental Research Funds for
   the Central UniversitiesFundamental Research Funds for the Central
   Universities; Key Research and Development Program of China
   [2016YFA0600104]; Sir Henry Dale Fellowship (Wellcome Trust / Royal
   Society) [204311/Z/16/Z]; European Research Council under the European
   Union's Seventh Framework ProgrammeEuropean Research Council (ERC)
   [FP7/2007-2013, 614725-PATHPHYLODYN]
FX Funding has been provided by the National Natural Science Foundation of
   China (81673234), http://www.nsfc.gov.cn/; Fundamental Research Funds
   for the Central Universities,
   http://www.moe.gov.cn/?National<http://www.moe.gov.cn/%EF%BC%9BNational>
   Key Research and Development Program of China (2016YFA0600104),
   http://www.most.gov.cn/; Sir Henry Dale Fellowship (Wellcome Trust /
   Royal Society Grant 204311/Z/16/Z), https://wellcome.ac.uk/. This work
   was funded by the European Research Council under the European Unions
   Seventh Framework Programme (FP7/2007-2013)/European Research Council
   grant agree- ment number 614725-PATHPHYLODYN ([https://erc.europa.eu]).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401
   Coudeville L, 2016, VACCINE, V34, P6426, DOI 10.1016/j.vaccine.2016.08.050
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   Faria NR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0196
   Gratz NG, 2000, B WORLD HEALTH ORGAN, V78, P995
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hutchinson R. A., 2005, J EUROPEAN MOSQUITO, V19, P12
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Misao T, 1945, RINSHO TO KENKYU, V22, P44
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   REEVES WC, 1994, J MED ENTOMOL, V31, P323, DOI 10.1093/jmedent/31.3.323
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   RUSSELL RC, 1987, B WORLD HEALTH ORGAN, V65, P659
   Sang SW, 2015, INFECT GENET EVOL, V32, P178, DOI 10.1016/j.meegid.2015.03.005
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08
   Sgouridis S, 2011, TRANSPORT RES A-POL, V45, P1077, DOI 10.1016/j.tra.2010.03.019
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Tatem AJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-57
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tian HY, 2016, ENVIRON RES, V150, P299, DOI 10.1016/j.envres.2016.05.039
   Tian HY, 2015, P NATL ACAD SCI USA, V112, P172, DOI 10.1073/pnas.1405216112
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Wang SF, 2016, AM J TROP MED HYG, V94, P193, DOI 10.4269/ajtmh.15-0422
NR 54
TC 31
Z9 31
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2017
VL 11
IS 8
AR e0005694
DI 10.1371/journal.pntd.0005694
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FH3SD
UT WOS:000411068800008
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Grubaugh, ND
   Ladner, JT
   Kraemer, MUG
   Dudas, G
   Tan, AL
   Gangavarapu, K
   Wiley, MR
   White, S
   Theze, J
   Magnani, DM
   Prieto, K
   Reyes, D
   Bingham, AM
   Paul, LM
   Robles-Sikisaka, R
   Oliveira, G
   Pronty, D
   Barcellona, CM
   Metsky, HC
   Baniecki, ML
   Barnes, KG
   Chak, B
   Freije, CA
   Gladden-Young, A
   Gnirke, A
   Luo, C
   MacInnis, B
   Matranga, CB
   Park, DJ
   Qu, J
   Schaffner, SF
   Tomkins-Tinch, C
   West, KL
   Winnicki, SM
   Wohl, S
   Yozwiak, NL
   Quick, J
   Fauver, JR
   Khan, K
   Brent, SE
   Reiner, RC
   Lichtenberger, PN
   Ricciardi, MJ
   Bailey, VK
   Watkins, DI
   Cone, MR
   Kopp, EW
   Hogan, KN
   Cannons, AC
   Jean, R
   Monaghan, AJ
   Garry, RF
   Loman, NJ
   Faria, NR
   Porcelli, MC
   Vasquez, C
   Agle, ERN
   Cummings, DAT
   Stanek, D
   Rambaut, A
   Sanchez-Lockhart, M
   Sabeti, PC
   Gillis, LD
   Michael, SF
   Bedford, T
   Pybus, OG
   Isern, S
   Palacios, G
   Andersen, KG
AF Grubaugh, Nathan D.
   Ladner, Jason T.
   Kraemer, Moritz U. G.
   Dudas, Gytis
   Tan, Amanda L.
   Gangavarapu, Karthik
   Wiley, Michael R.
   White, Stephen
   Theze, Julien
   Magnani, Diogo M.
   Prieto, Karla
   Reyes, Daniel
   Bingham, Andrea M.
   Paul, Lauren M.
   Robles-Sikisaka, Refugio
   Oliveira, Glenn
   Pronty, Darryl
   Barcellona, Carolyn M.
   Metsky, Hayden C.
   Baniecki, Mary Lynn
   Barnes, Kayla G.
   Chak, Bridget
   Freije, Catherine A.
   Gladden-Young, Adrianne
   Gnirke, Andreas
   Luo, Cynthia
   MacInnis, Bronwyn
   Matranga, Christian B.
   Park, Daniel J.
   Qu, James
   Schaffner, Stephen F.
   Tomkins-Tinch, Christopher
   West, Kendra L.
   Winnicki, Sarah M.
   Wohl, Shirlee
   Yozwiak, Nathan L.
   Quick, Joshua
   Fauver, Joseph R.
   Khan, Kamran
   Brent, Shannon E.
   Reiner, Robert C., Jr.
   Lichtenberger, Paola N.
   Ricciardi, Michael J.
   Bailey, Varian K.
   Watkins, David I.
   Cone, Marshall R.
   Kopp, Edgar W.
   Hogan, Kelly N.
   Cannons, Andrew C.
   Jean, Reynald
   Monaghan, Andrew J.
   Garry, Robert F.
   Loman, Nicholas J.
   Faria, Nuno R.
   Porcelli, Mario C.
   Vasquez, Chalmers
   Agle, Elyse R. N.
   Cummings, Derek A. T.
   Stanek, Danielle
   Rambaut, Andrew
   Sanchez-Lockhart, Mariano
   Sabeti, Pardis C.
   Gillis, Leah D.
   Michael, Scott F.
   Bedford, Trevor
   Pybus, Oliver G.
   Isern, Sharon
   Palacios, Gustavo
   Andersen, Kristian G.
TI Genomic epidemiology reveals multiple introductions of Zika virus into
   the United States
SO NATURE
LA English
DT Article
ID MAXIMUM-LIKELIHOOD; AEDES-AEGYPTI; SEQUENCE DATA; TRANSMISSION; AMERICA;
   DENGUE; INFECTION; OUTBREAK; FLORIDA; SPREAD
AB Zika virus (ZIKV) is causing an unprecedented epidemic linked to severe congenital abnormalities(1,2). In July 2016, mosquito-borne ZIKV transmission was reported in the continental United States; since then, hundreds of locally acquired infections have been reported in Florida(3,4). To gain insights into the timing, source, and likely route(s) of ZIKV introduction, we tracked the virus from its first detection in Florida by sequencing ZIKV genomes from infected patients and Aedes aegypti mosquitoes. We show that at least 4 introductions, but potentially as many as 40, contributed to the outbreak in Florida and that local transmission is likely to have started in the spring of 2016-several months before its initial detection. By analysing surveillance and genetic data, we show that ZIKV moved among transmission zones in Miami. Our analyses show that most introductions were linked to the Caribbean, a finding corroborated by the high incidence rates and traffic volumes from the region into the Miami area. Our study provides an understanding of how ZIKV initiates transmission in new regions.
C1 [Grubaugh, Nathan D.; Robles-Sikisaka, Refugio; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Ladner, Jason T.; Wiley, Michael R.; Prieto, Karla; Reyes, Daniel; Sanchez-Lockhart, Mariano; Palacios, Gustavo] US Army Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA.
   [Kraemer, Moritz U. G.; Theze, Julien; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Harbor Med Sch, Boston, MA 02115 USA.
   [Dudas, Gytis; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98109 USA.
   [Tan, Amanda L.; Paul, Lauren M.; Michael, Scott F.; Isern, Sharon] Florida Gulf Coast Univ, Coll Arts & Sci, Dept Biol Sci, Ft Myers, FL 33965 USA.
   [Wiley, Michael R.; Prieto, Karla] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA.
   [White, Stephen; Pronty, Darryl; Gillis, Leah D.] Florida Dept Hlth, Bur Publ Hlth Labs, Div Dis Control & Hlth Protect, Miami, FL 33125 USA.
   [Magnani, Diogo M.; Ricciardi, Michael J.; Bailey, Varian K.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Reyes, Daniel; Agle, Elyse R. N.; Sanchez-Lockhart, Mariano] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Bingham, Andrea M.] Florida Dept Hlth, Bur Epidemiol, Div Dis Control & Hlth Protect, Tallahassee, FL 32399 USA.
   [Oliveira, Glenn; Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA.
   [Metsky, Hayden C.; Baniecki, Mary Lynn; Barnes, Kayla G.; Chak, Bridget; Freije, Catherine A.; Gladden-Young, Adrianne; Gnirke, Andreas; Luo, Cynthia; MacInnis, Bronwyn; Matranga, Christian B.; Park, Daniel J.; Qu, James; Schaffner, Stephen F.; Tomkins-Tinch, Christopher; West, Kendra L.; Winnicki, Sarah M.; Wohl, Shirlee; Yozwiak, Nathan L.; Sabeti, Pardis C.] Broad Inst & Harvard, Cambridge, MA 02142 USA.
   [Quick, Joshua] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
   [Fauver, Joseph R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Khan, Kamran; Brent, Shannon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON M5S 1A8, Canada.
   [Reiner, Robert C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Lichtenberger, Paola N.] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA.
   [Cone, Marshall R.; Kopp, Edgar W.; Hogan, Kelly N.; Cannons, Andrew C.] Florida Dept Hlth, Bur Publ Hlth Labs, Div Dis Control & Hlth Protect, Tampa, FL 33612 USA.
   [Jean, Reynald] Florida Dept Hlth Miami Dade Cty, Miami, FL 33125 USA.
   [Monaghan, Andrew J.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA.
   [Garry, Robert F.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Porcelli, Mario C.; Vasquez, Chalmers] Miami Dade Cty Mosquito Control, Miami, FL 33178 USA.
   [Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA.
   [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.
   [Sabeti, Pardis C.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Andersen, Kristian G.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
RP Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Palacios, G (corresponding author), US Army Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA.; Andersen, KG (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
EM gustavo.f.palacios.ctr@mail.mil; andersen@scripps.edu
RI Sanchez-Lockhart, Mariano/H-1321-2019; Palacios, Gustavo/I-7773-2015;
   Pybus, Oliver G/B-2640-2012; Dudas, Gytis/H-5968-2019; Faria, Nuno
   R/I-2975-2012; Rambaut, Andrew/B-2481-2009; Loman, Nicholas/Z-1573-2019;
   Sanchez-Lockhart, Mariano/M-6446-2019; Schaffner, Stephen F/D-1189-2011
OI Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Palacios,
   Gustavo/0000-0001-5062-1938; Pybus, Oliver G/0000-0002-8797-2667; Dudas,
   Gytis/0000-0002-0227-4158; Faria, Nuno R/0000-0001-8839-2798; Rambaut,
   Andrew/0000-0003-4337-3707; Sanchez-Lockhart,
   Mariano/0000-0001-8009-7540; Magnani, Diogo/0000-0002-1773-2406; Garry,
   Robert/0000-0002-5683-3250; Loman, Nicholas/0000-0002-9843-8988; Paul,
   Lauren/0000-0001-5503-7570; Grubaugh, Nathan/0000-0003-2031-1933;
   Tomkins-Tinch, Christopher/0000-0002-9114-6421; Wiley,
   Michael/0000-0001-6688-007X; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X; White, Stephen/0000-0002-2112-1560
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33, R35 GM11977401];
   Mahan Postdoctoral Fellowship from the Computational Biology Program at
   Fred Hutch; ASTMH Shope Fellowship; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; US NIH MIDAS program [U54-GM088491]; CDCCentre National
   de la Recherche Scientifique (CNRS)United States Department of Health &
   Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK000510]; EUEuropean Union (EU) [278433-PREDEMICS]; ERCEuropean
   Research Council (ERC) [260864]; Horizon grant [643476-COMPARE]; NIH
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI110818, R01AI099210]; Howard Hughes
   Medical InstituteHoward Hughes Medical Institute; AWS Cloud Credits for
   Research; Broad Institute BroadNext10 program; EU ERCEuropean Union
   (EU)European Research Council (ERC) [614725-PATHPHYLODYN]; USAID
   Emerging Pandemic Threats Program-2 PREDICT-2United States Agency for
   International Development (USAID) [AID-OAA-A-14-00102]; DARPAUnited
   States Department of DefenseDefense Advanced Research Projects Agency
   (DARPA); NIH NCATS CTSAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001114]; NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272201400048C]; Ray Thomas Foundation
FX We thank J. Weger-Lucarelli, G. Ebel, C. Moore, B. Alto, G. Donatti, and
   S. Taylor for discussions; E. Spencer for IRB and logistics support; M.
   Pilcher for sequencing assistance; and G. Schroth and S. Gross for
   designing and providing enrichment probes. N.D.G. is supported by NIH
   training grant 5T32AI007244-33. G.D. is supported by the Mahan
   Postdoctoral Fellowship from the Computational Biology Program at Fred
   Hutch. K.G.B. is supported by the ASTMH Shope Fellowship. N.R.F. is
   funded by a Sir Henry Dale Fellowship (Wellcome Trust/Royal Society
   grant 204311/Z/16/Z). D.A.T.C. was supported by US NIH MIDAS program
   (U54-GM088491) and CDC Cooperative Agreement U01CK000510. A.R. is
   supported by EU Seventh Framework Programme (FP7/2007-2013) under grant
   278433-PREDEMICS, ERC grant 260864, Horizon 2020 grant 643476-COMPARE.
   P.C.S. is supported by Marc and Lynne Benioff; NIH NIAID U19AI110818;
   Howard Hughes Medical Institute; AWS Cloud Credits for Research; Broad
   Institute BroadNext10 program (also A. G.). T. B. is a Pew Biomedical
   Scholar and is supported by NIH R35 GM11977401. O.G.P. received funding
   from EU ERC Seventh Framework Programme (FP7/2007-2013)/ERC number
   614725-PATHPHYLODYN and the USAID Emerging Pandemic Threats Program-2
   PREDICT-2 (Cooperative Agreement No. AID-OAA-A-14-00102). S. I. and S.
   F. M. are supported by NIH NIAID R01AI099210. ZIKV sequencing at
   USAMRIID was supported by DARPA (PI: C. Kane). K. G. A. is a Pew
   Biomedical Scholar, and is supported by NIH NCATS CTSA UL1TR001114,
   NIAID contract HHSN272201400048C, and The Ray Thomas Foundation. The
   content of this publication does not necessarily reflect the views or
   policies of the US Army, the Department of Health and Human Services,
   the CDC, or the Florida Department of Health.
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   [Anonymous], 2017, NAT DIR EP SURV VECT
   [Anonymous], 2017, ZIK VIR
   [Anonymous], 2017, DENG PUERT RIC
   [Anonymous], 2017, DAIL ZIK UPD
   [Anonymous], 2016, ZIK CUM CAS
   [Anonymous], 2017, FCCA RES STAT
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Biggerstaff BJ., 2009, POOLEDINFRATE VERSIO
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Churcher TS, 2014, SCIENCE, V344, P1230, DOI 10.1126/science.1251449
   Corman VM, 2016, B WHO
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Faria N. R., 2017, NATURE
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauver JR, 2016, J MED ENTOMOL, V53, P425, DOI 10.1093/jme/tjv234
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Florida Department of Health, 2017, MOSQ BORN DIS SURV
   Gelman A, 1998, STAT SCI, V13, P163
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Hwang WH, 2011, METHODS ECOL EVOL, V2, P550, DOI 10.1111/j.2041-210X.2011.00105.x
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Koster J., 2012, OASICS OPENACCESS SE, V26
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee S, 2013, TOURISM MANAGE, V34, P236, DOI 10.1016/j.tourman.2012.03.009
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Metsky HC, 2017, NATURE
   Monaghan AJ, 2016, PLOS CURR
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Nelson B., 2016, PLOS CURR
   Nishiura H, 2012, J THEOR BIOL, V294, P48, DOI 10.1016/j.jtbi.2011.10.039
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Pan American Health Organisation, 2016, REG ZIK EP UPD AM
   Pan-American Health Organization, 2016, COUNTR TERR AUT TRAN
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Quick J., 2017, NAT PROTOCOLS
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rambaut A, 2016, VIRUS EVOL
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Teets Frank D, 2014, Virol Rep, V1-2, P2
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   World Health Organization, 2016, ZIK VIR COMPL
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
NR 79
TC 141
Z9 143
U1 2
U2 57
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 401
EP +
DI 10.1038/nature22400
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900034
PM 28538723
OA Green Accepted, Green Published
DA 2020-09-29
ER

PT J
AU Faria, NR
   Quick, J
   Claro, IM
   Theze, J
   de Jesus, JG
   Giovanetti, M
   Kraemer, MUG
   Hill, SC
   Black, A
   da Costa, AC
   Franco, LC
   Silva, SP
   Wu, CH
   Raghwani, J
   Cauchemez, S
   du Plessis, L
   Verotti, MP
   de Oliveira, WK
   Carmo, EH
   Coelho, GE
   Santelli, ACFS
   Vinhal, LC
   Henriques, CM
   Simpson, JT
   Loose, M
   Andersen, KG
   Grubaugh, ND
   Somasekar, S
   Chiu, CY
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Arias, CF
   Lewis-Ximenez, LL
   Baylis, SA
   Chieppe, AO
   Aguiar, SF
   Fernandes, CA
   Lemos, PS
   Nascimento, BLS
   Monteiro, HAO
   Siqueira, IC
   de Queiroz, MG
   de Souza, TR
   Bezerra, JF
   Lemos, MR
   Pereira, GF
   Loudal, D
   Moura, LC
   Dhalia, R
   Franca, RF
   Magalhaes, T
   Marques, ET
   Jaenisch, T
   Wallau, GL
   de Lima, MC
   Nascimento, V
   de Cerqueira, EM
   de Lima, MM
   Mascarenhas, DL
   Neto, JPM
   Levin, AS
   Tozetto-Mendoza, TR
   Fonseca, SN
   Mendes-Correa, MC
   Milagres, FP
   Segurado, A
   Holmes, EC
   Rambaut, A
   Bedford, T
   Nunes, MRT
   Sabino, EC
   Alcantara, LCJ
   Loman, NJ
   Pybus, OG
AF Faria, N. R.
   Quick, J.
   Claro, I. M.
   Theze, J.
   de Jesus, J. G.
   Giovanetti, M.
   Kraemer, M. U. G.
   Hill, S. C.
   Black, A.
   da Costa, A. C.
   Franco, L. C.
   Silva, S. P.
   Wu, C. -H.
   Raghwani, J.
   Cauchemez, S.
   du Plessis, L.
   Verotti, M. P.
   de Oliveira, W. K.
   Carmo, E. H.
   Coelho, G. E.
   Santelli, A. C. F. S.
   Vinhal, L. C.
   Henriques, C. M.
   Simpson, J. T.
   Loose, M.
   Andersen, K. G.
   Grubaugh, N. D.
   Somasekar, S.
   Chiu, C. Y.
   Munoz-Medina, J. E.
   Gonzalez-Bonilla, C. R.
   Arias, C. F.
   Lewis-Ximenez, L. L.
   Baylis, S. A.
   Chieppe, A. O.
   Aguiar, S. F.
   Fernandes, C. A.
   Lemos, P. S.
   Nascimento, B. L. S.
   Monteiro, H. A. O.
   Siqueira, I. C.
   de Queiroz, M. G.
   de Souza, T. R.
   Bezerra, J. F.
   Lemos, M. R.
   Pereira, G. F.
   Loudal, D.
   Moura, L. C.
   Dhalia, R.
   Franca, R. F.
   Magalhaes, T.
   Marques, E. T., Jr.
   Jaenisch, T.
   Wallau, G. L.
   de Lima, M. C.
   Nascimento, V.
   de Cerqueira, E. M.
   de Lima, M. M.
   Mascarenhas, D. L.
   Moura Neto, J. P.
   Levin, A. S.
   Tozetto-Mendoza, T. R.
   Fonseca, S. N.
   Mendes-Correa, M. C.
   Milagres, F. P.
   Segurado, A.
   Holmes, E. C.
   Rambaut, A.
   Bedford, T.
   Nunes, M. R. T.
   Sabino, E. C.
   Alcantara, L. C. J.
   Loman, N. J.
   Pybus, O. G.
TI Establishment and cryptic transmission of Zika virus in Brazil and the
   Americas
SO NATURE
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; EVOLUTION; TIME; EMERGENCE; MODELS; DENGUE;
   BAHIA; RECOMBINATION; SEQUENCES; SELECTION
AB Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil(1). Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 20162) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 20162). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease(3). However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.
C1 [Faria, N. R.; Theze, J.; Kraemer, M. U. G.; Hill, S. C.; Raghwani, J.; du Plessis, L.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
   [Faria, N. R.; Franco, L. C.; Silva, S. P.; Lemos, P. S.; Nascimento, B. L. S.; Monteiro, H. A. O.; Nunes, M. R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [de Jesus, J. G.; Giovanetti, M.; Siqueira, I. C.; Alcantara, L. C. J.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, M.] Univ Roma Tor Vergata, Rome, Italy.
   [Kraemer, M. U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Black, A.; Bedford, T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford OX1 3LB, England.
   [Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, S.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Cauchemez, S.] Ctr Natl Rech Sci, URA3012, Paris, France.
   [Verotti, M. P.] Minist Hlth, Coordena Lab Saude CGLAB DEVIT SVS, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Minist Hlth, Coordena Geral Vigilincia & Resposta Emergencias, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.
   [Carmo, E. H.; Henriques, C. M.] Minist Hlth, Dept Vigilincia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Coelho, G. E.; Santelli, A. C. F. S.; Vinhal, L. C.] Minist Hlth, Coordena Geral Programas Controle & Preven Malari, Brasilia, DF, Brazil.
   [Coelho, G. E.] PAHO, Buenos Aires, DF, Argentina.
   [Santelli, A. C. F. S.] Fundacao Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Simpson, J. T.] Ontario Inst Canc Res, Toronto, ON, Canada.
   [Loose, M.] Univ Nottingham, Nottingham, England.
   [Andersen, K. G.; Grubaugh, N. D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Med Infect & Dis, San Francisco, CA 94143 USA.
   [Munoz-Medina, J. E.; Gonzalez-Bonilla, C. R.] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Arias, C. F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Lewis-Ximenez, L. L.] Inst Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Baylis, S. A.] Paul Ehrlich Inst, Langen, Germany.
   [Chieppe, A. O.; Aguiar, S. F.; Fernandes, C. A.] Lab Cent Saude Publ Noel Nutels, Rio De Janeiro, Brazil.
   [de Queiroz, M. G.; de Souza, T. R.; Bezerra, J. F.] Labo Cent Saude Publ Estado Rio Grande Norte, Natal, RN, Brazil.
   [de Souza, T. R.] Univ Potiguar Rio Grande Norte, Natal, RN, Brazil.
   [Bezerra, J. F.] Fundacao Natalense Ensino & Cultura, Natal, RN, Brazil.
   [Lemos, M. R.; Pereira, G. F.; Loudal, D.; Moura, L. C.] Lab Cent Saude Publ Estado Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Dhalia, R.; Franca, R. F.; Magalhaes, T.; Marques, E. T., Jr.; Wallau, G. L.] Fundacao Oswaldo Cruz FIOCRUZ, Recife, PE, Brazil.
   [Magalhaes, T.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Jaenisch, T.] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [de Lima, M. C.; Nascimento, V.; de Cerqueira, E. M.] Lab Cent Saude Publ Estado Alagoas, Maceio, Brazil.
   [de Lima, M. M.] Univ Estadual Feira de Santana, Feira Santana, Bahia, Argentina.
   [Mascarenhas, D. L.] Secretaria Saude Feira Santana, Feira De Santana, Bahia, Brazil.
   [Moura Neto, J. P.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Fonseca, S. N.] Hosp Sao Francisco, Ribeirao Preto, Brazil.
   [Milagres, F. P.] Univ Fed Tocantins, Palmas, Brazil.
   [Holmes, E. C.] Univ Sydney, Sydney, NSW, Australia.
   [Rambaut, A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, A.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Nunes, M. R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Pybus, O. G.] Metabiota, San Francisco, CA 94104 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SY, England.; Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Sabino, EC (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.; Sabino, EC (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.; Alcantara, LCJ (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.
EM sabinoec@usp.br; lalcan@bahia.fiocruz.br; n.j.loman@bham.ac.uk;
   oliver.pybus@zoo.ox.ac.uk
RI Loman, Nicholas/Z-1573-2019; Levin, Anna S/C-8831-2012; Esteban, Munoz
   Medina Jose/B-6186-2015; Magalhaes, Tereza/V-6632-2019; Bezerra, Joao
   Felipe/AAE-2500-2020; de Siqueira, Isadora Cristina/R-9953-2016; Arias,
   Carlos/O-4036-2019; Oliveira, Claudia DL/G-8618-2011; milagres,
   flavio/Q-2403-2019; Dhalia, Rafael/AAD-5432-2020; Rambaut,
   Andrew/B-2481-2009; Marques, Ernesto T. A/L-4967-2013; Giovanetti,
   Marta/AAK-7408-2020; Sabino, Ester Cerdeira/F-7750-2010; da-Costa,
   Antonio Charlys/G-1548-2010; Wallau, Gabriel Luz/B-5911-2008; Faria,
   Nuno R/I-2975-2012; Bezerrra, Joao/C-8867-2017; Segurado, Aluisio
   C/K-2229-2012; Pybus, Oliver G/B-2640-2012
OI Levin, Anna S/0000-0003-2427-8368; Esteban, Munoz Medina
   Jose/0000-0002-1289-4457; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Arias, Carlos/0000-0003-3130-4501;
   Rambaut, Andrew/0000-0003-4337-3707; Marques, Ernesto T.
   A/0000-0003-3826-9358; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   da-Costa, Antonio Charlys/0000-0001-5516-5177; Wallau, Gabriel
   Luz/0000-0002-1419-5713; Faria, Nuno R/0000-0001-8839-2798; Bezerrra,
   Joao/0000-0002-9978-628X; Segurado, Aluisio C/0000-0002-6311-8036;
   Pybus, Oliver G/0000-0002-8797-2667; Wu, Chieh-Hsi/0000-0001-9386-725X;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Raghwani,
   Jayna/0000-0001-8538-4995; Grubaugh, Nathan/0000-0003-2031-1933;
   Giovanetti, Marta/0000-0002-5849-7326; Hill, Sarah/0000-0002-2995-2596;
   Alcantara, Luiz/0000-0002-6769-9931; Holmes, Edward/0000-0001-9596-3552;
   Vinhal Frutuoso, Livia Carla/0000-0001-7926-1075; Loose,
   Matthew/0000-0002-5264-0929; Loman, Nicholas/0000-0002-9843-8988; Black,
   Allison/0000-0002-6618-4127
FU MRC/Wellcome Trust/Newton Fund Zika Rapid Response grant
   [MC_PC_15100/ZK/16-078]; USAID Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]; MRC Bioinformatics Fellowship; Sir Henry Dale
   Fellowship [204311/Z/16/Z]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [457480/2014-9, 302584/2015-3,
   439975/2016-6]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/03417-7]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R35 GM119774,
   R01 HL105704]; NSFNational Science Foundation (NSF) [DGE-1256082];
   Abbott Laboratories, Inc.Abbott Laboratories; National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [GNT1037231]; MRCMedical Research Council UK (MRC); CRUKCancer
   Research UK [ANR00310]; Wellcome TrustWellcome Trust; Royal SocietyRoyal
   Society of London [101237/Z/13/Z]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN, 278433-PREDEMICS]; EUEuropean Union (EU)
   [643476-COMPARE, 734548-ZIKAlliance]; IDAMS; DENFREE; DengueTools;
   PPSUSFACEPE [APQ-0302-4.01/13]; FACEPE [APQ-0044.2.11/16,
   APQ-0055.2.11/16]; German Ministry of Health
FX We thank Fundacao Oswaldo Cruz in Bahia and Pernambuco states,
   University of Sao Paulo, Instituto Evandro Chagas, and the Brazilian
   Zika virus surveillance network for their essential contributions. We
   thank the following for giving us permission to use their unpublished
   genomes available on GenBank: R. Lanciotti, J. Lednicky, A. Enfissi, F.
   Baldanti, R. Shabman, B. Picket, R. Schinazi, M. Bonaldo, M. Gale, M.
   Capobianchi and C. Concetta, M. Leguia, J. Alberto Diaz, E.
   Sevilla-Reyes, A. Franz, M. GarciaBlanco and M. J. van Hemert. We thank
   P. Fernando da Costa Vasconcelos, S. Guerreiro Rodrigues, J. Cardoso, J.
   Vasconcelos, J. Vianez Jr, J. Gil Melgaco, J. Blumel, M. C. Brito
   Lobato, L. Nunes Fava, C. Ayres, L. Abade and F. Campos. L. C. J. A.
   thanks QIAGEN for reagents and equipment and M. R. T. N. thanks FERPEL
   for consumables. We thank Oxford Nanopore for technical support,
   particularly R. Dokos, Z. McDougall, S. Cowan, G. Sanghera, and O.
   Hartwell. This work was supported by an MRC/Wellcome Trust/Newton Fund
   Zika Rapid Response grant (MC_PC_15100/ZK/16-078) and by the USAID
   Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement
   AID-OAA-A-14-00102). N. J. L. is supported by an MRC Bioinformatics
   Fellowship. N. R. F. is funded by a Sir Henry Dale Fellowship (grant
   204311/Z/16/Z). CNPq contributed to trip expenses (grant 457480/2014-9).
   A.C.d.C. was supported by FAPESP # 2012/03417-7 and M. R. T. N. by CNPq
   grant no. 302584/2015-3. A. B. and T. B. were supported by NIH award R35
   GM119774. A. B. is supported by the NSF Graduate Research Fellowship
   Program (grant DGE-1256082). T. B. is a Pew Biomedical Scholar. C.Y.C.
   is partially supported by NIH grant R01 HL105704 and an award from
   Abbott Laboratories, Inc. E. C. H. is supported by a National Health and
   Medical Research Council Australia Fellowship (GNT1037231). C.- H. W. is
   supported by the MRC and CRUK (ANR00310) and by the Wellcome Trust and
   Royal Society (grant 101237/Z/13/Z). S. C. H. is supported by the
   Wellcome Trust. This research received funding from the ERC under grant
   agreements 614725-PATHPHYLODYN and 278433-PREDEMICS, and from EU Horizon
   2020 under agreements 643476-COMPARE and 734548-ZIKAlliance. T. J. and
   E. T. M. acknowledge funding from IDAMS, DENFREE, DengueTools, and
   PPSUSFACEPE (project APQ-0302-4.01/13). R. F. F. received funding from
   FACEPE (APQ-0044.2.11/16 and APQ-0055.2.11/16) and from CNPq
   (439975/2016-6). S. A. B. was supported by the Sicherheit von Blut und
   Geweben hinsichtlich der Abwesenheit von Zikaviren from the German
   Ministry of Health.
CR [Anonymous], 2014, R LANG ENV COMP
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grubaugh N. D., 2017, NATURE
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Metsky HC, 2017, NATURE
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Ministerio da Saade, 2017, B EP SECR VIG SAUD
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pacheco O., 2016, NEW ENGL J MED
   PAHO/WHO, 2016, PAHO WHO ZIK EP UPD
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quick J., 2017, NAT PROTOCOLS
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schierup MH, 2000, GENETICS, V156, P879
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 218
Z9 222
U1 10
U2 79
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 406
EP +
DI 10.1038/nature22401
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900035
PM 28538727
OA Green Accepted, Green Published
DA 2020-09-29
ER

PT J
AU Quick, J
   Grubaugh, ND
   Pullan, ST
   Claro, IM
   Smith, AD
   Gangavarapu, K
   Oliveira, G
   Robles-Sikisaka, R
   Rogers, TF
   Beutler, NA
   Burton, DR
   Lewis-Ximenez, LL
   de Jesus, JG
   Giovanetti, M
   Hill, SC
   Black, A
   Bedford, T
   Carroll, MW
   Nunes, M
   Alcantara, LC
   Sabino, EC
   Baylis, SA
   Faria, NR
   Loose, M
   Simpson, JT
   Pybus, OG
   Andersen, KG
   Loman, NJ
AF Quick, Joshua
   Grubaugh, Nathan D.
   Pullan, Steven T.
   Claro, Ingra M.
   Smith, Andrew D.
   Gangavarapu, Karthik
   Oliveira, Glenn
   Robles-Sikisaka, Refugio
   Rogers, Thomas F.
   Beutler, Nathan A.
   Burton, Dennis R.
   Lewis-Ximenez, Lia Laura
   de Jesus, Jaqueline Goes
   Giovanetti, Marta
   Hill, Sarah C.
   Black, Allison
   Bedford, Trevor
   Carroll, Miles W.
   Nunes, Marcio
   Alcantara, Luiz Carlos, Jr.
   Sabino, Ester C.
   Baylis, Sally A.
   Faria, Nuno R.
   Loose, Matthew
   Simpson, Jared T.
   Pybus, Oliver G.
   Andersen, Kristian G.
   Loman, Nicholas J.
TI Multiplex PCR method for MinION and Illumina sequencing of Zika and
   other virus genomes directly from clinical samples
SO NATURE PROTOCOLS
LA English
DT Article
ID SURESELECT TARGET ENRICHMENT; REAL-TIME; EBOLA; SURVEILLANCE;
   AMPLIFICATION; EVOLUTION; INSIGHTS; PASSAGES; ROBUST; LASSA
AB Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly from clinical samples (i.e., without isolation and culture) remains challenging for viruses such as Zika, for which metagenomic sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence-complete genomes, comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimized library preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an Internet connection for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences can be achieved in 1-2 d by starting with clinical samples and following a simple laboratory workflow. This method has been successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in the Americas. The protocol can be used to sequence other viral genomes using the online Primal Scheme primer designer software. It is suitable for sequencing either RNA or DNA viruses in the field during outbreaks or as an inexpensive, convenient method for use in the lab.
C1 [Quick, Joshua; Smith, Andrew D.; Loman, Nicholas J.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Grubaugh, Nathan D.; Gangavarapu, Karthik; Robles-Sikisaka, Refugio; Rogers, Thomas F.; Beutler, Nathan A.; Burton, Dennis R.; Andersen, Kristian G.] Scripps Res Inst, La Jolla, CA 92037 USA.
   [Pullan, Steven T.; Carroll, Miles W.; Andersen, Kristian G.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Oliveira, Glenn; Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA USA.
   [Rogers, Thomas F.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Lewis-Ximenez, Lia Laura] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [de Jesus, Jaqueline Goes; Giovanetti, Marta; Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Rome, Tor Vergata, Italy.
   [Hill, Sarah C.; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Black, Allison; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, Allison] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Carroll, Miles W.] Univ Southampton, South Gen Hosp, Southampton, Hants, England.
   [Nunes, Marcio] Inst Evandro Chagas, Belem, Para, Brazil.
   [Baylis, Sally A.] Paul Ehrlich Inst, Langen, Germany.
   [Loose, Matthew] Univ Nottingham, Sch Life Sci, DeepSeq, Nottingham, England.
   [Simpson, Jared T.] OICR, Toronto, ON, Canada.
RP Loman, NJ (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
EM n.j.loman@bham.ac.uk
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012; Loman,
   Nicholas/Z-1573-2019; Sabino, Ester Cerdeira/F-7750-2010; Giovanetti,
   Marta/AAK-7408-2020
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Loman,
   Nicholas/0000-0002-9843-8988; Alcantara, Luiz/0000-0002-6769-9931;
   Pullan, Steven/0000-0002-8983-599X; Grubaugh,
   Nathan/0000-0003-2031-1933; Black, Allison/0000-0002-6618-4127;
   Giovanetti, Marta/0000-0002-5849-7326; Loose,
   Matthew/0000-0002-5264-0929; Beutler, Nathan/0000-0003-3240-9524; Hill,
   Sarah/0000-0002-2995-2596
FU Brazilian Ministry of Health and the Latin American Community Engagement
   Networks (LACENs); Medical Research Council/Wellcome Trust/Newton Fund
   Zika Rapid Response Initiative [ZK/16-078]; Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project; National Institutes of Health
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33]; NIH National Center
   for Advancing Translational Studies Clinical and Translational Science
   Award [UL1TR001114]; National Institute of Allergy and Infectious
   Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201400048C]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R35 GM119774, U54 GM111274]; National Science
   Foundation Graduate Research Fellowship ProgramNational Science
   Foundation (NSF) [DGE-1256082]; Sir Henry Dale Fellowship (Wellcome
   Trust/Royal Society) [204311/Z/16/Z]; grant ('Sicherheit von
   Blut(produkten) und Geweben hinsichtlich der Abwesenheit von Zikaviren')
   from the German Ministry of Health; USAID Emerging Pandemic Threats
   Program-2 PREDICT-2United States Agency for International Development
   (USAID) [AID-OAA-A-14-00102]
FX The authors thank the Brazilian Ministry of Health and the Latin
   American Community Engagement Networks (LACENs) of Natal, Joao Pessoa,
   Recife, Maceio and Salvador for their support. We thank T. Fredeking
   from Antibody Systems for providing the Zika virus samples from
   Colombia. We thank K. Brunker for testing the Primal Scheme software.
   The Zika in Brazil Real-time Analysis (ZiBRA) project
   (http://www.zibraproject.org) is supported by the Medical Research
   Council/Wellcome Trust/Newton Fund Zika Rapid Response Initiative (grant
   no, ZK/16-078), which also provides J.Q.'s salary. N.J.L. is supported
   by a Medical Research Council Bioinformatics Fellowship as part of the
   Cloud Infrastructure for Microbial Bioinformatics (CLIMB) project.
   Primal Scheme is hosted on the CLIMB platform, where pipeline
   development and MinION data analysis was performed<SUP>59</SUP>. N.D.G.
   is supported by National Institutes of Health (NIH) training grant
   5T32AI007244-33. K.G.A. is a PEW Biomedical Scholar, and his work is
   supported by NIH National Center for Advancing Translational Studies
   Clinical and Translational Science Award UL1TR001114 and National
   Institute of Allergy and Infectious Diseases (NIAID) contract
   HHSN272201400048C. A.B. and T.B. were supported by NIH awards R35
   GM119774 and U54 GM111274. T.B. is a Pew Biomedical Scholar. A.B. is
   supported by the National Science Foundation Graduate Research
   Fellowship Program under Grant no. DGE-1256082. N.R.F. was funded by a
   Sir Henry Dale Fellowship (Wellcome Trust/Royal Society grant
   204311/Z/16/Z). Work at the Paul-Ehrlich-Institut was supported by a
   grant ('Sicherheit von Blut(produkten) und Geweben hinsichtlich der
   Abwesenheit von Zikaviren') from the German Ministry of Health. This
   study was supported by USAID Emerging Pandemic Threats Program-2
   PREDICT-2 (cooperative agreement AID-OAA-A-14-00102). The contents of
   this article are the responsibility of the authors and do not
   necessarily reflect the views of USAID or the US government.
CR Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Batty EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066129
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown JR, 2015, J CLIN VIROL, V70, pS12, DOI 10.1016/j.jcv.2015.07.037
   Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16
   Carrillo C, 2007, J VIROL, V81, P11341, DOI 10.1128/JVI.00930-07
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chan M, 2016, J APPL LAB MED, V1, P25, DOI 10.1373/jalm.2016.020131
   Connor TR, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000086
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087
   Faria N. R., 2017, NATURE
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Gardner Shea N., 2014, Advances in Bioinformatics, V2014, P101894, DOI 10.1155/2014/101894
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh N. D., 2017, NATURE
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Hysom DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034560
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z
   Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480
   KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999
   KWOK S, 1994, PCR METH APPL, V3, pS39
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261
   Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198
   Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419
   Marquez S, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.01673-16, 10.1128/genomea.01673-16]
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Metsky HC, 2017, NATURE
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666
   Misencik MJ, 2016, VECTOR-BORNE ZOONOT, V16, P181, DOI 10.1089/vbz.2015.1889
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219
   Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013
   Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480
   Sipos B., 2016, BIORXIV
   Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Yu Q, 2011, BIOINFORMATICS, V27, P266, DOI 10.1093/bioinformatics/btq624
   Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000
NR 59
TC 165
Z9 168
U1 5
U2 102
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PD JUN
PY 2017
VL 12
IS 6
BP 1261
EP 1276
DI 10.1038/nprot.2017.066
PG 16
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA EV9RK
UT WOS:000402122900001
PM 28538739
OA Green Accepted, Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Dudas, G
   Carvalho, LM
   Bedford, T
   Tatem, AJ
   Baele, G
   Faria, NR
   Park, DJ
   Ladner, JT
   Arias, A
   Asogun, D
   Bielejec, F
   Caddy, SL
   Cotten, M
   D'Ambrozio, J
   Dellicour, S
   Di Caro, A
   Diclaro, JW
   Duraffour, S
   Elmore, MJ
   Iii, LSF
   Faye, O
   Gilbert, ML
   Gevao, SM
   Gire, S
   Gladden-Young, A
   Gnirke, A
   Goba, A
   Grant, DS
   Haagmans, BL
   Hiscox, JA
   Jah, U
   Kugelman, JR
   Liu, D
   Lu, J
   Malboeuf, CM
   Mate, S
   Matthews, DA
   Matranga, CB
   Meredith, LW
   Qu, J
   Quick, J
   Pas, SD
   Phan, MVT
   Pollakis, G
   Reusken, CB
   Sanchez-Lockhart, M
   Schaffner, SF
   Schieffelin, JS
   Sealfon, RS
   Simon-Loriere, E
   Smits, SL
   Stoecker, K
   Thorne, L
   Tobin, EA
   Vandi, MA
   Watson, SJ
   West, K
   Whitmer, S
   Wiley, MR
   Winnicki, SM
   Wohl, S
   Wolfel, R
   Yozwiak, NL
   Andersen, KG
   Blyden, SO
   Bolay, F
   Carroll, MW
   Dahn, B
   Diallo, B
   Formenty, P
   Fraser, C
   Gao, GF
   Garry, RF
   Goodfellow, I
   Gnther, S
   Happi, CT
   Holmes, EC
   Kargbo, B
   Keita, S
   Kellam, P
   Koopmans, MPG
   Kuhn, JH
   Loman, NJ
   Magassouba, N
   Naidoo, D
   Nichol, ST
   Nyenswah, T
   Palacios, G
   Pybus, OG
   Sabeti, PC
   Sall, A
   Stroher, U
   Wurie, I
   Suchard, MA
   Lemey, P
   Rambaut, A
AF Dudas, Gytis
   Carvalho, Luiz Max
   Bedford, Trevor
   Tatem, Andrew J.
   Baele, Guy
   Faria, Nuno R.
   Park, Daniel J.
   Ladner, Jason T.
   Arias, Armando
   Asogun, Danny
   Bielejec, Filip
   Caddy, Sarah L.
   Cotten, Matthew
   D'Ambrozio, Jonathan
   Dellicour, Simon
   Di Caro, Antonino
   Diclaro, Joseph W.
   Duraffour, Sophie
   Elmore, Michael J.
   Iii, Lawrence S. Fakoli
   Faye, Ousmane
   Gilbert, Merle L.
   Gevao, Sahr M.
   Gire, Stephen
   Gladden-Young, Adrianne
   Gnirke, Andreas
   Goba, Augustine
   Grant, Donald S.
   Haagmans, Bart L.
   Hiscox, Julian A.
   Jah, Umaru
   Kugelman, Jeffrey R.
   Liu, Di
   Lu, Jia
   Malboeuf, Christine M.
   Mate, Suzanne
   Matthews, David A.
   Matranga, Christian B.
   Meredith, Luke W.
   Qu, James
   Quick, Joshua
   Pas, Suzan D.
   Phan, My V. T.
   Pollakis, Georgios
   Reusken, Chantal B.
   Sanchez-Lockhart, Mariano
   Schaffner, Stephen F.
   Schieffelin, John S.
   Sealfon, Rachel S.
   Simon-Loriere, Etienne
   Smits, Saskia L.
   Stoecker, Kilian
   Thorne, Lucy
   Tobin, Ekaete Alice
   Vandi, Mohamed A.
   Watson, Simon J.
   West, Kendra
   Whitmer, Shannon
   Wiley, Michael R.
   Winnicki, Sarah M.
   Wohl, Shirlee
   Wolfel, Roman
   Yozwiak, Nathan L.
   Andersen, Kristian G.
   Blyden, Sylvia O.
   Bolay, Fatorma
   Carroll, Miles W.
   Dahn, Bernice
   Diallo, Boubacar
   Formenty, Pierre
   Fraser, Christophe
   Gao, George F.
   Garry, Robert F.
   Goodfellow, Ian
   Gnther, Stephan
   Happi, Christian T.
   Holmes, Edward C.
   Kargbo, Brima
   Keita, Sakoba
   Kellam, Paul
   Koopmans, Marion P. G.
   Kuhn, Jens H.
   Loman, Nicholas J.
   Magassouba, N'Faly
   Naidoo, Dhamari
   Nichol, Stuart T.
   Nyenswah, Tolbert
   Palacios, Gustavo
   Pybus, Oliver G.
   Sabeti, Pardis C.
   Sall, Amadou
   Stroher, Ute
   Wurie, Isatta
   Suchard, Marc A.
   Lemey, Philippe
   Rambaut, Andrew
TI Virus genomes reveal factors that spread and sustained the Ebola
   epidemic
SO NATURE
LA English
DT Article
ID REAL-TIME; OUTBREAK; DISEASE; EVOLUTION; DYNAMICS; GUINEA; TRANSMISSION;
   MEASLES; HYPERMUTATION; SURVEILLANCE
AB The 2013-2016 West African epidemic caused by the Ebola virus was of unprecedented magnitude, duration and impact. Here we reconstruct the dispersal, proliferation and decline of Ebola virus throughout the region by analysing 1,610 Ebola virus genomes, which represent over 5% of the known cases. We test the association of geography, climate and demography with viral movement among administrative regions, inferring a classic 'gravity' model, with intense dispersal between larger and closer populations. Despite attenuation of international dispersal after border closures, cross-border transmission had already sown the seeds for an international epidemic, rendering these measures ineffective at curbing the epidemic. We address why the epidemic did not spread into neighbouring countries, showing that these countries were susceptible to substantial outbreaks but at lower risk of introductions. Finally, we reveal that this large epidemic was a heterogeneous and spatially dissociated collection of transmission clusters of varying size, duration and connectivity. These insights will help to inform interventions in future epidemics.
C1 [Dudas, Gytis; Carvalho, Luiz Max; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Kings Bldg, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Dudas, Gytis; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, WorldPop, Southampton SO17 1BJ, Hants, England.
   [Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden.
   [Baele, Guy; Bielejec, Filip; Dellicour, Simon; Lemey, Philippe] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3PS, England.
   [Park, Daniel J.; Gire, Stephen; Gladden-Young, Adrianne; Gnirke, Andreas; Malboeuf, Christine M.; Matranga, Christian B.; Qu, James; Schaffner, Stephen F.; Sealfon, Rachel S.; West, Kendra; Winnicki, Sarah M.; Wohl, Shirlee; Yozwiak, Nathan L.; Sabeti, Pardis C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.
   [Ladner, Jason T.; D'Ambrozio, Jonathan; Gilbert, Merle L.; Kugelman, Jeffrey R.; Mate, Suzanne; Sanchez-Lockhart, Mariano; Wiley, Michael R.; Palacios, Gustavo] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.
   [Arias, Armando; Caddy, Sarah L.; Lu, Jia; Meredith, Luke W.; Thorne, Lucy; Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England.
   [Arias, Armando] Tech Univ Denmark, Natl Vet Inst, Bulowsvej 27, DK-1870 Frederiksberg C, Denmark.
   [Asogun, Danny; Tobin, Ekaete Alice] Irrua Specialist Teaching Hosp, Inst Lassa Fever Res & Control, Irrua, Nigeria.
   [Asogun, Danny; Di Caro, Antonino; Duraffour, Sophie; Stoecker, Kilian; Tobin, Ekaete Alice; Wolfel, Roman; Carroll, Miles W.; Gnther, Stephan] European Mobile Lab Consortium, D-20359 Hamburg, Germany.
   [Cotten, Matthew; Phan, My V. T.; Watson, Simon J.; Kellam, Paul] Wellcome Trust Sanger Inst, Virus Genom, Cambridge CB10 1SA, England.
   [Cotten, Matthew; Haagmans, Bart L.; Pas, Suzan D.; Phan, My V. T.; Reusken, Chantal B.; Smits, Saskia L.; Koopmans, Marion P. G.] Erasmus Univ, Dept Virosci, Med Ctr, POB 2040, NL-300 CA Rotterdam, Netherlands.
   [Di Caro, Antonino] Natl Inst Infect Dis L Spallanzani IRCCS, Via Portuense 292, I-00149 Rome, Italy.
   [Diclaro, Joseph W.] Naval Med Res Unit 3, 3A Lmtidad Ramses St, Cairo 11517, Egypt.
   [Duraffour, Sophie; Gnther, Stephan] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
   [Elmore, Michael J.; Carroll, Miles W.] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England.
   [Iii, Lawrence S. Fakoli; Bolay, Fatorma] Liberian Inst Biomed Res, Charlesville, Liberia.
   [Faye, Ousmane; Sall, Amadou] Inst Pasteur, Arbovirus & Viral Hemorrhag Fever Unit, 36 Ave Pasteur,BP 220, Dakar, Senegal.
   [Gevao, Sahr M.; Wurie, Isatta] Univ Sierra Leone, Freetown, Sierra Leone.
   [Gire, Stephen; Wohl, Shirlee; Yozwiak, Nathan L.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.
   [Goba, Augustine; Grant, Donald S.; Vandi, Mohamed A.] Kenema Govt Hosp, Viral Hemorrhag Fever Program, 1 Combema Rd, Kenema, Sierra Leone.
   [Goba, Augustine; Grant, Donald S.; Vandi, Mohamed A.; Kargbo, Brima] Minist Hlth & Sanitat, 4th Floor Youyi Bldg, Freetown, Sierra Leone.
   [Hiscox, Julian A.; Pollakis, Georgios] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 2BE, Merseyside, England.
   [Hiscox, Julian A.; Carroll, Miles W.] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool L69 3GL, Merseyside, England.
   [Jah, Umaru; Meredith, Luke W.; Goodfellow, Ian] Univ Makeni, Makeni, Sierra Leone.
   [Liu, Di; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.
   [Matthews, David A.] Univ Bristol, Bristol BS8 1TD, Avon, England.
   [Quick, Joshua; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
   [Sanchez-Lockhart, Mariano; Wiley, Michael R.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA.
   [Schieffelin, John S.; Winnicki, Sarah M.] Infect Dis Sect, Dept Pediat, New Orleans, LA 70112 USA.
   [Sealfon, Rachel S.] Flatiron Inst, Ctr Computat Biol, New York, NY 10010 USA.
   [Sealfon, Rachel S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.
   [Simon-Loriere, Etienne] Inst Pasteur, Funct Genet Infect Dis Unit, 28 Rue Docteur Roux, F-75724 Paris 15, France.
   [Simon-Loriere, Etienne] CNRS URA3012, Genet Fonct Malad Infect, F-75015 Paris, France.
   [Stoecker, Kilian; Wolfel, Roman] Bundeswehr Inst Microbiol, Neuherbergstr 11, D-80937 Munich, Germany.
   [Whitmer, Shannon; Nichol, Stuart T.; Stroher, Ute] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.
   [Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA.
   [Blyden, Sylvia O.] Minist Social Welf Gender & Childrens Affairs, New Englandville, Freetown, Sierra Leone.
   [Carroll, Miles W.] Univ Southampton, South Gen Hosp, Southampton SO16 6YD, Hants, England.
   [Dahn, Bernice; Nyenswah, Tolbert] Minstry Hlth Liberia, Monrovia, Liberia.
   [Diallo, Boubacar] WHO, Conakry, Guinea.
   [Formenty, Pierre; Naidoo, Dhamari] WHO, Geneva, Switzerland.
   [Fraser, Christophe] Univ Oxford, Oxford Big Data Inst, Nuffield Dept Med, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford OX3 7FZ, England.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Beijing 102206, Peoples R China.
   [Garry, Robert F.] Dept Microbiol & Immunol, New Orleans, LA 70112 USA.
   [Happi, Christian T.] Redeemers Univ, Dept Biol Sci, Ede, Osun State, Nigeria.
   [Happi, Christian T.] Redeemers Univ, ACEGID, Ede, Osun State, Nigeria.
   [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.
   [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Keita, Sakoba] Minist Hlth Guinea, Conakry, Guinea.
   [Kellam, Paul] Imperial Coll London, Div Infect Dis, Fac Med, London W2 1PG, England.
   [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, B-8200 Res Plaza, Frederick, MD 21702 USA.
   [Magassouba, N'Faly] Univ Gamal Abdel Nasser Conakry, Lab Fievres Hemorrag Guinee, Conakry, Guinea.
   [Suchard, Marc A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Rambaut, Andrew] Univ Edinburgh, Ctr Immunol Infect & Evolut, Kings Bldg, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
RP Dudas, G; Rambaut, A (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Kings Bldg, Edinburgh EH9 3FL, Midlothian, Scotland.; Dudas, G (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.; Lemey, P (corresponding author), Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.; Rambaut, A (corresponding author), Univ Edinburgh, Ctr Immunol Infect & Evolut, Kings Bldg, Edinburgh EH9 3FL, Midlothian, Scotland.; Rambaut, A (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
EM gdudas@fredhutch.org; philippe.lemey@kuleuven.be; a.rambaut@ed.ac.uk
RI Schaffner, Stephen F/D-1189-2011; Lemey, Philippe/C-3755-2018; Dudas,
   Gytis/H-5968-2019; Pybus, Oliver G/B-2640-2012; Baele, Guy/R-8157-2017;
   Caddy, Sarah/AAG-9891-2019; Loman, Nicholas/Z-1573-2019; Dellicour,
   Simon/AAE-9054-2020; Georgios, Pollakis/Y-2341-2019; Fraser,
   Christophe/A-8109-2008; Sanchez-Lockhart, Mariano/H-1321-2019; Arias,
   Armando/E-1393-2016; Rambaut, Andrew/B-2481-2009; Sanchez-Lockhart,
   Mariano/M-6446-2019; Kuhn, Jens H./B-7615-2011; Faria, Nuno
   R/I-2975-2012; Di Caro, Antonino/K-6854-2016; Palacios,
   Gustavo/I-7773-2015; Koopmans, Marion/Y-9170-2019
OI Lemey, Philippe/0000-0003-2826-5353; Dudas, Gytis/0000-0002-0227-4158;
   Pybus, Oliver G/0000-0002-8797-2667; Baele, Guy/0000-0002-1915-7732;
   Dellicour, Simon/0000-0001-9558-1052; Fraser,
   Christophe/0000-0003-2399-9657; Sanchez-Lockhart,
   Mariano/0000-0001-8009-7540; Arias, Armando/0000-0002-4138-4608;
   Rambaut, Andrew/0000-0003-4337-3707; Sanchez-Lockhart,
   Mariano/0000-0001-8009-7540; Kuhn, Jens H./0000-0002-7800-6045; Faria,
   Nuno R/0000-0001-8839-2798; Di Caro, Antonino/0000-0001-6027-3009;
   Palacios, Gustavo/0000-0001-5062-1938; Koopmans,
   Marion/0000-0002-5204-2312; Holmes, Edward/0000-0001-9596-3552;
   Matthews, David/0000-0003-4611-8795; Kellam, Paul/0000-0003-3166-4734;
   Gunther, Stephan/0000-0002-6562-0230; Happi,
   Christian/0000-0002-3056-6705; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X; Goodfellow, Ian/0000-0002-9483-510X; Lu,
   Jia/0000-0003-3995-324X; Wiley, Michael/0000-0001-6688-007X; Hiscox,
   Julian/0000-0002-6582-0275; Cotten, Matthew/0000-0002-3361-3351; Phan,
   My VT/0000-0002-6905-8513; Meredith, Luke/0000-0002-3802-8290; Loman,
   Nicholas/0000-0002-9843-8988; , Etienne/0000-0001-8420-7743; Haagmans,
   Bart/0000-0001-6221-2015; Wohl, Shirlee/0000-0002-0311-3348; Garry,
   Robert/0000-0002-5683-3250
FU European UnionEuropean Union (EU) [278433-PREDEMICS, 643476-COMPARE,
   634650-VIROGENESIS, 666100-EVIDENT]; ERCEuropean Research Council (ERC)
   [260864]; European CommissionEuropean Commission Joint Research Centre
   [IFS/2011/272-372]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI107034, R01 AI117011, R01 HG006139]; National Science
   FoundationNational Science Foundation (NSF) [IIS 1251151, DMS 1264153];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI081982, AI082119, AI082805 AI088843,
   AI104216, AI104621, AI115754, HSN272200900049C, HHSN272201400048C, R35
   GM119774-01, 1U01HG007480-01, UL1TR001114]; National Health & Medical
   Research Council (Australia)National Health and Medical Research Council
   of Australia; Defense Threat Reduction AgencyUnited States Department of
   DefenseDefense Threat Reduction Agency; Global Emerging Infections
   System and the Targeted Acquisition of Reference Materials Augmenting
   Capabilities (TARMAC) Initiative agencies from the US Department of
   Defense; Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1106427, 1032350, OPP1134076, OPP1123407]; Wellcome
   TrustWellcome Trust [106866/Z/15/Z]; Clinton Health Access Initiative;
   National Institute for Health Research Health Protection Research Unit
   in Emerging and Zoonotic Infections; Ministry of Science and Technology
   of ChinaMinistry of Science and Technology, China [2016YFC1200800];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81590760, 81321063]; Mahan Post-doctoral
   fellowship Fred Hutchinson Cancer Research Center; National Institute of
   Allergy and Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI110818, 5R01AI114855-03];
   United States Agency for International DevelopmentUnited States Agency
   for International Development (USAID) [OAA-G-15-00001]; World BankThe
   World Bank India [ACE019]; PEW Biomedical Scholarship; NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272201400048C, HHSN272200700016I]
FX The authors acknowledge support from: European Union Seventh Framework
   278433-PREDEMICS (P.L., A.R.) and ERC 260864 (P.L., A.R., M.A.S.)
   European Union Horizon 2020 643476-COMPARE (M.P.G.K., A.R.),
   634650-VIROGENESIS (P.L., M.P.G.K.), 666100-EVIDENT and European
   Commission IFS/2011/272-372, EMLab (S.G.), National Institutes of Health
   R01 AI107034, R01 AI117011 and R01 HG006139 and National Science
   Foundation IIS 1251151 and DMS 1264153 (M.A.S.), NIH AI081982, AI082119,
   AI082805 AI088843, AI104216, AI104621, AI115754, HSN272200900049C,
   HHSN272201400048C (R.F.G.), NIH R35 GM119774-01 (T.B.) National Health &
   Medical Research Council (Australia) (E.C.H.). The Research Foundation -
   Flanders G0D5117N (G.B., P.L.), Work in Liberia was funded by the
   Defense Threat Reduction Agency, the Global Emerging Infections System
   and the Targeted Acquisition of Reference Materials Augmenting
   Capabilities (TARMAC) Initiative agencies from the US Department of
   Defense (G.Pa.), Bill and Melinda Gates Foundation OPP1106427, 1032350,
   OPP1134076, Wellcome Trust 106866/Z/15/Z, Clinton Health Access
   Initiative (A.J.T.), National Institute for Health Research Health
   Protection Research Unit in Emerging and Zoonotic Infections (J.A.H.),
   Key Research and Development Program from the Ministry of Science and
   Technology of China 2016YFC1200800 (D.L.), National Natural Science
   Foundation of China 81590760 and 81321063 (G.F.G.), Mahan Post-doctoral
   fellowship Fred Hutchinson Cancer Research Center (G.D.), National
   Institute of Allergy and Infectious Disease U19AI110818,
   5R01AI114855-03, United States Agency for International Development
   OAA-G-15-00001 and the Bill and Melinda Gates Foundation OPP1123407
   (P.C.S.), NIH 1U01HG007480-01 and the World Bank ACE019 (C.T.H.), PEW
   Biomedical Scholarship, NIH UL1TR001114, and NIAID contract
   HHSN272201400048C (K.G.A.). J.H.K., an employee of Tunnell Government
   Services, Inc., is a subcontractor under Battelle Memorial Institute's
   prime contract with the NIAID (contract HHSN272200700016I).
   Colour-blind-friendly colour palettes were designed by C. Brewer,
   Pennsylvania State University (http://colorbrewer2.org). Matplotlib
   (http://matplotlib.org) was used extensively throughout this article for
   data visualisation. We acknowledge support from NVIDIA Corporation with
   the donation of parallel computing resources used for this research.
   Finally, we recognize the contributions made by our colleagues who died
   from Ebola virus disease whilst fighting the epidemic.
CR Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X
   Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056
   Bielejec F, 2014, SYST BIOL, V63, P493, DOI 10.1093/sysbio/syu015
   Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378
   Carpenter JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-75
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7
   Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859
   Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudas Gytis, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253
   Folarin OA, 2016, J INFECT DIS, V214, pS102, DOI 10.1093/infdis/jiw190
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goba A, 2016, J INFECT DIS, V214, pS110, DOI 10.1093/infdis/jiw239
   Goodfellow I, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.12.21074
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522
   Kuhn JH, 2014, VIRUSES-BASEL, V6, P4760, DOI 10.3390/v6114760
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey Philippe, 2009, PLoS Curr, V1, pRRN1031, DOI 10.1371/currents.RRN1031
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   RUEDA P, 1994, VIROLOGY, V198, P653, DOI 10.1006/viro.1994.1077
   Sack K., 2014, EBOLA ROARED BACK
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Smits SL, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES.2015.20.40.30035
   Stadler T., 2014, PLOS CURR, V6, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS
   Togo S, 2015, PAN AFR MED J, V21, DOI 10.11694/pamj.supp.2015.22.1.6109
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Wesolowski A., 2014, PLOS CURR, V6
   Whitmer SLM, 2016, J INFECT DIS, V214, pS333, DOI 10.1093/infdis/jiw177
   WHO, 2016, EB SIT REP
   Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191
   World Health Organization Regional Office for Africa, 2014, EB VIR DIS W AFR SIT
   World-Health-Organisation, 2014, EB RESP ROADM SIT RE
   Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341
   Yang W, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0536
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
NR 57
TC 126
Z9 130
U1 11
U2 100
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD APR 20
PY 2017
VL 544
IS 7650
BP 309
EP +
DI 10.1038/nature22040
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES4SG
UT WOS:000399524400029
PM 28405027
OA Green Accepted, Green Published
DA 2020-09-29
ER

PT J
AU Kraemer, MUG
   Faria, NR
   Reiner, RC
   Golding, N
   Nikolay, B
   Stasse, S
   Johansson, MA
   Salje, H
   Faye, O
   Wint, GRW
   Niedrig, M
   Shearer, FM
   Hill, SC
   Thompson, RN
   Bisanzio, D
   Taveira, N
   Nax, HH
   Pradelski, BSR
   Nsoesie, EO
   Murphy, NR
   Bogoch, II
   Khan, K
   Brownstein, JS
   Tatem, AJ
   de Oliveira, T
   Smith, DL
   Sall, AA
   Pybus, OG
   Hay, SI
   Cauchemez, S
AF Kraemer, Moritz U. G.
   Faria, Nuno R.
   Reiner, Robert C., Jr.
   Golding, Nick
   Nikolay, Birgit
   Stasse, Stephanie
   Johansson, Michael A.
   Salje, Henrik
   Faye, Ousmane
   Wint, G. R. William
   Niedrig, Matthias
   Shearer, Freya M.
   Hill, Sarah C.
   Thompson, Robin N.
   Bisanzio, Donal
   Taveira, Nuno
   Nax, Heinrich H.
   Pradelski, Bary S. R.
   Nsoesie, Elaine O.
   Murphy, Nicholas R.
   Bogoch, Isaac I.
   Khan, Kamran
   Brownstein, John S.
   Tatem, Andrew J.
   de Oliveira, Tulin
   Smith, David L.
   Sall, Amadou A.
   Pybus, Oliver G.
   Hay, Simon I.
   Cauchemez, Simon
TI Spread of yellow fever virus outbreak in Angola and the Democratic
   Republic of the Congo 2015-16: a modelling study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION; INFECTION; DISEASE
AB Background Since late 2015, an epidemic of yellow fever has caused more than 7334 suspected cases in Angola and the Democratic Republic of the Congo, including 393 deaths. We sought to understand the spatial spread of this outbreak to optimise the use of the limited available vaccine stock.
   Methods We jointly analysed datasets describing the epidemic of yellow fever, vector suitability, human demography, and mobility in central Africa to understand and predict the spread of yellow fever virus. We used a standard logistic model to infer the district-specific yellow fever virus infection risk during the course of the epidemic in the region.
   Findings The early spread of yellow fever virus was characterised by fast exponential growth (doubling time of 5-7 days) and fast spatial expansion (49 districts reported cases after only 3 months) from Luanda, the capital of Angola. Early invasion was positively correlated with high population density (Pearson's r 0.52,95% CI 0.34-0.66). The further away locations were from Luanda, the later the date of invasion (Pearson's r 0.60, 95% CI 0.52-0.66). In a Cox model, we noted that districts with higher population densities also had higher risks of sustained transmission (the hazard ratio for cases ceasing was 0.74, 95% CI 0 43-0 . 92 per log-unit increase in the population size of a district). A model that captured human mobility and vector suitability successfully discriminated districts with high risk of invasion from others with a lower risk (area under the curve 0.94, 95% CI 0.92-0.97). If at the start of the epidemic, sufficient vaccines had been available to target 50 out of 313 districts in the area, our model would have correctly identified 27 (84%) of the 32 districts that were eventually affected.
   Interpretation Our findings show the contributions of ecological and demographic factors to the ongoing spread of the yellow fever outbreak and provide estimates of the areas that could be prioritised for vaccination, although other constraints such as vaccine supply and delivery need to be accounted for before such insights can be translated into policy. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
C1 [Kraemer, Moritz U. G.; Faria, Nuno R.; Hill, Sarah C.; Thompson, Robin N.; Bisanzio, Donal; Smith, David L.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Reiner, Robert C., Jr.; Nsoesie, Elaine O.; Smith, David L.; Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Golding, Nick; Shearer, Freya M.; Hay, Simon I.] Oxford Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.
   [Golding, Nick] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia.
   [Nikolay, Birgit; Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Nikolay, Birgit; Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Nikolay, Birgit; Salje, Henrik; Cauchemez, Simon] CNRS, URA 3012, Paris, France.
   [Stasse, Stephanie] European Commiss, Hlth Programme, Int Cooperat & Dev, Delegat RDC, Kinshasa, DEM REP CONGO.
   [Brownstein, John S.] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Johansson, Michael A.] Harvard Univ, Sch Med, Ctr Communicable Dis Dynam, Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Salje, Henrik] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MO USA.
   [Faye, Ousmane; Sall, Amadou A.] Inst Pasteur, Arbovirus & Viral Hemorrhag Fever Unit, Dakar, Senegal.
   [Wint, G. R. William] Environm Res Grp Oxford, Dept Zool, Oxford, England.
   [Niedrig, Matthias] Robert Koch Inst, Berlin, Germany.
   [Taveira, Nuno] Univ Lisbon, Res Inst Med iMed ULisboa, Fac Pharm, P-1699 Lisbon, Portugal.
   [Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, Caparica, Portugal.
   [Nax, Heinrich H.; Pradelski, Bary S. R.] ETH, Computat Social Sci, Zurich, Switzerland.
   [Murphy, Nicholas R.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
   [Bogoch, Isaac I.] Univ Hlth Network, Toronto Gen Hosp, Div Gen Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, WorldPop, Southampton, Hants, England.
   [Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden.
   [de Oliveira, Tulin] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Nelson R Mandela Sch Med, Coll Hlth Sci, Durban, South Africa.
   [Smith, David L.] Sanaria Inst Global Hlth & Trop Med, Rockville, MD USA.
RP Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM moritz.kraemer@zoo.ox.ac.uk
RI Smith, David L/L-8850-2013; Hay, Simon I/F-8967-2015; Taveira,
   Nuno/A-6252-2014; Faria, Nuno R/I-2975-2012; iMed.ULisboa,
   EEPHIV/B-4222-2014; Bogoch, Isaac/AAS-9631-2020; Pybus, Oliver
   G/B-2640-2012
OI Smith, David L/0000-0003-4367-3849; Hay, Simon I/0000-0002-0611-7272;
   Taveira, Nuno/0000-0003-0176-5585; Faria, Nuno R/0000-0001-8839-2798;
   Pybus, Oliver G/0000-0002-8797-2667; Johansson,
   Michael/0000-0002-5090-7722; Salje, Henrik/0000-0003-3626-4254;
   /0000-0003-1261-8134; Hill, Sarah/0000-0002-2995-2596; Golding,
   Nick/0000-0001-8916-5570
FU Wellcome TrustWellcome Trust
FX Wellcome Trust.
CR Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lessler J, 2014, PLOS CURR, DOI [10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369, DOI 10.1371/CURRENTS.OUTBREAKS.C5C9C9ABD636164A9B6FD4DBDA974369.]
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Nsoesie EO, 2015, EUROSURVEILLANCE, V21
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Ruktanonchai NW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004846
   Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Uchida H, AGGLOMERATION INDEX
   Valdez LD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12172
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wesolowski A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004267
   World Health Organization (WHO), 2016, SIT REP YELL FEV
NR 30
TC 75
Z9 78
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2017
VL 17
IS 3
BP 330
EP 338
DI 10.1016/S1473-3099(16)30513-8
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA EL6KX
UT WOS:000394732600042
PM 28017559
OA Other Gold, Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU Wu, J
   Lu, J
   Faria, NR
   Zeng, XQ
   Song, YC
   Zou, LR
   Yi, LN
   Liang, LJ
   Ni, HZ
   Kang, M
   Zhang, X
   Huang, GF
   Zhong, HJ
   Bowden, TA
   Raghwani, J
   He, JF
   He, X
   Lin, JY
   Koopmans, M
   Pybus, OG
   Ke, CW
AF Wu, Jie
   Lu, Jing
   Faria, Nuno R.
   Zeng, Xianqiao
   Song, Yingchao
   Zou, Lirong
   Yi, Lina
   Liang, Lijun
   Ni, Hanzhong
   Kang, Min
   Zhang, Xin
   Huang, Guofeng
   Zhong, Haojie
   Bowden, Thomas A.
   Raghwani, Jayna
   He, Jianfeng
   He, Xiang
   Lin, Jinyan
   Koopmans, Marion
   Pybus, Oliver G.
   Ke, Changwen
TI Effect of Live Poultry Market Interventions on Influenza A(H7N9) Virus,
   Guangdong, China
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID A H7N9 VIRUS; AVIAN INFLUENZA; HUMAN INFECTION; SUBSTITUTION; PROVINCE;
   CLOSURE; MODELS; ORIGIN
AB Since March 2013, three waves of human infection with avian influenza A(H7N9) virus have been detected in China. To investigate virus transmission within and across epidemic waves, we used surveillance data and whole-genome analysis of viruses sampled in Guangdong during 2013-2015. We observed a geographic shift of human A(H7N9) infections from the second to the third waves. Live poultry market interventions were undertaken in epicenter cities; however, spatial phylogenetic analysis indicated that the third-wave outbreaks in central Guangdong most likely resulted from local virus persistence rather than introduction from elsewhere. Although the number of clinical cases in humans declined by 35% from the second to the third waves, the genetic diversity of third-wave viruses in Guangdong increased. Our results highlight the epidemic risk to a region reporting comparatively few A(H7N9) cases. Moreover, our results suggest that live-poultry market interventions cannot completely halt A(H7N9) virus persistence and dissemination.
C1 [Wu, Jie; Lu, Jing; Zeng, Xianqiao; Song, Yingchao; Zou, Lirong; Yi, Lina; Liang, Lijun; Ni, Hanzhong; Kang, Min; Zhang, Xin; Huang, Guofeng; Zhong, Haojie; He, Jianfeng; He, Xiang; Lin, Jinyan; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou, Guangdong, Peoples R China.
   [Lu, Jing; Faria, Nuno R.; Bowden, Thomas A.; Raghwani, Jayna; Pybus, Oliver G.] Univ Oxford, Oxford, England.
   [Koopmans, Marion] Erasmus MC, Rotterdam, Netherlands.
RP Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou, Guangdong, Peoples R China.
EM kecw1965@aliyun.com
RI Pybus, Oliver G/B-2640-2012; Koopmans, Marion/Y-9170-2019; He,
   Xiang/E-7082-2013; Faria, Nuno R/I-2975-2012
OI Pybus, Oliver G/0000-0002-8797-2667; Koopmans,
   Marion/0000-0002-5204-2312; He, Xiang/0000-0003-2428-5349; Faria, Nuno
   R/0000-0001-8839-2798; Raghwani, Jayna/0000-0001-8538-4995; Bowden,
   Thomas/0000-0002-8066-8785
FU Research Project of H7N9 Influenza of Guangdong [1046]; Scientific,
   Technological Research of Prevention and Control of H7N9 Subtype Avian
   Influenza Virus [20140024]; China Scholarship CouncilChina Scholarship
   Council [201508440009]; Medical Research CouncilMedical Research Council
   UK (MRC) [MR/L009528/1] Funding Source: Researchfish
FX This work was supported by grants from the Research Project of H7N9
   Influenza of Guangdong [2014] (no. 1046), the Scientific, Technological
   Research of Prevention and Control of H7N9 Subtype Avian Influenza Virus
   (20140024), and China Scholarship Council (grant no. 201508440009).
CR Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Kang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126335
   Ke CW, 2014, EMERG INFECT DIS, V20, P2034, DOI 10.3201/eid2012.140765
   Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617
   Lu J, 2014, J VIROL, V88, P8297, DOI 10.1128/JVI.00630-14
   Peiris JSM, 2016, LANCET INFECT DIS, V16, P252, DOI 10.1016/S1473-3099(15)00502-2
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3
   Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Trock SC, 2008, AVIAN DIS, V52, P160, DOI 10.1637/7980-040607-Reg
   Wu J, 2015, J INFECTION, V71, P690, DOI 10.1016/j.jinf.2015.08.007
   Wu P, 2014, EMERG INFECT DIS, V20, P1891, DOI 10.3201/eid2011.140556
   Yi LN, 2015, J CLIN MICROBIOL, V53, P22, DOI 10.1128/JCM.02322-14
   Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2
   Yuan J, 2015, EMERG INFECT DIS, V21, P1784, DOI 10.3201/eid2110.150623
NR 25
TC 17
Z9 19
U1 1
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2016
VL 22
IS 12
BP 2104
EP 2112
DI 10.3201/eid2212.160450
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ED5SP
UT WOS:000388912900009
PM 27869613
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Dellicour, S
   Rose, R
   Faria, NR
   Lemey, P
   Pybus, OG
AF Dellicour, Simon
   Rose, Rebecca
   Faria, Nuno R.
   Lemey, Philippe
   Pybus, Oliver G.
TI SERAPHIM: studying environmental rasters and phylogenetically informed
   movements
SO BIOINFORMATICS
LA English
DT Article
AB SERAPHIM ("Studying Environmental Rasters and PHylogenetically Informed Movements") is a suite of computational methods developed to study phylogenetic reconstructions of spatial movement in an environmental context. SERAPHIM extracts the spatio-temporal information contained in estimated phylogenetic trees and uses this information to calculate summary statistics of spatial spread and to visualize dispersal history. Most importantly, SERAPHIM enables users to study the impact of customized environmental variables on the spread of the study organism. Specifically, given an environmental raster, SERAPHIM computes environmental "weights" for each phylogeny branch, which represent the degree to which the environmental variable impedes (or facilitates) lineage movement. Correlations between movement duration and these environmental weights are then assessed, and the statistical significances of these correlations are evaluated using null distributions generated by a randomization procedure. SERAPHIM can be applied to any phylogeny whose nodes are annotated with spatial and temporal information. At present, such phylogenies are most often found in the field of emerging infectious diseases, but will become increasingly common in other biological disciplines as population genomic data grows.
   Availability and Implementation: SERAPHIM 1.0 is freely available from http://evolve.zoo.ox.ac.uk/. R package, source code, example files, tutorials and a manual are also available from this website.
C1 [Dellicour, Simon; Lemey, Philippe] Univ Leuven, KU Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol & Immunol, Minderbroedersstaat 10, B-3000 Leuven, Belgium.
   [Rose, Rebecca] BioInfoExperts LLC, Norfolk, VA 23518 USA.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Dellicour, S (corresponding author), Univ Leuven, KU Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol & Immunol, Minderbroedersstaat 10, B-3000 Leuven, Belgium.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM simon.dellicour@kuleuven.be; oliver.pybus@zoo.ox.ac.uk
RI Dellicour, Simon/AAE-9054-2020; Lemey, Philippe/C-3755-2018; Pybus,
   Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012
OI Dellicour, Simon/0000-0001-9558-1052; Lemey,
   Philippe/0000-0003-2826-5353; Pybus, Oliver G/0000-0002-8797-2667;
   Faria, Nuno R/0000-0001-8839-2798
FU Wiener-Anspach Foundation; Fonds Wetenschappelijk Onderzoek (FWO,
   Flanders, Belgium)FWO; Medical Research Council under a Methodology
   Research Fellowship [99204]; European Union's Horizon research and
   innovation programme [634650-VIROGENESIS]; European Research Council
   under the European Community's Seventh Framework Programme (FP7)
   [278433-PREDEMICS]; European Research Council under the European Union's
   Seventh Framework Programme (FP7)/ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN]; ERCEuropean Research Council (ERC)
   [260864-ViralPhylogeography]
FX This work was funded by the Wiener-Anspach Foundation. S.D. is a
   post-doctoral research fellow funded by the Fonds Wetenschappelijk
   Onderzoek (FWO, Flanders, Belgium). R.R. received funding from the
   Medical Research Council under a Methodology Research Fellowship grant
   agreement no. 99204, and from the European Union's Horizon 2020 research
   and innovation programme under grant agreement 634650-VIROGENESIS. P.L.
   acknowledges funding from the European Research Council under the
   European Community's Seventh Framework Programme (FP7/2007-2013) under
   Grant Agreement no. 278433-PREDEMICS and ERC Grant agreement no.
   260864-ViralPhylogeography. OGP received funding from the European
   Research Council under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant agreement no. 614725-PATHPHYLODYN.
CR Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   Dellicour S, 2016, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-016-0924-x
   DIJKSTRA EW, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0196
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761
   McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   R Core Team, 2016, R LANG ENV STAT COMP
   Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x
   Trovao NS, 2015, MOL BIOL EVOL, V32, P3264, DOI 10.1093/molbev/msv185
NR 16
TC 24
Z9 24
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD OCT 15
PY 2016
VL 32
IS 20
BP 3204
EP 3206
DI 10.1093/bioinformatics/btw384
PG 3
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA DZ7CD
UT WOS:000386020700022
PM 27334476
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Naccache, SN
   Theze, J
   Sardi, SI
   Somasekar, S
   Greninger, AL
   Bandeira, AC
   Campos, GS
   Tauro, LB
   Faria, NR
   Pybus, OG
   Chiu, CY
AF Naccache, Samia N.
   Theze, Julien
   Sardi, Silvia I.
   Somasekar, Sneha
   Greninger, Alexander L.
   Bandeira, Antonio C.
   Campos, Gubio S.
   Tauro, Laura B.
   Faria, Nuno R.
   Pybus, Oliver G.
   Chiu, Charles Y.
TI Distinct Zika Virus Lineage in Salvador, Bahia, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OUTBREAK
AB Sequencing of isolates from patients in Bahia, Brazil, where most Zika virus cases in Brazil have been reported, resulted in 11 whole and partial Zika virus genomes. Phylogenetic analyses revealed a well-supported Bahia-specific Zika virus lineage, which indicates sustained Zika virus circulation in Salvador, Bahia's capital city, since mid-2014.
C1 [Naccache, Samia N.; Somasekar, Sneha; Chiu, Charles Y.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Naccache, Samia N.; Somasekar, Sneha; Chiu, Charles Y.] Univ Calif San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.
   [Theze, Julien; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Oxford, England.
   [Sardi, Silvia I.; Campos, Gubio S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Greninger, Alexander L.] Univ Washington, Seattle, WA 98195 USA.
   [Bandeira, Antonio C.] Hosp Alianca, Salvador, BA, Brazil.
   [Tauro, Laura B.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Faria, Nuno R.] Evandro Chagas Inst, Ananindeua, Brazil.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, UCSF China Basin, 185 Berry St,Box 0134, San Francisco, CA 94107 USA.
EM charles.chiu@ucsf.edu
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; sardi, silvia
   ines/P-9349-2016
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   sardi, silvia ines/0000-0002-2002-8436; Greninger,
   Alexander/0000-0002-7443-0527
FU Fundacao de Amparo a Pesquisa do Estado da Bahia; European Research
   Council under the European Union's Seventh Framework Program (FP7)/ERC
   [614725-PATHPHYLODYN]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01-HL105704, R21-AI120977]; Abbott Laboratories, Inc.Abbott
   Laboratories; American people through the United States Agency for
   International Development Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]
FX This study was supported in part by Fundacao de Amparo a Pesquisa do
   Estado da Bahia, the European Research Council under the European
   Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement
   no. 614725-PATHPHYLODYN, National Institutes of Health grants
   R01-HL105704 and R21-AI120977 (C.Y.C.), and a viral discovery award from
   Abbott Laboratories, Inc. (C.Y.C.). This study was made possible by the
   generous support of the American people through the United States Agency
   for International Development Emerging Pandemic Threats Program-2
   PREDICT-2 (Cooperative Agreement No. AID-OAA-A-14-00102).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sardi SI, 2016, J CLIN MICROBIOL IN
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 26
Z9 27
U1 1
U2 24
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2016
VL 22
IS 10
BP 1788
EP 1792
DI 10.3201/eid2210.160663
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DX4YQ
UT WOS:000384387400013
PM 27448188
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Rose, R
   Lamers, SL
   Nolan, DJ
   Maidji, E
   Faria, NR
   Pybus, OG
   Dollar, JJ
   Maruniak, SA
   McAvoy, AC
   Salemi, M
   Stoddart, CA
   Singer, EJ
   McGrath, MS
AF Rose, Rebecca
   Lamers, Susanna L.
   Nolan, David J.
   Maidji, Ekaterina
   Faria, N. R.
   Pybus, Oliver G.
   Dollar, James J.
   Maruniak, Samuel A.
   McAvoy, Andrew C.
   Salemi, Marco
   Stoddart, Cheryl A.
   Singer, Elyse J.
   McGrath, Michael S.
TI HIV Maintains an Evolving and Dispersed Population in Multiple Tissues
   during Suppressive Combined Antiretroviral Therapy in Individuals with
   Cancer
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-LIKE PROPERTIES; CD4(+) T-CELLS;
   HOMEOSTATIC PROLIFERATION; MACROPHAGE POLARIZATION; MAXIMUM-LIKELIHOOD;
   TUMOR PROGRESSION; INFECTED PATIENTS; RESERVOIR; PERSISTENCE
AB While combined antiretroviral therapy (cART) can result in undetectable plasma viral loads, it does not eradicate HIV infection. Furthermore, HIV-infected individuals while on cART remain at an increased risk of developing serious comorbidities, such as cancer, neurological disease, and atherosclerosis, suggesting that during cART, tissue-based HIV may contribute to such pathologies. We obtained DNA and RNA env, nef, and pol sequences using single-genome sequencing from postmortem tissues of three HIV+ cART-treated (cART(+)) individuals with undetectable viral load and metastatic cancer at death and performed time-scaled Bayesian evolutionary analyses. We used a sensitive in situ hybridization technique to visualize HIV gag-pol mRNA transcripts in cerebellum and lymph node tissues from one patient. Tissue-associated virus evolved at similar rates in cART(+) and cART-naive (cART(-)) patients. Phylogenetic trees were characterized by two distinct features: (i) branching patterns consistent with constant viral evolution and dispersal among tissues and (ii) very recently derived clades containing both DNA and RNA sequences from multiple tissues. Rapid expansion of virus near death corresponded to wide-spread metastasis. HIV RNA(+) cells clustered in cerebellum tissue but were dispersed in lymph node tissue, mirroring the evolutionary patterns observed for that patient. Activated, infiltrating macrophages were associated with HIV RNA. Our data provide evidence that tissues serve as a sanctuary for wild-type HIV during cART and suggest the importance of macrophages as an alternative reservoir and mechanism of virus spread.
   IMPORTANCE
   Combined antiretroviral therapy (cART) reduces plasma HIV to undetectable levels; however, removal of cART results in plasma HIV rebound, thus highlighting its inability to entirely rid the body of infection. Additionally, HIV-infected individuals on cART remain at high risk of serious diseases, which suggests a contribution from residual HIV. In this study, we isolated and sequenced HIV from postmortem tissues from three HIV+ cART(+) individuals who died with metastatic cancer and had no detectable plasma viral load. Using high-resolution evolutionary analyses, we found that tissue-based HIV continues to replicate, evolve, and migrate among tissues during cART. Furthermore, cancer onset and metastasis coincided with increased HIV expansion, suggesting a linked mechanism. HIV-expressing cells were associated with tissue macrophages, a target of HIV infection. Our results suggest the importance of tissues, and macrophages in particular, as a target for novel anti-HIV therapies.
C1 [Rose, Rebecca; Lamers, Susanna L.; Nolan, David J.] Bioinfoexperts LLC, Thibodaux, LA USA.
   [Nolan, David J.; Dollar, James J.; Maruniak, Samuel A.; McAvoy, Andrew C.; Salemi, Marco] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA.
   [Nolan, David J.; Dollar, James J.; Maruniak, Samuel A.; McAvoy, Andrew C.; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Maidji, Ekaterina; Stoddart, Cheryl A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Faria, N. R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Singer, Elyse J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Natl Neurol AIDS Bank, Los Angeles, CA 90095 USA.
   [McGrath, Michael S.] Univ Calif San Francisco, AIDS & Canc Specimen Resource, San Francisco, CA 94143 USA.
   [McGrath, Michael S.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [McGrath, Michael S.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.
   [McGrath, Michael S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
RP McGrath, MS (corresponding author), Univ Calif San Francisco, AIDS & Canc Specimen Resource, San Francisco, CA 94143 USA.; McGrath, MS (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; McGrath, MS (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.; McGrath, MS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
EM MMcGrath@php.ucsf.edu
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   McAvoy, Andrew/0000-0002-3647-3956
FU HHS \ NIH \ National Cancer Institute (NCI) [UM1 CA181255]; HHS \ NIH \
   National Institute of Mental Health (NIMH) [NIH R01 MH100984, NIMH
   U24MH100929]
FX This work, including the efforts of Ekaterina Maidji, Cheryl A.
   Stoddart, Elyse J. Singer, and Michael S. McGrath, was funded by HHS
   vertical bar NIH vertical bar National Cancer Institute (NCI) (UM1
   CA181255). This work, including the efforts of Rebecca Rose, Susanna L.
   Lamers, David J. Nolan, Marco Salemi, and Michael S. McGrath, was funded
   by HHS vertical bar NIH vertical bar National Institute of Mental Health
   (NIMH) (NIH R01 MH100984). This work, including the efforts of Elyse J.
   Singer, was funded by HHS vertical bar NIH vertical bar National
   Institute of Mental Health (NIMH) (NIMH U24MH100929).
CR Ahr Barbara, 2004, Retrovirology, V1, P12, DOI 10.1186/1742-4690-1-12
   Alfano M, 2013, ARTERIOSCL THROM VAS, V33, P1145, DOI 10.1161/ATVBAHA.112.300171
   Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123
   Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11
   Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950
   Bonnet F, 2009, CLIN INFECT DIS, V48, P633, DOI 10.1086/596766
   Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445
   Cha L, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.1
   Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972
   Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0
   Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duncan CJA, 2014, J VIROL, V88, P2025, DOI 10.1128/JVI.03245-13
   Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326
   Finzi D, 1999, NAT MED, V5, P512
   Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295
   Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111
   Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446
   Gavegnano C, 2013, ANTIMICROB AGENTS CH, V57, P1262, DOI 10.1128/AAC.02012-12
   Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374
   GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428
   Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283
   Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542
   Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070
   Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6
   Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110
   Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010
   Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242
   Kumar A, 2014, VIRUSES-BASEL, V6, P1837, DOI 10.3390/v6041837
   Lamers SL, 2015, J NEUROVIROL
   Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16
   Lamers SL, 2010, J NEUROVIROL, V16, P230, DOI 10.3109/13550281003735709
   Lemey P, 2006, AIDS REV, V8, P125
   Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194
   Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251
   Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010
   Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005
   Palmer S, 1999, AIDS, V13, P661, DOI 10.1097/00002030-199904160-00006
   Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014
   Salemi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008153
   Schinazi RF, 2010, J VIRAL HEPATITIS, V17, P77, DOI 10.1111/j.1365-2893.2009.01246.x
   Shafer RW, 2000, J VIROL METHODS, V86, P143, DOI 10.1016/S0166-0934(00)00144-0
   Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707
   Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004
   Simard EP, 2010, CLIN INFECT DIS, V51, P957, DOI 10.1086/656416
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304
   Zhang JY, 2010, J VIROL, V84, P12336, DOI 10.1128/JVI.01228-10
   Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845
NR 55
TC 17
Z9 17
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2016
VL 90
IS 20
BP 8984
EP 8993
DI 10.1128/JVI.00684-16
PG 10
WC Virology
SC Virology
GA DX7NO
UT WOS:000384574900034
PM 27466425
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Faria, NR
   Sabino, EC
   Nunes, MRT
   Alcantara, LC
   Loman, NJ
   Pybus, OG
AF Faria, Nuno Rodrigues
   Sabino, Ester C.
   Nunes, Marcio R. T.
   Junior Alcantara, Luiz Carlos
   Loman, Nicholas J.
   Pybus, Oliver G.
TI Mobile real-time surveillance of Zika virus in Brazil
SO GENOME MEDICINE
LA English
DT Article
C1 [Faria, Nuno Rodrigues; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Junior Alcantara, Luiz Carlos] Oswaldo Cruz Fdn FIOCRUZ, BR-40296710 Salvador, BA, Brazil.
   [Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
RP Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
EM n.j.loman@bham.ac.uk
RI Faria, Nuno R/I-2975-2012; Sabino, Ester Cerdeira/F-7750-2010; Loman,
   Nicholas/Z-1573-2019; Pybus, Oliver G/B-2640-2012
OI Faria, Nuno R/0000-0001-8839-2798; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Pybus, Oliver G/0000-0002-8797-2667;
   Loman, Nicholas/0000-0002-9843-8988; Alcantara, Luiz/0000-0002-6769-9931
FU Medical Research Council/Wellcome Trust/Newton Fund Zika Rapid Response
   Initiative [ZK/16-078]; Medical Research Council Bioinformatics
   Fellowship, Cloud Infrastructure for Microbial Bioinformatics (CLIMB)
   project; Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15100, MR/L015080/1, MR/M501621/1] Funding Source: Researchfish
FX We are grateful to Wanderson Kleber de Oliveira (Coordinator of the
   Surveillance and Response Program to Public Health Emergencies (CGVR),
   Brazilian Ministry of Health), Giovanini Evelim Coelho and Livia Carla
   Vinhal Frutuoso (National Control of Dengue (PNCD), Brazilian Ministry
   of Health), Mariana Pastorello Verotti (Coordinator of the Central
   Laboratories of Public Health (CGLAB), Brazilian Ministry of Health),
   Eduardo Hage Carmo and Claudio Maerovich (Department of Infectious
   Disease Surveillance (DEVIT), Brazilian Ministry of Health). The ZiBRA
   project is supported by the Medical Research Council/Wellcome
   Trust/Newton Fund Zika Rapid Response Initiative (grant number
   ZK/16-078). NJL is supported by a Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   World Health Organization, 2016, WHO ZIK VIR SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 71
Z9 72
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-994X
J9 GENOME MED
JI Genome Med.
PD SEP 29
PY 2016
VL 8
AR 97
DI 10.1186/s13073-016-0356-2
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA DX4UM
UT WOS:000384376600001
PM 27683027
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Born, PS
   Siqueira, MM
   Faria, NR
   Resende, PC
   Motta, FC
   Bello, G
AF Born, Priscila Silva
   Siqueira, Marilda Mendonca
   Faria, Nuno Rodrigues
   Resende, Paola Cristina
   Motta, Fernando Couto
   Bello, Gonzalo
TI Phylodynamics of influenza A(H3N2) in South America, 1999-2012
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Influenza A; H3N2; Viral evolution; Phylogeography; South America
ID PHYLOGENETIC INFERENCE; EVOLUTIONARY DYNAMICS; GLOBAL CIRCULATION;
   MAXIMUM-LIKELIHOOD; WEB SERVER; CD-HIT; VIRUS; SEASONALITY; SEQUENCES;
   TROPICS
AB The limited influenza A(H3N2) genetic data available from the Southern Hemisphere (particularly from Africa and Latin America), constrains the accurate reconstruction of viral dissemination dynamics within those regions. Our objective was to describe the spatial dissemination dynamics of influenza A(H3N2) within South America. A total of 469 sequences of the HA1 portion of the hemagglutinin gene (HA) from influenza A(H3N2) viruses sampled in temperate and tropical South American countries between 1999 and 2012 were combined with available contemporary sequences from Australia, Hong Kong, United Kingdom and the United States. Phylogenetic analyses revealed that influenza A(H3N2) sequences from South America were highly intermixed with sequences from other geographical regions, although a clear geographic virus population structure was detected globally. We identified 14 clades mostly (>= 80%) composed of influenza sequences from South American countries. Bayesian phylogeographic analyses of those clades support a significant role of both temperate and tropical regions in the introduction and dissemination of new influenza A(H3N2) strains within South America and identify an intensive bidirectional viral exchange between different geographical areas. These findings indicate that seasonal influenza A(H3N2) epidemics in South America are seeded by both the continuous importation of viral variants from other geographic regions and the short-term persistence of local lineages. This study also supports a complex metapopulation model of influenza A(H3N2) dissemination in South America, with no preferential direction in viral movement between temperate and tropical regions. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Born, Priscila Silva; Siqueira, Marilda Mendonca; Resende, Paola Cristina; Motta, Fernando Couto] Fiocruz MS, Inst Oswaldo Cruz, Resp Viruses & Measles Lab, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, AIDS & Mol Immunol Lab, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Born, PS (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Resp Viruses & Measles Lab, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM psborn@ioc.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Bentancor, Gonzalo Jose Bello/N-7377-2019;
   Bello, Gonzalo/E-6842-2013
OI Faria, Nuno R/0000-0001-8839-2798; Bentancor, Gonzalo Jose
   Bello/0000-0002-2724-2793; 
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400150/2011-5]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [112.654/2012];
   Decit/SCTIE/MS [TC 1812009]
FX We thank Dr. David Brown for critical review of the manuscript. We also
   gratefully acknowledge the authors, originating and submitting
   laboratories of the sequences from GISAID's EpiFlu Database, which we
   used for this research. All submitters of data may be contacted directly
   via the GISAID website www.gisaid.org. This work was supported by the
   CNPq (grant 400150/2011-5), FAPERJ (grant 112.654/2012) and
   Decit/SCTIE/MS (grant TC 1812009).
CR ACI, 2012, AIRP COUNC INT ACI W
   Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012
   Ann J, 2012, J CLIN VIROL, V53, P88, DOI 10.1016/j.jcv.2011.09.016
   Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108
   Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460
   Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914
   Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a
   Chan J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001005
   Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905
   de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2002, GENETICS, V161, P1307
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270
   Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712
   Galiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033166
   Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003
   KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922
   Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955
   Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180
   Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125
   Palese PS, 2007, FIELDS VIROLOGY, P1647
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Pollett S, 2015, EMERG INFECT DIS, V21, P1330, DOI 10.3201/eid2108.150084
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A, 2009, FIGTREE V1 4 TREE FI
   Rambaut A, 2007, TRACER V1 5
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001
NR 50
TC 1
Z9 1
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2016
VL 43
BP 312
EP 320
DI 10.1016/j.meegid.2016.06.012
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DR1YP
UT WOS:000379701100042
PM 27275847
DA 2020-09-29
ER

PT J
AU Lu, J
   Fang, L
   Zheng, HY
   Lao, JQ
   Yang, F
   Sun, LM
   Xiao, JP
   Lin, JY
   Song, T
   Ni, T
   Raghwani, J
   Ke, CW
   Faria, NR
   Bowden, TA
   Pybus, OG
   Li, H
AF Lu, Jing
   Fang, Lin
   Zheng, Huanying
   Lao, Jiaqian
   Yang, Fen
   Sun, Limei
   Xiao, Jianpeng
   Lin, Jinyan
   Song, Tie
   Ni, Tao
   Raghwani, Jayna
   Ke, Changwen
   Faria, Nuno R.
   Bowden, Thomas A.
   Pybus, Oliver G.
   Li, Hui
TI The Evolution and Transmission of Epidemic GII.17 Noroviruses
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE norovirus; phylogenetic; phylogeographic; epidemic; virus transmission
ID HUMAN-POPULATIONS; EMERGENCE; CHINA; VARIANT; GASTROENTERITIS;
   PREDOMINANCE; PERSISTENCE; MECHANISMS; SEQUENCES; ORIGIN
AB Background. In recent decades, the GII.4 norovirus genotype has predominated in epidemics worldwide and been associated with an increased rate of evolutionary change. In 2014, a novel GII.17 variant emerged and persisted, causing large outbreaks of gastroenteritis in China and sporadic infections globally. The origin, evolution, and transmission history of this new variant are largely unknown.
   Methods. We generated 103 full capsid and 8 whole-genome sequences of GII.17 strains collected between August 2013 and November 2015 in Guangdong, China. Phylogenetic analyses were performed by integrating our data with those for all publically available GII.17 sequences.
   Results. The novel emergent lineage GII.17_Kawasaki_2014 most likely originated from Africa around 2001 and evolved at a rate of 5.6 x 10(-3) substitutions/site/year. Within this lineage, a new variant containing several important amino acid changes emerged around August 2013 and caused extensive epidemics in 2014-2015. The phylodynamic and epidemic history of the GII.17_Kawasaki lineage shows similarities with the pattern observed for GII.4 norovirus evolution. Virus movements from Hong Kong to neighboring coastal cities were frequently observed.
   Conclusions. Our results provide new insights into GII.17 norovirus evolution and transmission and highlight the potential for a rare norovirus genotype to rapidly replace existing strains and cause local epidemics.
C1 [Lu, Jing; Fang, Lin; Zheng, Huanying; Lao, Jiaqian; Yang, Fen; Sun, Limei; Xiao, Jianpeng; Lin, Jinyan; Song, Tie; Ke, Changwen; Li, Hui] Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou, Guangdong, Peoples R China.
   [Lu, Jing; Xiao, Jianpeng] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Lu, Jing; Raghwani, Jayna; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [Ni, Tao; Bowden, Thomas A.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX1 2JD, England.
RP Li, H (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou, Guangdong, Peoples R China.
EM gdcdclihui@163.com
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Bowden, Thomas/0000-0002-8066-8785; Raghwani, Jayna/0000-0001-8538-4995
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81501754]; Natural Science Foundation of
   Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2015A030313709]; Science and Technology Planning Project of
   Guangdong Province [2014A020212243]; China Scholarship CouncilChina
   Scholarship Council [201508440009]; Medical Research CouncilMedical
   Research Council UK (MRC) [MPJL009528/1]; Wellcome TrustWellcome Trust
   [090532/Z/09/Z]; European Research Council under the European
   UnionEuropean Research Council (ERC) [614725-PATHPHYLODYN]; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L009528/1] Funding
   Source: Researchfish
FX This work was supported by the National Natural Science Foundation of
   China (grant 81501754), the Natural Science Foundation of Guangdong
   Province (grant 2015A030313709), the Science and Technology Planning
   Project of Guangdong Province (grant 2014A020212243), the China
   Scholarship Council (grant 201508440009), the Medical Research Council
   (grant MPJL009528/1), the Wellcome Trust (grant 090532/Z/09/Z), and the
   European Research Council, under the European Union's Seventh Framework
   Programme (FP7/2007-2013/ERC grant 614725-PATHPHYLODYN to O. G. P.)
CR Ayukekbong J, 2011, J MED VIROL, V83, P2135, DOI 10.1002/jmv.22243
   Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09
   Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08
   Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831
   Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P55
   Chan MCW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10061
   de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178
   Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370
   Dinu S, 2015, EURO SURVEILL, V20
   Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Fu J, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21157
   Gao ZY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1315-z
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Han JK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0370-9
   Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lee CC, 2015, CLIN INFECT DIS, V61, P1762, DOI 10.1093/cid/civ647
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031
   Lu J, 2015, EMERG INFECT DIS, V21, P1240, DOI 10.3201/eid2107.150226
   Mahar JE, 2013, J VIROL, V87, P3687, DOI 10.1128/JVI.03056-12
   Matsushima Y, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.26.21173
   Medici MC, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.35.30010
   Murray TY, 2013, J APPL MICROBIOL, V114, P1843, DOI 10.1111/jam.12167
   Parra GI, 2015, EMERG INFECT DIS, V21, P1477, DOI 10.3201/eid2108.150652
   Rackoff LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059394
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07
   Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884
   Sun Limei, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P615
   van Beek J, 2013, EUROSURVEILLANCE, V18, P8
   Wang X, 2016, J APPL MICROBIOL, V120, P226, DOI 10.1111/jam.12978
NR 37
TC 38
Z9 44
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2016
VL 214
IS 4
BP 556
EP 564
DI 10.1093/infdis/jiw208
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DY1JB
UT WOS:000384849600007
PM 27354370
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Giovanetti, M
   Faria, NR
   Nunes, MRT
   de Vasconcelos, JM
   Lourenco, J
   Rodrigues, SG
   Vianez, JL
   da Silva, SP
   Lemos, PS
   Tavares, FN
   Martin, DP
   do Rosario, MS
   Siqueira, IC
   Ciccozzi, M
   Pybus, OG
   de Oliveira, T
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Teixeira Nunes, Marcio Roberto
   de Vasconcelos, Janaina Mota
   Lourenco, Jose
   Rodrigues, Sueli Guerreiro
   Vianez, Joao Lidio, Jr.
   da Silva, Sandro Patroca
   Lemos, Poliana Silva
   Tavares, Fernando Neto
   Martin, Darren Patrick
   do Rosario, Mateus Santana
   Siqueira, Isadora Cristina
   Ciccozzi, Massimo
   Pybus, Oliver G.
   de Oliveira, Tulio
   Alcantara Junior, Luiz Carlos
TI Zika virus complete genome from Salvador, Bahia, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Full-length sequence; Phylogeny
AB In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Giovanetti, Marta; do Rosario, Mateus Santana; Siqueira, Isadora Cristina; Alcantara Junior, Luiz Carlos] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [Teixeira Nunes, Marcio Roberto; de Vasconcelos, Janaina Mota; Rodrigues, Sueli Guerreiro; Vianez, Joao Lidio, Jr.; Lemos, Poliana Silva; Tavares, Fernando Neto] Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Martin, Darren Patrick] Univ Cape Town, Fac Hlth Sci, Div Computat Biol, ZA-7925 Cape Town, South Africa.
   [do Rosario, Mateus Santana] Hosp Santa Isabel, Salvador, BA, Brazil.
   [Ciccozzi, Massimo] Natl Inst Hlth, Rome, Italy.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr, Durban, South Africa.
RP Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, BR-42296710 Salvador, BA, Brazil.
EM giovanetti.marta@gmail.com
RI Pybus, Oliver G/B-2640-2012; Giovanetti, Marta/AAK-7408-2020; Faria,
   Nuno R/I-2975-2012; CICCOZZI, MASSIMO/C-6484-2016; de Siqueira, Isadora
   Cristina/R-9953-2016; Vianez Junior, Joao Lidio/I-9547-2016
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   CICCOZZI, MASSIMO/0000-0003-3866-9239; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; Giovanetti, Marta/0000-0002-5849-7326;
   Alcantara, Luiz/0000-0002-6769-9931; Lourenco, Jose/0000-0002-9318-2581;
   do Rosario, Mateus/0000-0001-7404-6392
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O., 2014, PLOS NEGLECT TROP D, V9, P8
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grard G, 2014, PLOS NEGLECT TROP D, P8
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, N ENGL J MED
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rodrigues Faria N., 2016, PLOS CURR OUTBREAKS
   Ventura C. V., 2016, LANCET, V16
   Zamree I, 2005, Trop Biomed, V22, P217
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 17
Z9 17
U1 0
U2 112
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2016
VL 41
BP 142
EP 145
DI 10.1016/j.meegid.2016.03.030
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DL5BU
UT WOS:000375652800020
PM 27071531
OA Green Published
DA 2020-09-29
ER

PT J
AU Faria, NR
   Azevedo, RDD
   Kraemer, MUG
   Souza, R
   Cunha, MS
   Hill, SC
   Theze, J
   Bonsall, MB
   Bowden, TA
   Rissanen, I
   Rocco, IM
   Nogueira, JS
   Maeda, AY
   Vasami, FGD
   Macedo, FLD
   Suzuki, A
   Rodrigues, SG
   Cruz, ACR
   Nunes, BT
   Medeiros, DBD
   Rodrigues, DSG
   Queiroz, ALN
   da Silva, EVP
   Henriques, DF
   da Rosa, EST
   de Oliveira, CS
   Martins, LC
   Vasconcelos, HB
   Casseb, LMN
   Simith, DD
   Messina, JP
   Abade, L
   Loureno, J
   Alcantara, LCJ
   de Lima, MM
   Giovanetti, M
   Hay, SI
   de Oliveira, RS
   Lemos, PD
   de Oliveira, LF
   de Lima, CPS
   da Silva, SP
   de Vasconcelos, JM
   Franco, L
   Cardoso, JF
   Vianez, JLDG
   Mir, D
   Bello, G
   Delatorre, E
   Khan, K
   Creatore, M
   Coelho, GE
   de Oliveira, WK
   Tesh, R
   Pybus, OG
   Nunes, MRT
   Vasconcelos, PFC
AF Faria, Nuno Rodrigues
   da Silva Azevedo, Raimunda do Socorro
   Kraemer, Moritz U. G.
   Souza, Renato
   Cunha, Mariana Sequetin
   Hill, Sarah C.
   Theze, Julien
   Bonsall, Michael B.
   Bowden, Thomas A.
   Rissanen, Ilona
   Rocco, Iray Maria
   Nogueira, Juliana Silva
   Maeda, Adriana Yurika
   da Silva Vasami, Fernanda Giseli
   de Lima Macedo, Fernando Luiz
   Suzuki, Akemi
   Rodrigues, Sueli Guerreiro
   Ribeiro Cruz, Ana Cecilia
   Nunes, Bruno Tardeli
   de Almeida Medeiros, Daniele Barbosa
   Guerreiro Rodrigues, Daniela Sueli
   Nunes Queiroz, Alice Louize
   Pinto da Silva, Eliana Vieira
   Henriques, Daniele Freitas
   Travassos da Rosa, Elisabeth Salbe
   de Oliveira, Consuelo Silva
   Martins, Livia Caricio
   Vasconcelos, Helena Baldez
   Neves Casseb, Livia Medeiros
   Simith, Darlene de Brito
   Messina, Jane P.
   Abade, Leandro
   Loureno, Jose
   Junior Alcantara, Luiz Carlos
   de Lima, Maricelia Maia
   Giovanetti, Marta
   Hay, Simon I.
   de Oliveira, Rodrigo Santos
   Lemos, Poliana da Silva
   de Oliveira, Layanna Freitas
   Silva de Lima, Clayton Pereira
   da Silva, Sandro Patroca
   de Vasconcelos, Janaina Mota
   Franco, Luciano
   Cardoso, Jedson Ferreira
   da Silva Gonalves Vianez-Junior, Joao Lidio
   Mir, Daiana
   Bello, Gonzalo
   Delatorre, Edson
   Khan, Kamran
   Creatore, Marisa
   Coelho, Giovanini Evelim
   de Oliveira, Wanderson Kleber
   Tesh, Robert
   Pybus, Oliver G.
   Nunes, Marcio R. T.
   Vasconcelos, Pedro F. C.
TI Zika virus in the Americas: Early epidemiological and genetic findings
SO SCIENCE
LA English
DT Article
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; BRAZIL; OUTBREAK; EVOLUTION;
   ISLAND; TRAVEL; CHILD
AB Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with similar to 30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.
C1 [Faria, Nuno Rodrigues; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; de Oliveira, Layanna Freitas; Silva de Lima, Clayton Pereira; da Silva, Sandro Patroca; de Vasconcelos, Janaina Mota; Franco, Luciano; Cardoso, Jedson Ferreira; da Silva Gonalves Vianez-Junior, Joao Lidio; Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Faria, Nuno Rodrigues; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Bonsall, Michael B.; Messina, Jane P.; Abade, Leandro; Loureno, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [da Silva Azevedo, Raimunda do Socorro; Rodrigues, Sueli Guerreiro; Ribeiro Cruz, Ana Cecilia; Nunes, Bruno Tardeli; de Almeida Medeiros, Daniele Barbosa; Guerreiro Rodrigues, Daniela Sueli; Nunes Queiroz, Alice Louize; Pinto da Silva, Eliana Vieira; Henriques, Daniele Freitas; Travassos da Rosa, Elisabeth Salbe; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Vasconcelos, Helena Baldez; Neves Casseb, Livia Medeiros; Simith, Darlene de Brito; Vasconcelos, Pedro F. C.] Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.
   [Souza, Renato; Cunha, Mariana Sequetin; Rocco, Iray Maria; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva Vasami, Fernanda Giseli; de Lima Macedo, Fernando Luiz; Suzuki, Akemi] Univ Sao Paulo, Inst Adolfo Lutz, Sao Paulo, Brazil.
   [Bowden, Thomas A.; Rissanen, Ilona; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Messina, Jane P.; Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA.
   [Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [de Lima, Maricelia Maia] Univ Estadual Feira de Santana, Ctr Post Grad Collect Hlth, Dept Hlth, Feira De Santana, BA, Brazil.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Mir, Daiana; Bello, Gonzalo; Delatorre, Edson] Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Creatore, Marisa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Coelho, Giovanini Evelim; de Oliveira, Wanderson Kleber] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Tesh, Robert; Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Nunes, MRT (corresponding author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.; Vasconcelos, PFC (corresponding author), Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.; Nunes, MRT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM oliver.pybus@zoo.ox.ac.uk; marcionunesbrasil@yahoo.com.br;
   pedrovasconcelos@iec.pa.gov.br
RI Cruz, Ana Cecilia Ribeiro/V-9276-2019; Vasconcelos, Pedro/AAH-3142-2019;
   Giovanetti, Marta/AAK-7408-2020; Azevedo, Raimunda/T-4656-2019; ,
   daiana/J-5515-2019; Bello, Gonzalo/E-6842-2013; Oliveira,
   Wanderson/AAF-5182-2019; Delatorre, Edson/J-8330-2015; Bentancor,
   Gonzalo Jose Bello/N-7377-2019; Pybus, Oliver G/B-2640-2012; Faria, Nuno
   R/I-2975-2012; Hay, Simon I/F-8967-2015; Vianez Junior, Joao
   Lidio/I-9547-2016
OI Azevedo, Raimunda/0000-0003-1932-9976; , daiana/0000-0002-3172-4867;
   Oliveira, Wanderson/0000-0002-9662-1930; Delatorre,
   Edson/0000-0002-5746-0820; Bentancor, Gonzalo Jose
   Bello/0000-0002-2724-2793; Pybus, Oliver G/0000-0002-8797-2667; Faria,
   Nuno R/0000-0001-8839-2798; Hay, Simon I/0000-0002-0611-7272; Alcantara,
   Luiz/0000-0002-6769-9931; Lourenco, Jose/0000-0002-9318-2581; Rissanen,
   Ilona/0000-0003-4937-1825; Hill, Sarah/0000-0002-2995-2596; Vianez
   Junior, Joao Lidio/0000-0001-6226-9441; Pereira de Souza,
   Renato/0000-0003-1315-7085; Bowden, Thomas/0000-0002-8066-8785; de Lima
   Macedo, Fernando Luiz/0000-0003-2097-0429; Giovanetti,
   Marta/0000-0002-5849-7326
FU European Research Council (ERC) under the European UnionEuropean
   Research Council (ERC) [614725-PATHPHYLODYN]; ERC under the European
   Union [268904-DIVERSITY]; Metabiota; American people through the United
   States Agency for International Development (USAID) Emerging Pandemic
   Threats Program-PREDICTUnited States Agency for International
   Development (USAID); Wellcome TrustWellcome Trust [095066, 102427,
   090532/Z/09/Z]; Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Evandro
   Chagas Institute; Brazilian Ministry of Health; CNPq (Brazilian National
   Council for Scientific and Technological Development)National Council
   for Scientific and Technological Development (CNPq) [302032/2011-8,
   200024/2015-9]; National Institute of Science and Technology for Viral
   Hemorrhagic Fevers; U.S. NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24 AT 120942]; UK
   Medical Research CouncilMedical Research Council UK (MRC)
   [MR/L009528/1]; CNPq-National Agency for Scientific and Technologic
   Development [573739/2008-0, 301641/2010-2, 457664/2013-4]; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L009528/1] Funding
   Source: Researchfish
FX We thank X. de Lamballerie and J. Lednicky for permission to include
   their unpublished ZIKV genomes in our analysis. We thank the Death
   Verification Service (SVO); Central Laboratories of Public Health
   (LACEN); and health departments of the Ceara State and Maranhao State,
   Brazil, for collaboration. O.G.P. is supported by the European Research
   Council (ERC) under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 614725-PATHPHYLODYN. J.L. is supported by the
   ERC under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 268904-DIVERSITY. O.G.P. received consulting
   fees from Metabiota between 2015 and 2016. This study is made possible
   in part by the generous support of the American people through the
   United States Agency for International Development (USAID) Emerging
   Pandemic Threats Program-PREDICT. The contents are the responsibility of
   the authors and do not necessarily reflect the views of USAID or the
   U.S. government. S.I.H. is funded by a Senior Research Fellowship from
   the Wellcome Trust (095066) and grants from the Bill and Melinda Gates
   Foundation (OPP1119467, OPP1093011, OPP1106023, and OPP1132415).
   M.R.T.N. is funded as an associated researcher in public health by the
   Evandro Chagas Institute, Brazilian Ministry of Health, and as a
   researcher in scientific productivity by CNPq (Brazilian National
   Council for Scientific and Technological Development) grants
   302032/2011-8 and 200024/2015-9 and is also supported in part by the
   National Institute of Science and Technology for Viral Hemorrhagic
   Fevers. R.T. is funded by grant R24 AT 120942 from the U.S. NIH. S.C.H.
   is supported by a Wellcome Trust grant (102427). T.A.B. and I.R. are
   supported by grants from the UK Medical Research Council (MR/L009528/1)
   and the Wellcome Trust (090532/Z/09/Z). P.F.C.V. is supported by
   CNPq-National Agency for Scientific and Technologic Development (grants
   573739/2008-0, 301641/2010-2, and 457664/2013-4). All samples were
   obtained from persons visiting local clinics or hospitalized by the
   Brazilian Ministry of Health personnel as part of dengue, chikungunya,
   and Zika fever surveillance activities. In these cases, patient consent
   was oral and not recorded. The study was authorized by the Coordination
   of the National Program for Dengue, Chikungunya, and Zika Control
   coordinated by Brazil's Ministry of Health. The data are available at
   DRYAD (DOI: 10.5061/dryad.6kn23). The ZIKV genomes reported in this
   study are deposited in GenBank under accession numbers KU321639,
   KU365777 to KU365780, KU729217, and KU729218.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meyer AG, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 542
Z9 553
U1 5
U2 247
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 345
EP 349
DI 10.1126/science.aaf5036
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100041
PM 27013429
OA Green Accepted, Bronze
DA 2020-09-29
ER

PT J
AU Arias, A
   Watson, SJ
   Asogun, D
   Tobin, EA
   Lu, J
   Phan, MVT
   Jah, U
   Wadoum, REG
   Meredith, L
   Thorne, L
   Caddy, S
   Tarawalie, A
   Langat, P
   Dudas, G
   Faria, NR
   Dellicour, S
   Kamara, A
   Kargbo, B
   Kamara, BO
   Gevao, S
   Cooper, D
   Newport, M
   Horby, P
   Dunning, J
   Sahr, F
   Brooks, T
   Simpson, AJH
   Groppelli, E
   Liu, GY
   Mulakken, N
   Rhodes, K
   Akpablie, J
   Yoti, Z
   Lamunu, M
   Vitto, E
   Otim, P
   Owilli, C
   Boateng, I
   Okoror, L
   Omomoh, E
   Oyakhilome, J
   Omiunu, R
   Yemisis, I
   Adomeh, D
   Ehikhiametalor, S
   Akhilomen, P
   Aire, C
   Kurth, A
   Cook, N
   Baumann, J
   Gabriel, M
   Wolfel, R
   Di Caro, A
   Carroll, MW
   Gunther, S
   Redd, J
   Naidoo, D
   Pybus, OG
   Rambaut, A
   Kellam, P
   Goodfellow, I
   Cotten, M
AF Arias, Armando
   Watson, Simon J.
   Asogun, Danny
   Tobin, Ekaete Alice
   Lu, Jia
   Phan, My V. T.
   Jah, Umaru
   Wadoum, Raoul Emeric Guetiya
   Meredith, Luke
   Thorne, Lucy
   Caddy, Sarah
   Tarawalie, Alimamy
   Langat, Pinky
   Dudas, Gytis
   Faria, Nuno R.
   Dellicour, Simon
   Kamara, Abdul
   Kargbo, Brima
   Kamara, Brima Osaio
   Gevao, Sahr
   Cooper, Daniel
   Newport, Matthew
   Horby, Peter
   Dunning, Jake
   Sahr, Foday
   Brooks, Tim
   Simpson, Andrew J. H.
   Groppelli, Elisabetta
   Liu, Guoying
   Mulakken, Nisha
   Rhodes, Kate
   Akpablie, James
   Yoti, Zabulon
   Lamunu, Margaret
   Vitto, Esther
   Otim, Patrick
   Owilli, Collins
   Boateng, Isaac
   Okoror, Lawrence
   Omomoh, Emmanuel
   Oyakhilome, Jennifer
   Omiunu, Racheal
   Yemisis, Ighodalo
   Adomeh, Donatus
   Ehikhiametalor, Solomon
   Akhilomen, Patience
   Aire, Chris
   Kurth, Andreas
   Cook, Nicola
   Baumann, Jan
   Gabriel, Martin
   Woelfel, Roman
   Di Caro, Antonino
   Carroll, Miles W.
   Guenther, Stephan
   Redd, John
   Naidoo, Dhamari
   Pybus, Oliver G.
   Rambaut, Andrew
   Kellam, Paul
   Goodfellow, Ian
   Cotten, Matthew
TI Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies
   transmission chains linked to sporadic cases
SO VIRUS EVOLUTION
LA English
DT Article
DE Ebola virus; evolution; transmission; outbreak sequencing
ID PHYLOGENETIC ANALYSIS; SEXUAL TRANSMISSION; DYNAMICS; SURVEILLANCE;
   EVOLUTION; LIBERIA
AB To end the largest known outbreak of Ebola virus disease (EVD) in West Africa and to prevent new transmissions, rapid epidemiological tracing of cases and contacts was required. The ability to quickly identify unknown sources and chains of transmission is key to ending the EVD epidemic and of even greater importance in the context of recent reports of Ebola virus (EBOV) persistence in survivors. Phylogenetic analysis of complete EBOV genomes can provide important information on the source of any new infection. A local deep sequencing facility was established at the Mateneh Ebola Treatment Centre in central Sierra Leone. The facility included all wetlab and computational resources to rapidly process EBOV diagnostic samples into full genome sequences. We produced 554 EBOV genomes from EVD cases across Sierra Leone. These genomes provided a detailed description of EBOV evolution and facilitated phylogenetic tracking of new EVD cases. Importantly, we show that linked genomic and epidemiological data can not only support contact tracing but also identify unconventional transmission chains involving body fluids, including semen. Rapid EBOV genome sequencing, when linked to epidemiological information and a comprehensive database of virus sequences across the outbreak, provided a powerful tool for public health epidemic control efforts.
C1 [Kellam, Paul; Goodfellow, Ian; Cotten, Matthew] Univ Cambridge, Div Virol, Dept Pathol, Cambridge, MA USA.
   [Wadoum, Raoul Emeric Guetiya; Thorne, Lucy; Gevao, Sahr; Akpablie, James; Lamunu, Margaret; Boateng, Isaac; Yemisis, Ighodalo] Wellcome Trust Sanger Inst, Hinxton, England.
   [Wadoum, Raoul Emeric Guetiya; Dudas, Gytis; Gevao, Sahr; Mulakken, Nisha; Rhodes, Kate; Lamunu, Margaret; Ehikhiametalor, Solomon] Irrua Specialist Teaching Hosp, Inst Lassa Fever Res & Control, Irrua, Nigeria.
   [Meredith, Luke; Caddy, Sarah; Dellicour, Simon; Rhodes, Kate; Akhilomen, Patience] Bernhard Nocht Inst Trop Med, European Mobile Lab Consortium, Hamburg, Germany.
   [Lamunu, Margaret; Boateng, Isaac; Yemisis, Ighodalo] Univ Makeni, Makeni, Sierra Leone.
   [Omomoh, Emmanuel; Omiunu, Racheal] Inst Evolutionary Biol, Ashworth Labs, Edinburgh, Midlothian, Scotland.
   [Kargbo, Brima; Gevao, Sahr; Lamunu, Margaret; Omiunu, Racheal] Univ Oxford, Dept Zool, Oxford, England.
   [Otim, Patrick; Adomeh, Donatus] Sierra Leone Minist Hlth, Freetown, Sierra Leone.
   [Jah, Umaru; Kargbo, Brima] Int Med Corps, Los Angeles, CA USA.
   [Lu, Jia; Caddy, Sarah; Dudas, Gytis; Dellicour, Simon; Cooper, Daniel] Univ Oxford, Ctr Trop Med & Global Hlth Nuffield, ERGO, Dept Med, Oxford, England.
   [Wadoum, Raoul Emeric Guetiya; Newport, Matthew] Republ Sierra Leone Armed Forces, Freetown, Sierra Leone.
   [Phan, My V. T.; Tarawalie, Alimamy; Langat, Pinky; Dudas, Gytis; Kargbo, Brima] Publ Hlth England, Rare & Imported Pathogens Lab, Porton Down, England.
   [Jah, Umaru; Wadoum, Raoul Emeric Guetiya; Dudas, Gytis] Thermo Fisher Sci, San Francisco, CA USA.
   [Kamara, Abdul; Gevao, Sahr] WHO Ebola Response Team, Geneva, Switzerland.
   [Phan, My V. T.; Tarawalie, Alimamy; Dellicour, Simon; Dunning, Jake] Fed Univ, Oye Ekit, Nigeria.
   [Newport, Matthew] Robert Koch Inst, Berlin, Germany.
   [Watson, Simon J.; Kargbo, Brima; Newport, Matthew] Publ Hlth England, Porton Down, England.
   [Tarawalie, Alimamy; Kargbo, Brima; Gevao, Sahr] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Meredith, Luke; Thorne, Lucy; Dellicour, Simon; Kamara, Abdul] Bundeswehr Inst Microbiol, Munich, Germany.
   [Wadoum, Raoul Emeric Guetiya; Newport, Matthew] Natl Inst Infect Dis L Spallanzani, Rome, Italy.
   [Wadoum, Raoul Emeric Guetiya; Cooper, Daniel] Sierra Leone & Div Global Hlth Protect, Georgia Ctr Global Hlth Centers Dis Control & Pre, CDC Country Off, Atlanta, GA USA.
   [Kamara, Brima Osaio; Horby, Peter] NIH, Fogarty Int Ctr, Bethesda, MD USA.
   [Kamara, Abdul; Gevao, Sahr] Ctr Immunol, Ashworth Labs, Infect & Evolut, Edinburgh, Midlothian, Scotland.
   [Lu, Jia; Kargbo, Brima; Kamara, Brima Osaio; Gevao, Sahr] UCL, Divis Infect & Immun, London, England.
RP Kellam, P; Goodfellow, I; Cotten, M (corresponding author), Univ Cambridge, Div Virol, Dept Pathol, Cambridge, MA USA.
EM pk5@sanger.ac.uk; ig299@cam.ac.uk; mc13@sanger.ac.uk
RI Rambaut, Andrew/B-2481-2009; Di Caro, Antonino/K-6854-2016; Pybus,
   Oliver G/B-2640-2012; Dellicour, Simon/AAE-9054-2020; Dunning,
   Jake/U-7181-2019; Caddy, Sarah/AAG-9891-2019; Arias,
   Armando/E-1393-2016; Faria, Nuno R/I-2975-2012; Dudas, Gytis/H-5968-2019
OI Rambaut, Andrew/0000-0003-4337-3707; Di Caro,
   Antonino/0000-0001-6027-3009; Pybus, Oliver G/0000-0002-8797-2667;
   Dellicour, Simon/0000-0001-9558-1052; Dunning, Jake/0000-0002-4035-4562;
   Arias, Armando/0000-0002-4138-4608; Faria, Nuno R/0000-0001-8839-2798;
   Dudas, Gytis/0000-0002-0227-4158; Phan, My VT/0000-0002-6905-8513;
   Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Cooper,
   Daniel/0000-0002-3643-7605; Gunther, Stephan/0000-0002-6562-0230; OWILI,
   COLLINS/0000-0001-8001-6878; Horby, Peter/0000-0002-9822-1586; Ramadan,
   Otim Patrick Cossy/0000-0003-2326-9291; Kellam,
   Paul/0000-0003-3166-4734; Guetiya Wadoum, Raoul
   Emeric/0000-0002-1031-0649; Lu, Jia/0000-0003-3995-324X; Groppelli,
   Elisabetta/0000-0003-4241-2858; Cotten, Matthew/0000-0002-3361-3351
FU UK Department for International Development; Wellcome TrustWellcome
   Trust [098051, 097997/Z/11/A, 097997/Z/11/Z, 106491/Z/14/Z]; EU
   [FP7]European Union (EU) [278433]; Wellcome Trust Strategic Award
   (VIZIONS) [093724]; Health Innovation Challenge Fund [T5-344]; European
   Union's Horizon research and innovation programme [643476]; European
   Commission, Directorate-General for International Cooperation and
   Development [IFS/2011/272-372]; Department of Health; Wellcome
   TrustWellcome Trust; National Institute for Health ResearchNational
   Institute for Health Research (NIHR) [1774] Funding Source: Researchfish
FX The authors would like to thank the Public Health England diagnostic
   teams deployed to staff the laboratories in Kerrytown, Port Loko and
   Makeni for their dedicated contribution to the processing and
   identification of EBOV positive samples. The UK Department for
   International Development funded the PHE diagnostic laboratories and
   provided logistic support. The authors would also like to thank Deb
   Walsh (University of Cambridge), members of the Goodfellow laboratory at
   the Division of Virology, University of Cambridge, and Cathy Styles,
   Florence Pethick, Andrew Gaze, and Andrew Felton (Thermo Fisher
   Scientific) for their support. We thank Nick Loman for sharing MinION
   sequence data. Funding for this work includes Wellcome Trust Grants
   098051 to P.K., 097997/Z/11/A and 097997/Z/11/Z to I.G. and
   106491/Z/14/Z to P.H., EU [FP7/2007-2013] Grant Agreement no.
   278433-PREDEMICS to A.R., and a Wellcome Trust Strategic Award (VIZIONS;
   093724). This publication presents independent research supported by the
   Health Innovation Challenge Fund T5-344 (ICONIC), a parallel funding
   partnership between the Department of Health and Wellcome Trust and the
   COMPARE project Funded by the European Union's Horizon 2020 research and
   innovation programme under Grant agreement no. 643476. The work of EMLab
   was supported by the European Commission, Directorate-General for
   International Cooperation and Development (Contract IFS/2011/272-372
   "EMLab"). The views expressed in this publication are those of the
   author(s) and not necessarily those of the Department of Health
   orWellcome Trust and do not necessarily represent the official position
   of the US Centers for Disease Control and Prevention.
CR [Anonymous], 2016, NCBI EBOLAVIRUS RESO
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   Deen GF, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1511410, DOI 10.1056/NEJMOA1511410]
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goodfellow I, 2015, RECENT EVOLUTION PAT
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Moreau M, 2015, EUROSURVEILLANCE, V20, P10, DOI 10.2807/1560-7917.ES2015.20.3.21017
   Neher R., 2015, REAL TIME ANAL EBOLA
   Nordenstedt H, 2016, EMERG INFECT DIS, V22, P759, DOI 10.3201/eid2204.151880
   Nouvellet P, 2015, NATURE, V528, pS109, DOI 10.1038/nature16041
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Sow MS, 2016, J INFECT DIS, V214, P1475, DOI 10.1093/infdis/jiw078
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205
   WHO, 2016, EB SIT REP
   WHO, 2015, REC EB TRANSM LIB
   World Health Organisation, 2016, WHO CONT STRESS RISK
   World Health Organization, 2015, EB OUTBR LIB IS
NR 35
TC 57
Z9 57
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD JAN
PY 2016
VL 2
IS 1
AR vew016
DI 10.1093/ve/vew016
PG 10
WC Virology
SC Virology
GA ET0KA
UT WOS:000399949900019
PM 28694998
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU Bezemer, D
   Cori, A
   Ratmann, O
   van Sighem, A
   Hermanides, HS
   Dutilh, BE
   Gras, L
   Faria, NR
   van den Hengel, R
   Duits, AJ
   Reiss, P
   de Wolf, F
   Fraser, C
AF Bezemer, Daniela
   Cori, Anne
   Ratmann, Oliver
   van Sighem, Ard
   Hermanides, Hillegonda S.
   Dutilh, Bas E.
   Gras, Luuk
   Faria, Nuno Rodrigues
   van den Hengel, Rob
   Duits, Ashley J.
   Reiss, Peter
   de Wolf, Frank
   Fraser, Christophe
CA ATHENA Observational Cohort
TI Dispersion of the HIV-1 Epidemic in Men Who Have Sex with Men in the
   Netherlands: A Combined Mathematical Model and Phylogenetic Analysis
SO PLOS MEDICINE
LA English
DT Article
ID TRANSMISSION; ALIGNMENTS; INFERENCE
AB Background
   The HIV-1 subtype B epidemic amongst men who have sex with men (MSM) is resurgent in many countries despite the widespread use of effective combination antiretroviral therapy (cART). In this combined mathematical and phylogenetic study of observational data, we aimed to find out the extent to which the resurgent epidemic is the result of newly introduced strains or of growth of already circulating strains.
   Methods and Findings
   As of November 2011, the ATHENA observational HIV cohort of all patients in care in the Netherlands since 1996 included HIV-1 subtype B polymerase sequences from 5,852 patients. Patients who were diagnosed between 1981 and 1995 were included in the cohort if they were still alive in 1996. The ten most similar sequences to each ATHENA sequence were selected from the Los Alamos HIV Sequence Database, and a phylogenetic tree was created of a total of 8,320 sequences. Large transmission clusters that included >= 10 ATHENA sequences were selected, with a local support value >= 0.9 and median pairwise patristic distance below the fifth percentile of distances in the whole tree. Time-varying reproduction numbers of the large MSM-majority clusters were estimated through mathematical modeling. We identified 106 large transmission clusters, including 3,061 (52%) ATHENA and 652 Los Alamos sequences. Half of the HIV sequences from MSM registered in the cohort in the Netherlands (2,128 of 4,288) were included in 91 large MSM-majority clusters. Strikingly, at least 54 (59%) of these 91 MSM-majority clusters were already circulating before 1996, when cART was introduced, and have persisted to the present. Overall, 1,226 (35%) of the 3,460 diagnoses among MSM since 1996 were found in these 54 long-standing clusters. The reproduction numbers of all large MSM-majority clusters were around the epidemic threshold value of one over the whole study period. A tendency towards higher numbers was visible in recent years, especially in the more recently introduced clusters. The mean age of MSM at diagnosis increased by 0.45 years/year within clusters, but new clusters appeared with lower mean age. Major strengths of this study are the high proportion of HIV-positive MSM with a sequence in this study and the combined application of phylogenetic and modeling approaches. Main limitations are the assumption that the sampled population is representative of the overall HIV-positive population and the assumption that the diagnosis interval distribution is similar between clusters.
   Conclusions
   The resurgent HIV epidemic amongst MSM in the Netherlands is driven by several large, persistent, self-sustaining, and, in many cases, growing sub-epidemics shifting towards new generations of MSM. Many of the sub-epidemics have been present since the early epidemic, to which new sub-epidemics are being added.
C1 [Bezemer, Daniela; van Sighem, Ard; Gras, Luuk; van den Hengel, Rob; Reiss, Peter] HIV Monitoring Fdn, Amsterdam, Netherlands.
   [Cori, Anne; Ratmann, Oliver; Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, Ctr Outbreak Anal & Modellin,MRC, London, England.
   [Hermanides, Hillegonda S.] Red Cross Blood Bank Fdn, Willemstad, Curacao, Netherlands.
   [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands.
   [Dutilh, Bas E.] Univ Fed Rio de Janeiro, Inst Biol, Dept Marine Biol, Rio De Janeiro, Brazil.
   [Dutilh, Bas E.] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands.
   [Reiss, Peter] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.
RP Bezemer, D (corresponding author), HIV Monitoring Fdn, Amsterdam, Netherlands.
EM d.o.bezemer@amc.uva.nl
RI Faria, Nuno R/I-2975-2012; Schinkel, Janke/I-3099-2012; Dutilh, Bas
   E./B-9719-2011; Hofstede, Hadewych ter/AAD-1118-2019; Fraser,
   Christophe/A-8109-2008
OI Faria, Nuno R/0000-0001-8839-2798; Schinkel, Janke/0000-0002-1112-0644;
   Dutilh, Bas E./0000-0003-2329-7890; Fraser,
   Christophe/0000-0003-2399-9657; Cori, Anne/0000-0002-8443-9162; Ratmann,
   Oliver/0000-0001-8667-4118; Kroes, Aloysius/0000-0002-9866-2461; van
   Rossum, Annemarie/0000-0002-1259-477X; Peters,
   Edgar/0000-0002-3410-1227; Rijnders, Bart/0000-0003-3343-9610
FU NIH through NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [UM1 AI068619]; European
   Research CouncilEuropean Research Council (ERC) [AdG 339251]; Wellcome
   TrustWellcome Trust [WR092311MF]; Bill AMP; Melinda Gates Foundation via
   PANGEA-HIV consortium; NWO VeniNetherlands Organization for Scientific
   Research (NWO) [016.111.075]; CAPES/BRASILCAPES; Bristol-Myers
   SquibbBristol-Myers Squibb; ViiV Healthcare; Gilead SciencesGilead
   Sciences; Janssen Pharmaceuticals Inc.Johnson & Johnson USAJanssen
   Biotech Inc; MerckCo.Merck & Company; scientific advisory board for
   Gilead Sciences; data safety monitoring committee for Janssen
   Pharmaceuticals Inc.; European Centre for Disease Prevention and Control
   [ECDC/2012/050]; Dutch Ministry of Health, Welfare and Sport through
   Centre for Infectious Disease Control of the National Institute for
   Public Health and the Environment; Medical Research CouncilMedical
   Research Council UK (MRC) [MR/K010174/1B, G0800596, MR/K010174/1]
   Funding Source: Researchfish
FX AC and CF thank the NIH for funding through the NIAID cooperative
   agreement UM1 AI068619. CF acknowledges funding by European Research
   Council AdG 339251 (BEEHIVE). OR is supported by the Wellcome Trust
   (fellowship WR092311MF). OR and CF thank the Bill & Melinda Gates
   Foundation for funding via the PANGEA-HIV consortium. BED was supported
   by NWO Veni (016.111.075) and CAPES/BRASIL. PR and AS through their
   institution have received independent scientific grant support from
   Bristol-Myers Squibb and ViiV Healthcare, and travel support through
   their institution from Gilead Sciences. PR through his institution has
   received independent scientific grant support from Gilead Sciences,
   Janssen Pharmaceuticals Inc., Merck&Co. In addition, PR has served on a
   scientific advisory board for Gilead Sciences and serves on a data
   safety monitoring committee for Janssen Pharmaceuticals Inc., for which
   his institution has received remuneration. AS through his institution
   has received a grant from the European Centre for Disease Prevention and
   Control (Framework Contract No. ECDC/2012/050). The ATHENA database is
   maintained by Stichting HIV Monitoring and supported by a grant from the
   Dutch Ministry of Health, Welfare and Sport through the Centre for
   Infectious Disease Control of the National Institute for Public Health
   and the Environment. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2015, MOL EVOLUTION PHYLOG
   Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca
   Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33
   Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c
   Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001
   Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee
   Cabello M, 2015, AIDS, V29, P483, DOI 10.1097/QAD.0000000000000552
   Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Cohen MS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001232
   de Coul ELMO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133232
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Gras L, 2010, MONITORING HUMAN IMM
   Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845
   Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9
   Johnson Victoria A, 2013, Top Antivir Med, V21, P6
   Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489
   Kelley CF, 2011, J INFECT DIS, V204, P761, DOI 10.1093/infdis/jir400
   Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951
   Kramer MA, 2011, AIDS RES HUM RETROV, V27, P123, DOI 10.1089/aid.2010.0115
   Leventhal GE, 2014, MOL BIOL EVOL, V31, P6, DOI 10.1093/molbev/mst172
   Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050
   Los Alamos National Laboratory, 2015, HIV SE QUENC DAT
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312
   Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stadler T, 2012, MOL BIOL EVOL, V29, P347, DOI 10.1093/molbev/msr217
   Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004
   van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819
   van Sighem A, 2012, AIDS, V26, P1840, DOI 10.1097/QAD.0b013e3283574df9
   van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946
   Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
NR 39
TC 38
Z9 38
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD NOV
PY 2015
VL 12
IS 11
AR e1001898
DI 10.1371/journal.pmed.1001898
PG 23
WC Medicine, General & Internal
SC General & Internal Medicine
GA CX7UZ
UT WOS:000365909700002
PM 26529093
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU von Stockenstrom, S
   Odevall, L
   Lee, E
   Sinclair, E
   Bacchetti, P
   Killian, M
   Epling, L
   Shao, W
   Hoh, R
   Ho, T
   Faria, NR
   Lemey, P
   Albert, J
   Hunt, P
   Loeb, L
   Pilcher, C
   Poole, L
   Hatano, H
   Somsouk, M
   Douek, D
   Boritz, E
   Deeks, SG
   Hecht, FM
   Palmer, S
AF von Stockenstrom, Susanne
   Odevall, Lina
   Lee, Eunok
   Sinclair, Elizabeth
   Bacchetti, Peter
   Killian, Maudi
   Epling, Lorrie
   Shao, Wei
   Hoh, Rebecca
   Ho, Terence
   Faria, Nuno R.
   Lemey, Philippe
   Albert, Jan
   Hunt, Peter
   Loeb, Lisa
   Pilcher, Christopher
   Poole, Lauren
   Hatano, Hiroyu
   Somsouk, Ma
   Douek, Daniel
   Boritz, Eli
   Deeks, Steven G.
   Hecht, Frederick M.
   Palmer, Sarah
TI Longitudinal Genetic Characterization Reveals That Cell Proliferation
   Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE HIV-1 persistence; HIV-1 reservoir; memory T cells
ID SUPPRESSIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; MEMORY; SITES;
   INTENSIFICATION; INFECTION; RESERVOIR; SURVIVAL; MULTIPLE; DRIVEN
AB Background. The stability of the human immunodeficiency virus type 1 (HIV-1) reservoir and the contribution of cellular proliferation to the maintenance of the reservoir during treatment are uncertain. Therefore, we conducted a longitudinal analysis of HIV-1 in T-cell subsets in different tissue compartments from subjects receiving effective antiretroviral therapy (ART).
   Methods. Using single-proviral sequencing, we isolated intracellular HIV-1 genomes derived from defined subsets of CD4+ T cells from peripheral blood, gut-associated lymphoid tissue and lymph node tissue specimens from 8 subjects with virologic suppression during long-term ART at 2 time points (time points 1 and 2) separated by 7-9 months.
   Results. DNA integrant frequencies were stable over time (<4-fold difference) and highest in memory T cells. Phylogenetic analyses showed that subjects treated during chronic infection contained viral populations with up to 73% identical sequence expansions, only 3 of which were observed in specimens obtained before therapy. At time points 1 and 2, such clonally expanded populations were found predominantly in effector memory T cells from peripheral blood and lymph node tissue specimens.
   Conclusions. Memory T cells maintained a relatively constant HIV-1 DNA integrant pool that was genetically stable during long-term effective ART. These integrants appear to be maintained by cellular proliferation and longevity of infected cells, rather than by ongoing viral replication.
C1 [von Stockenstrom, Susanne; Odevall, Lina; Albert, Jan; Palmer, Sarah] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.
   [von Stockenstrom, Susanne; Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.
   [Lee, Eunok; Palmer, Sarah] Westmead Millennium Inst Med Res, Westmead, NSW, Australia.
   [Lee, Eunok; Palmer, Sarah] Univ Sydney, Westmead, NSW 2145, Australia.
   [Sinclair, Elizabeth; Killian, Maudi; Epling, Lorrie; Hoh, Rebecca; Ho, Terence; Hunt, Peter; Loeb, Lisa; Pilcher, Christopher; Poole, Lauren; Hatano, Hiroyu; Somsouk, Ma; Deeks, Steven G.; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Shao, Wei] Leidos Biomedical Res INC, Frederick Natl Lab Canc Res, Bethesda, MD USA.
   [Douek, Daniel; Boritz, Eli] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.
   [Faria, Nuno R.; Lemey, Philippe] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
RP von Stockenstrom, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.
EM susanne.vonstockenstrom@ki.se
RI Lemey, Philippe/C-3755-2018; Faria, Nuno R/I-2975-2012
OI Lemey, Philippe/0000-0003-2826-5353; Faria, Nuno R/0000-0001-8839-2798;
   Loeb Stanga, Lisa/0000-0001-7471-5381; Hecht,
   Frederick/0000-0002-5782-1171; Deeks, Steven/0000-0001-6371-747X
FU Foundation for AIDS Research (amfAR Research Consortium on HIV
   Eradication Collaborative research grant) [108074-50-RGRL]; Delaney AIDS
   Research Enterprise [U19 AI096109]; Australian National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [AAP1061681]; Erik and Edith Fernstrom Foundation for Medical
   Research; Karolinska InstitutetKarolinska Institutet
FX This work was supported by the Foundation for AIDS Research (amfAR
   Research Consortium on HIV Eradication Collaborative research grant
   108074-50-RGRL), Delaney AIDS Research Enterprise (U19 AI096109), the
   Australian National Health and Medical Research Council (AAP1061681),
   the Erik and Edith Fernstrom Foundation for Medical Research (to S. v.
   S.), and the Karolinska Institutet (alumni funds to S. v. S.).
CR Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288
   Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646
   Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111
   Chomont N, 2011, CURR OPIN HIV AIDS, V6, P30, DOI 10.1097/COH.0b013e3283413775
   Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Geginat J, 2003, PATHOL BIOL, V51, P64, DOI 10.1016/S0369-8114(03)00098-1
   Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864
   Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110
   Josefsson L, 2012, J INFECT DIS, V206, P28, DOI 10.1093/infdis/jis301
   Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08
   Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478
   Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735
   Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341
   Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194
   Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005
   Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304
   Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb
NR 18
TC 81
Z9 81
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2015
VL 212
IS 4
BP 596
EP 607
DI 10.1093/infdis/jiv092
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CP1ZW
UT WOS:000359677600012
PM 25712966
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Nunes, MRT
   Faria, NR
   de Vasconcelos, JM
   Golding, N
   Kraemer, MUG
   de Oliveira, LF
   Azevedo, RDD
   da Silva, DEA
   da Silva, EVP
   da Silva, SP
   Carvalho, VL
   Coelho, GE
   Cruz, ACR
   Rodrigues, SG
   Vianez, JLDG
   Nunes, BTD
   Cardoso, JF
   Tesh, RB
   Hay, SI
   Pybus, OG
   Vasconcelos, PFD
AF Teixeira Nunes, Marcio Roberto
   Faria, Nuno Rodrigues
   de Vasconcelos, Janaina Mota
   Golding, Nick
   Kraemer, Moritz U. G.
   de Oliveira, Layanna Freitas
   da Silva Azevedo, Raimunda do Socorro
   Andrade da Silva, Daisy Elaine
   Pinto da Silva, Eliana Vieira
   da Silva, Sandro Patroca
   Carvalho, Valeria Lima
   Coelho, Giovanini Evelim
   Ribeiro Cruz, Ana Cecilia
   Rodrigues, Sueli Guerreiro
   da Silva Goncalves Vianez, Joao Lidio, Jr.
   Diniz Nunes, Bruno Tardelli
   Cardoso, Jedson Ferreira
   Tesh, Robert B.
   Hay, Simon I.
   Pybus, Oliver G.
   da Costa Vasconcelos, Pedro Fernando
TI Emergence and potential for spread of Chikungunya virus in Brazil
SO BMC MEDICINE
LA English
DT Article
DE Chikungunya virus; National surveillance; Public health; Spatial
   prediction; Statistical methods
ID AEDES-ALBOPICTUS; POPULATION-DYNAMICS; INFERENCE; AEGYPTI; IMPACT
AB Background: In December 2013, an outbreak of Chikungunya virus (CHIKV) caused by the Asian genotype was notified in the Caribbean. The outbreak has since spread to 38 regions in the Americas. By September 2014, the first autochthonous CHIKV infections were confirmed in Oiapoque, North Brazil, and in Feira de Santana, Northeast Brazil.
   Methods: We compiled epidemiological and clinical data on suspected CHIKV cases in Brazil and polymerase-chain-reaction-based diagnostic was conducted on 68 serum samples from patients with symptom onset between April and September 2014. Two imported and four autochthonous cases were selected for virus propagation, RNA isolation, full-length genome sequencing, and phylogenetic analysis. We then followed CDC/PAHO guidelines to estimate the risk of establishment of CHIKV in Brazilian municipalities.
   Results: We detected 41 CHIKV importations and 27 autochthonous cases in Brazil. Epidemiological and phylogenetic analyses indicated local transmission of the Asian CHIKV genotype in Oiapoque. Unexpectedly, we also discovered that the ECSA genotype is circulating in Feira de Santana. The presumed index case of the ECSA genotype was an individual who had recently returned from Angola and developed symptoms in Feira de Santana. We estimate that, if CHIKV becomes established in Brazil, transmission could occur in 94% of municipalities in the country and provide maps of the risk of importation of each strain of CHIKV in Brazil.
   Conclusions: The etiological strains associated with the early-phase CHIKV outbreaks in Brazil belong to the Asian and ECSA genotypes. Continued surveillance and vector mitigation strategies are needed to reduce the future public health impact of CHIKV in the Americas.
C1 [Teixeira Nunes, Marcio Roberto; de Vasconcelos, Janaina Mota; de Oliveira, Layanna Freitas; Andrade da Silva, Daisy Elaine; da Silva, Sandro Patroca; da Silva Goncalves Vianez, Joao Lidio, Jr.; Cardoso, Jedson Ferreira] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Faria, Nuno Rodrigues; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Golding, Nick; Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England.
   [da Silva Azevedo, Raimunda do Socorro; Pinto da Silva, Eliana Vieira; Carvalho, Valeria Lima; Ribeiro Cruz, Ana Cecilia; Rodrigues, Sueli Guerreiro; Diniz Nunes, Bruno Tardelli; da Costa Vasconcelos, Pedro Fernando] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, BR-67030000 Ananindeua, PA, Brazil.
   [Coelho, Giovanini Evelim] Brazilian Minist Hlth, Natl Dengue Control Program, BR-70058900 Brasilia, DF, Brazil.
   [Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Hay, Simon I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [da Costa Vasconcelos, Pedro Fernando] Para State Univ, Dept Pathol, BR-66087670 Belem, Para, Brazil.
RP Nunes, MRT (corresponding author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
EM marcionunesbrasil@yahoo.com.br
RI Azevedo, Raimunda/T-4656-2019; Cruz, Ana Cecilia Ribeiro/V-9276-2019;
   Hay, Simon I/F-8967-2015; Vasconcelos, Pedro/AAH-3142-2019; Pybus,
   Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; Vianez Junior, Joao
   Lidio/I-9547-2016; Nunes, Marcio Roberto/B-2238-2016
OI Azevedo, Raimunda/0000-0003-1932-9976; Hay, Simon I/0000-0002-0611-7272;
   Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Golding, Nick/0000-0001-8916-5570; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; Nunes, Marcio Roberto/0000-0001-9739-5499
FU Brazilian National Council of Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [302032/2011-8]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [573.739/2008-0, 240/2008/FAPESPA/INCT,
   142492/2011-6]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1053338]; German Academic Exchange Service
   (DAAD)Deutscher Akademischer Austausch Dienst (DAAD); Wellcome
   TrustWellcome Trust [095066]; Li Ka Shing Foundation; RAPIDD program of
   the Science & Technology Directorate, Department of Homeland
   SecurityUnited States Department of Homeland Security (DHS); Fogarty
   International Center (FIC), National Institutes of Health (NIH);
   European Research Council under the European UnionEuropean Research
   Council (ERC) [614725]
FX We are grateful to the Brazilian Dengue and Chikungunya network composed
   by 17 national laboratories for their assistance on preliminary
   screening diagnostics. We thank Oliver Brady for useful discussions and
   Thessika Hialla Araujo, Luiz Carlos Jr. Alcantara, and Daniele Barbosa
   Medeiros for providing epidemiological information. MRTN is supported by
   the Brazilian National Council of Scientific and Technological
   Development (CNPq) grant no. 302032/2011-8. PFCV is supported by CNPq
   grant no. 573.739/2008-0 and 240/2008/FAPESPA/INCT. JMV is a PhD student
   supported by CNPq grant no. 142492/2011-6. NG is funded by a grant from
   the Bill & Melinda Gates Foundation (#OPP1053338). MUGK is funded by the
   German Academic Exchange Service (DAAD) graduate scholarship. SIH is
   funded by a Senior Research Fellowship from the Wellcome Trust (#095066)
   and receives support from the Li Ka Shing Foundation and also
   acknowledges funding support from the RAPIDD program of the Science &
   Technology Directorate, Department of Homeland Security, and the Fogarty
   International Center (FIC), National Institutes of Health (NIH). This
   research has received funding from the European Research Council under
   the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC
   grant agreement no. 614725.
CR Apandi Y, 2009, J GEN MOL VIROL, V1, P35
   Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI 10.1093/nar/gkt1030
   Brazilian Health Portal, 2015, B EP
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Coelho GE, 2012, REV INST MED TROP SP, V54, pS13, DOI 10.1590/S0036-46652012000700006
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   FILIPE AR, 1973, B WORLD HEALTH ORGAN, V49, P37
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hassing RJ, 2010, EURO SURVEILLANCE, V15
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308
   Pan American Health Organization, CHIK
   Pan American Health Organization, 2011, PREP RESP CHIK VIR I
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242
   Sam IC, 2009, J CLIN VIROL, V46, P180, DOI 10.1016/j.jcv.2009.07.016
   Saude MD, DENG NOT REG NO SIST
   Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069
   Socioeconomic Data and Applications Center (sedac), 2010, GRIDD POP WORLD VERS
   Soumahoro MK, 2010, EMERG INFECT DIS, V16, P162, DOI 10.3201/eid1601.080776
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   TAYLOR R M, 1946, Am J Trop Med Hyg, V26, P69
   Team RC, 2014, R A LANG ENV COMP
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
NR 42
TC 194
Z9 202
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD APR 30
PY 2015
VL 13
AR 102
DI 10.1186/s12916-015-0348-x
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA CI0KC
UT WOS:000354425000001
PM 25976325
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Li, GD
   Piampongsant, S
   Faria, NR
   Voet, A
   Pineda-Pena, AC
   Khouri, R
   Lemey, P
   Vandamme, AM
   Theys, K
AF Li, Guangdi
   Piampongsant, Supinya
   Faria, Nuno Rodrigues
   Voet, Arnout
   Pineda-Pena, Andrea-Clemencia
   Khouri, Ricardo
   Lemey, Philippe
   Vandamme, Anne-Mieke
   Theys, Kristof
TI An integrated map of HIV genome-wide variation from a population
   perspective
SO RETROVIROLOGY
LA English
DT Article
DE HIV genome; Genomic diversity; Conservation; Peptide inhibitor;
   HIV-human protein interaction; HIV phylogenetic tree; HIV inter- and
   inter-clade genetic diversity; Selective pressure; Protein
   multimerization; Protein intrinsic disorder
ID IMMUNODEFICIENCY-VIRUS TYPE-1; DISORDERED REGIONS; SEQUENCE ALIGNMENT;
   VACCINE; DIVERSITY; INFECTION; EVOLUTION; INHIBITORS; PREDICTION;
   PROTEINS
AB Background: The HIV pandemic is characterized by extensive genetic variability, which has challenged the development of HIV drugs and vaccines. Although HIV genomes have been classified into different types, groups, subtypes and recombinants, a comprehensive study that maps HIV genome-wide diversity at the population level is still lacking to date. This study aims to characterize HIV genomic diversity in large-scale sequence populations, and to identify driving factors that shape HIV genome diversity.
   Results: A total of 2996 full-length genomic sequences from 1705 patients infected with 16 major HIV groups, subtypes and circulating recombinant forms (CRFs) were analyzed along with structural, immunological and peptide inhibitor information. Average nucleotide diversity of HIV genomes was almost 50% between HIV-1 and HIV-2 types, 37.5% between HIV-1 groups, 14.7% between HIV-1 subtypes, 8.2% within individual HIV-1 subtypes and less than 1% within single patients. Along the HIV genome, diversity patterns and compositions of nucleotides and amino acids were highly similar across different groups, subtypes and CRFs. Current HIV-derived peptide inhibitors were predominantly derived from conserved, solvent accessible and intrinsically ordered structures in the HIV-1 subtype B genome. We identified these conserved regions in Capsid, Nucleocapsid, Protease, Integrase, Reverse transcriptase, Vpr and the GP41 N terminus as potential drug targets. In the analysis of factors that impact HIV-1 genomic diversity, we focused on protein multimerization, immunological constraints and HIV-human protein interactions. We found that amino acid diversity in monomeric proteins was higher than in multimeric proteins, and diversified positions were preferably located within human CD4 T cell and antibody epitopes. Moreover, intrinsic disorder regions in HIV-1 proteins coincided with high levels of amino acid diversity, facilitating a large number of interactions between HIV-1 and human proteins.
   Conclusions: This first large-scale analysis provided a detailed mapping of HIV genomic diversity and highlighted drug-target regions conserved across different groups, subtypes and CRFs. Our findings suggest that, in addition to the impact of protein multimerization and immune selective pressure on HIV-1 diversity, HIV-human protein interactions are facilitated by high variability within intrinsically disordered structures.
C1 [Li, Guangdi; Piampongsant, Supinya] Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China.
   [Li, Guangdi; Piampongsant, Supinya; Pineda-Pena, Andrea-Clemencia; Khouri, Ricardo; Lemey, Philippe; Vandamme, Anne-Mieke; Theys, Kristof] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Voet, Arnout] RIKEN, Inst Labs, Zhang IRU, Wako, Saitama, Japan.
   [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Fac Sci & Math, Clin & Mol Infect Dis Grp, Bogota, Colombia.
   [Khouri, Ricardo] Fiocruz MS, Ctr Pesquisa Goncalo Moniz, LIMI LIP, Salvador, Brazil.
   [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal.
   [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, P-1200 Lisbon, Portugal.
RP Li, GD (corresponding author), Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China.
EM liguangdi.research@gmail.com; Kristof.Theys@rega.kuleuven.be
RI Khouri, Ricardo/M-3184-2018; Lemey, Philippe/C-3755-2018; Faria, Nuno
   R/I-2975-2012; Vandamme, Anne-Mieke/I-4127-2012; Li,
   Guangdi/AAU-6951-2020; Pineda-Pena, Andrea-Clemencia/N-9809-2015
OI Khouri, Ricardo/0000-0001-5664-4436; Lemey,
   Philippe/0000-0003-2826-5353; Faria, Nuno R/0000-0001-8839-2798;
   Vandamme, Anne-Mieke/0000-0002-6594-2766; Pineda-Pena,
   Andrea-Clemencia/0000-0003-1937-0506; Li, Guangdi/0000-0001-8852-034X
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81130015]; National Basic Research Program
   of ChinaNational Basic Research Program of China [2014CB910500]; Fonds
   voor Wetenschappelijk Onderzoek - Flanders (FWO)FWO [PDO/11, G069214N];
   European CommunityEuropean Community (EC) [223131]
FX We thank Fossie Ferreira, Jasper Edgar Neggers, Soraya Maria Menezes and
   Tim Dierckx for technical assistance and valuable contributions to our
   analysis. This work was supported by the National Nature Science
   Foundation of China [81130015]; the National Basic Research Program of
   China [2014CB910500]; the Fonds voor Wetenschappelijk Onderzoek -
   Flanders (FWO) [PDO/11 to K.T., G069214N]; the European Community's
   Seventh Framework Programme (FP7/2007-2013) under the project
   "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)"
   [223131].
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594
   Boons E, 2014, ANTIVIR RES, V112, P91, DOI 10.1016/j.antiviral.2014.10.007
   Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005
   Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427
   Buck PM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003291
   Burnett JC, 2012, CURR OPIN IMMUNOL, V24, P625, DOI 10.1016/j.coi.2012.08.013
   Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436
   Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8
   Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747
   Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213
   Fauci AS, 2013, NAT IMMUNOL, V14, P1104, DOI 10.1038/ni.2735
   Fernandez-Garcia A, 2009, AIDS RES HUM RETROV, V25, P93, DOI 10.1089/aid.2008.0174
   Fernandez-Garcia A, 2012, AIDS RES HUM RETROV, V28, P1340, DOI 10.1089/aid.2011.0393
   Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1
   Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0
   He YX, 2013, CURR PHARM DESIGN, V19, P1800, DOI 10.2174/1381612811319100004
   Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001
   Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93
   Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529
   Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195
   Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719
   Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480
   Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19
   Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P727, DOI 10.1089/aid.2008.0239
   Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516
   Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028
   Li G, 2014, THESIS U LEUVEN
   Li GD, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-014-0031-8
   Li GD, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0079-7
   Li GD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-126
   Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200
   Llano A, 2009, HIV MOL IMMUNOL, V2009, P3, DOI DOI 10.1016/J.M0LIMM.2008.12.019
   Mayrose I, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-164
   Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208
   Perry CM, 2014, DRUGS, V74, P75, DOI 10.1007/s40265-013-0158-4
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246
   Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477
   Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157
   Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519
   Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316
   Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009
   Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552
   Santoro M.M., 2013, ISRN MICROBIOL, V2013, P1, DOI DOI 10.1155/2013/481314
   Snoeck J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-87
   Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079
   Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073
   Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739
   Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022
   van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92
   Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08
   Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3
   Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801
NR 64
TC 54
Z9 54
U1 0
U2 20
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD FEB 15
PY 2015
VL 12
AR 18
DI 10.1186/s12977-015-0148-6
PG 16
WC Virology
SC Virology
GA CD1RW
UT WOS:000350853000001
PM 25808207
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Pineda-Pena, AC
   Faria, NR
   Mina, T
   Amini-Bavil-Olyaee, S
   Alavian, SM
   Lemey, P
   Maes, P
   Van Ranst, M
   Pourkarim, MR
AF Pineda-Pena, Andrea-Clemencia
   Faria, Nuno Rodrigues
   Mina, Thomas
   Amini-Bavil-Olyaee, Samad
   Alavian, Seyed Moayed
   Lemey, Philippe
   Maes, Piet
   Van Ranst, Marc
   Pourkarim, Mahmoud Reza
TI Epidemiological history and genomic characterization of non-D1 HBV
   strains identified in Iran
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Hepatitis B virus; D2; D3; Evolution; Ancestor; Mutation; Iran
ID HEPATITIS-B-VIRUS; FULL-LENGTH GENOMES; BELGIAN PATIENTS;
   SURFACE-ANTIGEN; MOLECULAR CHARACTERIZATION; EVOLUTIONARY ANALYSIS;
   PHYLOGENETIC ANALYSIS; CORE PROMOTER; BLOOD-DONORS; GENOTYPE-D
AB Background: Hepatitis B virus (HBV) has been classified into eight genotypes and forty subgenotypes. Genotype D of HBV is the most worldwide distributed genotype and HBV subgenotype D1 has been isolated from Iranian patients.
   Objective: To characterize for the first time complete genomes of recently emerged non-D1 strains in Iran.
   Study design: HBV complete genomes isolated from 9 Iranian HBV carriers were sequenced. Different diversities of the ORFs were mapped and evolutionary history relationships were investigated.
   Results: Phylogenetic analysis identified four D2 subgenotypes and five D3 subgenotypes of HBV in the studied patients. Of note, D2 strains clustered with strains from Lebanon and Syria. The time of the most recent common ancestor (TMRCA) of the first cluster of D2 was dated at 1953 (BCI = 1926, 1976) while the second cluster was dated at 1947 (BCI= 1911, 1978). All five Iranian D3 strains formed a monophyletic cluster with Indian strain and dated back to 1967 (BCI= 1946, 1987). Surprisingly, two D3 strains had an adw2 subtype. Interestingly, more than 80% of the present strains showed precore mutations, while two isolates carried basal core promoter variation.
   Conclusion: Iranian D2 and D3 isolates were introduced on at least two and one occasion in Iran and diverged from west and south Asian HBV strains, respectively. Considering the impact of the different (sub) genotypes on clinical outcome, exploring the distinct mutational patterns of Iranian D1 and non-D1 strains is of clinical importance. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Pineda-Pena, Andrea-Clemencia; Mina, Thomas; Lemey, Philippe; Maes, Piet; Van Ranst, Marc; Pourkarim, Mahmoud Reza] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Pineda-Pena, Andrea-Clemencia] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia.
   [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Sch Med & Hlth Sci, Dept Basic Sci, Bogota, Colombia.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Amini-Bavil-Olyaee, Samad] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
   [Alavian, Seyed Moayed] Middle East Liver Dis Clin, Tehran 141553651, Iran.
   [Pourkarim, Mahmoud Reza] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran 146651157, Iran.
RP Pourkarim, MR (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium.
EM mahmoudreza.pourkarim@uzleuven.be
RI Lemey, Philippe/C-3755-2018; Faria, Nuno R/I-2975-2012; Van Ranst,
   Marc/P-7522-2017; Pineda-Pena, Andrea-Clemencia/N-9809-2015; POURKARIM,
   MAHMOUDREZA/M-9690-2018; Maes, Piet/P-7782-2017
OI Lemey, Philippe/0000-0003-2826-5353; Faria, Nuno R/0000-0001-8839-2798;
   Van Ranst, Marc/0000-0002-1674-4157; Pineda-Pena,
   Andrea-Clemencia/0000-0003-1937-0506; POURKARIM,
   MAHMOUDREZA/0000-0003-4620-6453; Maes, Piet/0000-0002-4571-5232
FU "Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen" of Belgium
FX Mahmoud Reza Pourkarim (MRP) is supported by a postdoctoral grant from
   the "Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen" of Belgium.
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Garmiri P, 2011, J MED VIROL, V83, P948, DOI 10.1002/jmv.21772
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049
   Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183
   McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z
   Pourkarim MR, 2011, CLIN MICROBIOL INFEC, V17, P947, DOI 10.1111/j.1469-0691.2010.03374.x
   Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152
   Pourkarim MR, 2014, J MED VIROL, V86, P745, DOI 10.1002/jmv.23864
   Pourkarim MR, 2014, J MED VIROL, V86, P144, DOI 10.1002/jmv.23798
   Pourkarim MR, 2011, J MED VIROL, V83, P1876, DOI 10.1002/jmv.22174
   Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015
   Pourkarim MR, 2010, J MED VIROL, V82, P379, DOI 10.1002/jmv.21726
   Pourkarim MR, 2010, J CLIN VIROL, V47, P93, DOI 10.1016/j.jcv.2009.09.032
   Pourkarim MR, 2009, J CLIN VIROL, V46, P61, DOI 10.1016/j.jcv.2009.06.015
   Poustchi H, 2008, J VIRAL HEPATITIS, V15, P753, DOI 10.1111/j.1365-2893.2008.00998.x
   Purdy MA, 2007, INTERVIROLOGY, V50, P45, DOI 10.1159/000096312
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Schaefer S, 2009, INTERVIROLOGY, V52, P323, DOI 10.1159/000242353
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Smolle E, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7879
   Tacke F, 2007, J CLIN VIROL, V38, P353, DOI 10.1016/j.jcv.2006.12.024
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Zehender G, 2008, VIROLOGY, V380, P84, DOI 10.1016/j.virol.2008.07.009
   Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198
   Zidan A, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6894
   Zuckerman AJ, 2006, J MED VIROL, V78, pS1, DOI 10.1002/jmv.20597
NR 32
TC 5
Z9 5
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD FEB
PY 2015
VL 63
BP 38
EP 41
DI 10.1016/j.jcv.2014.12.010
PG 4
WC Virology
SC Virology
GA AZ2BT
UT WOS:000348040300008
PM 25600602
DA 2020-09-29
ER

PT J
AU Faria, NR
   Rambaut, A
   Suchard, MA
   Baele, G
   Bedford, T
   Ward, MJ
   Tatem, AJ
   Sousa, JD
   Arinaminpathy, N
   Pepin, J
   Posada, D
   Peeters, M
   Pybus, OG
   Lemey, P
AF Faria, Nuno R.
   Rambaut, Andrew
   Suchard, Marc A.
   Baele, Guy
   Bedford, Trevor
   Ward, Melissa J.
   Tatem, Andrew J.
   Sousa, Joao D.
   Arinaminpathy, Nimalan
   Pepin, Jacques
   Posada, David
   Peeters, Martine
   Pybus, Oliver G.
   Lemey, Philippe
TI The early spread and epidemic ignition of HIV-1 in human populations
SO SCIENCE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-DEFICIENCY-SYNDROME; GENETIC
   DIVERSITY; NONPANDEMIC HIV-1; CONGO SUGGESTS; SYNDROME AIDS; GROUP-O;
   TYPE-1; ORIGIN; STRAINS
AB Thirty years after the discovery of HIV-1, the early transmission, dissemination, and establishment of the virus in human populations remain unclear. Using statistical approaches applied to HIV-1 sequence data from central Africa, we show that from the 1920s Kinshasa (in what is now the Democratic Republic of Congo) was the focus of early transmission and the source of pre-1960 pandemic viruses elsewhere. Location and dating estimates were validated using the earliest HIV-1 archival sample, also from Kinshasa. The epidemic histories of HIV-1 group M and nonpandemic group O were similar until similar to 1960, after which group M underwent an epidemiological transition and outpaced regional population growth. Our results reconstruct the early dynamics of HIV-1 and emphasize the role of social changes and transport networks in the establishment of this virus in human populations.
C1 [Faria, Nuno R.; Arinaminpathy, Nimalan; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Faria, Nuno R.; Baele, Guy; Sousa, Joao D.; Lemey, Philippe] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, B-3000 Leuven, Belgium.
   [Rambaut, Andrew; Ward, Melissa J.] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland.
   [Rambaut, Andrew; Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Rambaut, Andrew] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA.
   [Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England.
   [Sousa, Joao D.] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, P-1349008 Lisbon, Portugal.
   [Sousa, Joao D.] Univ Nova Lisboa, Unidade Microbiol, Inst Higiene & Med Trop, P-1349008 Lisbon, Portugal.
   [Pepin, Jacques] Univ Sherbrooke, Dept Microbiol & Infect Dis, CHUS, Sherbrooke, PQ J1H 5N4, Canada.
   [Posada, David] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain.
   [Peeters, Martine] Inst Rech Dev, Retrovirus Lab, UMI233, F-34032 Montpellier, France.
   [Peeters, Martine] Univ Montpellier, F-34032 Montpellier, France.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
EM oliver.pybus@zoo.ox.ac.uk; philippe.lemey@rega.kuleuven.be
RI Lemey, Philippe/C-3755-2018; Pybus, Oliver G/B-2640-2012; Baele,
   Guy/R-8157-2017; Faria, Nuno R/I-2975-2012; Rambaut, Andrew/B-2481-2009;
   Posada, David/C-4502-2008
OI Lemey, Philippe/0000-0003-2826-5353; Pybus, Oliver
   G/0000-0002-8797-2667; Baele, Guy/0000-0002-1915-7732; Faria, Nuno
   R/0000-0001-8839-2798; Rambaut, Andrew/0000-0003-4337-3707; Posada,
   David/0000-0003-1407-3406; Bedford, Trevor/0000-0002-4039-5794;
   Rodrigues Faria, Nuno/0000-0002-9747-8822; Sousa,
   Joao/0000-0002-7604-3109; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X
FU European UnionEuropean Union (EU) [278433-PREDEMICS]; European Research
   CouncilEuropean Research Council (ERC) [260864]; "Onderzoeksfonds KU
   Leuven/Research Fund KU Leuven"KU Leuven; NSFNational Science Foundation
   (NSF) [DMS 1264153, EF-0423641]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 HG006139];
   National Evolutionary Synthesis Center (NESCent)National Science
   Foundation (NSF)NSF - Directorate for Biological Sciences (BIO);
   Wellcome TrustWellcome Trust [092807]; Royal SocietyRoyal Society of
   London; Fonds voor Wetenschappelijk Onderzoek FlandersFWO [G.0692.14];
   Medical Research CouncilMedical Research Council UK (MRC)
   [MR/K010174/1B, MR/K010174/1] Funding Source: Researchfish
FX We thank the researchers whose publicly available data made this work
   possible and A. M. Vandamme, M. L. Kalish, M. Worobey, and G. Leonard
   for helpful discussions. The research leading to these results has
   received funding from the European Union Seventh Framework Programme for
   research, technological development, and demonstration under grant
   agreement no. 278433-PREDEMICS and European Research Council grant
   agreement no. 260864. P. L. was partly supported by the "Onderzoeksfonds
   KU Leuven/Research Fund KU Leuven." M. A. S. is partly supported by NSF
   grant DMS 1264153 and NIH grant R01 HG006139. Collaboration between M.
   A. S., A. R., and P. L. was supported by the National Evolutionary
   Synthesis Center (NESCent) and NSF grant EF-0423641. This work was
   supported by the Wellcome Trust (grant 092807) to A. R. T. B. was
   supported by the Royal Society. J.D.S. is partly supported by the Fonds
   voor Wetenschappelijk Onderzoek Flanders grant G.0692.14. The data
   reported in this paper are deposited in the Dryad Repository
   (http://dx.doi.org/10.5061/dryad.nn952). Author contributions: P. L.,
   O.G.P., A. R., M. A. S., M. P., and N.R.F. conceived the experiments and
   designed the study. N.R.F. and P. L. conducted the phylodynamic
   analyses. D. P. performed the recombination analysis and G. B. the model
   selection analysis. M. A. S. and T. B. contributed methodology. T. B.,
   M.J.W., and N.A. assisted the sequence analysis. J.P., A.J.T., and
   J.D.S. contributed historical and spatial data. M. P. provided sequence
   data. N.R.F., P. L., O.G.P., and A. R. wrote the paper. All authors
   discussed the results and approved the final manuscript. We declare no
   competing financial interests.
CR Ayouba A, 2000, AIDS, V14, P2623, DOI 10.1097/00002030-200011100-00033
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   BEHEYT P, 1953, Ann Soc Belg Med Trop (1920), V33, P297
   Bikandou B, 2004, AIDS RES HUM RETROV, V20, P1005, DOI 10.1089/aid.2004.20.1005
   Bonacci G., 2008, CAHIERS DETUDES AFRI, V192, P895
   Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39
   Centers for Disease Control and Prevention, 1981, MMWR-MORBID MORTAL W, V30, P250
   Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548
   de Saint-Moulin L., 2010, VILLES ET ORGANISATI
   de Sousa JD, 2012, VIRUSES-BASEL, V4, P1950, DOI 10.3390/v4101950
   de Sousa JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009936
   Duke-Sylvester SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0194
   Flouriot J., 1994, INTRODUCTION A LA GE
   GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823
   Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104
   Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61
   HANCE WA, 1970, POPULATION MIGRATION
   Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93
   Huybrechts A., 1970, TRANSPORTS ET STRUCT
   Iles JC, 2013, INFECT GENET EVOL, V19, P386, DOI 10.1016/j.meegid.2013.01.021
   Institut National de la Statistique, 1969, ETUDE SOCIO DEMOGRAP
   JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K
   Kalish ML, 2004, EMERG INFECT DIS, V10, P1227
   Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531
   Kita K, 2004, AIDS RES HUM RETROV, V20, P1352, DOI 10.1089/aid.2004.20.1352
   Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789
   KUYU C, 2006, LES HAITIENS AU CONG
   Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666
   Lemey P, 2006, AIDS REV, V8, P125
   Magiorkinis G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002876
   Mulanga-Kabeya C, 1998, AIDS, V12, P905, DOI 10.1097/00002030-199808000-00013
   Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660
   Ngimbi M., 1982, KINSHASA 1881 1981 1
   Niama FR, 2006, INFECT GENET EVOL, V6, P337, DOI 10.1016/j.meegid.2005.12.001
   NZILAMBI N, 1988, NEW ENGL J MED, V318, P276, DOI 10.1056/NEJM198802043180503
   Pandrea I, 2002, AIDS RES HUM RETROV, V18, P1103, DOI 10.1089/088922202320567842
   Peeters M, 1997, AIDS, V11, P493, DOI 10.1097/00002030-199704000-00013
   Pepin J, 2012, SEX TRANSM INFECT, V88, P307, DOI 10.1136/sextrans-2011-050277
   Pepin Jacques, 2011, THE ORIGINS OF AIDS
   PIOT P, 1984, LANCET, V2, P65
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407
   Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246
   Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179
   ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0
   Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje
   Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004
   Schierup M. H., 2003, PROCEEDINGS OF THE C, V187, P231
   Schierup MH, 2000, GENETICS, V156, P879
   Sharp PM, 2008, NATURE, V455, P605, DOI 10.1038/455605a
   UNAIDS, 2013, GLOBAL REPORTS UNAID
   Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10
   Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018
   VANDEPERRE P, 1984, LANCET, V2, P62
   Vangroenweghe D, 2001, PHILOS T ROY SOC B, V356, P923, DOI 10.1098/rstb.2001.0876
   Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000
   Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94
   Ward MJ, 2013, J VIROL, V87, P1967, DOI 10.1128/JVI.02478-12
   Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266
   Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390
   Yusim K, 2001, PHILOS T R SOC B, V356, P855, DOI 10.1098/rstb.2001.0859
   Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400
NR 63
TC 265
Z9 272
U1 6
U2 225
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD OCT 3
PY 2014
VL 346
IS 6205
BP 56
EP 61
DI 10.1126/science.1256739
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ0BR
UT WOS:000342446900048
PM 25278604
OA Green Accepted
DA 2020-09-29
ER

PT J
AU Nunes, MRT
   Palacios, G
   Faria, NR
   Sousa, EC
   Pantoja, JA
   Rodrigues, SG
   Carvalho, VL
   Medeiros, DBA
   Savji, N
   Baele, G
   Suchard, MA
   Lemey, P
   Vasconcelos, PFC
   Lipkin, WI
AF Nunes, Marcio R. T.
   Palacios, Gustavo
   Faria, Nuno Rodrigues
   Sousa, Edivaldo Costa, Jr.
   Pantoja, Jamilla A.
   Rodrigues, Sueli G.
   Carvalho, Valeria L.
   Medeiros, Daniele B. A.
   Savji, Nazir
   Baele, Guy
   Suchard, Marc A.
   Lemey, Philippe
   Vasconcelos, Pedro F. C.
   Lipkin, W. Ian
TI Air Travel Is Associated with Intracontinental Spread of Dengue Virus
   Serotypes 1-3 in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEQUENCE ALIGNMENT; DYNAMICS; PHYLOGEOGRAPHY; MODEL; REPLACEMENT;
   PERFORMANCE; INTERFACE; EVOLUTION; SELECTION; HISTORY
AB Dengue virus and its four serotypes (DENV-1 to DENV-4) infect 390 million people and are implicated in at least 25,000 deaths annually, with the largest disease burden in tropical and subtropical regions. We investigated the spatial dynamics of DENV-1, DENV-2 and DENV-3 in Brazil by applying a statistical framework to complete genome sequences. For all three serotypes, we estimated that the introduction of new lineages occurred within 7 to 10-year intervals. New lineages were most likely to be imported from the Caribbean region to the North and Northeast regions of Brazil, and then to disperse at a rate of approximately 0.5 km/day. Joint statistical analysis of evolutionary, epidemiological and ecological data indicates that aerial transportation of humans and/or vector mosquitoes, rather than Aedes aegypti infestation rates or geographical distances, determine dengue virus spread in Brazil.
   Author Summary
   Dengue virus serotypes are associated with millions of infections and thousands of deaths globally each year, primarily in tropical and subtropical regions. We investigated the spatial dynamics of DENV (serotypes 1-3) in Brazil by applying a statistical framework to complete genome sequences. Co-circulation of distinct genotypes, lineage extinction and replacement and multiple viral introduction events were found for all three serotypes. New lineages were typically introduced from the Caribbean into Northern Brazil and dispersed thereafter at a rate of approximate to 0.5 km/year. Our analysis indicates that aerial transportation is a more important determinant of viral dispersal than Aedes aegypti infestation rates or geographical distance.
C1 [Nunes, Marcio R. T.; Sousa, Edivaldo Costa, Jr.; Pantoja, Jamilla A.] Inst Evandro Chagas, Ctr Inovacao Tecnol, Ananindeua, Brazil.
   [Palacios, Gustavo] US Army, Ctr Genom Sci, Med Res Inst Infect Dis, Frederick, MD USA.
   [Palacios, Gustavo; Savji, Nazir; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY USA.
   [Faria, Nuno Rodrigues; Baele, Guy; Lemey, Philippe] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Rodrigues, Sueli G.; Carvalho, Valeria L.; Medeiros, Daniele B. A.; Vasconcelos, Pedro F. C.] Inst Evandro Chagas, Dept Arbovirol & Febres Hemorrag, Ananindeua, Brazil.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA.
   [Vasconcelos, Pedro F. C.] Univ Estado Para, Belem, Para, Brazil.
RP Nunes, MRT (corresponding author), Inst Evandro Chagas, Ctr Inovacao Tecnol, Ananindeua, Brazil.
EM marcionunes@iec.pa.gov.br
RI Faria, Nuno R/I-2975-2012; Baele, Guy/R-8157-2017; Palacios,
   Gustavo/I-7773-2015; Lemey, Philippe/C-3755-2018; Vasconcelos,
   Pedro/AAH-3142-2019; Nunes, Marcio Roberto/B-2238-2016
OI Faria, Nuno R/0000-0001-8839-2798; Baele, Guy/0000-0002-1915-7732;
   Palacios, Gustavo/0000-0001-5062-1938; Lemey,
   Philippe/0000-0003-2826-5353; Lipkin, W. Ian/0000-0002-8768-9386; Nunes,
   Marcio Roberto/0000-0001-9739-5499; Rodrigues Faria,
   Nuno/0000-0002-9747-8822
FU National Institute of Science and Technology for Viral Hemorrhagic
   Fevers (INCT-FHV) [CNP/FAPESPA/CAPES 573739/2008-0]; CNPQNational
   Council for Scientific and Technological Development (CNPq)
   [302032/2011-8, 301421/2010-2]; Fundacao para a Ciencia e
   TecnologiaPortuguese Foundation for Science and Technology
   [SFRH/BD/64530/2009]; European Union Seventh Framework Programme
   (FP7)European Union (EU) [278433-PREDEMICS]; ERCEuropean Research
   Council (ERC) [260864]; US National Science FoundationNational Science
   Foundation (NSF) [DMS 0856099]; US National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 GM086887, R01 HG006139]; National Institutes of
   Health (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); USAID (PREDICT)United States
   Agency for International Development (USAID)
FX This study was partially supported by the National Institute of Science
   and Technology for Viral Hemorrhagic Fevers (INCT-FHV grant
   CNP/FAPESPA/CAPES 573739/2008-0), MRTN is supported by CNPQ (grant
   302032/2011-8). PFCV is supported by CNPq (grant 301421/2010-2). NRF is
   supported by Fundacao para a Ciencia e Tecnologia under grant agreement
   no. SFRH/BD/64530/2009. The research leading to these results has
   received funding from the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no. 278433-PREDEMICS and ERC grant
   agreement no. 260864, the US National Science Foundation (DMS 0856099)
   and the US National Institutes of Health (R01 GM086887 and R01
   HG006139). Work in the Center for Infection and Immunity is supported by
   grants from the National Institutes of Health (NIAID) and USAID
   (PREDICT). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   Alfonso HL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-124
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI 10.1093/nar/gkq1079
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0196
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784
   Gibbons R V, 1563, CLIN REV DENGUE ESCA
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Gubler D. J., 1997, Dengue Bulletin, V21, P1
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
   Holmes EC, 2013, CURR OPIN VIROL, V3, P180, DOI 10.1016/j.coviro.2012.12.003
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lemey P, 2012, ARXIV12105877V1QBIOP, P1
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lourenco J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000894
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785
   Ordonez-Gonzalez JG, 2001, J AM MOSQUITO CONTR, V17, P93
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Patz J. A., 2005, HUMAN HLTH ECOSYSTEM
   Pedro A, 1923, BRAS MED, V1, P172
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rambaut A, 2002, SE AL SEQUENCE ALIGN
   Rodhain F., 1997, DENGUE DENGUE HEMORR
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757
   WHO, 2008, DENG FEV DENG HEM FE
NR 55
TC 50
Z9 50
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2014
VL 8
IS 4
DI 10.1371/journal.pntd.0002769
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AG3TK
UT WOS:000335342400043
PM 24743730
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Bezemer, D
   Faria, NR
   Hassan, A
   Hamers, RL
   Mutua, G
   Anzala, O
   Mandaliya, K
   Cane, P
   Berkley, JA
   de Wit, TFR
   Wallis, C
   Graham, SM
   Price, MA
   Coutinho, RA
   Sanders, EJ
AF Bezemer, Daniela
   Faria, Nuno Rodrigues
   Hassan, Amin
   Hamers, Raph L.
   Mutua, Gaudensia
   Anzala, Omu
   Mandaliya, Kishor
   Cane, Patricia
   Berkley, James A.
   de Wit, Tobias F. Rinke
   Wallis, Carole
   Graham, Susan M.
   Price, Matthew A.
   Coutinho, Roel A.
   Sanders, Eduard J.
TI HIV Type 1 Transmission Networks Among Men Having Sex with Men and
   Heterosexuals in Kenya
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; SUB-SAHARAN AFRICA; MOLECULAR
   EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; DIVERSITY;
   DYNAMICS; WORKERS; MOMBASA; PHYLODYNAMICS
AB We performed a molecular phylogenetic study on HIV-1 polymerase sequences of men who have sex with men (MSM) and heterosexual patient samples in Kenya to characterize any observed HIV-1 transmission networks. HIV-1 polymerase sequences were obtained from samples in Nairobi and coastal Kenya from 84 MSM, 226 other men, and 364 women from 2005 to 2010. Using Bayesian phylogenetics, we tested whether sequences clustered by sexual orientation and geographic location. In addition, we used trait diffusion analyses to identify significant epidemiological links and to quantify the number of transmissions between risk groups. Finally, we compared 84 MSM sequences with all HIV-1 sequences available online at GenBank. Significant clustering of sequences from MSM at both coastal Kenya and Nairobi was found, with evidence of HIV-1 transmission between both locations. Although a transmission pair between a coastal MSM and woman was confirmed, no significant HIV-1 transmission was evident between MSM and the comparison population for the predominant subtype A (60%). However, a weak but significant link was evident when studying all subtypes together. GenBank comparison did not reveal other important transmission links. Our data suggest infrequent intermingling of MSM and heterosexual HIV-1 epidemics in Kenya.
C1 [Bezemer, Daniela] HIV Monitoring Fdn, Amsterdam, Netherlands.
   [Faria, Nuno Rodrigues] Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium.
   [Hassan, Amin; Berkley, James A.; Graham, Susan M.; Sanders, Eduard J.] Kenya Govt Med Res Ctr, Ctr Geog Med Research Coast, Kilifi, Kenya.
   [Hamers, Raph L.; de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, PharmAccess Fdn,Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands.
   [Mutua, Gaudensia; Anzala, Omu] Univ Nairobi, Kenya AIDS Vaccine Initiat, Nairobi, Kenya.
   [Mandaliya, Kishor] Coast Prov Gen Hosp, Mombasa, Kenya.
   [Cane, Patricia] Hlth Protect Agcy, London, England.
   [Berkley, James A.; Sanders, Eduard J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England.
   [Wallis, Carole] Lancet Labs, Johannesburg, South Africa.
   [Graham, Susan M.] Univ Washington, Seattle, WA 98195 USA.
   [Price, Matthew A.] Int AIDS Vaccine Initiat, New York, NY USA.
   [Price, Matthew A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Coutinho, Roel A.] RIVM, Ctr Infect Dis Control, Utrecht, Netherlands.
   [Coutinho, Roel A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
RP Bezemer, D (corresponding author), Stichting HIV Monitoring, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM dnladnla@gmail.com
RI Graham, Susan/W-6133-2019; Faria, Nuno R/I-2975-2012
OI Graham, Susan/0000-0001-7847-8686; Faria, Nuno R/0000-0001-8839-2798;
   Price, Matt/0000-0002-2918-1373; Berkley, James/0000-0002-1236-849X;
   Rodrigues Faria, Nuno/0000-0002-9747-8822
FU HIV Monitoring Foundation in Amsterdam, The NetherlandsNetherlands
   Government; Wellcome TrustWellcome Trust [077092]; Fundacao para a
   Ciencia e TecnologiaPortuguese Foundation for Science and Technology
   [SFRH/BD/64530/2009]; University of Washington Center for AIDS Research
   (CFAR), an NIH [P30 AI027757]; Ministry of Foreign Affairs of The
   Netherlands through Stichting Aids Fonds [12454]; International AIDS
   Vaccine Initiative (IAVI)
FX The authors would like to thank the HIV Monitoring Foundation in
   Amsterdam, The Netherlands for supporting this study; Willem Vermin at
   SARA, Amsterdam, for help in using R on the supercomputer; Michael
   Worobey at the University of Arizona, Tucson, Arizona, for reading and
   commenting on an earlier draft of the article; Philippe Lemey at the
   Katholieke Universiteit, Leuven, Belgium, for helpful comments on the
   study design; and Bas E. Dutilh at the University of Nijmegen, The
   Netherlands, for discussions and help with the figures. We thank all
   participants in the study and the International AIDS Vaccine Initiative
   (IAVI) for supporting the high-risk cohort study in Kilifi and Nairobi,
   and the staff of the HIV/STI project at The Kenya Medical Research
   Institute-Wellcome Trust Research Programme (KWTRP) in Kilifi and
   KAVI-Kangemi, Nairobi, for their commitment to serving MSM.; The KWTRP
   at the Centre for Geographical Medicine Research-Kilifi is supported by
   core funding from the Wellcome Trust (#077092). Nuno Rodrigues Faria is
   supported by Fundacao para a Ciencia e Tecnologia, under Grant
   SFRH/BD/64530/2009. The KEMRI-Clinic in Mtwapa also received support
   from the University of Washington Center for AIDS Research (CFAR), an
   NIH-funded program (P30 AI027757). This work was made possible in part
   by the generous support of the American people through the United States
   Agency for International Development (USAID). The contents are the
   responsibility of the study authors and do not necessarily reflect the
   views of USAID, the NIH, or the United States Government. This report
   was published with permission from the Director of KEMRI. The
   PharmAccess African Studies to Evaluate Resistance (PASER) is an
   initiative of the PharmAccess Foundation, with financial support
   provided by the Ministry of Foreign Affairs of The Netherlands through a
   partnership with Stichting Aids Fonds (Grant 12454).
CR Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09
   [Anonymous], 2012, FIGTREE TRACER
   Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108
   Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011
   Bezemer D, 2008, AIDS, V22, P309, DOI 10.1097/QAD.0b013e3282f37489
   Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee
   de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Fisher M, 2010, AIDS, V24, P1739, DOI 10.1097/QAD.0b013e32833ac9e6
   Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d
   Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61
   Hamers RL, 2012, INT J EPIDEMIOL, V41, P43, DOI 10.1093/ije/dyq192
   Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9
   HOLMES EC, 1995, J INFECT DIS, V171, P45, DOI 10.1093/infdis/171.1.45
   Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102
   Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]
   Hue S, 2012, AIDS RES HUM RETROV, V28, P220, DOI 10.1089/aid.2011.0048
   Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08
   Johnson Victoria A, 2010, Top HIV Med, V18, P156
   Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489
   Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951
   Kramer MA, 2011, AIDS RES HUM RETROV, V27, P123, DOI 10.1089/aid.2010.0115
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050
   Mannava P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052547
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581
   Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030
   Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693
   Resik S, 2007, AIDS RES HUM RETROV, V23, P347, DOI 10.1089/aid.2006.0158
   Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a
   Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81
   Sanders EJ, 2010, SEX TRANSM INFECT, V86, P440, DOI 10.1136/sti.2010.043224
   Skar H, 2011, J VIROL, V85, P510, DOI 10.1128/JVI.01413-10
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tovanabutra S, 2010, AIDS RES HUM RETROV, V26, P123, DOI 10.1089/aid.2009.0115
   UNAIDS, 2011, 2011 REP GLOB AIDS E
   Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390
NR 48
TC 24
Z9 24
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD FEB 1
PY 2014
VL 30
IS 2
BP 118
EP 126
DI 10.1089/aid.2013.0171
PG 9
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA AA6NI
UT WOS:000331214600002
PM 23947948
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Lemey, P
   Rambaut, A
   Bedford, T
   Faria, N
   Bielejec, F
   Baele, G
   Russell, CA
   Smith, DJ
   Pybus, OG
   Brockmann, D
   Suchard, MA
AF Lemey, Philippe
   Rambaut, Andrew
   Bedford, Trevor
   Faria, Nuno
   Bielejec, Filip
   Baele, Guy
   Russell, Colin A.
   Smith, Derek J.
   Pybus, Oliver G.
   Brockmann, Dirk
   Suchard, Marc A.
TI Unifying Viral Genetics and Human Transportation Data to Predict the
   Global Transmission Dynamics of Human Influenza H3N2
SO PLOS PATHOGENS
LA English
DT Article
ID PANDEMIC INFLUENZA; SPREAD; MODEL; VIRUS; SIMULATION; EVOLUTION;
   EPIDEMIC; ACCURATE; SCALE
AB Information on global human movement patterns is central to spatial epidemiological models used to predict the behavior of influenza and other infectious diseases. Yet it remains difficult to test which modes of dispersal drive pathogen spread at various geographic scales using standard epidemiological data alone. Evolutionary analyses of pathogen genome sequences increasingly provide insights into the spatial dynamics of influenza viruses, but to date they have largely neglected the wealth of information on human mobility, mainly because no statistical framework exists within which viral gene sequences and empirical data on host movement can be combined. Here, we address this problem by applying a phylogeographic approach to elucidate the global spread of human influenza subtype H3N2 and assess its ability to predict the spatial spread of human influenza A viruses worldwide. Using a framework that estimates the migration history of human influenza while simultaneously testing and quantifying a range of potential predictive variables of spatial spread, we show that the global dynamics of influenza H3N2 are driven by air passenger flows, whereas at more local scales spread is also determined by processes that correlate with geographic distance. Our analyses further confirm a central role for mainland China and Southeast Asia in maintaining a source population for global influenza diversity. By comparing model output with the known pandemic expansion of H1N1 during 2009, we demonstrate that predictions of influenza spatial spread are most accurate when data on human mobility and viral evolution are integrated. In conclusion, the global dynamics of influenza viruses are best explained by combining human mobility data with the spatial information inherent in sampled viral genomes. The integrated approach introduced here offers great potential for epidemiological surveillance through phylogeographic reconstructions and for improving predictive models of disease control.
   Author Summary What explains the geographic dispersal of emerging pathogens? Reconstructions of evolutionary history from pathogen gene sequences offer qualitative descriptions of spatial spread, but current approaches are poorly equipped to formally test and quantify the contribution of different potential explanatory factors, such as human mobility and demography. Here, we use a novel phylogeographic method to evaluate multiple potential predictors of viral spread in human influenza dynamics. We identify air travel as the predominant driver of global influenza migration, whilst also revealing the contribution of other mobility processes at more local scales. We demonstrate the power of our inter-disciplinary approach by using it to predict the global pandemic expansion of H1N1 influenza in 2009. Our study highlights the importance of integrating evolutionary and ecological information when studying the dynamics of infectious disease.
C1 [Lemey, Philippe; Faria, Nuno; Bielejec, Filip; Baele, Guy] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium.
   [Rambaut, Andrew; Bedford, Trevor] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Russell, Colin A.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England.
   [Russell, Colin A.; Smith, Derek J.] WHO, Collaborating Ctr Modeling Evolut & Control Emerg, Cambridge, England.
   [Smith, Derek J.] Erasmus MC, Dept Virol, Rotterdam, Netherlands.
   [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Brockmann, Dirk] Northwestern Univ, Evanston, IL USA.
   [Brockmann, Dirk] Northwestern Inst Complex Syst, Evanston, IL USA.
   [Brockmann, Dirk] Robert Koch Inst, Berlin, Germany.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA.
RP Lemey, P (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium.
EM philippe.lemey@rega.kuleuven.be
RI Smith, Derek/Z-3075-2019; Baele, Guy/R-8157-2017; Pybus, Oliver
   G/B-2640-2012; Lemey, Philippe/C-3755-2018; Rambaut, Andrew/B-2481-2009;
   Faria, Nuno R/I-2975-2012
OI Smith, Derek/0000-0002-2393-1890; Baele, Guy/0000-0002-1915-7732; Pybus,
   Oliver G/0000-0002-8797-2667; Lemey, Philippe/0000-0003-2826-5353;
   Rambaut, Andrew/0000-0003-4337-3707; Faria, Nuno R/0000-0001-8839-2798;
   Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Rodrigues Faria,
   Nuno/0000-0002-9747-8822; Bedford, Trevor/0000-0002-4039-5794; Russell,
   Colin/0000-0002-2113-162X
FU European UnionEuropean Union (EU) [278433-PREDEMICS, 260864];
   NSFNational Science Foundation (NSF) [DMS 1264153]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI107034, R01 HG006139]; National Evolutionary Synthesis
   Center (NESCent)National Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO) [NSF EF-0423641]; Wellcome TrustWellcome Trust
   [092807]; Royal SocietyRoyal Society of London; EUEuropean Union (EU)
   [223498, 278976]; Human Frontier Science Program (HFSP)Human Frontier
   Science Program [P0050/2008]; NIH Director's Pioneer AwardUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [DP1-OD000490-01]; National Institute of Allergy and Infectious
   Diseases NIH CEIRS [HHSN266200700010C]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme [FP7/2007-2013] under Grant
   Agreement no. 278433-PREDEMICS and ERC Grant agreement no. 260864. MAS
   is in part supported by NSF grant DMS 1264153 and NIH grants R01
   AI107034 and R01 HG006139. Collaboration between MAS, AR and PL was
   supported by the National Evolutionary Synthesis Center (NESCent), NSF
   EF-0423641. This work was supported by the Wellcome Trust [092807] to
   AR. TB is supported by the Royal Society. DJS and CAR acknowledge EU FP7
   programs EMPERIE (223498) and ANTIGONE (278976), Human Frontier Science
   Program (HFSP) program grant P0050/2008, Wellcome 087982AIA, NIH
   Director's Pioneer Award DP1-OD000490-01 and National Institute of
   Allergy and Infectious Diseases NIH CEIRS contract HHSN266200700010C.
   CAR was supported by a University Research Fellowship from the Royal
   Society. Further, research was partially completed while PL and MAS were
   visiting the Institute for Mathematical Sciences, National University of
   Singapore in 2011. No funding bodies had any role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108
   Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918
   Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401
   Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921
   Chipman H., 2001, IMS LECT NOTES MONOG, V38, P67, DOI DOI 10.1214/LNMS/1215540964.655
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322
   Grady D, 2012, SPRINGER SER OPTIM A, V57, P169, DOI 10.1007/978-1-4614-0754-6_7
   Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da
   Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7
   LONGINI IM, 1986, AM J EPIDEMIOL, V123, P383, DOI 10.1093/oxfordjournals.aje.a114253
   MALLICK B., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137
   RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1
   Schuster H. G., 2009, DIFFUSION FUNDAMENTA, P55
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422
   Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-37
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503
   Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350
NR 36
TC 149
Z9 150
U1 2
U2 52
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2014
VL 10
IS 2
AR e1003932
DI 10.1371/journal.ppat.1003932
PG 10
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA AB9CC
UT WOS:000332085900036
PM 24586153
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Josefsson, L
   von Stockenstrom, S
   Faria, NR
   Sinclair, E
   Bacchetti, P
   Killian, M
   Epling, L
   Tan, A
   Ho, T
   Lemey, P
   Shao, W
   Hunt, PW
   Somsouk, M
   Wylie, W
   Douek, DC
   Loeb, L
   Custer, J
   Hoh, R
   Poole, L
   Deeks, SG
   Hecht, F
   Palmer, S
AF Josefsson, Lina
   von Stockenstrom, Susanne
   Faria, Nuno R.
   Sinclair, Elizabeth
   Bacchetti, Peter
   Killian, Maudi
   Epling, Lorrie
   Tan, Alice
   Ho, Terence
   Lemey, Philippe
   Shao, Wei
   Hunt, Peter W.
   Somsouk, Ma
   Wylie, Will
   Douek, Daniel C.
   Loeb, Lisa
   Custer, Jeff
   Hoh, Rebecca
   Poole, Lauren
   Deeks, Steven G.
   Hecht, Frederick
   Palmer, Sarah
TI The HIV-1 reservoir in eight patients on long-term suppressive
   antiretroviral therapy is stable with few genetic changes over time
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; LOW-LEVEL VIREMIA;
   DRUG-RESISTANCE; RALTEGRAVIR INTENSIFICATION; INFECTED INDIVIDUALS;
   LYMPHOID-TISSUE; IN-VIVO; TYPE-1; REPLICATION
AB The source and dynamics of persistent HIV-1 during long-term combinational antiretroviral therapy (cART) are critical to understanding the barriers to curing HIV-1 infection. To address this issue, we isolated and genetically characterized HIV-1 DNA from naive and memory T cells from peripheral blood and gut-associated lymphoid tissue (GALT) from eight patients after 4-12 y of suppressive cART. Our detailed analysis of these eight patients indicates that persistent HIV-1 in peripheral blood and GALT is found primarily in memory CD4(+) T cells [CD45RO(+)/CD27((+/-))]. The HIV-1 infection frequency of CD4(+) T cells from peripheral blood and GALT was higher in patients who initiated treatment during chronic compared with acute/early infection, indicating that early initiation of therapy results in lower HIV-1 reservoir size in blood and gut. Phylogenetic analysis revealed an HIV-1 genetic change between RNA sequences isolated before initiation of cART and intracellular HIV-1 sequences from the T-cell subsets after 4-12 y of suppressive cART in four of the eight patients. However, evolutionary rate analyses estimated no greater than three nucleotide substitutions per gene region analyzed during all of the 4-12 y of suppressive therapy. We also identified a clearly replication incompetent viral sequence in multiple memory T cells in one patient, strongly supporting asynchronous cell replication of a cell containing integrated HIV-1 DNA as the source. This study indicates that persistence of a remarkably stable population of infected memory cells will be the primary barrier to a cure, and, with little evidence of viral replication, this population could be maintained by homeostatic cell proliferation or other processes.
C1 [Josefsson, Lina; von Stockenstrom, Susanne; Palmer, Sarah] Swedish Inst Infect Dis Control, Dept Diagnost & Vaccinol, S-17182 Solna, Sweden.
   [Josefsson, Lina; von Stockenstrom, Susanne; Palmer, Sarah] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17182 Solna, Sweden.
   [Faria, Nuno R.; Lemey, Philippe] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Louvain, Belgium.
   [Sinclair, Elizabeth; Killian, Maudi; Epling, Lorrie; Tan, Alice; Ho, Terence; Hunt, Peter W.; Somsouk, Ma; Loeb, Lisa; Custer, Jeff; Hoh, Rebecca; Poole, Lauren; Deeks, Steven G.; Hecht, Frederick] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA.
   [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Shao, Wei] NCI, Adv Biomed Comp Ctr, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21702 USA.
   [Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.
   [Palmer, Sarah] Westmead Millennium Inst, Ctr Virus Res, Westmead, NSW 2145, Australia.
   [Palmer, Sarah] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
RP Josefsson, L (corresponding author), Swedish Inst Infect Dis Control, Dept Diagnost & Vaccinol, S-17182 Solna, Sweden.
EM Lina.Odevall@gmail.com
RI Faria, Nuno R/I-2975-2012; Lemey, Philippe/C-3755-2018
OI Faria, Nuno R/0000-0001-8839-2798; Lemey, Philippe/0000-0003-2826-5353;
   Rodrigues Faria, Nuno/0000-0002-9747-8822; Loeb Stanga,
   Lisa/0000-0001-7471-5381; Hecht, Frederick/0000-0002-5782-1171
FU amfAR Research Consortium on HIV Eradication (ARCHE); Foundation for
   AIDS Research [amfAR 107857-48-RGRL]; Delaney AIDS Research Enterprise
   [U19 AI096109]; Swedish International Development Agency [SWE-2009-046];
   Swedish Research CouncilSwedish Research Council [K2011-56X-21749-01-6];
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI071713,
   K24AI069994, K23 CA157929]; UCSF-Gladstone Institute of Virology and
   Immunology Center for AIDS Research [P30AI027763, P30 MH59037];
   NIH/National Center for Research Resources UCSF Clinical and
   Translational Science InstituteUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [UL1RR024131]; European Union
   Seventh Framework ProgrammeEuropean Union (EU) [FP7/2007-2013,
   278433-PREDEMICS]; European Research CouncilEuropean Research Council
   (ERC) [260864]; Erik and Edith Fernstrom Foundation for Medical
   Research; Fundacao para a Ciencia e TecnologiaPortuguese Foundation for
   Science and Technology [SFRH/BD/64530/2009]; Karolinska Institutet
   alumni funds
FX We thank the patients participating in this study. This work was
   primarily supported by an amfAR Research Consortium on HIV Eradication
   (ARCHE) Collaborative Research Grant from The Foundation for AIDS
   Research (amfAR 107857-48-RGRL) and Delaney AIDS Research Enterprise
   (U19 AI096109). The work was also supported by the Swedish International
   Development Agency (SWE-2009-046), The Swedish Research Council
   (K2011-56X-21749-01-6), the National Institutes of Health (NIH)
   [(AI071713, K24AI069994, and K23 CA157929), the UCSF-Gladstone Institute
   of Virology and Immunology Center for AIDS Research (P30AI027763 and P30
   MH59037), the NIH/National Center for Research Resources UCSF Clinical
   and Translational Science Institute (UL1RR024131), the European Union
   Seventh Framework Programme [FP7/2007-2013] under Grant Agreement
   278433-PREDEMICS, and European Research Council Grant Agreement 260864.
   L. J. was supported by the Erik and Edith Fernstrom Foundation for
   Medical Research and by Karolinska Institutet alumni funds. N. R. F. is
   supported by Fundacao para a Ciencia e Tecnologia under Grant Agreement
   SFRH/BD/64530/2009.
CR Almodovar S, 2007, VIROLOGY, V369, P35, DOI 10.1016/j.virol.2007.07.010
   Anton PA, 2003, AIDS, V17, P53, DOI 10.1097/00002030-200301030-00008
   Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06
   Burke B, 2007, J VIROL, V81, P7424, DOI 10.1128/JVI.02838-06
   Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111
   Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972
   Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324
   Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869
   Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262
   Di Stefano M, 2001, J MED VIROL, V65, P637, DOI 10.1002/jmv.2084
   Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106
   Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581
   Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174
   Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506
   Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295
   Fulcher JA, 2004, J VIROL, V78, P7883, DOI 10.1128/JVI.78.15.7883-7893.2004
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Havlir DV, 2005, J INFECT DIS, V191, P1164, DOI 10.1086/428588
   HUDSON RR, 1992, GENETICS, V132, P583
   Josefsson L, 2012, J INFECT DIS, V206, P28, DOI 10.1093/infdis/jis301
   Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08
   Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478
   Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488
   Kim HJ, 2006, PLOS COMPUT BIOL, V2, P1232, DOI 10.1371/journal.pcbi.0020135
   Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114
   Lampinen TM, 2000, AIDS, V14, pF69, DOI 10.1097/00002030-200003310-00001
   Lemey P, 2006, AIDS REV, V8, P125
   Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999
   Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046
   McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749
   Mens H, 2007, AIDS RES HUM RETROV, V23, P107, DOI 10.1089/aid.2006.0089
   Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f
   MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04
   Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005
   Palmer S, 2011, J INTERN MED, V270, P550, DOI 10.1111/j.1365-2796.2011.02457.x
   Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105
   Persaud D, 2007, AIDS RES HUM RETROV, V23, P381, DOI 10.1089/aid.2006.0175
   Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14
   Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907
   Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777
   Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005
   Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001
   Wightman F, 2010, J INFECT DIS, V202, P1738, DOI 10.1086/656721
   Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291
   Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722
   Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb
   Zalar A, 2010, ANTIVIR RES, V87, P269, DOI 10.1016/j.antiviral.2010.05.005
   Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06
   Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101
   Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002
NR 57
TC 164
Z9 166
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 17
PY 2013
VL 110
IS 51
BP E4987
EP E4996
DI 10.1073/pnas.1308313110
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 273PR
UT WOS:000328548600010
PM 24277811
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Pineda-Pena, AC
   Faria, NR
   Imbrechts, S
   Libin, P
   Abecasis, AB
   Deforche, K
   Gomez-Lopez, A
   Camacho, RJ
   de Oliveira, T
   Vandamme, AM
AF Pineda-Pena, Andrea-Clemencia
   Faria, Nuno Rodrigues
   Imbrechts, Stijn
   Libin, Pieter
   Abecasis, Ana Barroso
   Deforche, Koen
   Gomez-Lopez, Arley
   Camacho, Ricardo J.
   de Oliveira, Tulio
   Vandamme, Anne-Mieke
TI Automated subtyping of HIV-1 genetic sequences for clinical and
   surveillance purposes: Performance evaluation of the new REGA version 3
   and seven other tools
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE HIV-1; Subtypes; Subtyping; Sensitivity; Phylogenetic analysis; CRF
ID IMMUNODEFICIENCY-VIRUS TYPE-1; NON-B SUBTYPES; CIRCULATING RECOMBINANT
   FORM; DRUG-RESISTANCE; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD;
   DIVERSITY; RECOMMENDATIONS; RELIABILITY; ALGORITHMS
AB Background: To investigate differences in pathogenesis, diagnosis and resistance pathways between HIV-1 subtypes, an accurate subtyping tool for large datasets is needed. We aimed to evaluate the performance of automated subtyping tools to classify the different subtypes and circulating recombinant forms using pol, the most sequenced region in clinical practice. We also present the upgraded version 3 of the Rega HIV subtyping tool (REGAv3).
   Methodology: HIV-1 pol sequences (PR + RT) for 4674 patients retrieved from the Portuguese HIV Drug Resistance Database, and 1872 pol sequences trimmed from full-length genomes retrieved from the Los Alamos database were classified with statistical-based tools such as COMET, jpHMM and STAR; similarity-based tools such as NCBI and Stanford; and phylogenetic-based tools such as REGA version 2 (REGAv2), REGAv3, and SCUEAL. The performance of these tools, for pol, and for PR and RT separately, was compared in terms of reproducibility, sensitivity and specificity with respect to the gold standard which was manual phylogenetic analysis of the pol region.
   Results: The sensitivity and specificity for subtypes B and C was more than 96% for seven tools, but was variable for other subtypes such as A, D, F and G. With regard to the most common circulating recombinant forms (CRFs), the sensitivity and specificity for CRF01_AE was similar to 99% with statistical-based tools, with phylogenetic-based tools and with Stanford, one of the similarity based tools. CRF02_AG was correctly identified for more than 96% by COMET, REGAv3, Stanford and STAR. All the tools reached a specificity of more than 97% for most of the subtypes and the two main CRFs (CRF01_AE and CRF02_AG). Other CRFs were identified only by COMET, REGAv2, REGAv3, and SCUEAL and with variable sensitivity. When analyzing sequences for PR and RT separately, the performance for PR was generally lower and variable between the tools. Similarity and statistical-based tools were 100% reproducible, but this was lower for phylogenetic-based tools such as REGA (similar to 99%) and SCUEAL (similar to 96%).
   Conclusions: REGAv3 had an improved performance for subtype B and CRF02_AG compared to REGAv2 and is now able to also identify all epidemiologically relevant CRFs. In general the best performing tools, in alphabetical order, were COMET, jpHMM, REGAv3, and SCUEAL when analyzing pure subtypes in the pol region, and COMET and REGAv3 when analyzing most of the CRFs. Based on this study, we recommend to confirm subtyping with 2 well performing tools, and be cautious with the interpretation of short sequences. (C) 2013 The Authors. Published by Elsevier B. V. All rights reserved.
C1 [Pineda-Pena, Andrea-Clemencia; Faria, Nuno Rodrigues; Imbrechts, Stijn; Libin, Pieter; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, B-3000 Louvain, Belgium.
   [Pineda-Pena, Andrea-Clemencia; Gomez-Lopez, Arley] Univ Rosario, Fac Sci & Math, Clin & Mol Infect Dis Grp, Bogota, Colombia.
   [Libin, Pieter; Deforche, Koen] MyBioData, Rotselaar, Belgium.
   [Abecasis, Ana Barroso; Camacho, Ricardo J.; Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal.
   [Abecasis, Ana Barroso; Camacho, Ricardo J.; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, P-1200 Lisbon, Portugal.
   [Camacho, Ricardo J.] Ctr Hosp Lisboa Ocidental Lisboa, Mol Biol Lab, Lisbon, Portugal.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
RP Vandamme, AM (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.
EM andreapinedap@gmail.com; annemie.vandamme@uzleuven.be
RI Vandamme, Anne-Mieke/I-4127-2012; Abecasis, Ana B/B-6295-2009; Faria,
   Nuno R/I-2975-2012; Camacho, Ricardo J/I-7629-2012; Pineda-Pena,
   Andrea-Clemencia/N-9809-2015
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Abecasis, Ana
   B/0000-0002-3903-5265; Faria, Nuno R/0000-0001-8839-2798; Camacho,
   Ricardo J/0000-0002-9129-3237; Pineda-Pena,
   Andrea-Clemencia/0000-0003-1937-0506; Rodrigues Faria,
   Nuno/0000-0002-9747-8822
FU Doctoral Research Training Program "Francisco Jose de Caldas";
   Departamento Administrativo de Ciencia, Tecnologia e Innovacion,
   COLCIENCIAS, Republic of ColombiaDepartamento Administrativo de Ciencia,
   Tecnologia e Innovacion Colciencias; ERACOL academic exchange in
   medicine and the health sciences; European CommunityEuropean Community
   (EC) [223131]; Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO)FWO
   [G.0611.09]; Fundacao para a Ciencia e a TecnologiaPortuguese Foundation
   for Science and Technology [SFRH/BD/64530/2009, SFRH/BPD/65605/2009]
FX Pineda-Pena AC was supported by a Doctoral Research Training Program
   "Francisco Jose de Caldas" by the Departamento Administrativo de
   Ciencia, Tecnologia e Innovacion, COLCIENCIAS, Republic of Colombia and
   ERACOL academic exchange in medicine and the health sciences, between
   Europe and Latin America. The research was supported in part by the
   European Community's Seventh Framework Programme (FP7/2007-2013) under
   the project "Collaborative HIV and Anti-HIV Drug Resistance Network
   (CHAIN)" grant agreement no 223131; and by the Fonds voor
   Wetenschappelijk Onderzoek - Flanders (FWO) grant G.0611.09. Faria NR
   was supported by the Fundacao para a Ciencia e a Tecnologia (grant no.
   SFRH/BD/64530/2009). Abecasis A was supported by a post-doc fellowship
   by the Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/65605/2009).
CR Abecasis A., 2008, 6 EUR HIV DRUG RES W
   Abecasis AB, 2006, ANTIVIR THER, V11, P581
   Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07
   Abecasis AB, 2011, AIDS RES HUM RETROV, V27, P803, DOI [10.1089/aid.2010.0312, 10.1089/AID.2010.0312]
   Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7
   Abecasis AB, 2010, INFECT GENET EVOL, V10, P380, DOI 10.1016/j.meegid.2009.09.020
   Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682
   Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575
   Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b
   Camacho RJ, 2007, CURR OPIN HIV AIDS, V2, P123, DOI 10.1097/COH.0b013e328029824a
   Carr JK, 1996, J VIROL, V70, P5935, DOI 10.1128/JVI.70.9.5935-5943.1996
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   Delgado E, 2002, J ACQ IMMUN DEF SYND, V29, P536, DOI 10.1097/00126334-200204150-00016
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Gifford R, 2006, AIDS, V20, P1521, DOI 10.1097/01.aids.0000237368.64488.ae
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93
   HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540
   Holguin A, 2008, J CLIN MICROBIOL, V46, P3896, DOI 10.1128/JCM.00515-08
   Hue S., 2011, AIDS RES HUM RETROV, V27
   Jacobs GB, 2009, J MED VIROL, V81, P1852, DOI 10.1002/jmv.21609
   Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Kosakovsky Pond S.L., 2009, PLOS COMPUT BIOL, V5
   KUHNER MK, 1994, MOL BIOL EVOL, V11, P459
   LEITNER T, 1995, VIROLOGY, V209, P136, DOI 10.1006/viro.1995.1237
   Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864
   Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Loveday C, 2006, ANTIVIR THER, V11, pS129
   MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995
   Martinez-Cajas JL, 2008, AIDS REV, V10, P212
   Myers RE, 2005, BIOINFORMATICS, V21, P3535, DOI 10.1093/bioinformatics/bti569
   Njouom R, 2003, J VIROL METHODS, V110, P1, DOI 10.1016/S0166-0934(03)00080-6
   Ntemgwa M, 2008, AIDS RES HUM RETROV, V24, P995, DOI 10.1089/aid.2008.0064
   Pasquier C, 2001, J VIROL METHODS, V94, P45, DOI 10.1016/S0166-0934(01)00272-5
   Posada D, 2001, MOL BIOL EVOL, V18, P897, DOI 10.1093/oxfordjournals.molbev.a003890
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246
   Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427
   Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b
   Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d
   Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371
   Snoeck J, 2002, VIRUS RES, V85, P95, DOI 10.1016/S0168-1702(02)00021-7
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   STRUCK D, 2010, 8 EUR HIV DRUG RES W
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961
   Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923
   UNAIDS/WHO, 2012, GLOB REP UNAIDS REP
   Vandamme AM, 2011, AIDS REV, V13, P77
   Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493
   Yahi N, 2001, J INFECT DIS, V183, P1311, DOI 10.1086/319859
   Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010
   Yebra G, 2011, ANTIVIR RES, V89, P19, DOI 10.1016/j.antiviral.2010.10.008
   Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25
NR 64
TC 152
Z9 153
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD OCT
PY 2013
VL 19
BP 337
EP 348
DI 10.1016/j.meegid.2013.04.032
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA 261XT
UT WOS:000327698700046
PM 23660484
OA Other Gold
DA 2020-09-29
ER

PT J
AU Josefsson, L
   Palmer, S
   Faria, NR
   Lemey, P
   Casazza, J
   Ambrozak, D
   Kearney, M
   Shao, W
   Kottilil, S
   Sneller, M
   Mellors, J
   Coffin, JM
   Maldarelli, F
AF Josefsson, Lina
   Palmer, Sarah
   Faria, Nuno R.
   Lemey, Philippe
   Casazza, Joseph
   Ambrozak, David
   Kearney, Mary
   Shao, Wei
   Kottilil, Shyamasundaran
   Sneller, Michael
   Mellors, John
   Coffin, John M.
   Maldarelli, Frank
TI Single Cell Analysis of Lymph Node Tissue from HIV-1 Infected Patients
   Reveals that the Majority of CD4(+) T-cells Contain One HIV-1 DNA
   Molecule
SO PLOS PATHOGENS
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VIVO; ANTIRETROVIRAL THERAPY;
   PERIPHERAL-BLOOD; REVERSE-TRANSCRIPTASE; INFECTED INDIVIDUALS; TYPE-1;
   RECOMBINATION; LYMPHOCYTES; MEMORY
AB Genetic recombination contributes to the diversity of human immunodeficiency virus (HIV-1). Productive HIV-1 recombination is, however, dependent on both the number of HIV-1 genomes per infected cell and the genetic relationship between these viral genomes. A detailed analysis of the number of proviruses and their genetic relationship in infected cells isolated from peripheral blood and tissue compartments is therefore important for understanding HIV-1 recombination, genetic diversity and the dynamics of HIV-1 infection. To address these issues, we used a previously developed single-cell sequencing technique to quantify and genetically characterize individual HIV-1 DNA molecules from single cells in lymph node tissue and peripheral blood. Analysis of memory and naive CD4(+) T cells from paired lymph node and peripheral blood samples from five untreated chronically infected patients revealed that the majority of these HIV-1-infected cells (>90%) contain only one copy of HIV-1 DNA, implying a limited potential for productive recombination in virus produced by these cells in these two compartments. Phylogenetic analysis revealed genetic similarity of HIV-1 DNA in memory and naive CD4(+) T-cells from lymph node, peripheral blood and HIV-1 RNA from plasma, implying exchange of virus and/or infected cells between these compartments in untreated chronic infection.
C1 [Josefsson, Lina; Palmer, Sarah] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden.
   [Josefsson, Lina; Palmer, Sarah] Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden.
   [Josefsson, Lina; Palmer, Sarah; Kearney, Mary; Shao, Wei; Maldarelli, Frank] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21701 USA.
   [Faria, Nuno R.; Lemey, Philippe] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Louvain, Belgium.
   [Casazza, Joseph; Ambrozak, David] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.
   [Kottilil, Shyamasundaran; Sneller, Michael] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.
   [Mellors, John] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA USA.
   [Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.
RP Josefsson, L (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden.
EM Lina.josefsson@ki.se
RI Lemey, Philippe/C-3755-2018; Maldarelli, Frank/O-2428-2016; t,
   lf/AAJ-4924-2020; Faria, Nuno R/I-2975-2012; Kearney, Mary/AAU-8132-2020
OI Lemey, Philippe/0000-0003-2826-5353; Faria, Nuno R/0000-0001-8839-2798;
   Kearney, Mary/0000-0003-3839-6576; Rodrigues Faria,
   Nuno/0000-0002-9747-8822
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; National Cancer Institute, Center for
   Cancer Research, the National Institutes of Health; Swedish Research
   CouncilSwedish Research Council; Foundation for AIDS Research [amfAR:
   107170-44-RGRL]; Erik and Edith Fernstrom Foundation for Medical
   Research; Sven Gard Foundation for Virology Research; Fundacao para a
   Ciencia e TecnologiaPortuguese Foundation for Science and Technology
   [SFRH/BD/64530/2009]; FM Kirby Foundation
FX This study was supported by a NIH Bench to Bedside Award to FM in the
   HIV DRP, the Intramural Research Program of the National Cancer
   Institute, Center for Cancer Research, the National Institutes of
   Health, the Swedish Research Council, and The Foundation for AIDS
   Research (amfAR: 107170-44-RGRL). LJ was supported by The Erik and Edith
   Fernstrom Foundation for Medical Research and Sven Gard Foundation for
   Virology Research. NRF was supported by Fundacao para a Ciencia e
   Tecnologia under grant agreement No. SFRH/BD/64530/2009. Logistical
   support was provided through PACT - MMC contract. JMC was a research
   Professor of the American Cancer Society with support from the FM Kirby
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Batorsky R, 2011, P NATL ACAD SCI USA, V108, P5661, DOI 10.1073/pnas.1102036108
   Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925
   Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004
   BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601
   Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07
   Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972
   COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947
   Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566
   Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-52
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864
   Hu WS, 2003, FRONT BIOSCI, V8, pD143, DOI 10.2741/940
   HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556
   HUDSON RR, 1992, MOL BIOL EVOL, V9, P138
   Hufert FT, 1997, AIDS, V11, P849, DOI 10.1097/00002030-199707000-00003
   Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108
   Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a
   Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08
   Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478
   Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283
   MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995
   Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196
   Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637
   NADLER SB, 1962, SURGERY, V51, P224
   Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660
   NUOVO GJ, 1994, J ACQ IMMUN DEF SYND, V7, P916
   Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999
   Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005
   PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0
   Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665
   Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Qatarneh Sharif M., 2006, Anatomical Record Part B:The New Anatomist, V289, P98, DOI 10.1002/ar.b.20102
   Rouzine IM, 2005, GENETICS, V170, P7, DOI 10.1534/genetics.104.029926
   SCHNEIDER T, 1995, GUT, V37, P524, DOI 10.1136/gut.37.4.524
   SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058
   Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347
   SLATKIN M, 1989, GENETICS, V123, P603
   Sleasman JW, 1996, AIDS, V10, P1477, DOI 10.1097/00002030-199611000-00004
   Suspene R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036246
   TAMALET C, 1994, AIDS, V8, P1083, DOI 10.1097/00002030-199408000-00007
   TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127
   Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001
   WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539
   Wightman F, 2010, J INFECT DIS, V202, P1738, DOI 10.1086/656721
   Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06
NR 46
TC 71
Z9 71
U1 1
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2013
VL 9
IS 6
AR e1003432
DI 10.1371/journal.ppat.1003432
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 175CG
UT WOS:000321206600039
PM 23818847
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU Faria, NR
   Suchard, MA
   Rambaut, A
   Streicker, DG
   Lemey, P
AF Faria, Nuno Rodrigues
   Suchard, Marc A.
   Rambaut, Andrew
   Streicker, Daniel G.
   Lemey, Philippe
TI Simultaneously reconstructing viral cross-species transmission history
   and identifying the underlying constraints
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE Bayesian diffusion models; branch partitioning; cross-species
   transmission; rabies virus
ID RABIES VIRUS; STATISTICAL PHYLOGENETICS; POPULATION-DYNAMICS;
   INFECTIOUS-DISEASES; EMERGENCE; EVOLUTION; BATS; ORIGINS; INTERFACE;
   PATHOGENS
AB The factors that determine the origin and fate of cross-species transmission events remain unclear for the majority of human pathogens, despite being central for the development of predictive models and assessing the efficacy of prevention strategies. Here, we describe a flexible Bayesian statistical framework to reconstruct virus transmission between different host species based on viral gene sequences, while simultaneously testing and estimating the contribution of several potential predictors of cross-species transmission. Specifically, we use a generalized linear model extension of phylogenetic diffusion to perform Bayesian model averaging over candidate predictors. By further extending this model with branch partitioning, we allow for distinct host transition processes on external and internal branches, thus discriminating between recent cross-species transmissions, many of which are likely to result in dead-end infections, and host shifts that reflect successful onwards transmission in the new host species. Our approach corroborates genetic distance between hosts as a key determinant of both host shifts and cross-species transmissions of rabies virus in North American bats. Furthermore, our results indicate that geographical range overlap is a modest predictor for cross-species transmission, but not for host shifts. Although our evolutionary framework focused on the multi-host reservoir dynamics of bat rabies virus, it is applicable to other pathogens and to other discrete state transition processes.
C1 [Faria, Nuno Rodrigues; Lemey, Philippe] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Louvain, Belgium.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Streicker, Daniel G.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
RP Faria, NR (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Louvain, Belgium.
EM nuno.faria@rega.kuleuven.be
RI Faria, Nuno R/I-2975-2012; Rambaut, Andrew/B-2481-2009; Lemey,
   Philippe/C-3755-2018
OI Faria, Nuno R/0000-0001-8839-2798; Rambaut, Andrew/0000-0003-4337-3707;
   Lemey, Philippe/0000-0003-2826-5353; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X; Rodrigues Faria, Nuno/0000-0002-9747-8822
FU European UnionEuropean Union (EU) [278433-PREDEMICS]; ERCEuropean
   Research Council (ERC) [260864]; US National Science FoundationNational
   Science Foundation (NSF) [DMS 0856099]; US National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 GM086887, R01 HG006139]; Fundacao
   para a Ciencia e TecnologiaPortuguese Foundation for Science and
   Technology [SFRH/BD/64530/2009]; National Evolutionary Synthesis Center
   (NESCent), NSFNational Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO) [EF-0423641]; Wellcome TrustWellcome Trust
   [WT092807MA]
FX We are grateful to two anonymous reviewers for their helpful comments.
   The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no. 278433-PREDEMICS and ERC grant agreement no. 260864, the
   US National Science Foundation (DMS 0856099) and the US National
   Institutes of Health (R01 GM086887 and R01 HG006139). N.R.F. is
   supported by Fundacao para a Ciencia e Tecnologia under grant agreement
   no. SFRH/BD/64530/2009. This work was facilitated by the participation
   of D. G. S. and P. L. in the 2010 RAPIDD Workshop on Cross-species
   Transmission, hosted by the National Institutes of Health. Collaboration
   between M. A. S., A. R. and P. L. was supported by the National
   Evolutionary Synthesis Center (NESCent), NSF EF-0423641. A. R. is
   supported by the Wellcome Trust (WT092807MA). Further, research was
   partially completed while M. A. S. and P. L. were visiting the Institute
   for Mathematical Sciences, National University of Singapore in 2011.
CR Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532
   Biek R, 2007, P NATL ACAD SCI USA, V104, P7993, DOI 10.1073/pnas.0700741104
   Blanton JD, 2011, JAVMA-J AM VET MED A, V239, P773, DOI 10.2460/javma.239.6.773
   Bourhy H, 1999, J GEN VIROL, V80, P2545, DOI 10.1099/0022-1317-80-10-2545
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114
   Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104
   Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053
   Hass J, 2011, INFECT GENET EVOL, V11, P437, DOI 10.1016/j.meegid.2010.12.001
   Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003
   Hughes GJ, 2005, J GEN VIROL, V86, P1467, DOI 10.1099/vir.0.80710-0
   Jackson FR, 2008, J WILDLIFE DIS, V44, P612, DOI 10.7589/0090-3558-44.3.612
   Jeffreys H, 1961, THEORY PROBABILITY
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Lemey P, 2012, SEASONAL FLIGHT INFL, P1
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Longdon B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002260
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Morens DM, 2008, LANCET INFECT DIS, V8, P710, DOI 10.1016/S1473-3099(08)70256-1
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   Real LA, 2005, P NATL ACAD SCI USA, V102, P12107, DOI 10.1073/pnas.0500057102
   Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088
   Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262
   Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]
   Streicker DG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002720
   Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021
   Weinert LA, 2012, BIOL LETTERS, V8, P829, DOI 10.1098/rsbl.2012.0290
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560
   Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009
NR 44
TC 73
Z9 73
U1 1
U2 45
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD MAR 19
PY 2013
VL 368
IS 1614
AR 20120196
DI 10.1098/rstb.2012.0196
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 088DH
UT WOS:000314813500003
PM 23382420
OA Bronze, Green Published, Green Accepted
DA 2020-09-29
ER

PT J
AU Gill, MS
   Lemey, P
   Faria, NR
   Rambaut, A
   Shapiro, B
   Suchard, MA
AF Gill, Mandev S.
   Lemey, Philippe
   Faria, Nuno R.
   Rambaut, Andrew
   Shapiro, Beth
   Suchard, Marc A.
TI Improving Bayesian Population Dynamics Inference: A Coalescent-Based
   Model for Multiple Loci
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE coalescent; smoothing; effective population size; Gaussian Markov random
   fields
ID DEMOGRAPHIC HISTORY; MOLECULAR CLOCK; SEQUENCES; DNA; ACCURACY; SKYLINE
AB Effective population size is fundamental in population genetics and characterizes genetic diversity. To infer past population dynamics from molecular sequence data, coalescent-based models have been developed for Bayesian nonparametric estimation of effective population size over time. Among the most successful is a Gaussian Markov random field (GMRF) model for a single gene locus. Here, we present a generalization of the GMRF model that allows for the analysis of multilocus sequence data. Using simulated data, we demonstrate the improved performance of our method to recover true population trajectories and the time to the most recent common ancestor (TMRCA). We analyze a multilocus alignment of HIV-1 CRF02_AG gene sequences sampled from Cameroon. Our results are consistent with HIV prevalence data and uncover some aspects of the population history that go undetected in Bayesian parametric estimation. Finally, we recover an older and more reconcilable TMRCA for a classic ancient DNA data set.
C1 [Gill, Mandev S.; Suchard, Marc A.] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA.
   [Lemey, Philippe; Faria, Nuno R.] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Louvain, Belgium.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
RP Suchard, MA (corresponding author), Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA.
EM msuchard@ucla.edu
RI Rambaut, Andrew/B-2481-2009; Faria, Nuno R/I-2975-2012; Lemey,
   Philippe/C-3755-2018
OI Rambaut, Andrew/0000-0003-4337-3707; Faria, Nuno R/0000-0001-8839-2798;
   Lemey, Philippe/0000-0003-2826-5353; Rodrigues Faria,
   Nuno/0000-0002-9747-8822; Shapiro, Beth/0000-0002-2733-7776; Rambaut
   FRSE, Professor Andrew/0000-0002-1278-598X
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 GM086887, R01
   HG006139, 5T32AI007370-22]; NESCent through its BEAST working group;
   Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science
   and Technology [SFRH/BD/64530/2009]; European UnionEuropean Union (EU)
   [278433-PREDEMICS]; European Research CouncilEuropean Research Council
   (ERC) [260864]
FX The authors thank Vladimir Minin and Alexei Drummond for helpful
   discussions. This work was supported by National Institute of Health
   grants R01 GM086887, R01 HG006139, and 5T32AI007370-22, and NESCent
   through its BEAST working group. N.R.F. was supported by Fundacao para a
   Ciencia e a Tecnologia (grant no. SFRH/BD/64530/2009). The research
   leading to these results has received funding from the European Union
   Seventh Framework Programme [FP7/2007-2013] under grant agreement no.
   278433-PREDEMICS and European Research Council grant agreement no.
   260864.
CR [Anonymous], 2008, UNAIDS WHO EP FACT S
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Brennan CA, 2008, JAIDS-J ACQ IMM DEF, V49, P432, DOI 10.1097/QAI.0b013e31818a6561
   Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107
   Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2002, GENETICS, V161, P1307
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079
   GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hein J, 2005, GENE GENEALOGIES VAR
   Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289
   Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93
   Kingman J.F.C, 1982, ADV APPL PROBAB A, V19A, P27
   Knorr-Held L, 2002, SCAND J STAT, V29, P597, DOI 10.1111/1467-9469.00308
   Kuhner MK, 1998, GENETICS, V149, P429
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Opgen-Rhein R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-6
   Pybus OG, 2000, GENETICS, V155, P1429
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Rodrigo A, 1999, EVOLUTION HIV COALES
   Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074
   Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776
NR 26
TC 187
Z9 187
U1 0
U2 45
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD MAR
PY 2013
VL 30
IS 3
BP 713
EP 724
DI 10.1093/molbev/mss265
PG 12
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA 089EG
UT WOS:000314891800018
PM 23180580
OA Green Published
DA 2020-09-29
ER

PT J
AU de Carvalho, LMF
   Santos, LBL
   Faria, NR
   Silveira, WD
AF Fagundes de Carvalho, Luiz Max
   Lima Santos, Leonardo Bacelar
   Faria, Nuno Rodrigues
   Silveira, Waldemir de Castro
TI Phylogeography of foot-and-mouth disease virus serotype O in Ecuador
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Foot-and-mouth disease virus; Phylogeography; Molecular epidemiology;
   Ecuador
ID PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; PHYLODYNAMICS; EPIDEMIC;
   GENETICS; SPREAD
AB Foot-and-mouth disease virus (FMDV) is the causative agent of the most important disease of domestic cattle, foot-and-mouth disease. In Ecuador, FMDV is maintained at an endemic state, with sporadic outbreaks. To unravel the tempo and mode of FMDV spread within the country we conducted a Bayesian phylogeographic analysis using a continuous time Markov chain (CTMC) to model the diffusion of FMDV between Ecuadorian provinces. We implement this framework through Markov chain Monte Carlo available in the BEAST package to study 90 FMDV serotype O isolates from 17 provinces in the period 2002-2010. The Bayesian approach also allowed us to test hypotheses on the mechanisms of viral spread by incorporating environmental and epidemiological data in our prior distributions and perform Bayesian model selection. Our analyses suggest an intense flow of viral strains throughout the country that is possibly coupled to animal movements and ecological factors, since most of inferred viral spread routes were in Coast and Highland regions. Moreover, our results suggest that both short- and long-range spread occur within Ecuador. The province of Esmeraldas, in the border with Colombia and where most animal commerce is done, was found to be the most probable origin of the circulating strains, pointing to a transboundary behavior of FMDV in South America. These findings suggest that uncontrolled animal movements can create a favorable environment for FMDV maintenance and pose a serious threat to control programmes. Also, we show that phylogeographic modeling can be a powerful tool in unraveling the spatial dynamics of viruses and potentially in controlling the spread of these pathogens. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Fagundes de Carvalho, Luiz Max; Silveira, Waldemir de Castro] PAHO WHO, Pan Amer Foot & Mouth Dis Ctr PANAFTOSA, Duque De Caxias, RJ, Brazil.
   [Lima Santos, Leonardo Bacelar] Natl Inst Space Res INPE, Sao Jose Dos Campos, SP, Brazil.
   [Faria, Nuno Rodrigues] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium.
RP de Carvalho, LMF (corresponding author), PAHO WHO, Pan Amer Foot & Mouth Dis Ctr PANAFTOSA, Duque De Caxias, RJ, Brazil.
EM lcarvalho@paho.org; santoslbl@gmail.com; nuno.faria@rega.kuleuven.be;
   silveiraw@paho.org
RI Carvalho, Luiz Max F/J-6446-2014; Carvalho, Luiz Max/AAC-8266-2020;
   Faria, Nuno R/I-2975-2012; Santos, Leonardo Bacelar Lima/A-2837-2014
OI Carvalho, Luiz Max F/0000-0001-5736-5578; Carvalho, Luiz
   Max/0000-0001-5736-5578; Faria, Nuno R/0000-0001-8839-2798; Rodrigues
   Faria, Nuno/0000-0002-9747-8822
CR Abdul-Hamid NF, 2011, INFECT GENET EVOL, V11, P320, DOI 10.1016/j.meegid.2010.11.003
   Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108
   Balinda SN, 2010, INFECT GENET EVOL, V10, P1058, DOI 10.1016/j.meegid.2010.06.017
   Biek R, 2007, P NATL ACAD SCI USA, V104, P7993, DOI 10.1073/pnas.0700741104
   Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Carvalho L., 2011, P 10 BRAZ C DYN CONT
   Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648
   Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Kuhnert D, 2011, INFECT GENET EVOL, V11, P1825, DOI 10.1016/j.meegid.2011.08.005
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindholm A, 2007, INT J APPL RES VET M, V5, P17
   Malirat V, 2007, VIRUS RES, V124, P22, DOI 10.1016/j.virusres.2006.09.006
   Malirat V, 2011, VET MICROBIOL, V152, P74, DOI 10.1016/j.vetmic.2011.04.021
   Maradei E, 2011, VACCINE, V29, P8230, DOI 10.1016/j.vaccine.2011.08.120
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077
   OPENSHAW S, 1984, ENVIRON PLANN A, V16, P17, DOI 10.1068/a160017
   PAHO/WHO, 2006, SIT PROGR ERR FIEBR, V1, P40
   PAHO/WHO, 2008, SIT PROGR ERR FIEBR, V1, P67
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766
   Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609
   Sangula AK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-371
   Shim E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005503
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Yoon SH, 2011, MOL CELLS, V31, P413, DOI 10.1007/s10059-011-0249-6
NR 41
TC 7
Z9 7
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JAN
PY 2013
VL 13
BP 76
EP 88
DI 10.1016/j.meegid.2012.08.016
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA 089HQ
UT WOS:000314902000010
PM 22985683
DA 2020-09-29
ER

PT J
AU Nunes, MRT
   Faria, NR
   Vasconcelos, HB
   Medeiros, DBDA
   de Lima, CPS
   Carvalho, VL
   da Silva, EVP
   Cardoso, JF
   Sousa, EC
   Nunes, KNB
   Rodrigues, SG
   Abecasis, AB
   Suchard, MA
   Lemey, P
   Vasconcelos, PFD
AF Teixeira Nunes, Marcio Roberto
   Faria, Nuno Rodrigues
   Vasconcelos, Helena Baldez
   de Almeida Medeiros, Daniele Barbosa
   Silva de Lima, Clayton Pereira
   Carvalho, Valeria Lima
   Pinto da Silva, Eliana Vieira
   Cardoso, Jedson Ferreira
   Sousa, Edivaldo Costa, Jr.
   Barbosa Nunes, Keley Nascimento
   Rodrigues, Sueli Guerreiro
   Abecasis, Ana Barroso
   Suchard, Marc A.
   Lemey, Philippe
   da Costa Vasconcelos, Pedro Fernando
TI Phylogeography of Dengue Virus Serotype 4, Brazil, 2010-2011
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID DYNAMICS; TYPE-4; EVOLUTIONARY; PHYLOGENETICS; STATE
AB Dengue virus serotype 4 (DENV-4) reemerged in Roraima State, Brazil, 28 years after it was last detected in the country in 1982. To study the origin and evolution of this reemergence, full-length sequences were obtained for 16 DENV-4 isolates from northern (Roraima, Amazonas, Para States) and northeastern (Bahia State) Brazil during the 2010 and 2011 dengue virus seasons and for an isolate from the 1982 epidemic in Roraima. Spatiotemporal dynamics of DENV-4 introductions in Brazil were applied to envelope genes and full genomes by using Bayesian phylogeographic analyses. An introduction of genotype I into Brazil from Southeast Asia was confirmed, and full genome phylogeographic analyses revealed multiple introductions of DENV-4 genotype II in Brazil, providing evidence for >3 introductions of this genotype within the last decade: 2 from Venezuela to Roraima and 1 from Colombia to Amazonas. The phylogeographic analysis of full genome data has demonstrated the origins of DENV-4 throughout Brazil.
C1 [Teixeira Nunes, Marcio Roberto; Vasconcelos, Helena Baldez; de Almeida Medeiros, Daniele Barbosa; Silva de Lima, Clayton Pereira; Carvalho, Valeria Lima; Pinto da Silva, Eliana Vieira; Cardoso, Jedson Ferreira; Sousa, Edivaldo Costa, Jr.; Barbosa Nunes, Keley Nascimento; Rodrigues, Sueli Guerreiro; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, BR-67030000 Ananindeua, Brazil.
   [Faria, Nuno Rodrigues; Lemey, Philippe] Katholieke Univ Leuven, Louvain, Belgium.
   [Abecasis, Ana Barroso] Univ Nova Lisboa, P-1200 Lisbon, Portugal.
   [Suchard, Marc A.] Univ Calif Los Angeles, Los Angeles, CA USA.
   [da Costa Vasconcelos, Pedro Fernando] Univ Estado Para, Belem, Para, Brazil.
RP Vasconcelos, PFD (corresponding author), Inst Evandro Chagas, Minist Saude, Dept Arbovirol & Febres Hemorrag, Rodovia BR 316 Km 7, BR-67030000 Ananindeua, Brazil.
EM pedrovasconcelos@iec.pa.gov.br
RI FHV, Inct/K-2346-2013; Faria, Nuno R/I-2975-2012; Vasconcelos,
   Pedro/AAH-3142-2019; Lemey, Philippe/C-3755-2018; Abecasis, Ana
   B/B-6295-2009; Nunes, Marcio Roberto/B-2238-2016
OI Faria, Nuno R/0000-0001-8839-2798; Lemey, Philippe/0000-0003-2826-5353;
   Abecasis, Ana B/0000-0002-3903-5265; Nunes, Marcio
   Roberto/0000-0001-9739-5499; Rodrigues Faria, Nuno/0000-0002-9747-8822
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [302987/2008-8, 301641/2010-2]; CNPq/Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior/Fundacao de Amparo a
   Pesquisa do Estado do Para [573739/2008-0]; Fundacao para a Ciencia e
   TecnologiaPortuguese Foundation for Science and Technology
   [SFRH/BD/64530/2009, SFRH/BPD/65605/2009]; National Science
   FoundationNational Science Foundation (NSF) [DMS0856099]; European
   Research Council under the European CommunityEuropean Research Council
   (ERC) [278433-PREDEMICS, 260864]; Network of the Portuguese-Speaking
   Countries Community, Instituto de Higiene e Medicina Tropical,
   Universidade Nova de Lisboa, Lisboa, Portugal
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) grants (302987/2008-8 and 301641/2010-2)
   and a CNPq/Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior/Fundacao de Amparo a Pesquisa do Estado do Para grant
   (573739/2008-0). N.R.F. is supported by Fundacao para a Ciencia e
   Tecnologia (grant SFRH/BD/64530/2009). M.A.S. is partially supported by
   the National Science Foundation (grant DMS0856099. A.B.A. is supported
   by Fundacao para a Ciencia e Tecnologia (grant SFRH/BPD/65605/2009).
   M.A.S. and P.L. had financial, support from the European Research
   Council under the European Community's Seventh Framework Program
   (FP7/2007-2013; under grant 278433-PREDEMICS and ERC grant 260864). The
   collaboration between M.R.T.N., N.R.F., and A.B.A. was supported by the
   Network of the Portuguese-Speaking Countries Community, Instituto de
   Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa,
   Portugal.
CR Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P249
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dussart P, 2006, EMERG INFECT DIS, V12, P1748, DOI 10.3201/eid1211.060339
   Dussart P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001482
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Fernandez J, 2011, ARCH VIROL, V156, P1865, DOI 10.1007/s00705-011-1049-1
   Forshey BM, 2009, EMERG INFECT DIS, V15, P1815, DOI 10.3201/eid1511.090663
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindback H, 2003, EMERG INFECT DIS, V9, P438, DOI 10.3201/eid0904.020267
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Ministerio da Sande/Secretara de Vigilancia em Sande MS/SVS, 2009, DENG CAS TECHN REP
   Ministerio da Sande/Secretaria de Vigilancia em Sande MS/SVS, 2011, SEMPR HOR COMB DENG
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   World Health Organization, 2009, DENG FEV DENG HEM FE
NR 33
TC 55
Z9 55
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2012
VL 18
IS 11
BP 1858
EP 1864
DI 10.3201/eid1811.120217
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 268LQ
UT WOS:000328172600019
PM 23092706
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Josefsson, L
   Eriksson, S
   Sinclair, E
   Ho, T
   Killian, M
   Epling, L
   Tan, A
   Lemey, P
   Faria, NR
   Shao, W
   Hunt, P
   Somsouk, M
   Douek, D
   Bacchetti, P
   Loeb, L
   Custer, J
   Poole, L
   Deeks, S
   Hecht, FM
   Palmer, S
AF Josefsson, L.
   Eriksson, S.
   Sinclair, E.
   Ho, T.
   Killian, M.
   Epling, L.
   Tan, A.
   Lemey, P.
   Faria, N. R.
   Shao, W.
   Hunt, P.
   Somsouk, M.
   Douek, D.
   Bacchetti, P.
   Loeb, L.
   Custer, J.
   Poole, L.
   Deeks, S.
   Hecht, F. M.
   Palmer, S.
TI Characterization of persistent HIV-1 in a broad spectrum of CD4+T cells
   isolated from peripheral blood and gut associated lymphoid tissue from
   patients on long-term suppressive therapy
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Meeting Abstract
C1 [Josefsson, L.; Palmer, S.] Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Solna, Sweden.
   [Josefsson, L.; Eriksson, S.; Palmer, S.] Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden.
   [Sinclair, E.; Ho, T.; Killian, M.; Epling, L.; Tan, A.; Hunt, P.; Somsouk, M.; Loeb, L.; Custer, J.; Poole, L.; Deeks, S.; Hecht, F. M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Lemey, P.; Faria, N. R.] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium.
   [Shao, W.] NCI, Adv Biomed Comp Ctr, SAIC, Frederick, MD 21701 USA.
   [Douek, D.] NIAID, NIH, Immunol Lab, Vaccine Res Ctr, Bethesda, MD 20892 USA.
   [Bacchetti, P.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
EM lina.josefsson@smi.se
RI Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798
NR 0
TC 0
Z9 0
U1 0
U2 5
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD OCT
PY 2012
VL 15
SU 3
BP 18
EP 19
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 030RQ
UT WOS:000310588200042
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Faria, NR
   Hodges-Mameletzis, I
   Silva, JC
   Rodes, B
   Erasmus, S
   Paolucci, S
   Ruelle, J
   Pieniazek, D
   Taveira, N
   Trevino, A
   Goncalves, MF
   Jallow, S
   Xu, L
   Camacho, RJ
   Soriano, V
   Goubau, P
   de Sousa, JD
   Vandamme, AM
   Suchard, MA
   Lemey, P
AF Faria, Nuno R.
   Hodges-Mameletzis, Ioannis
   Silva, Joana C.
   Rodes, Berta
   Erasmus, Smit
   Paolucci, Stefania
   Ruelle, Jean
   Pieniazek, Danuta
   Taveira, Nuno
   Trevino, Ana
   Goncalves, Maria F.
   Jallow, Sabelle
   Xu, Li
   Camacho, Ricardo J.
   Soriano, Vincent
   Goubau, Patrick
   de Sousa, Joao D.
   Vandamme, Anne-Mieke
   Suchard, Marc A.
   Lemey, Philippe
TI Phylogeographical footprint of colonial history in the global dispersal
   of human immunodeficiency virus type 2 group A
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID HIV-2 INFECTION; SUBTYPE-B; RESISTANCE MUTATIONS; GUINEA-BISSAU;
   COTE-DIVOIRE; EPIDEMIC; SPREAD; ORIGIN; IDENTIFICATION; PREVALENCE
AB Human immunodeficiency virus type 2 (HIV-2) emerged in West Africa and has spread further to countries that share socio-historical ties with this region. However, viral origins and dispersal patterns at a global scale remain poorly understood. Here, we adopt a Bayesian phylogeographic approach to investigate the spatial dynamics of HIV-2 group A (HIV-2A) using a collection of 320 partial pol and 248 partial env sequences sampled throughout 19 countries worldwide. We extend phylogenetic diffusion models that simultaneously draw information from multiple loci to estimate location states throughout distinct phylogenies and explicitly attempt to incorporate human migratory fluxes. Our study highlights that Guinea-Bissau, together with Cote d'Ivoire and Senegal, have acted as the main viral sources in the early stages of the epidemic. We show that convenience sampling can obfuscate the estimation of the spatial root of HIV-2A. We explicitly attempt to circumvent this by incorporating rate priors that reflect the ratio of human flow from and to West Africa. We recover four main routes of HIV-2A dispersal that are laid out along colonial ties: Guinea-Bissau and Cape Verde to Portugal, Cote d'Ivoire and Senegal to France. Within Europe, we find strong support for epidemiological linkage from Portugal to Luxembourg and to the UK. We demonstrate that probabilistic models can uncover global patterns of HIV-2A dispersal providing sampling bias is taken into account and we provide a scenario for the international spread of this virus.
C1 [Faria, Nuno R.; de Sousa, Joao D.; Vandamme, Anne-Mieke; Lemey, Philippe] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium.
   [Hodges-Mameletzis, Ioannis; Jallow, Sabelle] Univ Oxford, Weatherall Inst Mol Med, Oxford, England.
   [Silva, Joana C.; Goncalves, Maria F.; Camacho, Ricardo J.] Ctr Hosp Lisboa Ocidental, Mol Biol Lab, Lisbon, Portugal.
   [Rodes, Berta; Trevino, Ana; Soriano, Vincent] Hosp Carlos III, Dept Infect Dis, Madrid, Spain.
   [Erasmus, Smit; Xu, Li] Birmingham Heartlands Hosp, HPA Birmingham, Birmingham B9 5ST, W Midlands, England.
   [Paolucci, Stefania] Fdn IRCCS Policlin, San Matteo, Italy.
   [Ruelle, Jean; Goubau, Patrick] Catholic Univ Louvain, AIDS Reference Lab, B-1200 Brussels, Belgium.
   [Pieniazek, Danuta] Ctr Dis Control & Prevent, Incidence & Case Surveillance Branch, Atlanta, GA USA.
   [Taveira, Nuno] Fac Farm Lisboa, Unidade Retrovirus & Infeccoes Associadas, Ctr Patogenese Mol, Lisbon, Portugal.
   [Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz CiiEM, Monte De Caparica, Portugal.
   [Taveira, Nuno] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.
   [Camacho, Ricardo J.; Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA.
RP Faria, NR (corresponding author), Katholieke Univ Leuven, Rega Inst, Louvain, Belgium.
EM nuno.faria@rega.kuleuven.be
RI Vandamme, Anne-Mieke/I-4127-2012; Soriano, Vicente/O-5730-2018; Lemey,
   Philippe/C-3755-2018; Paolucci, Stefania/J-4055-2018; JALLOW,
   SABELLE/M-7364-2019; iMed.ULisboa, EEPHIV/B-4222-2014; Cavaco-Silva,
   Joana/J-4708-2012; Faria, Nuno R/I-2975-2012; Camacho, Ricardo
   J/I-7629-2012; Taveira, Nuno/A-6252-2014
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Soriano,
   Vicente/0000-0002-4624-5199; Lemey, Philippe/0000-0003-2826-5353;
   Paolucci, Stefania/0000-0001-8447-8586; Faria, Nuno
   R/0000-0001-8839-2798; Camacho, Ricardo J/0000-0002-9129-3237; Taveira,
   Nuno/0000-0003-0176-5585; Rodrigues Faria, Nuno/0000-0002-9747-8822;
   Sousa, Joao/0000-0002-7604-3109; Hodges-Mameletzis,
   Ioannis/0000-0002-7245-8198; /0000-0002-4436-5517
FU Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science
   and Technology [SFRH/BD/64530/2009]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   GM86887]; European UnionEuropean Union (EU) [FP7/2007-2013, 278433,
   223131]; ERCEuropean Research Council (ERC) [260864]; National
   Evolutionary Synthesis Center (NESCent)National Science Foundation
   (NSF)NSF - Directorate for Biological Sciences (BIO)
FX N. R. F. is supported by Fundacao para a Ciencia e Tecnologia (grant no.
   SFRH/BD/64530/2009). M. A. S. is supported by NIH R01 GM86887. We are
   grateful to Vitor Duque, Ana Trevino, Jose Miguel Pereira, Fausto
   Baldanti, Maurizio Zazzi, Carlo Perno, Catherine Brennan, Francoise
   Brun-Vezinet, Florence Damond, Diane Descamps, Gab Jung Kim, Sung Kim,
   Eric Arts, Carlo Torti, Robin Mukhopadhyaya, Anita Desai, Susmita Gurjan
   and Soo-Yon Rhee for valuable information concerning sampling dates and
   locations of the isolates, and Emmanuel Gilisseu for insight on the
   range of C. atys atys. The research leading to these results has
   received funding from the European Union Seventh Framework Programme
   [FP7/2007-2013] under grant agreement no. 278433 (PREDEMICS), grant
   agreement no. 223131 (CHAIN) and ERC grant agreement no. 260864. P. L.
   and M. A. S. acknowledge the support of the National Evolutionary
   Synthesis Center (NESCent) through a working group (Software for
   Bayesian Evolutionary Analysis).
CR AYANIAN JZ, 1989, NEW ENGL J MED, V320, P1422, DOI 10.1056/NEJM198905253202119
   Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Brandin E, 2003, AIDS RES HUM RETROV, V19, P543, DOI 10.1089/088922203322230905
   Brennan CA, 1997, AIDS RES HUM RETROV, V13, P401, DOI 10.1089/aid.1997.13.401
   BRUCKER G, 1987, LANCET, V1, P223
   Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997
   Chen ZW, 1996, J VIROL, V70, P3617, DOI 10.1128/JVI.70.6.3617-3627.1996
   Costarelli S, 2008, AIDS PATIENT CARE ST, V22, P489, DOI 10.1089/apc.2007.0149
   da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d
   Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392
   Damond F, 2001, VIROLOGY, V280, P19, DOI 10.1006/viro.2000.0685
   de Sousa JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009936
   DECOCK KM, 1990, AIDS, V4, P443, DOI 10.1097/00002030-199005000-00010
   DJOMAND G, 1995, J ACQ IMMUN DEF SYND, V10, P358
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   EsuWilliams E, 1997, J ACQ IMMUN DEF SYND, V16, P204, DOI 10.1097/00042560-199711010-00010
   GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0
   Garcia J. L., 2000, PORTUGAL MIGRANTE EM
   Gomes P, 2003, LANCET INFECT DIS, V3, P683, DOI 10.1016/S1473-3099(03)00797-7
   GREZ M, 1994, J VIROL, V68, P2161, DOI 10.1128/JVI.68.4.2161-2168.1994
   Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607
   Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   KAWAMURA M, 1989, LANCET, V1, P385
   Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531
   KVINESDAL BB, 1992, SCAND J INFECT DIS, V24, P419, DOI 10.3109/00365549209052626
   Lakiss S., 7 INT C AIDS FLOR IT, V6, P16
   LeBreton M, 2007, EMERG INFECT DIS, V13, P1579, DOI 10.3201/eid1310.070338
   LEGUENNO B, 1989, T ROY SOC TROP MED H, V83, P847, DOI 10.1016/0035-9203(89)90350-7
   Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   MABEY DCW, 1988, BRIT MED J, V296, P83, DOI 10.1136/bmj.296.6615.83
   Mansson F, 2009, AIDS, V23, P1575, DOI 10.1097/QAD.0b013e32832cedfb
   Marx PA, 2001, PHILOS T R SOC B, V356, P911, DOI 10.1098/rstb.2001.0867
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Nam JG, 2006, J CLIN MICROBIOL, V44, P1543, DOI 10.1128/JCM.44.4.1543-1546.2006
   NEUMANN PW, 1989, CAN MED ASSOC J, V140, P125
   Newmark P, 1988, Nature, V332, P295
   Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x
   OECD, 2011, OECD STATEXTRACTS
   Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Peeters M, 1998, AIDS RES HUM RETROV, V14, P51, DOI 10.1089/aid.1998.14.51
   Pepin J, 2006, AIDS, V20, P1303, DOI 10.1097/01.aids.0000232239.05545.33
   Pieniazek D, 1999, AIDS RES HUM RETROV, V15, P603, DOI 10.1089/088922299311132
   PIENIAZEK D, 1991, AIDS, V5, P1293, DOI 10.1097/00002030-199111000-00002
   POPOVSKY MA, 1990, NEW ENGL J MED, V322, P1887
   Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   POULSEN AG, 1989, LANCET, V1, P827, DOI 10.1016/S0140-6736(89)92281-2
   POULSEN AG, 1993, J ACQ IMMUN DEF SYND, V6, P941
   Poulsen AG, 1997, LANCET, V349, P911, DOI 10.1016/S0140-6736(96)04402-9
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395
   Rambaut A, 2007, MOL EVOLUTION PHYLOG
   RICARD D, 1994, AIDS, V8, P977, DOI 10.1097/00002030-199407000-00016
   Ruelle J, 2007, AIDS RES HUM RETROV, V23, P955, DOI 10.1089/aid.2007.0034
   Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005
   SMALLMANRAYNOR M, 1991, INT J EPIDEMIOL, V20, P480, DOI 10.1093/ije/20.2.480
   Smith SM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-103
   Soares RS, 2011, J VIROL, V85, P2429, DOI 10.1128/JVI.01921-10
   Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Takehisa J, 1997, AIDS RES HUM RETROV, V13, P621, DOI 10.1089/aid.1997.13.621
   Trevino A, 2011, J ANTIMICROB CHEMOTH, V66, P1484, DOI 10.1093/jac/dkr164
   UNAIDS/WHO, 2006, AIDS EP UPD, p[1, 53]
   United Nations, 2010, POP DIV POP EST PROJ
   Valadas E, 2009, CLIN INFECT DIS, V48, P1166, DOI 10.1086/597504
   VANTIENEN C, 2009, J ACQ IMMUN DEF SYND, V53, P640
   Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377
   WILKINS A, 1991, AIDS, V5, P1529, DOI 10.1097/00002030-199112000-00018
   Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789
   Zeh C, 2005, AIDS RES HUM RETROV, V21, P17, DOI 10.1089/aid.2005.21.17
NR 77
TC 43
Z9 44
U1 0
U2 15
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD APR
PY 2012
VL 93
BP 889
EP 899
DI 10.1099/vir.0.038638-0
PN 4
PG 11
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 929OF
UT WOS:000303074500025
PM 22190015
OA Bronze, Green Published
DA 2020-09-29
ER

PT J
AU Faria, NR
   Suchard, MA
   Abecasis, A
   Sousa, JD
   Ndembi, N
   Bonfim, I
   Camacho, RJ
   Vandamme, AM
   Lemey, P
AF Faria, Nuno R.
   Suchard, Marc A.
   Abecasis, Ana
   Sousa, Joao D.
   Ndembi, Nicaise
   Bonfim, Idalina
   Camacho, Ricardo J.
   Vandamme, Anne-Mieke
   Lemey, Philippe
TI Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE HIV-1; CRF02_AG; Bayesian inference; Phylogeography; Molecular
   epidemiology; Cameroon
ID HUMAN-IMMUNODEFICIENCY-VIRUS; GEOGRAPHICAL-DISTRIBUTION; GENETIC
   DIVERSITY; CONGO SUGGESTS; CENTRAL-AFRICA; TYPE-1; RECOMBINANT;
   POPULATION; SEQUENCE; SUBTYPE
AB Evolutionary analyses have revealed an origin of pandemic HIV-1 group M in the Congo River basin in the first part of the XX century, but the patterns of historical viral spread in or around its epicentre remain largely unexplored. Here, we combine epidemiologic and molecular sequence data to investigate the spatiotemporal patterns of the CRF02_AG clade. By explicitly integrating prevalence counts and genetic population size estimates we date the epidemic emergence of CRF02_AG at 1973.1 (1972.1, 1975.3, 95% Cl). To infer the phylogeographic signature of this clade at a regional scale, we analyze pol and env time-stamped sequence data from 10 countries using a Bayesian phylogeographic approach based on an asymmetric discretized diffusion model. Our data confirms a spatial origin of CRF02_AG in the Democratic Republic of Congo (DRC) and suggests that viral dissemination to Cameroon occurred at an early stage of the evolutionary history of CRF02_AG. We find considerable support for epidemiological linkage between neighbour countries. Compilation of ethnographic data suggested that well-supported viral migration did not reflect sustained human migratory flows. Finally, using sequence data from 15 locations in Cameroon, we use relaxed random walk models to explore the spatiotemporal dynamics of CRF02_AG at a finer geographical detail. Phylogeographic dispersal in continuous space reveals that at least two distinct CRF02_AG lineages are circulating in overlapping regions that are evolving at different evolutionary and diffusion rates. In conclusion, by combining molecular and epidemiological data, our results provide a time scale for CRF02_AG, early 70s, place its spatial root in the DRC within the putative root of group-M diversity and propose a scenario of chance-exportation events for the spatiotemporal patterns of a successful HIV-1 lineage both at a regional and country-scale. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Faria, Nuno R.; Sousa, Joao D.; Vandamme, Anne-Mieke; Lemey, Philippe] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, UCLA Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA.
   [Abecasis, Ana; Bonfim, Idalina; Camacho, Ricardo J.] Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Tropicais, Lisbon, Portugal.
   [Camacho, Ricardo J.] Ctr Hosp Lisboa Ocidental, Lab Biol Mol, Lisbon, Portugal.
   [Ndembi, Nicaise] Inst Human Virol, Abuja, Nigeria.
   [Ndembi, Nicaise] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
RP Faria, NR (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.
EM nuno.faria@rega.kuleuven.be
RI Vandamme, Anne-Mieke/I-4127-2012; Camacho, Ricardo J/I-7629-2012; Lemey,
   Philippe/C-3755-2018; NDEMBI, Nicaise/AAE-4383-2020; Abecasis, Ana
   B/B-6295-2009; Faria, Nuno R/I-2975-2012
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Camacho, Ricardo
   J/0000-0002-9129-3237; Lemey, Philippe/0000-0003-2826-5353; Abecasis,
   Ana B/0000-0002-3903-5265; Faria, Nuno R/0000-0001-8839-2798; Rodrigues
   Faria, Nuno/0000-0002-9747-8822; Sousa, Joao/0000-0002-7604-3109
FU Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science
   and Technology [SFRH/BD/64530/2009, SFRH/BPD/65605/2009]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 GM86887]; European CommissionEuropean Commission
   Joint Research Centre [223131]; European Research Council under the
   European CommunityEuropean Research Council (ERC) [260864]
FX N.R.F. is supported by Fundacao para a Ciencia e Tecnologia (Grant No.
   SFRH/BD/64530/2009). M.A.S. is supported by NIH R01 GM86887. A.B. is
   supported by Fundacao para a Ciencia e Tecnologia (Grant No.
   SFRH/BPD/65605/2009). The research leading to these results has received
   funding from the European Commission (EC Grant CHAIN 7FP, 223131) and
   from the European Research Council under the European Community's
   Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No.
   260864. We thank Aurelia Vessiere from the Centre Pausteur du Cameroun,
   Joseph Tedou and Leandre Ngogang Wandji, from the Institut National de
   la Statistique, Yaounde, Cameroon, Fabien Kazu Kifa, from the Institut
   de la Statistique, Kinshasa, Democratic Republic of Congo, and Parfait
   Maixent Nalibert, from the Direction Generale de la Statistique, des
   Etudes Economiques et Sociales, Bangui, Central African Republic, for
   their help in supplying statistical documents from their respective
   countries. We thank Martine Peeters from the IRD and Universite
   Montpellier, Montpellier, France, for critical reading of the
   manuscript.
CR Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07
   Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09
   Ajoge HO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017865
   [Anonymous], 2008, UNAIDS WHO EP FACT S
   Avise J., 2000, PHYLOGEOGRAPHY HIST
   Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07
   Bikandou B, 2000, AIDS RES HUM RETROV, V16, P613, DOI 10.1089/088922200308837
   Bodelle P, 2004, AIDS RES HUM RETROV, V20, P902, DOI 10.1089/0889222041725262
   Brennan CA, 2008, JAIDS-J ACQ IMM DEF, V49, P432, DOI 10.1097/QAI.0b013e31818a6561
   Bulla I, 2010, BIOINFORMATICS, V26, P1409, DOI 10.1093/bioinformatics/btq159
   Caron M, 2008, AIDS RES HUM RETROV, V24, P1225, DOI 10.1089/aid.2008.0097
   Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39
   Ceiridwen J.E., MULTIPLE HYBRI UNPUB
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   de Sousa JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009936
   Djoko CF, 2010, AIDS RES HUM RETROV, V26, P1027, DOI 10.1089/aid.2010.0046
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61
   Howard TM, 1996, AIDS RES HUM RETROV, V12, P1413, DOI 10.1089/aid.1996.12.1413
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531
   Kita K, 2004, AIDS RES HUM RETROV, V20, P1352, DOI 10.1089/aid.2004.20.1352
   Konings FAJ, 2004, AIDS RES HUM RETROV, V20, P105, DOI 10.1089/088922204322749558
   Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lydie N, 2004, JAIDS-J ACQ IMM DEF, V35, P67, DOI 10.1097/00126334-200401010-00010
   Macro I.N.d.l.S.I.e.O., 2004, ENQUETE DEMOGRAPHIQU
   Mamadou S, 2002, AIDS RES HUM RETROV, V18, P723, DOI 10.1089/088922202760072357
   Marechal V, 2006, AIDS RES HUM RETROV, V22, P1036, DOI 10.1089/aid.2006.22.1036
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Muller-Trutwin MC, 1999, J ACQ IMMUN DEF SYND, V21, P164
   Niama FR, 2006, INFECT GENET EVOL, V6, P337, DOI 10.1016/j.meegid.2005.12.001
   Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40
   Pandrea I, 2002, AIDS RES HUM RETROV, V18, P1103, DOI 10.1089/088922202320567842
   Peeters M, 1997, AIDS, V11, P493, DOI 10.1097/00002030-199704000-00013
   Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016
   QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407
   Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179
   REMY G, 1993, ANN SOC BELG MED TR, V73, P127
   Sharp PM, 2008, NATURE, V455, P605, DOI 10.1038/455605a
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373
   Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9
   Vallari A., 2010, J VIROL
   Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000
   Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94
   Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021
   Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390
   Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25
NR 59
TC 40
Z9 40
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2012
VL 12
IS 2
BP 453
EP 460
DI 10.1016/j.meegid.2011.04.028
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA 921XT
UT WOS:000302512100034
PM 21565285
OA Green Accepted
DA 2020-09-29
ER

PT J
AU Faria, NR
   Suchard, MA
   Rambaut, A
   Lemey, P
AF Faria, Nuno Rodrigues
   Suchard, Marc A.
   Rambaut, Andrew
   Lemey, Philippe
TI Toward a quantitative understanding of viral phylogeography
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1; COMPARTMENTALIZATION; EMERGENCE;
   EVOLUTION; HISTORY; ORIGIN; BLOOD; POPULATIONS; DISPERSAL
AB Phylogeographic approaches help uncover the imprint that spatial epidemiological processes leave in the genomes of fast evolving viruses. Recent Bayesian inference methods that consider phylogenetic diffusion of discretely and continuously distributed traits offer a unique opportunity to explore genotypic and phenotypic evolution in greater detail. To provide a taste of the recent advances in viral diffusion approaches, we highlight key findings arising at the intrahost, local and global epidemiological scales. We also outline future areas of research and discuss how these may contribute to a quantitative understanding of the phylodynamics of RNA viruses.
C1 [Faria, Nuno Rodrigues; Lemey, Philippe] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, Dept Biostat, UCLA Sch Publ Hlth, Los Angeles, CA 90095 USA.
   [Rambaut, Andrew] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
RP Lemey, P (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium.
EM philippe.Lemey@rega.kuleuven.be
RI Rambaut, Andrew/B-2481-2009; Lemey, Philippe/C-3755-2018; Faria, Nuno
   R/I-2975-2012
OI Rambaut, Andrew/0000-0003-4337-3707; Lemey,
   Philippe/0000-0003-2826-5353; Faria, Nuno R/0000-0001-8839-2798;
   Rodrigues Faria, Nuno/0000-0002-9747-8822; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X
FU Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science
   and Technology [SFRH/BD/64530/2009]; European Commission (EC Grant CHAIN
   7FP)European Commission Joint Research Centre [223131]; European
   Research Council under the European Community's Seventh Framework
   Programme (FP7)/ERC GrantEuropean Research Council (ERC) [260864]; US
   National Science FoundationNational Science Foundation (NSF) [DMS
   0856099]; US National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   GM086887, R01 HG006139, NS063897]
FX NRF is supported by Fundacao para a Ciencia e Tecnologia under grant
   agreement No. SFRH/BD/64530/2009. The research leading to these results
   has received funding from the European Commission (EC Grant CHAIN 7FP,
   223131), the European Research Council under the European Community's
   Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No.
   260864, the US National Science Foundation (DMS 0856099) and the US
   National Institutes of Health (R01 GM086887, R01 HG006139 and NS063897).
CR Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005
   Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bloomquist EW, 2010, TRENDS ECOL EVOL, V25, P626, DOI 10.1016/j.tree.2010.08.010
   Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292
   Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401
   Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203
   Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Fulcher JA, 2004, J VIROL, V78, P7883, DOI 10.1128/JVI.78.15.7883-7893.2004
   Hass J, 2011, INFECT GENET EVOL, V11, P437, DOI 10.1016/j.meegid.2010.12.001
   Hennig W, 1966, PHYLOGENETIC SYSTEMA
   HOLMES EC, 1995, J INFECT DIS, V171, P45, DOI 10.1093/infdis/171.1.45
   Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
   Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100
   Lamers SL, 2011, INFECT GENET EVOL, V11, P31, DOI 10.1016/j.meegid.2010.10.016
   Lemey Philippe, 2009, PLoS Curr, V1, pRRN1031, DOI 10.1371/currents.RRN1031
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8
   Monjane AL, 2011, J VIROL, V85, P9623, DOI 10.1128/JVI.00640-11
   Navas S, 1998, J VIROL, V72, P1640, DOI 10.1128/JVI.72.2.1640-1646.1998
   Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053
   Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077
   Nelson MI, 2009, VIROLOGY, V388, P270, DOI 10.1016/j.virol.2009.03.026
   Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005
   Potter SJ, 2004, J LEUKOCYTE BIOL, V76, P562, DOI 10.1189/jlb.0404234
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137
   Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005
   Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950
   Salemi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008153
   Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Suchard MA, 2003, SYST BIOL, V52, P649, DOI 10.1080/10635150390238879
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503
   Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104
   Wallace RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001697
   Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06
NR 57
TC 46
Z9 47
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD NOV
PY 2011
VL 1
IS 5
BP 423
EP 429
DI 10.1016/j.coviro.2011.10.003
PG 7
WC Virology
SC Virology
GA 051FU
UT WOS:000312112400016
PM 22440846
OA Green Accepted, Green Published
DA 2020-09-29
ER

PT J
AU de Vries, M
   Deijs, M
   Canuti, M
   van Schaik, BDC
   Faria, NR
   van de Garde, MDB
   Jachimowski, LCM
   Jebbink, MF
   Jakobs, M
   Luyf, ACM
   Coenjaerts, FEJ
   Claas, ECJ
   Molenkamp, R
   Koekkoek, SM
   Lammens, C
   Leus, F
   Goossens, H
   Ieven, M
   Baas, F
   van der Hoek, L
AF de Vries, Michel
   Deijs, Martin
   Canuti, Marta
   van Schaik, Barbera D. C.
   Faria, Nuno R.
   van de Garde, Martijn D. B.
   Jachimowski, Loes C. M.
   Jebbink, Maarten F.
   Jakobs, Marja
   Luyf, Angela C. M.
   Coenjaerts, Frank E. J.
   Claas, Eric C. J.
   Molenkamp, Richard
   Koekkoek, Sylvie M.
   Lammens, Christine
   Leus, Frank
   Goossens, Herman
   Ieven, Margareta
   Baas, Frank
   van der Hoek, Lia
TI A Sensitive Assay for Virus Discovery in Respiratory Clinical Samples
SO PLOS ONE
LA English
DT Article
ID INFECTIONS; COMMUNITY; CHILDREN; DISEASE; IDENTIFICATION; CORONAVIRUS;
   PNEUMONIA; DIAGNOSIS; ETIOLOGY; PCR
AB In 5-40% of respiratory infections in children, the diagnostics remain negative, suggesting that the patients might be infected with a yet unknown pathogen. Virus discovery cDNA-AFLP (VIDISCA) is a virus discovery method based on recognition of restriction enzyme cleavage sites, ligation of adaptors and subsequent amplification by PCR. However, direct discovery of unknown pathogens in nasopharyngeal swabs is difficult due to the high concentration of ribosomal RNA (rRNA) that acts as competitor. In the current study we optimized VIDISCA by adjusting the reverse transcription enzymes and decreasing rRNA amplification in the reverse transcription, using hexamer oligonucleotides that do not anneal to rRNA. Residual cDNA synthesis on rRNA templates was further reduced with oligonucleotides that anneal to rRNA but can not be extended due to 3'-dideoxy-C6-modification. With these modifications >90% reduction of rRNA amplification was established. Further improvement of the VIDISCA sensitivity was obtained by high throughput sequencing (VIDISCA-454). Eighteen nasopharyngeal swabs were analysed, all containing known respiratory viruses. We could identify the proper virus in the majority of samples tested (11/18). The median load in the VIDISCA-454 positive samples was 7.2 E5 viral genome copies/ml (ranging from 1.4 E3-7.7 E6). Our results show that optimization of VIDISCA and subsequent high-throughput-sequencing enhances sensitivity drastically and provides the opportunity to perform virus discovery directly in patient material.
C1 [de Vries, Michel; Deijs, Martin; Canuti, Marta; Faria, Nuno R.; van de Garde, Martijn D. B.; Jachimowski, Loes C. M.; Jebbink, Maarten F.; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   [van Schaik, Barbera D. C.; Luyf, Angela C. M.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands.
   [Jakobs, Marja; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands.
   [Coenjaerts, Frank E. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.
   [Claas, Eric C. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.
   [Molenkamp, Richard; Koekkoek, Sylvie M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Clin Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   [Lammens, Christine; Goossens, Herman; Ieven, Margareta] Univ Antwerp, Univ Antwerp Hosp, Vaccine & Infect Dis Inst, Dept Med Microbiol, Antwerp, Belgium.
   [Leus, Frank] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Data Management, Utrecht, Netherlands.
RP de Vries, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM c.m.vanderhoek@amc.uva.nl
RI Faria, Nuno R/I-2975-2012; van der Hoek, Lia/Y-6412-2019; Canuti,
   Marta/I-3145-2019; Baas, Frank/F-9574-2010
OI Faria, Nuno R/0000-0001-8839-2798; Canuti, Marta/0000-0002-9959-128X;
   Baas, Frank/0000-0003-3912-5428; van Schaik,
   Barbera/0000-0002-5568-8127; van de Garde, Martijn/0000-0003-0509-7713;
   Rodrigues Faria, Nuno/0000-0002-9747-8822
FU European Community (EC)European Commission Joint Research CentreEuropean
   Community (EC) [FP7/2007-2013, 223498, LSHM-CT-2005-518226]; Netherlands
   Organization for Scientific Research (NWO)Netherlands Organization for
   Scientific Research (NWO) [016.066.318]
FX This study was supported by funding from the European Community's
   Seventh Framework Programme (FP7/2007-2013) under the project EMPERIE,
   EC grant agreement number 223498, European Community's Sixth Framework
   Programme under the project GRACE, EC grant agreement number
   LSHM-CT-2005-518226 and VIDI grant 016.066.318 from the Netherlands
   Organization for Scientific Research (NWO). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102
   Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07
   Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Brilot F, 2004, J VIROL, V78, P9854, DOI 10.1128/JVI.78.18.9854-9861.2004
   de Pol ACV, 2010, J CLIN MICROBIOL, V48, P3569, DOI 10.1128/JCM.00097-10
   de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07
   Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064
   Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064
   Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48
   Jubelt B, 2001, NEUROLOGY, V57, P945, DOI 10.1212/WNL.57.6.945
   Leitch ECM, 2009, J CLIN VIROL, V44, P119, DOI 10.1016/j.jcv.2008.11.015
   Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287
   Pyrc K, 2006, ANTIMICROB AGENTS CH, V50, P2000, DOI 10.1128/AAC.01598-05
   Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8
   Scheltinga SA, 2005, J CLIN VIROL, V33, P306, DOI 10.1016/j.jcv.2004.08.021
   Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440
   Shingadia D, 2002, LANCET INFECT DIS, V2, P310, DOI 10.1016/S1473-3099(02)00265-7
   Stohlman SA, 2001, BRAIN PATHOL, V11, P92
   Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004
   Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996
   van de Pol AC, 2006, CRIT CARE, V10, DOI 10.1186/cc4895
   van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
NR 25
TC 55
Z9 55
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 24
PY 2011
VL 6
IS 1
AR e16118
DI 10.1371/journal.pone.0016118
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 710PJ
UT WOS:000286523400019
PM 21283679
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Faria, NR
   de Vries, M
   van Hemert, FJ
   Benschop, K
   van der Hoek, L
AF Faria, Nuno R.
   de Vries, Michel
   van Hemert, Formijn J.
   Benschop, Kimberley
   van der Hoek, Lia
TI Rooting human parechovirus evolution in time
SO BMC EVOLUTIONARY BIOLOGY
LA English
DT Article
ID RNA VIRUS EVOLUTION; AMINO-ACID SITES; POSITIVE SELECTION; MOLECULAR
   CLOCKS; STOOL SAMPLES; IDENTIFICATION; RATES; INFECTIONS; INFERENCE;
   DYNAMICS
AB Background: The Picornaviridae family contains a number of important pathogenic viruses, among which the recently reclassified human parechoviruses (HPeVs). These viruses are widespread and can be grouped in several types. Understanding the evolutionary history of HPeV could answer questions such as how long the circulating lineages last shared a common ancestor and how the evolution of this viral species is shaped by its population dynamics. Using both strict and relaxed clock Bayesian phylogenetics we investigated 1) the substitutions rates of the structural P1 and capsid VP1 regions and 2) evolutionary timescale of currently circulating HPeV lineages.
   Results: Our estimates reveal that human parechoviruses exhibit high substitution rates for both structural P1 and capsid VP1 regions, respectively 2.21 x 10(-3) (0.48 - 4.21 x 10(-3)) and 2.79 x 10(-3) (2.05 - 3.66 x 10(-3)) substitutions per site per year. These are within the range estimated for other picornaviruses. By employing a constant population size coalescent prior, the date of the most recent common ancestor was estimated to be at around 1600 (1427-1733). In addition, by looking at the frequency of synonymous and non-synonymous substitutions within the VP1 gene we show that purifying selection constitutes the dominating evolutionary force leading to strong amino acid conservation.
   Conclusion: In conclusion, our estimates provide a timescale for the evolution of HPeVs and suggest that genetic diversity of current circulating HPeV types has arisen about 400 years ago.
C1 [Faria, Nuno R.; de Vries, Michel; van Hemert, Formijn J.; Benschop, Kimberley; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, CINIMA, NL-1105 AZ Amsterdam, Netherlands.
RP van der Hoek, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, CINIMA, NL-1105 AZ Amsterdam, Netherlands.
EM nmrfaria@gmail.com; micheldevries@amc.uva.nl; f.j.vanhemert@amc.uva.nl;
   k.s.benschop@amc.uva.nl; c.m.vanderhoek@amc.uva.nl
RI van der Hoek, Lia/Y-6412-2019; Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798; Rodrigues Faria,
   Nuno/0000-0002-9747-8822
FU Netherlands Organization for Scientific Research (NWO)Netherlands
   Organization for Scientific Research (NWO) [016.066.318]
FX We are grateful to Philippe Lemey for helpful comments on the paper and
   for computational assistance. Also, we thank Dr. Richard Hoffmann, Dr.
   Vladimir Lukashov and to three anonymous reviewers for their valuable
   comments on the paper. We thank Wilma Vermeulen-Oost and Ron Berkhout
   for culturing the Harris-like type 1 virus, Filipa Campos for graphical
   design assistance on Figure 1 and Katja Wolthers for critical reading of
   the manuscript. Lia van der Hoek is supported by VIDI grant 016.066.318
   from the Netherlands Organization for Scientific Research (NWO).
CR Abed Y, 2006, EMERG INFECT DIS, V12, P969, DOI 10.3201/eid1206.051675
   Al-Sunaidi M, 2007, J VIROL, V81, P1013, DOI 10.1128/JVI.00584-06
   Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07
   Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08
   Benschop KSM, 2008, J GEN VIROL, V89, P1030, DOI 10.1099/vir.0.83498-0
   Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647
   Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905
   Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606
   Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999
   de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07
   Domingo E, 1996, FASEB J, V10, P859
   Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910
   Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028
   Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000
   GOJOBORI T, 1983, GENETICS, V105, P1011
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Grist N R, 1978, Prog Med Virol, V24, P114
   Gurumurthy CB, 2002, ARCH VIROL, V147, P85, DOI 10.1007/s705-002-8304-y
   Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145
   Hofmann J, 2008, EMERG INFECT DIS, V14, P850, DOI 10.3201/eid1405.071533
   Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x
   Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003
   Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
   Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0
   Johansson S, 2002, J VIROL, V76, P8920, DOI 10.1128/JVI.76.17.8920-8930.2002
   Joki-Korpela P, 2001, J VIROL, V75, P1958, DOI 10.1128/JVI.75.4.1958-1967.2001
   Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07
   Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29
   Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341
   Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0
   Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863
   Niklasson B, 1999, VIROLOGY, V255, P86, DOI 10.1006/viro.1998.9557
   Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000
   Pettersson L, 2008, EMERG INFECT DIS, V14, P808, DOI 10.3201/eid1405.071124
   Robinson M, 1998, MOL BIOL EVOL, V15, P1091, DOI 10.1093/oxfordjournals.molbev.a026016
   Sauvage F, 2002, EMERG INFECT DIS, V8, P1509
   Shapiro B, 2006, MOL BIOL EVOL, V23, P1724, DOI 10.1093/molbev/msl037
   Shapiro BA, 2006, J MOL GRAPH MODEL, V25, P514, DOI 10.1016/j.jmgm.2006.04.004
   Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06
   Sironen T, 2001, J VIROL, V75, P11803, DOI 10.1128/JVI.75.23.11803-11810.2001
   Stanway G, 1999, J VIROL, V73, P5249, DOI 10.1128/JVI.73.7.5249-5254.1999
   Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042
   Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896
   WIGAND REINHARD, 1961, ARCH GES VIRUSFORSCH, V11, P224, DOI 10.1007/BF01241688
   Wolthers KC, 2008, CLIN INFECT DIS, V47, P358, DOI 10.1086/589752
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   2009, HOME PICORNAVIRUSES
   2009, BAYESIAN EVOLUTIONAR
   2009, MOL EVOLUTION PHYLOG
NR 57
TC 26
Z9 26
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2148
J9 BMC EVOL BIOL
JI BMC Evol. Biol.
PD JUL 15
PY 2009
VL 9
AR 164
DI 10.1186/1471-2148-9-164
PG 8
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA 490AG
UT WOS:000269468400001
PM 19604368
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

EF